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Summary of each chapter 
This report, written following European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) guidelines,1 is divided into two parts. Part A is an overview of new 
developments and trends in the drugs area in Ireland for 2008 and, in some cases, for 
the first six months of 2009. These are covered under the following headings: 
1. Drug policy: legislation, strategies and economic analysis 
2. Drug use in the general population and specific sub-groups 
3. Prevention 
4. Problem drug use 
5. Drug-related treatment: treatment demand and treatment availability 
6. Health correlates and consequences 
7. Responses to health correlates and consequences 
8. Social correlates and social reintegration 
9. Drug-related crime, prevention of drug-related crime and prison 
10. Drug Markets 
 
Part B examines two specific issues considered important at an EU level. The Selected 
Issues are: 
1. Cannabis markets and production  
2. Treatment for older drug users 
 
 
Main points from Part A 
1. Drug policy: legislation, strategies and economic analysis 
• The Criminal Justice (Surveillance) Act 2009 provides for the first time a legal 
framework to allow covert surveillance material to be used in criminal trials. 
• The Criminal Justice (Amendment) Act 2009 provides for all organised crime 
offences to be declared scheduled offences for the purpose of trial in the 
Special Criminal Court unless the Director of Public Prosecutions directs 
otherwise. The Special Criminal Court operates with three judges and without a 
jury. The Act has led to a number of criticisms from lawyers and human rights 
groups. 
• The Criminal Justice (Miscellaneous Provisions) Act 2009 provides a statutory 
framework for controlling firearms and seeks to halt the emergence of a gun 
culture in Ireland. 
• The Community, Rural and Gaeltacht Affairs (Miscellaneous Provisions) Act 
2007 provides a statutory mandate for the functions and responsibilities of the 
Minister for Community, Rural and Gaeltacht Affairs, including the co-ordination 
of the implementation of the National Drugs Strategy. 
• In March 2009, Minister for Health and Children, Mary Harney TD, announced 
that 1-benzylpiperazine (BZP) is now a controlled drug within the terms of the 
Misuse of Drugs Act, 1977 
• The Criminal Justice (Mutual Assistance) Act 2008 commenced in August 
2008. This defines the competent authorities, the Revenue Commissioners and 
the Garda Síochána, in relation to controlled deliveries of drugs and confirms 
current procedures adopted in relation to controlled deliveries of drugs. The 
Attorney-General’s advice regarding interpretation of certain provisions in the 
Act is currently awaited. 
• In its opening debate of the 2008 academic year, the Trinity College Historical 
Society debated the motion ‘That the sale of cannabis should be legalised’. 
Opposing the motion Pat Carey TD, former Minister of State for the national 
                                                
1 A copy of the EMCDDA guidelines is available from the EMCDDA website at www.emcdda.eu.int 
The guidelines require each Focal Point to write its National Report in a prescribed format using standard 
headings and covering each topic using a check list of items. This helps to ensure comparability of 
reporting across the EU. 
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drugs strategy, set out in detail not generally provided the government’s 
position on this controversial issue.  
• In September 2009 a new national drugs strategy, covering the period 2009–
2016, was published. It continues to be based on five pillars – Supply 
Reduction, Prevention, Treatment, Rehabilitation, and Research.  
• Under the supply reduction pillar, the primary aim of reducing the availability of 
drugs remains. However, there is a greater note of realism, for example in the 
way in which the impact of drug supply reduction activities is determined.  
• Having reviewed progress under the NDS 2001–2008, the Steering Group 
concluded that ‘a tiered or graduated approach to prevention and education 
measures in relation to drugs and alcohol should be developed with a view to 
providing a framework for the future design and development of interventions’. 
• The Steering Group stated that this pillar, which combines the treatment and 
rehabilitation pillars, had a wider focus than in the NDS 2001–2008. It aimed to 
develop a more comprehensive treatment service capable of dealing with all 
problem substances nationally, rather than focusing mainly on opiate misuse in 
Dublin. 
• The NDS 2009–2016 intends to collect information and complete research 
projects in order to inform policy formulation and to develop or enhance 
responses to the drug situation, while the NDS 2001–2008 intended to measure 
the extent of drug use by person, place and time, and describe the 
characteristics of drug users, but did not state how the new information would 
be used. 
• The Government has approved the development of a combined substance 
misuse policy to include both alcohol and drugs. A new steering group is to be 
established in the autumn of 2009 to develop proposals for the overall 
substance misuse strategy. It will incorporate the already agreed drugs policy 
element. The group will be asked to report by the end of 2010. 
• While there was no formal evaluation of the national drugs strategy, two 
independent studies identified opportunities for enhancing the management of 
the drugs strategy.  
• A review of the strategic management processes and governance 
arrangements underpinning the national drugs strategy between 2001 and 2007 
highlighted four underlying tensions, with regard to performance management, 
research and analysis, co-ordination and strategic control that might have 
influenced the achievement of outcomes.  
• A value-for-money study of drug treatment and rehabilitation services called for 
improvements in the monitoring and evaluation of measures through 
establishing service levels and monitoring not only outputs but also outcomes 
and costs.  
• Following the introduction in 2007 of the life-cycle approach to the framing of 
social inclusion policy, including illicit drug policy, a systematic review of the 
broader literature on the concept has been undertaken, and consideration given 
to how it should be translated into specific forms of policy prescription and 
evaluation.  
• In the new national drugs strategy the co-ordination mechanisms have been 
completely revised and streamlined.  
• An Office of the Minister for Drugs (OMD) is to be established, incorporating 
both the former Drugs Strategy Unit in the Department of Community, Rural and 
Gaeltacht Affairs (DCRGA) and the National Drugs Strategy Team. The OMD 
will report directly to the Cabinet Committee on Social Inclusion, Children and 
Integration.  
• The Interdepartmental Group on Drugs (IDG) is to be re-constituted as the 
Oversight Forum on Drugs (OFD).  Its primary role will be the high-level 
monitoring of progress being achieved across the strategy and agreeing 
appropriate ways forward where issues are blocked or progress is being 
impeded.  
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• Local and regional drugs task forces will continue to play a strong role in 
addressing the drug problem in Ireland. The participation in and commitment by 
all sectors to the drugs task force process will be strengthened, and more active 
engagement by service users and services working with specific at-risk groups 
in the design and planning of interventions under the new strategy will be 
promoted.  
• It is estimated that approximately €264 million was spent on core services for 
problem drug users in 2008, an increase of 13 per cent over spending in 2007. 
A similar level of spending was initially approved for 2009 but, on foot of the 
continuing decline of the Irish economy and the need to achieve a ‘prudent 
fiscal outturn’ for 2009, expenditures across all government bodies were 
reduced. Details of the spending cuts are not yet available but a reduction of 15 
to 20 per cent has been mentioned in relation to the drugs task forces.  
• The new strategy states that the OMD should oversee the development of a 
performance management framework, including mechanisms whereby 
government departments, agencies and drugs task forces report regularly to the 
OMD on expenditures and outputs and outcomes.  
• On 1 January 2009 the Young People’s Facilities and Services Fund (YPFSF) 
was transferred from the DCRGA, where it was administered by the Drugs 
Strategy Unit, to the Office of the Minister for Children and Youth Affairs 
(OMCYA).  
• In recent years the role of families in tackling the drugs problem has become 
increasingly recognised and funding has followed. 
• No studies of the social cost of drug use have been undertaken. However, in 
the past decade or so, there have been significant advances in the collection of 
data relating to the drug problem in Ireland, which may be expected to yield 
data relevant to such a study. Several one-off studies have also been 
undertaken, which may, in the absence of system-level data, help in the 
estimation of economic values. 
 
2. Drug use in the general population and specific sub-groups 
• On 25 January 2008, the National Advisory Committee on Drugs (NACD) and 
the Drug and Alcohol Information and Research Unit (DAIRU) in Northern 
Ireland published jointly the results of the second all-Ireland general population 
drug prevalence survey. The proportion of adults (aged 15–64 years) who 
reported using an illegal drug in their lifetime increased by five percentage 
points, from 19% in 2002/3 to 24% in 2006/7. The proportion of adults who 
reported using an illegal drug in the last year increased marginally, from 6% in 
2002/3 to 7% in 2006/7.  
• Cannabis was the most commonly used illegal drug in Ireland. The proportion of 
adults who reported using cannabis at some point in their life increased from 
17% in 2002/3 to 22% in 2006/7. Nine per cent of young adults claimed to have 
tried ecstasy at least once in their lifetime in 2006/7.  
• Cocaine use increased in 2006/7 compared to 2002/3. The proportion of adults 
who reported using cocaine (including crack) at some point in their lives 
increased from 3% in 2002/3 to 5% in 2006/7. The proportion of adults who 
reported using cocaine in the last year increased from 1% in 2002/3 to 2% in 
2006/7.  
• The proportion of adults who reported using a sedative or tranquilliser at some 
point in their lives was almost 11%. The proportion of young adults was 6%, 
while the proportion of older adults was higher at just under 15%. More women 
(13%) than men (8%) reported using a sedative or tranquilliser in their lifetime.  
• The proportion of adults who reported using an anti-depressant at some point in 
their lives was just over 9%. The proportion of young adults was 7% while the 
proportion of older adults was higher at just under 11%. More women (13%) 
than men (6%) reported using an anti-depressant in their lifetime.  
• On 29 April 2008, the Department of Health and Children published the third 
SLÁN Survey of Lifestyle, Attitudes and Nutrition in Ireland. The survey involved 
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10,364 face-to-face interviews with adults resident in Ireland, which represented 
a 62% response rate. In the 2007 survey, respondents were asked about their 
use of illegal drugs in the last year. Six per cent reported that they had used an 
illegal drug in the year prior to the survey; the reported use of such drugs was 
higher for men (9%) than for women (4%). As expected, cannabis was the most 
commonly-used drug. The percentage of those who used cocaine in the last 
year was surprisingly low at 1%. In general, these data are not comparable to 
the results of the 2006/7 general population survey by the NACD as the SLÁN 
survey excluded those aged between 15 and 17 and included those over 65 
years. 
• The fourth ESPAD survey was conducted in 35 European countries during 2007 
and collected information on alcohol and illicit drug use among 15–16-year-olds. 
In terms of drug use, the Irish data showed a marked decrease in lifetime use of 
any illicit drug between 2003 (40%) and 2007 (22%), a fall of 18 percentage 
points. As the majority of those who have tried any illicit drug have used 
cannabis (marijuana or hashish), the decrease in illicit drug use was influenced 
by the considerable decrease in the number of students who had tried cannabis 
at some point in their lives, from 39% in 2003 to 20% in 2007 (European 
average 19%). Lifetime use of solvents/inhalants decreased from 18% in 2003 
to 15% in 2007, but remained higher than the European average (9%). In the 
case of both amphetamines and cocaine powder, the proportions reporting 
lifetime use increased marginally above the European average of 3%. In 2007, 
one in ten of the survey participants reported that they had taken prescribed 
tranquillisers or sedatives at some point in their lives; the use of such drugs had 
decreased marginally since 1999.  
 
3. Prevention 
• Secondary school students in Ireland were perceived to have poorer levels of 
social bonding with the educational system compared to the OECD average.  
• The effectiveness of the Social, Personal and Health Education (SPHE) 
programme, which is the main vehicle through which substance use prevention 
interventions are implemented in secondary schools, was consistently 
questioned during the recent review of the national drugs strategy, in particular 
by students themselves. 
• In the National Drugs Strategy (interim) 2009–2016 (para. 3.67) the steering 
group calls for improved delivery of SPHE in primary and post-primary schools, 
encompassing the implementation of the recommendations of the recent SPHE 
evaluation in post-primary schools and the development of a ‘whole of school’ 
approach to substance use education in the context of SPHE. 
• Crosscare published and disseminated an evidence-based booklet to support 
families to discuss and address substance use problems within the family unit. 
• In late 2008, to dovetail with the national awareness campaign on cocaine use, 
‘The Party’s Over’ funding was allocated from DCRGA for cocaine awareness 
campaigns at local and regional level, to be delivered through the local and 
regional drugs task forces.   
• A recent report on educational disadvantage identified the strengths and 
weaknesses of the Delivering Equality of Opportunity in Schools (DEIS) 
programme, which targets a number of schools in disadvantaged areas 
throughout the country. 
• Headstrong, the National Centre for Youth Mental Health, promised a ‘new 
direction’ based on evidence for tackling the mental health needs of young 
people growing up in Ireland.  
• Recent research undertaken by Headstrong showed that  
- young people are not engaging with services; 
- supports and services are inaccessible; 
- services are inappropriate to the needs of young people.  
• Young marginalised people did benefit from interventions to improve their 
involvement in youth participation structures. 
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4. Problem drug use  
• Dr Alan Kelly and colleagues estimated the prevalence of problem opiate use in 
Ireland using a three-source capture-recapture method. The three data sources 
employed to generate the estimate were the Central (methadone) Treatment 
List, Hospital In-Patient Enquiry Scheme and Garda PULSE data. The three 
sources of data indicated that there were 11,807 opiate users known to services 
in Ireland in 2006 and indicated that there were an estimated 8,943 users not 
known to the services (hidden population). The estimate indicated that there 
were between 18,136 and 23,576 problem opiate users in Ireland in 2006; the 
point estimate was 20,790. The authors reported that the estimate is likely to be 
inflated because the population is not closed, that is, it continues to recruit 
people into treatment and police custody. In addition and critical to the size of 
the estimate, the overlap between the three populations sources is small.  
• Drug overdose was the most common form of deliberate self-harm, 
representing 72% of all such episodes reported in 2008. Forty-one per cent of 
all drug overdoses involved a minor tranquilliser, 23% involved paracetamol-
containing medicines and 22% involved anti-depressants/mood stabilisers. 
There was evidence of alcohol consumption in 42% of all episodes of deliberate 
self-harm emphasising the strong association between alcohol consumption 
and suicidal behaviour. Illicit drugs such as cocaine and heroin were involved in 
3.8% of all overdose acts. The biggest rise in deliberate self harm was 
observed in men, an increase of 11% from 2007, resulting in the highest rate 
since the Registry was established in 2002. 
  
5. Drug-related treatment: treatment demand and treatment availability 
• The HSE’s National Service Plan (NSP) contains the agency’s plans in the drug 
and alcohol areas during 2009.  The HSE’s Addiction Services, including both 
illicit drugs and alcohol, are located within through Social Inclusion Services, 
which are part of the Primary, Community and Continuing Care (PCCC) 
directorate. Nationally, the level of activity in the addiction services area 
increased in 2008 and should be maintained in 2009, but the level of 
performance is expected to remain static at 2007 levels.  In 2008, 7,636 clients 
were in methadone treatment and the HSE expects to reach this level of activity 
again in 2009.  Eighty-four per cent of substance misusers should commence 
treatment within one calendar month.  Eighty-eight per cent of substance 
misusers under the age of 18 should commence suitable treatment within a 
calendar month. 
• A needs assessment study was carried out the in NERDTF to examine the 
number and profile of drug-users, assess in-patient and out-patient drug 
treatment services, explore needs of drug treatment service users and their 
families; identify gaps in service provision, and make recommendations.  This 
study found that drug use in the region had increased in recent years.  The 
main problem drugs identified were cocaine, cannabis, alcohol, heroin and 
prescription drugs. One of the issues raised was the normalisation of cannabis 
use to the point where it was considered equivalent to consuming alcohol.  The 
recommendations included more residential detoxification treatment, out-of-
hours treatment, crisis and early intervention, and treatment for under-18s, 
better information, wider scope of treatment options and more focus on 
polydrug treatment including alcohol. 
• The Comptroller and Auditor General (CAG) published a report examining drug 
treatment services (mainly cannabis, cocaine, ecstasy and heroin addiction).  
For problem opiate treatment some of the issues identified were that although 
there had been an increase in provision, gaps in needle exchange services still 
existed.  The CAG report found that compared to the numbers of opiate users 
who received methadone, the numbers who received detoxification or attended 
follow-on rehabilitation were very low.  
• In the area of treatment for problem drug use (excluding opiates) the CAG 
report found that although there was an increase in the prevalence of cannabis 
use there had not been a commensurate increase in the number of cases 
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treated over the same time period.  The report noted that changes in the pattern 
of drug misuse in both urban and rural areas posed a difficult challenge for 
services.  The report suggested that there were two separate client groups: 1) a 
largely opiate-based polydrug addiction problem concentrated in certain 
marginalised sectors of society, and 2) those with problem use of drugs such as 
cannabis, cocaine and ecstasy, spread more widely across social groups and 
geographic areas. 
• While the CAG report noted that accurate information about the level of demand 
for problem drug treatment is very important for service planning purposes, the 
current national drug treatment database (NDTRS) is not able to track the 
progression of an individual from one service provider to another. The report 
recommended improved methods of recording individual information in the 
NDTRS should be sought. 
• Looking at access to treatment, the CAG report noted that the current database 
may underestimate the extent of waiting for assessment.  Additionally, some 
service providers also operate ‘informal’ waiting lists, and call those on the 
informal list only when an assessment appointment becomes available.  The 
report called for improvement in the recording this type of information so the 
true extent of waiting for treatment may be gauged.  The data showed that while 
a high proportion of individuals commenced treatment within the one-month 
target, approximately 460 people were recorded as waiting for methadone 
treatment in April 2008. The average waiting time for those on the lists in some 
areas was over a year.  
• The CAG report recommended that the effectiveness of treatment for problem 
use of drugs other than opiates needs to be evaluated. 
• A summary of opiate treatment outcomes in Ireland at one year and at three 
years after entry to treatment showed that of the 404 users recruited, 289 
individuals completed all three interviews.  Results found an overall sustained 
reduction in the use and amount of drug use.  The numbers of those who 
reported using heroin in the 90 days preceding data collection fell from 81% at 
intake to 47% at one year and remained at that level at three years.  The 
proportion who reported use of more than one drug decreased from 78% at 
intake to 50% one year later and to 45% three years after intake.  There were 
also sustained improvements in other areas with the largest achievements 
between one and three years in housing, training and employment. There was 
also a sustained decrease in acquisitive crime from 31% at intake to 14% at 
one year and this level was sustained at three years. Of those for whom 
treatment status at three years was reported, 201 (70%) were still in treatment, 
of whom 173 were in methadone treatment. 
• A survey was conducted with GPs who had undergone training in the 
management of methadone clients, of which 35% responded to the 
questionnaire.  Of these, two of every three practices were in an urban area. 
Just over two-fifths said that illicit drugs were a major problem in their area.  
Seventy-two per cent were providing patients with methadone treatment at the 
time of the survey. The vast majority of GPs thought that the MTP was 
beneficial to patients.  Some of the issues highlighted with the training were the 
difficulty of managing complications of drug use, managing patients who 
continue to use drugs, managing patients with alcohol or benzodiazepine 
problems. These could be dealt with in future training programmes. The 
additional services most desired by GPs were addiction counselling, in-patient 
detoxification and rehabilitation beds, and employment schemes. 
• Figures from the two national registers for recording drug treatment data in 
Ireland, the National Drug Treatment Reporting System (NDTRS) and the 
Central Treatment List (CTL), show that the total number of cases receiving 
methadone treatment increased by 32% between 2002 and 2007. The number 
receiving treatment in private general practice increased by 36% during the 
same period. In each of the six years, at least 30% of cases who received 
methadone treatment were treated in private general practice.   
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• A study conducted with young people in Dublin accessing opiate treatment 
found that, despite strict controls, they reported that illicit methadone was easy 
to obtain.  More than half of participants reported the use of illicit methadone 
both prior to and during treatment, frequently to counteract opiate withdrawal 
symptoms.  During treatment, failure to attend the clinic was the most common 
reason for withdrawal symptoms.  Two-fifths obtained illicit methadone in order 
to do their own detox or maintenance while one-third reported using methadone 
for hedonic effects prior to commencing treatment. Participants reporting the 
misuse of benzodiazepines were more likely to report use of illicit methadone.  
• The Council of Europe’s Pompidou Group commissioned a survey of quasi-
compulsory treatment (QCT) in Europe.  The primary form QCT available in 
Ireland is that offered by the Irish Drug Treatment Court (DTC). The DTC deals 
with offenders who have either pleaded guilty or been convicted of minor crimes 
committed as a consequence of drug abuse. Anecdotal reports from the DTC 
suggest that despite low graduation numbers the programme is successful in 
Ireland and is due to be expanded.  
• The Ana Liffey Drug Project (ALDP) continues to develop its assertive street-
based outreach work in which staff seek to engage people who are based on 
the streets of Dublin's inner city and who may experience problem drug use 
and/ or homelessness. In November 2008 it launched peer-led outreach, 
disseminating information about keeping safe on the streets. In March 2009 the 
Dublin City Business Improvement District (DBID) announced a long-term 
partnership with the ALDP, and as the first step, announced its contribution 
towards the purchase of an eight-seater van to support the ALDP outreach 
programme. In June 2009 the ALDP established an SMS text messaging 
service for its service users.  
• In July 2009, a feasibility study to look at providing buprenorphine/naloxone 
treatment as an alternative to methadone commenced.  The aim is to enrol up 
to 80 problem opiate users who agree to treatment and are suitable (40 in 
specialist centres and 40 in the community).  The study is to be reviewed after 
eight months with a view to deciding if it will be offered to all drug treatment 
clients.  The evaluation of the study will be conducted according to agreed 
evaluation criteria and using a recognised audit tool.    
• The annual number of treated cocaine cases increased from 954 in 2002 to 
2,643 in 2007.  Almost four out of five cases who reported cocaine as their main 
problem drug used more than one drug. However, there are two different 
profiles: those who use opiates alongside cocaine and those who use 
combinations of alcohol, cannabis and/or ecstasy alongside cocaine.  Half of 
the treated cocaine cases were under 27 years old and the majority were male.   
• The number of cases who reported an opiate as a problem drug increased from 
8,804 in 2002 to 11,392 in 2007. The rate of increase in new opiate cases was 
highest outside Dublin. Cannabis, benzodiazepines and, in more recent years, 
cocaine were the most common additional problem drugs used alongside 
opiates.  Overall, 40% of problem heroin users injected the drug, but the 
proportion doing so decreased between 2003 and 2007 and was linked to a 
corresponding increase in smoking opiates, indicating the success of harm 
reduction messages.   
• Between 2001 and 2007 there was a decrease in the number of cases 
presenting for treatment and reporting cannabis as their main problem 
substance, from 1,384 in 2003 to 958 in 2007.  Nearly three-quarters used one 
or more additional drugs. The number of cases reporting cannabis as an 
additional problem drug increased from 1,383 in 2001 to 1,630 in 2007. The 
drugs associated with cannabis use were alcohol, ecstasy, amphetamines and 
cocaine.  Frequency of cannabis use among treated cases was considerably 
higher than that among the general population.  Half had commenced cannabis 
use before they were 14 years old, and the majority were men.   
• Between 2001 to 2007, the annual number of treated cases reporting sedatives 
or tranquillisers as a main problem drug ranged between 78 and 171.  Of these, 
87% reported a benzodiazepine as their main problem drug, while three 
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quarters used one or more additional drugs.  The number of cases reporting 
sedatives or tranquillisers as an additional problem drug exceeded 1,000 per 
year between 2001 and 2007. The main drugs associated with sedative or 
tranquilliser use by new cases entering treatment were cannabis, alcohol, 
stimulants, cocaine and opiates.   
• Between 2001 to 2007, only 10 treated cases reported anti-depressants as a 
main problem drug, of whom half used one or more additional drugs. Fifty-six 
cases reported anti-depressants as an additional problem drug. The drugs 
associated with anti-depressant use were opiates and sedatives.  
• In 2007, 5,977 cases entered treatment in Ireland.  The majority of cases 
attended outpatient services. Heroin was the most common main problem drug 
and over two-thirds reported polysubstance use.  Many problem drug users in 
treatment were young and male. 
• In 2008, 6,247 cases entered treatment, the majority for problem heroin use.  Of 
those who entered treatment, the majority attended outpatient services. 
 
6. Health correlates and consequences 
• Between 2001 and 2008 there was an overall decline in the number of new 
injector HIV cases (38, 50, 49, 71, 66, 57 54 and 36 respectively) when 
compared to 2000. Of the 36 new HIV cases among injecting drug users 
reported to the HPSC in 2008, 27 were male and nine were female and the 
average age was 33 years. Twenty-two of the 34 cases with a known address 
lived in the HSE Eastern Region (Dublin, Kildare and Wicklow). 
• The HPSC reported that there were 1,537 cases of hepatitis C reported in 2008, 
compared to 1,128 cases in 2004, and 85 cases of hepatitis ‘type unspecified’ 
in 2003. In 2008, 38% of newly-reported hepatitis C cases had risk factor status 
reported. As expected, the majority of these cases (76.9%) reported injecting 
drug use as the main risk factor. Just over 4% of cases said that they were 
recipients of blood or blood products at some time in the past and according to 
the HPSC were late reports to the system. Of the 447 cases who reported 
injecting drug use as their main risk factor, 85% were notified by services in 
Dublin, Kildare and Wicklow and the remainder by services in HSE areas 
outside these counties. Seventy-one per cent were male and 62% were under 
35 years old.  
• The HPSC was informed of four cases of wound botulism – all affecting 
injecting drug users – in late November 2008 by.  
• Data from the Hospital In-Patient Enquiry (HIPE) scheme show that there were 
a total of 14,770 not-fatal overdose cases recorded in the period 2005–2007.  
The age group at risk of non-fatal overdoses is the 15–24-year age group and 
non-fatal overdose cases are more common among females than among 
males. Over two thirds (69.5%, 10,259) of all overdose cases involved 
nonopioid analgesics. Narcotic or hallucinogen drugs were involved in 11.1% 
(1,647) of cases. More than one quarter (27.5%, 453) of males overdosed using 
narcotic or hallucinogen-type drugs.  
• According to the sixth annual report from the National Registry of Deliberate 
Self Harm for the period 2006–2007 (2008) drug overdose was the most 
common form of deliberate self-harm, representing 74% of all such episodes 
reported in 2006–2007. The national rate of deliberate self-harm in both 2006 
and 2007 was higher among females than among males and largely confined to 
the younger age groups. For the six-year period 2002–2007, the rate of 
presentation of deliberate self-harm is relatively stable. 
• Patients attending for methadone treatment were significantly more likely to 
have a chronic illness, to be prescribed recurrent medications and to attend a 
general practice than their matched counterparts who are not prescribed 
methadone. 
• A recent study has estimated that 35% (95% CI = 28–41%) of  current or former 
heroin users attending primary care for methadone treatment were classified as 
problem alcohol users and 14% were classified as dependent users. According 
to data for the National Drug Treatment Reporting System, 24% of opiate users 
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entering opiate treatment reported alcohol as an additional problem drug which 
is lower than the estimate presented in this recent study. 
• In 2007, the total number of admissions to psychiatric inpatient care in Ireland 
has continued to fall.  In 2006, 724 cases were admitted to psychiatric facilities 
with a drug disorder, of whom 265 were treated for the first time.  The report 
does not present data on co-morbidity, so it is not possible to determine 
whether or not these admissions were appropriate. 
• Between 2003 and 2007, the number of poisonings recorded in Ireland (as per 
Selection D) has risen from 108 to 185.  
• In the last two years for which data are available, 2006–2007, over three-
quarters of cases have been male (287, 78.4%), and the majority of cases (258, 
70.5%) have been aged between 20 and 40 years.  This is a very similar profile 
to poisoning deaths reported in Ireland in previous years. 
• Of the 366 cases of poisoning recorded in 2006 and 2007, heroin and 
unspecified opiates accounted for 84 (23.0%) of these deaths while methadone 
alone accounted for 20 (5.5%) deaths.  Almost half of all deaths owing to 
poisoning (180, 49.2%) were attributable to polysubstances including an opiate.  
• The first national report on non-poisoning deaths among drug users in Ireland 
between  1998 and 2005 showed that 476 (63.8%) were due to trauma and 270 
(36.2%) were due to medical causes.   
• Half of trauma deaths were in young men aged between 20 and 29 years and 
the most common causes of death were hanging (174, 36.5%) and road traffic 
collisions (95, 20.0%).   
• A positive toxicology report was available in 412 (86.5%) cases of death owing 
to trauma.  In many cases more than one substance was present.  Alcohol and 
cannabis were most frequently present.   
• The annual number of deaths owing to medical causes increased from 11 in 
1998 to 63 in 2005.  The majority (180, 66.7%) of drug users who died of 
medical causes had a history of opiate use.  The majority were aged between 
30 and 44 years.  The most common medical causes of death were cardiac 
events (67, 24.8%), followed by respiratory infections (48, 17.8%) and liver 
disease (31, 11.5%).   
• The correlation of toxicology and drug-use history with the type of death 
recorded supports the argument that drug use is contributing to the premature 
death of drug users in Ireland. The continuing upward trend in drug-related 
deaths reflects the increasing numbers in the population who are consuming 
drugs and taking risks and who have acquired infections or developed medical 
conditions associated with drug use. 
  
7. Responses to health correlates and consequences 
• The National Immunisation Advisory Committee and the Department of Health 
and Children are recommending significant changes to Ireland’s national 
childhood immunisation programme in 2008 (National Immunisation Advisory 
Committee 2008). These changes, which were published in the revised 
Immunisation guidelines for Ireland in August 2008, include the addition of 
hepatitis B vaccine, to the routine childhood programme. The 5-in-1 childhood 
vaccine will be replaced with a 6-in-1 vaccine which includes hepatitis B 
vaccine. 
• Needle and syringe exchange services were first provided in Ireland in 1989, 
when five exchanges were established (Robinson et al. 2008). There are now 
34 exchanges in the country, operating three models of service: fixed-site 
exchanges, home visit exchanges, and exchanges in public locations. Peer-
based, pharmacy, prison-based or vending machine exchange services are not 
available in Ireland. 
• Relatively few patients infected with the hepatitis C virus through intravenous 
drug abuse receive effective antiviral therapy. A pilot study of supervised anti-
viral treatment in a community non-residential drug treatment facility was 
conducted. Thirteen patients infected with hepatitis C virus genotype 2 or 3 
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were identified in a drug treatment clinic. Six patients agreed to treatment. Full 
treatment course was administered in all six, with sustained viral response in 
5/6. This study demonstrates that effective treatment penetration can be 
improved for this patient group by shared care with drug treatment services, 
without the need for significant increases in resources. 
 
8. Social correlates and social reintegration 
• Data from the final report of the ROSIE study showed that at least 10% of 
opiate users in drug treatment were likely to experience frequent episodes of 
homelessness. 
• Recent research on sex work, risk and drug use revealed that the majority of 
study participants grew up in inner-city, working-class poverty-stricken 
communities, where a well-established heroin market exposed them to a range 
of substances from an early age. Peers and social networks were the dominant 
route into sex work; economic necessity to cater for their opiate habits the main 
reason. Involvement in sex work often led to an escalation in drug use, which 
was paid for with the extra cash. Heroin, cocaine and crack cocaine use was 
prevalent in the daily lives of these sex workers.  
• The latest findings from a longitudinal study investigating the lives of young 
homeless people in Dublin found that there are pathways out of homelessness 
for young people whose contact with their families had remained strong; they 
received support in accessing treatment for their substance use and in making 
the transition to supported living conditions. The research also showed that 
there are young people who remain trapped in homelessness and substance 
use through repeated exposure to unstable accommodation and the street ‘drug 
scene’. 
• The recent review of drug treatment and rehabilitation services by the 
Comptroller and Auditor General recommended the development of ‘step-down’ 
accommodation facilities to support individuals coming from residential drug 
treatment who want to put distance between themselves and their ‘old lifestyle’. 
• The Steering Group that drafted the new National Drugs Strategy highlighted 
the need to provide the provision of appropriate housing if treatment and 
rehabilitation services were to achieve sustained successful outcomes. 
• The Homeless Agency recommended a shift in policy towards an evidence-
based ‘housing first’ strategy to meet the needs of homeless people in Dublin, 
including homeless drug users and those at-risk of becoming homeless.  
• Homeless people, surveyed by the Homeless Agency, highlighted relationship 
breakdown, mental health issues and alcohol and drug use as key factors 
contributing to their becoming homeless. 
• Homeless people identified lack of information about services, difficulty in 
accessing private rented accommodation, addiction to alcohol or drugs and the 
stigma of being homeless as obstacles preventing them from exiting 
homelessness.  
• Homeless people highlighted the problem of open drug use in homeless 
services, and service providers highlighted the lack of detox beds and 
rehabilitation support available to homeless people with alcohol or drug 
addiction.  
• The ROSIE study of treatment outcomes found significant increases at one year 
and at three years in the number of participants undertaking vocational training 
courses. 
• The ROSIE study also revealed that the number of people currently employed 
increased significantly between intake and three-year follow-up, with figures 
rising from 16% (64) to 29% (102). The number of participants deemed ‘not 
working’ decreased substantially.  
•  
9. Drug-related crime, prevention of drug-related crime and prison 
• In 2007, of the total drug offences (n = 11,647), almost 72% were for simple 
possession. Obstruction offences, which often involve an alleged offender 
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resisting a drug search or an arrest or attempting to dispose of drugs to evade 
detection, increased from 208 offences in 2003 to 407 in 2007, an increase of 
96%. Since 2005, drug cultivation or manufacture offences have more than 
trebled, increasing from 29 offences in 2005 to 109 in 2007. 
• In every year between 2003 and 2007, except 2006, cannabis-related 
proceedings represented more than 50% of the total of all drug types.    
In 2006, cocaine-related proceedings bypassed heroin-related proceedings for 
the first time. In 2007, heroin-related proceedings have again overtook cocaine-
related proceedings but only marginally, with both continuing their upward trend 
since 2003. Ecstasy-related proceedings have also continued to rise since 
2005, following a slight decline since 2003. 
• In 2007, there was an increase of almost 60% in Driving Under the Influence of 
Drugs (DUID) prosecutions. 
• In early 2009, the Family Support Network (FSN) published the findings of 
research into the issue of intimidation of the families of drug users by those 
involved in drug dealing. Nearly all family support services indicated that their 
clients, mostly family members of drug users, had experienced debt-related 
intimidation. The burden of intimidation fell primarily on the mothers of users, 
but siblings, fathers, grand-parents, children and partners of users were also 
affected. About 35% of the cases of intimidation related to debts of between 
€100 and €500. 
• In October 2008 the Limerick Regeneration Agencies launched their 
regeneration plan to implement the recommendations of the Fitzgerald report, 
which was published in 2007. This report had been tasked with addressing 
social exclusion, crime and disorder issues (including illicit drugs) in certain 
communities and disadvantaged areas in Limerick city. 
• In September 2008 a Dial to Stop Drug Dealing campaign was officially 
launched. Individuals and communities affected by drug dealing are being 
urged to pass on information relating to drug dealing in their local communities 
by dialling a confidential telephone number. By June 2009, the campaign had 
been launched across the country and was considered to be ‘very successful’; 
there had been in excess of 3,300 calls that generated over 920 information 
reports to the Gardaí.  
• Operation Resolute is a joint Customs and Garda Síochána project aimed at 
building up intelligence on organised crime groups. Following a highly 
successful pilot phase, Revenue plan to extend the operation nationwide. 
• A recent report has highlighted the low number of offenders progressing 
through the Drug Treatment Court (DTC). The Department of Justice, Equality 
and Law Reform is currently seeking to determine the reasons behind the 
relatively low numbers being dealt with in the DTC and to consider if measures 
can be taken to improve its operation. This review will determine whether a 
further expansion of the DTC will take place. 
• The Joint Policing Committee (JPC) pilot was evaluated in early 2008 and final 
guidelines were issued to enable the establishment of JPCs in all local authority 
areas. Further guidelines are due to be published in the latter half of 2009 
enabling the establishment of Local Policing Fora (LPFs) in local drug task force 
areas.  
•  The Irish Prison Service (IPS) annual report for 2007 detailed developments in 
drug supply reduction measures in Irish prisons, including the seizure of mobile 
phones from prisoners, new prison visiting arrangements, enhanced perimeter 
security and the introduction of drug detection dogs. 
• The IPS annual report for 2007 also described developments in rehabilitation 
and treatment services for prisoners during 2007. Measures advanced during 
2007 to enhance drug rehabilitation included the provision of addiction 
counsellor services and the allocation of additional nurse officers and prison 
officers to dedicated drug treatment teams. Nine prisons provided methadone 
substitution treatment to 1,840 prisoners in 2007, of whom 185 were receiving 
methadone for the first time. 
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• The first detailed study into prison recidivism was conducted by the Institute of 
Criminology at University College Dublin. Although the study was focused not 
only on drug-related offenders, some of its findings highlighted the links 
between problematic drug use, crime and recidivism. 
 
10. Drug markets 
• In the all-Ireland general population drug prevalence survey in 2006/7, the 
majority (62%) of recent cannabis users considered it ‘very easy’ or ‘fairly easy’ 
to obtain the drug within a 24-hour period, and almost two-thirds of recent 
cocaine powder users said that cocaine powder was easy to obtain within a 24-
hour period.  
• A study of illicit methadone use and abuse in young people accessing treatment 
for opiate dependence in Ireland found that, despite strict controls, 73% of 
participants reported that illicit methadone was easy to obtain. 
• The fourth ESPAD study, undertaken in 2007, found that 43% of Irish students 
said marijuana or hashish would be ‘fairly easy’ or ‘very easy’ to obtain, 25% 
said the same for amphetamine and 31% for ecstasy. 
• According to Customs Drug Law Enforcement (CDLE) South Africa continues to 
be the main source for herbal cannabis with Amsterdam and Belgium being the 
main transit hubs for the majority of seizures during 2008.  Over the past 18 
months, CDLE reports that there has been a ‘noticeable increase in detections 
of sapling cannabis plants and seeds’. 
• CDLE also reports the seizure of a significant supply of Methamphetamine in 
July 2008. This is the first significant detection of Methamphetamine (also 
known as Meth or Crystal Meth or Ice) in the history of the State. 
• The number of drug supply offences in the Dublin Metropolitan Region (DMR) 
has increased steadily from 846 in 2004 to 1,477 in 2007. This represents just 
over 55 % of the total number of supply offences throughout the State in 2007. 
• During 2007 prosecutions for drug supply increased in the southern region by 
60% and by 40% in the south-eastern region, by 44% in the eastern region and 
70% in the western region. They decreased slightly in the northern region. 
• Research commissioned by the Clondalkin Local Drugs Task Force in west 
Dublin, found that a greater amount and variety of illegal drugs has become 
available in recent years. Drug dealing has become more open, frequently 
being conducted in public places, and is seen as an attractive and lucrative 
‘career option’ for a proportion of young people living in Clondalkin. 
• In October 2008, the Alcohol and Drug Research Unit of the Health Research 
Board (HRB) launched Crack cocaine in the Dublin region: an evidence base 
for a crack cocaine strategy. The north Dublin inner city remains the primary 
crack market in Dublin. Non-Irish national dealers who import small amounts of 
cocaine via couriers dominate the market. However, a growing number of Irish 
dealers are reported to be involved in the distribution of crack throughout the 
Dublin region, and prepared crack has been available throughout the city since 
2006. Findings indicate that the crack market is a closed market, meaning that 
dealers do not sell to strangers, exchanges are generally arranged using mobile 
phones, and buyers are directed to exchange points outside the inner city. 
• Drug seizures have continued to increase since 2005. Of the 10,444 reported 
drug seizures in 2007, 5,176 (49.6%) were cannabis-related. There has been a 
continuous steady rise in cocaine and heroin seizures since 2005. In 2007, 
there were 1,749 cocaine seizures and 1,698 heroin seizures. The number of 
seizures of ecstasy-type substances has also continued to rise, following a 
decline from 2003 to 2005.  
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Main points from Part B 
11. Cannabis markets and production 
• Drug seizure data, survey findings and law enforcement operations in recent 
years (2006–2008) suggest that commercial domestic cannabis production is 
gaining momentum in Ireland. 
• There is limited evidence available to ascertain the size and growth of domestic 
cannabis production. 
• There has been an increase in ‘grow shops’ nationwide since 2000. Grow 
shops are generally referred to as ‘head shops’ in Ireland. Information on the 
extent of the head shop industry is not reliable as there is no official register of 
head shops in Ireland. 
• According to media reports, the first head shop in Ireland opened in 2000 and 
by 2007 there were at least 24 head shops operating nationwide. 
• Two recent all-Ireland general population drug prevalence surveys (2002/3 and 
2006/7) highlight cannabis use patterns in the adult Irish population. The 
majority (60%) of current cannabis users reported using a form of cannabis 
resin. Almost two-in-five (38%) reported using a form of herbal cannabis. 
• No research studies have been conducted in Ireland on the nature of the Irish 
drug market. Research currently being completed by the Health Research 
Board will look at the organisation and structure of Irish illicit drug markets. A 
number of books have been written by investigative journalists about specific 
criminals or organised crime groups involved in the trade in illicit drugs 
including cannabis. 
• Wholesale prices for cannabis are not currently available in Ireland. 
• As part of ‘Operation Vacuum’, the Garda Síochána targeted domestic 
production of cannabis in 2008. Several large scale ‘cannabis factories’ were 
uncovered nationwide. Many were located indoors, both in private residences 
and commercial premises. The largest production facility successfully targeted 
by police in January 2009, had 1,200 cannabis plants, using the water based 
hydroponic system of cultivation. 
• Morocco is the major producing country of cannabis resin, the principal form of 
the drug used in Ireland. According to Customs Drug Law Enforcement ‘South 
Africa continues to be the main source for herbal cannabis with Amsterdam and 
Belgium being the main transit hubs for the majority of seizures during 2008.  
• Drug seizure data highlight increasing numbers of both cannabis plants and 
herbal cannabis seizures. Although drug seizures are seen as an indirect 
indicator of drug availability, it is important to remember that they can also 
merely reflect changes in police emphasis or priorities. There has been a sharp 
increase in cannabis herb seizures, from 609 seizures in 2006 to 1,910 in 2007. 
The number of cannabis plants seized more than doubled from 47 seizures in 
2006 to 100 seizures in 2007. 
• Trend data for proceedings for possession of herbal cannabis in the Dublin 
Metropolitan Region (DMR) and Nationally from 2003 to 2007 show that there 
has been a steady upward trend in proceedings in the DMR since 2004. The 
steep upward trend in such proceedings nationally since 2006 in particular, is 
due to the upward trend in all garda regions since 2004 and a sharp rise in the 
South Eastern region during 2007 where proceedings for the possession of 
herbal cannabis increased from 218 in 2006 to 472 the following year. 
 
12. Treatment for older drug users 
• The proportion of drug users aged 40 and over in treatment has increased from 
3.1% of the total in 1998 to 9.4% of the total in 2008. 
• The biggest increase was observed in the age group 40–49, increasing from 
2.7% in 1998 to 8.0% in 2008. 
• The proportion of treated clients aged over 60 is very low and remained almost 
constant for all years between 1998 to 2008. 
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• Between 1998 and 2007, one-fifth (22%) of the total deaths due to poisonings 
recorded in Ireland (as per Selection D) were among individuals aged 40 and 
over.  
• The number of deaths in the older age groups increased steadily from 18 cases 
in 1998 to 28 cases in 2004, after which there was a jump in the number of 
deaths to 45.  Since 2005, the number of deaths in this age group has fallen 
slightly. 
• In the older age groups, the majority of deaths due to poisonings occurred 
among those aged 40 to 49.  The majority of older drug-related deaths were 
male.   
• Nearly two thirds of poisonings among older drug users were due to more than 
one substance.  Of these, almost all included an opiate-type drug. 
• The proportion of drug users aged 40 and over in methadone maintenance 
treatment has increased from 4% in 1994 to 19% in 2008. 
• Only a very small proportion (less than 0.5%) of treated clients started their 
drug use after the age of 40.  The proportion did not change over the 10 years 
under review. 
• Overall, heroin is the main problem drug reported by all older drug users. 
• Only a small proportion of older drug users reported cocaine as their main 
problem drug. Very few drug users aged over 50 years reported cocaine as 
their main problem drug. 
• The small number of drug users aged 50 and over makes inferences about 
these older groups more difficult. 
• In 2008, almost one in ten clients entering drug treatment were aged 40 years 
or older.  The majority of these older users were aged between 40 and 49.   
• In 2008, the majority of older drug users reported using heroin.  Lower 
proportions of older drug users reported cocaine as their main problem drug 
compared to younger users. 
• In 2008, benzodiazepines and other opiates were the main problem drugs for 
clients aged 60 or over. However, the small numbers make inferences difficult.   
• Older drug users have not been identified as a vulnerable or high-risk group in 
Ireland who need dedicated services. No specific research has been done on 
this group, but as the cohort ages this may need to be re-evaluated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  21
Part A: New Developments and Trends 
1. Drug policy: legislation, strategies and economic analysis 
1.1 Introduction 
The classification of drugs and precursors in Ireland is made in accordance with the 
three United Nations conventions of 1961, 1971 and 1988. Irish legislation defines as 
criminal offences the importation, manufacture, trade in and possession, other than by 
prescription, of most psychoactive substances. The principal criminal legislative 
framework is laid out in the Misuse of Drugs Acts (MDA) 1977 and 1984, and the 
Misuse of Drugs Regulations 1988. The offences of drug possession (s.3 MDA) and 
possession for the purpose of supply (s.15 MDA) are the principal forms of criminal 
charge used in the prosecution of drug offences in Ireland. The Misuse of Drugs 
Regulations 1988 list under five schedules the various substances to which the laws 
apply. 
The National Drugs Strategy 2009–2016 provides the implementation framework for 
illicit drugs policy in Ireland. The Strategy has an overall strategic objective, ‘To 
continue to tackle the harm caused to individuals and society by the misuse of drugs 
through a concerted focus on the five pillars of supply reduction, prevention, treatment, 
rehabilitation and research’. 
 
Implementation is based on a ‘partnership’ approach, whereby over 20 statutory 
agencies, multiple service providers and community and voluntary groups work 
together in a nationwide network of regional and local drugs task forces (DTFs) to 
deliver the Strategy, with the statutory agencies critical in terms of core service 
provision. Two central entities provide national oversight. The Office of the Minister for 
Drugs (OMD) develops policy, co-ordinates the implementation of the Strategy, and 
supports the work of the DTFs and the community and voluntary sectors in relation to 
the Strategy. It reports to the Cabinet Committee on Social Inclusion, Children and 
Integration. An Oversight Forum on Drugs (OFD), comprising senior representatives of 
the various statutory agencies involved in delivering on the Strategy, and 
representatives from the community and voluntary sectors, provides high-level 
monitoring of progress against the Strategy and agrees ways forward where issues are 
blocked or progress is being impeded. It reports to the OMD. 
 
With regard to funding, priorities for public expenditure on the drugs issue are set out in 
the National Drugs Strategy and the National Development Plan. Public funds are 
allocated by way of the annual parliamentary Estimates process, which allocates funds 
to departmental Votes. Funding for regional or local initiatives may be either directly 
from government agencies, or funds such as the Young People’s Facilities and 
Services Fund (YPFSF), administered by the Office of the Minister for Children and 
youth Affairs, or via the regional and local DTFs. The funding mechanism via DTFs 
proceeds from ‘initial’ to ‘mainstreamed’ funding as follows: 
° Initial funding: DTF projects are initially set up as pilot projects with funding provided 
through the Drugs Initiative, administered by the Department of Community, Rural 
and Gaeltacht Affairs (DCRGA). The government department or agency most 
closely associated with the nature of the project acts as the channel of funding to the 
project during this pilot phase.  
° Mainstreamed funding: after the pilot phase, each project is evaluated and a 
decision taken with regard to mainstreaming it in the appropriate government 
department or agency.  Once a project is mainstreamed, the responsibility for the 
funding of the project transfers to that department or agency and DCRGA is no 
longer involved. DTFs continue to have a monitoring role in relation to 
mainstreamed projects. 
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Other public funding mechanisms include the Dormant Accounts Fund and the national 
lottery. The statutorily-based Dormant Accounts Fund contains unclaimed monies 
transferred by credit institutions and insurance undertakings. The Dormant Accounts 
legislation provides that these funds may be allocated to projects and programmes 
designed to alleviate poverty and social deprivation. 
 
 
1.2 Legal framework 
1.2.1 Laws, regulations, directives or guidelines 
This section lists firstly criminal justice and secondly other legislation, introduced or 
enacted during the past year, which may impact directly or indirectly on the illicit drugs 
situation. 
 
The Criminal Justice (Surveillance) Act 2009 provides for the first time a legal 
framework to allow covert surveillance material to be used in criminal trials. The Garda 
Síochána, the Defence Forces and the Revenue Commissioners will have a statutory 
framework for the operation of secret electronic surveillance to combat serious crime 
as well as subversive and terrorist threats against the security of the State. The 
legislation also builds in safeguards with regard to its authorisation, duration and 
operation.  
 
The Act provides that secret surveillance can be used as evidence either to support 
other direct evidence on criminal charges, or as a basis on its own for a charge of 
conspiracy.  Some of the specific provisions of the Act include:  
° Carrying out of surveillance on foot of an authorisation granted by a District Court 
Judge under strict conditions for a period of up to three months, or in urgent 
situations by authorisation from a senior officer for a period of no longer than 72 
hours. 
° Imposition of strict rules governing approval, administrative procedures and the 
keeping of records in all cases. 
° Provision of safeguards regarding the retention and disclosure of information 
concerning the operation of the act including criminal sanctions for breach of 
confidentiality. 
° A complaints procedure whereby a person may complain to a Complaints Referee.  
° A system of judicial oversight of the operation of the Act by a Judge of the High 
Court, designated by the Government. 
° The admissibility as evidence of information obtained as a result of surveillance in 
criminal proceedings.  
° Rules regarding disclosure of information surrounding authorised surveillance in 
proceedings. 
 
The Criminal Justice (Amendment) Act 2009 makes provisions to enable all 
organised crime offences to be declared scheduled offences for the purpose of trial in 
the Special Criminal Court unless the Director of Public Prosecutions directs otherwise. 
The Special Criminal Court operates with three judges and without a jury.  In this 
legislation, an organised crime group is within the meaning of part seven of the 
Criminal Justice Act 2006. In that Act, ‘a criminal organisation means a structured 
group, however organised, that: 
° is composed of 3 or more persons acting in concert, 
° is established over a period of time, 
° has as its main purpose or main activity the commission or facilitation of one or 
more serious offences in order to obtain, directly or indirectly, a financial or material 
benefit’. 
 
In relation to bail, organised crime offences will be scheduled as ‘serious offences’ 
within the meaning of the Bail Act 1997, thereby providing for circumstances where bail 
may be refused by the courts.  Moreover, as of 1 May 2009, the Director of Public 
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Prosecutions can appeal to the High Court against a decision of the District Court to 
grant bail.  An appeal can also be taken against conditions attached by the District 
Court to bail. This is intended to ensure tighter conditions where bail is granted. 
 
The Act has led to a number of criticisms from lawyers and human rights groups. Some 
300 lawyers wrote a letter to The Irish Times challenging its constitutionality. The Irish 
Human Rights Commission (IHRC), which is Ireland’s national human rights institution 
and which is mandated to make recommendations to the Government in relation to the 
protection and promotion of human rights in the State, opposed a number of measures 
in the Criminal Justice (Amendment) Bill 2009. With regard to restrictions on the Irish 
constitutional right to trial by jury the IHRC stated: ‘the IHRC is cognisant that 
organised crime is a problem in Ireland and that it has the potential to cause great 
harm in Irish society. However, the IHRC considers that the exigencies of the situation 
in Ireland do not justify the restriction of the Constitutional right to trial by jury’ (Irish 
Human Rights Commission 2009). 
  
With regard to the justification that the measures introduced in the Bill are a response 
to the risk of jury intimidation, the IHRC stated ‘the risk of jury intimidation is one 
means by which the normal administration of justice can be undermined. However, in 
the absence of supporting data the IHRC queries a blanket assumption about the 
actual or potential level of jury intimidation in Ireland’. The IHRC suggested that a 
number of other measures could be adopted to address this potential problem 
including having an anonymous jury, screening the jury from public view, protecting the 
jury during the trial, or locating the jury in a different place from where the trial is being 
held with communication by video link. The IHRC also made a number of 
recommendations in relation to other aspects of the Act, including provisions to restrict  
the right to silence and provisions relating to ‘organised crime’. With regard to the 
latter, the IHRC was concerned that the seriousness of the penalty proposed under 
section 5 of the Act relating to the offence of ‘directing’ a criminal organisation, with the 
potential for life imprisonment, might give rise to arbitrary or disproportionate 
sentences for an accused who is proved to have played a minor role in a criminal 
organisation. The IHRC recommended that ‘the proposed penalty under section 5 of 
the 2009 Act should be qualified and revised downwards to take account of the level at 
which the accused directs a criminal organisation’ (p12). 
 
The Irish Council for Civil Liberties (ICCL) also strongly condemned provisions allowing 
the role of the Special Criminal Court to be expanded. According to Mark Kelly, director 
of the human rights watchdog: 
 
            In a matter of weeks, the United Nations’ top human rights experts will call upon 
the Minister’s senior officials to justify the continued existence of the Special 
Criminal Court. In these circumstances, for Dermot Ahern (the Minister) to moot 
the expansion of the Court shows a flagrant disregard for Ireland’s international 
human rights obligations. …If we are to effectively tackle gangland crime, the 
Gardaí must be placed in a position to fully enforce existing criminal laws, 
especially in cases where attempts are made to intimidate key witnesses.  The 
emphasis should be upon intelligence-led and community-based policing 
coupled with improved witness protection, rather than on undermining the rule 
of law by expanding the Special Criminal Court. 
 
In July 2009, the President of Ireland, as provided for in the Irish Constitution, 
Bunreacht na hÉireann, following consultation with the Council of State as to whether 
she should refer the Criminal Justice (Amendment) Bill 2009 to the Supreme Court for 
a test as to its compatibility with the Irish Constitution, decided not to take this course 
of action and, on 23 July, she signed the Bill into law.  
 
The Criminal Justice (Miscellaneous Provisions) Act 2009  provides a statutory 
framework for controlling firearms and seeks to halt the emergence of a gun culture in 
Ireland. 
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The Community, Rural and Gaeltacht Affairs (Miscellaneous Provisions) Act 2007 
provides a statutory mandate for the functions and responsibilities of the Minister for 
Community, Rural and Gaeltacht Affairs, including:  
 
Co-ordinate the implementation of the National Drugs Strategy (including 
matters relating to the allocation of services and facilities to counter drug 
misuse in areas of the State where such misuse is significantly higher 
than in other areas of the State). (Section 2 (1) (d)) 
 
Section 2 (2–4) of the Act provides the Minister with the power to develop, implement, 
maintain or expand any scheme that in her or his opinion supports or promotes the 
functions for which he or she is responsible, including the co-ordination of the National 
Drugs Strategy. It also allows the Minister to terminate any such scheme. 
 
The Spent Convictions Bill 2007 was introduced in Dáil Éireann for its second 
reading. The Bill is intended to apply where a prison sentence not exceeding six 
months or a fine or penalty have been imposed, and then only after a certain number 
of years have elapsed without a further conviction.  The purpose of the Bill is to help 
rehabilitate convicted persons through facilitating their reintegration into the workforce 
and allowing them to build new careers. Following a debate, the Bill was referred to the 
Select Committee on Justice, Equality, Defence and Women’s Rights. 
 
The Criminal Procedure Bill 2009 makes provisions for a modification of the rule 
against double jeopardy in order to allow a person who has been acquitted of an 
offence to be re-tried in circumstances where new and compelling evidence emerges 
or where the acquittal is tainted due, for example, to corruption or intimidation of 
witnesses or jurors or perjury. The rule against double jeopardy provides that no 
person may be put at risk of being punished twice for the same offence. The legislation 
applies to a number of drug-related offences.   
 
The Housing (Miscellaneous Provisions) Bill 2008 was introduced into Dáil Éireann 
for its second reading. Section 35 of the Bill requires each local housing authority to 
adopt a strategy for the prevention and reduction of anti-social behaviour in its housing 
stock. The Bill also amends the definition of anti-social behaviour in the Housing 
(Miscellaneous Provisions) Act 1997, extending it to include damage to property, graffiti 
and significant impairment of the use or enjoyment of a person’s home.  
 
The Communications (Retention of Data) Bill 2009 (No 52 of 2009) requires service 
providers, those engaged in the provision of a publicly electronic communication 
service or a public communication network by means of fixed line or mobiles or the 
internet to retain data relating to fixed and mobile telephony, for 1 year, and data 
relating to internet access, internet email and internet telephony for 2 years, and 
provides for disclosure in relation to the investigation of specified offences including 
Customs offences. 
 
The Health (Miscellaneous Provisions) Bill 2009 makes arrangements for 
progressing the integration of health service agencies in line with Government policy 
on the rationalisation of public sector agencies. Part 5 of the bill provides for the 
dissolution of the Drug Treatment Centre Board and the transfer of its rights, liabilities, 
land and any other assets to the Health Service Executive. 
 
1.2.2 Laws implementation 
In March 2009, Minister for Health and Children, Mary Harney TD, announced that 1-
benzylpiperazine (BZP) is now a controlled drug through statutory instruments (121 
and 122 of 2009) amending the Misuse of Drugs Act 1977, and that its possession or 
sale is now a criminal offence. The new statutory instruments will ensure that BZP is 
no longer available for sale in ‘head shops’ around the country or on the streets.  
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BZP is a relatively new synthetic psychotropic (mood altering) substance which has 
been sold as ecstasy under the street names ‘Legal E’, ‘Legal X’ ‘XTC’, ‘A2’, 
‘piperazine’, or ‘party pills’. In Ireland, party pills containing BZP have been widely sold 
in head shops. The European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) conducted a risk assessment of BZP in 2007 and found that its use can 
lead to various medical problems, though the long-term effects of the substance are 
still unknown (Europol-EMCDDA 2007). The risk assessment report concluded that 
due to its stimulant properties, risk to health and the lack of medical benefits there was 
a need to control BZP. Against this background, the Council of the European Union 
decided in July 2007 that BZP should be defined as a new psychoactive substance 
and to be made subject to control measures and criminal provisions.  
 
The Criminal Justice (Mutual Assistance) Act 2008 commenced in August 2008. It 
defines the competent authorities, the Revenue Commissioners and the Garda 
Síochána, in relation to controlled deliveries of drugs and confirms current procedures 
adopted in relation to controlled deliveries of drugs. A memorandum of understanding 
and operational protocol in relation to these procedures have been placed in the library 
of the Oireachtas. With regard to the provisions contained in the Act, the Garda 
Síochána have recently taken the view that the Garda Commissioner is the only 
competent authority in the State to accept controlled deliveries of drugs from foreign 
law enforcement authorities, that is police and customs. Revenue believes that this 
view is at variance with the legislation. The advice of the Attorney General is awaited 
on this issue. 
 
Minister’s contribution to Trinity cannabis debate  
 
In its opening debate of the 2008 academic year, the Trinity College Historical Society 
debated the motion ‘That the sale of cannabis should be legalised’. In opposing the 
motion Pat Carey TD, at the time Minister of State for the national drugs strategy, set 
out in detail not generally provided the government’s position on this controversial 
issue.  With regard to the health effects of cannabis use, the Minister argued that 
cannabis cigarettes produce ‘three times more carcinogenic “tars” than tobacco and 
five times more poisonous carbon monoxide’ and that this put users at risk ‘of 
bronchitis and double(d) the risk of certain types of cancer, including lung and throat 
cancer’. Referring to the association between cannabis use and mental illness, the 
Minister stated that long-term cannabis use could, in some cases, ‘trigger mental 
illness such as schizophrenia and depression – two sicknesses that cannot afford to be 
promoted considering this country’s intolerable suicide rates’. 
 
The Minister stated that the ‘vast majority’ of young people who have used a variety of 
illegal substances initiated their illicit drug consumption with cannabis. Consequently, 
‘they become involved and immersed in the drug culture’, come to know drug dealers 
and ‘more often than not’ come into contact with users of drugs of a more serious 
nature. With regard to the potency of cannabis, the Minister suggested that, while 
previously most cannabis contained approximately 2% of the active substance THC, 
newer ‘specially cultivated strains of cannabis can be up to 16% THC’. He 
acknowledged, however, that these ‘newer strains’ are not the most commonly used 
types of cannabis in Ireland. The Minister, who is a former schoolteacher, highlighted 
research which, he said, pointed to a connection between cannabis use and early 
school leaving. While cannabis use is, Minister Carey stated, ‘far from the only factor 
stopping teenagers and young adults reaching their educational potential, it seems 
somewhat ridiculous to me that we would risk further exacerbating the already existing 
difficulties by legalising cannabis.’ 
 
With regard to the reclassification of cannabis to a Class C drug in the UK,2 the 
Minister stated that equivalent penalties continue to be much higher than those 
currently in force in this country. The changes in the UK appear to allow greater 
                                                
2 Cannabis in the UK has subsequently been reclassified again, to class B. 
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discretion in dealing with people found to be in possession of cannabis. Under Irish 
law, the gardaí and the Courts already have a very high degree of discretion in dealing 
with these cases.  
 
Referring to developments in the Netherlands, the Minister said that the Mayor of 
Rotterdam had recently announced that 27 of the city’s 62 coffee shops must close as 
of 1January 2009, because these shops were located too close to secondary and 
vocational schools. This was part of a rowing back by Holland at both national and at 
local level of its existing perceived ‘liberal’ policy. 
 
The Minister argued that, although the level of acceptance of cannabis use is growing, 
‘the majority of people in Ireland … are against the legalisation of cannabis. This is a 
fundamental reason in a democracy as to why you wouldn’t legalise a drug.’ Finally, 
the Minister questioned the assertion that legalisation would result in the elimination of 
criminal activity surrounding cannabis. ‘It may’, he argued, ‘only result in a transfer 
from drug-related criminal activity to other forms of criminal activity.’ Even if cannabis 
were legalised, he suggested, ‘it is difficult to envisage that its provision would be 
anything other than heavily regulated.  This would provide continued opportunities for 
criminals to continue their involvement in the illegal supply of cannabis.’ The motion 
was defeated by a narrow majority. 
 
 
1.3  National action plan, strategy, evaluation and co-ordination 
1.3.1 Implementation and evaluation of national action plan and/or strategy 
On 10 September 2009 a new national drugs strategy, the National Drugs Straegy 
(interim), 2009–2016, (NDS 2009–2016) was launched by the Irish government 
(Department of Community Rural and Gaeltacht Affairs 2009). The document was 
prepared by a Steering Group, chaired by DCRGA and comprising representatives of 
the key departments and agencies involved in delivering the current drugs strategy, as 
well as representatives from the community and voluntary sectors. The Steering Group 
examined the progress and impact of the previous strategy and its relevance to the 
current nature and extent of drug-related problems in Ireland, reviewed the operational 
effectiveness of the structures for implementing the strategy, and examined 
developments in drug policies, and responses to the problem, at EU and international 
level. In light of this information, and following extensive public consultations, the 
Steering Group drew up a new strategy, which was approved by the government.  
 
During the consultation process for the NDS 2009–2016, there was widespread public 
concern in relation to the problem use of alcohol, both as a stand-alone public health 
issue and in association with illicit drug use.  On 31 March 2009, the Government 
approved the development of a National Substance Misuse Strategy to cover both 
alcohol and drugs.   
 
The contents of the new strategy, and the arrangements being made to manage the 
inclusion of alcohol in a ‘national substance misuse strategy’, are described below, 
following a summary of the Steering Group’s assessment of the progress made during 
the lifetime of the previous national drugs strategy (NDS 2001–2008).  
 
No formal process or output/outcome evaluation of the NDS 2001–2008 was 
undertaken. However, two independent studies published earlier in 2009 reviewed 
aspects of the previous drugs strategy. The contents of these two studies are outlined 
at the end of this section. 
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National Drugs Strategy 2001–2008 (NDS 2001–2008) – Steering Group’s 
assessment 
 
The Steering Group that managed the preparation of the NDS 2009–2016 assessed 
progress against the key performance indicators (KPIs) under each of the pillars in the 
previous strategy.3  
 
Supply reduction  
All KPIs under this pillar were achieved. The targets of a 50% increase in volume of 
drugs seized based on 2000 figures and a 20% increase in the number of seizures 
based on 2004 figures were both exceeded.  The 125% increase in supply detections 
between 2004 and 2008 significantly exceeded the target of 20%.  While 
acknowledging the operational success which this represented for law enforcement, 
the Steering Group noted that, without a reliable estimate of the size of the illegal drug 
market in Ireland, the impact of increased seizures on the overall supply could not be 
measured. 
 
Other areas of progress included increases in Garda Síochána resources in LDTF 
areas and various initiatives aimed at reducing the supply of drugs, such as the ‘Dial to 
Stop Drug Dealing’ scheme, undertaken by local and regional DTFs. Less progress 
was achieved in expanding Community Policing Fora (CPF) and reducing the 
availability of drugs in prisons.   
Prevention 
The KPIs under this pillar related to levels of problem drug use, prevalence, substance 
use policies in schools and rates of early school leaving.  Heroin use stabilised in the 
Dublin area with a significant drop in new entrants.  However, heroin use outside 
Dublin rose substantially.  Drug prevalence targets were not achieved and the 2006/07 
drug prevalence survey reported increases in recent and current use. The target of 
having substance use policies in all schools was near completion at the time of a 
Department of Education and Science survey in 2005.  A number of data sources were 
used to estimate the levels of early school leaving and, while precise figures were not 
available, it appeared that early school leaving had decreased during the period of the 
NDS 2001–2008. 
While many of the actions relating to implementation of prevention programmes were 
completed or near completion, the Steering Group questioned the effectiveness of a 
number of the programmes. Despite the high number of schools which reported that 
they had implemented substance misuse policies, the quality of these policies had not 
been assessed and there was a need to determine how actively they were being 
implemented.  The Social Personal Health Education (SPHE) programme, the 
foundation for developing awareness of drugs and alcohol issues in schools, is a 
mandatory part of the curriculum but its effectiveness as a drug prevention measure 
was constantly questioned during the consultation process. 
 
Treatment and rehabilitation  
   
Three of the KPIs under the treatment and rehabilitation pillar specified increased 
availability of treatment and harm reduction services and one sought a reduction in the 
incidence of HIV.  The target of a maximum waiting period of one month for treatment 
for problem drug use had been achieved for almost all non-opiate addiction cases.  
However, there were still difficulties in providing access to treatment within one month 
after assessment for methadone services in many areas.  No person under 18 years of 
                                                
3 The KPIs used to measure progress under the pillars in the NDS 2001–2008 were revised by the 
Steering Group that undertook the mid-term review of the drugs strategy Steering Group for the Mid-Term 
Review of the National Drugs Strategy (2005). Mid-term review of the National Drugs Strategy 2001-2008. 
Department of Community, Rural and Gaeltacht Affairs, Dublin.. 
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age had had to wait longer than a month to initiate treatment following assessment, but 
there were still not enough residential places or community supports.  There was 
limited progress in providing harm-reduction services, but the incidence of HIV among 
IDUs had seen a consistent reduction.  The incidence of hepatitis C continued to cause 
concern.  
 
While rehabilitation was covered under the treatment pillar in the NDS 2001–2008, the 
mid-term review of the NDS 2001–2008 (Department of Community Rural and 
Gaeltacht Affairs 2005)  recommended that a separate pillar be established.  Following 
a recommendation in the report of the Working Group on Drugs Rehabilitation (Working 
Group on Drugs Rehabilitation 2007), a National Drug Rehabilitation Implementation 
Committee (NDRIC), chaired by the HSE, was set up.  
 
The Steering Group found there had been progress in several areas related to the mid-
term review’s recommendation to strengthen support for families and the HSE had 
significantly developed its family support services. 
 
Research  
 
The KPIs under this pillar dealt with information on prevalence in the general 
population, problem drug use, demand for drug treatment, drug-related deaths and 
drug-related infectious diseases. In 2005 the National Advisory Committee on Drugs 
(NACD)  published the findings of a drug prevalence survey carried out in Ireland and 
Northern Ireland in 2002/03. This survey was repeated in 2006/07 and the results 
published in 2008. The NACD also commissioned studies on drug prevalence among 
vulnerable groups, including the homeless, new communities in Ireland and Travellers. 
Other studies had given some insight into alcohol and cannabis use among the youth 
and school-going populations. While work on the second 3-source capture-recapture 
study, to estimate the prevalence of problematic opiate use, has yet to be completed, 
the Research Outcome Study in Ireland (ROSIE), and the information provided through 
the National Drug Treatment Reporting System ( NDTRS), had provided significant 
insights into the patterns of problem drug use. 
 
Improvements in the reporting of problem drug use to the Health Research Board’s 
Drug Misuse Research Division (renamed Alcohol and Drug Research Unit (ADRU) in 
2007) increased the efficiency of the flow of the  data on drug treatment demand and 
the quality of the information.  In 2005 the Health Research Board (HRB) developed a 
National Drug-Related Deaths Index (NDRDI), which subsequently published data for 
the period 1998–2005 (Lyons, Suzi et al. 2008). The Health Protection Surveillance 
Centre (HPSC) introduced an extended surveillance system for hepatitis B in 2004 and 
for hepatitis C in 2007. The Steering Group noted that there had been no concerted 
effort to monitor the incidence and prevalence of hepatitis B, hepatitis C or HIV among 
drug users since the NDS 2001–2008 was launched. 
 
National Drugs Strategy 2009–2016 (NDS 2009–2016) 
 
In his foreword to the NDS 2009–2016, the Taoiseach, Brian Cowen TD, observed that 
the previous drugs strategy had been successful in tackling the heroin problem in 
Dublin but that the situation had now changed:  ‘problem drug use has spread to other 
areas and the range of drugs available has increased. The challenge involved is 
complicated by the fact that drug use can be linked to circumstances of social 
exclusion as well as to circumstances of economic prosperity.’  
 
In their forewords to the new strategy, both the Taoiseach and the Minister of State 
with responsibility for the Drugs Strategy, John Curran TD, emphasised that 
partnership both at national and local level, including the drugs task forces, would 
continue to form the basis of the government’s approach to tackling the problem. 
Deputy Curran confirmed that the government would also continue to base its 
approach on the five pillars – supply reduction, prevention, treatment, rehabilitation and 
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reducing the overall supply of drugs was questioned’ (para.2.22). The Steering Group 
stated, ‘Due to the problems associated with estimating the size of the illegal drug 
market in Ireland, it is difficult to conclude whether increased seizures are actually 
resulting in a reduction in overall supply – or whether the overall supply of drugs has 
increased and the percentage of seizures has remained relatively even’ (para. 2.27). 
The Steering Group further acknowledged that ‘the figures often quoted in relation to 
drugs seizures as a percentage of the total drugs market in Ireland are speculative and 
currently, have no proven basis’ (para. 2.27). Consequently, the Steering Group  
concluded that there is a need to develop other measurements to determine the 
effectiveness of supply reduction activities rather than just relying on drug seizures.  
 
An issue highlighted during the consultation phase was the possibility of decriminalising 
or changing the legal status for the simple possession of certain drugs such as 
cannabis, owing to the garda resources involved in prosecuting such cases. The 
Steering Group reported that, according to the gardaí, ‘about 20% of drugs crime 
relates to supply offences and 80% to possession’ (para. 2.29). Despite this, most of 
the Steering Group were not in favour of ‘legalising, decriminalising, or 
changing/redefining the legal status of certain illicit drugs (cannabis was the focus of 
most discussion in this context’ (para. 2.49). The Steering Group noted that the findings 
of the nationwide drug prevalence surveys conducted in 2002/03 and 2006/07 
indicated that approximately 70% of respondents did not think recreational cannabis 
use should be permitted (support for the medicinal use of cannabis was about 70%). 
The Steering Group did, however, agree to prioritise the ongoing monitoring of 
legislative and regulatory frameworks with a view to pursuing changes where 
necessary.  
 
Other priorities identified by the Steering Group included developing local partnership 
approaches through the Joint Policing Committees and Local Policing Fora provided for 
in the Garda Síochána Act 2005; tackling underage drinking and drug-related 
intimidation; the development of an integrated system to track the progression of 
offenders with drug-related offences through the criminal justice system; the continued 
implementation of measures to curtail the supply of drugs in Irish prisons; and a 
renewed focus on addressing the use of precursors in the manufacture of illicit 
synthetic drugs. The last priority calls for increased collaboration with international 
bodies such as the EMCDDA and Pompidou Group of the Council of Europe.  
 
Prevention 
 
In their forewords to the NDS 2009–2016 both the Taoiseach and the Minister for 
Drugs emphasised the importance of prevention. Minister Curran stated: ‘If we could 
achieve more in regard to prevention, I believe that the impact on the overall problem 
would be greatly enhanced.’  
 
Having reviewed progress under the NDS 2001–2008, the Steering Group concluded 
that ‘a tiered or graduated approach to prevention and education measures in relation 
to drugs and alcohol should be developed with a view to providing a framework for the 
future design and development of interventions’ (para. 3.56).  The Steering Group 
identified three levels in this framework, which are outlined below. In naming the three 
levels, the Group combined the current prevention classification framework – universal, 
selected and indicative – with the old classificatory framework of primary, secondary 
and tertiary.   
 
Universal (primary) prevention programmes 
Aimed at reaching the general population, such as students in schools, to promote 
overall health of the population and to prevent the onset of drug and alcohol misuse.  
Measures often associated with this type of programme include awareness campaigns, 
school drug/alcohol education programmes and multi-component community initiatives. 
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Selected (secondary) prevention programmes 
Aimed at groups at risk, as well as subsets of the general population including children 
of drug users, early school leavers and those involved in anti-social behaviour.  These 
programmes aim to reduce the effect of risk factors present in these subgroups by 
building on strengths and developing resilience and protective factors. 
 
Indicative (tertiary) prevention programmes 
Targeted at people who have already started using drugs/alcohol, or who are 
likely/vulnerable to engage in problematic drug/alcohol use (but may not necessarily be 
drug/alcohol dependent), or to prevent relapse.  These require individual or small group 
programmes aimed at addressing specific needs. 
 
With regard to specific interventions, the Steering Group identified the following 
priorities:  
° improved delivery of SPHE in primary and post-primary schools – the Steering 
Group acknowledged that while the focus of prevention measures in the NDS 2001–
2008 had been on the provision of education services in school settings for the 
school-going population, their application and delivery had limited their 
effectiveness. 
° the co-ordination of the activities and funding of youth interventions in out-of-school 
settings to optimise their impacts – under the NDS 2001–2008 the provision of 
education in non-school settings had been fragmented, the provision of alternative 
recreational facilities for young people had been under-developed, and many young 
people had not had access to recreational facilities in out-of-school settings. 
° a continued focus on orienting educational and youth services towards early 
interventions for people and communities most at risk – the Steering Group 
recommended that actions be developed to further support the families of drugs 
users, and it acknowledged community development as an important step in building 
the capacity of local communities to avoid, or respond to and cope with, drug 
problems.  
° the development of timely awareness campaigns targeted in a way that takes 
individual social and environmental conditions into account – the Steering Group 
saw the need to further develop and promote prevention strategies in a number of 
key areas such as third-level institutions, workplaces, sports and other community 
and voluntary organisations. 
 
Treatment and rehabilitation  
 
The Steering Group stated that this pillar, which combines the treatment and 
rehabilitation pillars, had a wider focus than in the NDS 2001–2008. It aimed to develop 
a more comprehensive treatment service capable of dealing with all problem 
substances nationally, rather than focusing mainly on opiate misuse in Dublin.  The 
Steering Group identified a number of priorities grouped under four main themes. 
 
1. Development of general problem substance use services – develop an integrated 
national treatment and rehabilitation service for all substances, using a four-tier model 
approach, underpinned by an appropriate clinical governance regime. 
 
The Steering Group supported the HSE’s reorientation of  addiction services towards 
polydrug use using a four-tier model.  The focus of the strategy will be on the 
development of addiction services, and of pathways between them and other relevant 
health and social services. 
 
The treatment of drug users with hepatitis C is specifically mentioned for the first time 
in the NDS 2009–2016. The Steering Group noted that there has been a gradual and 
consistent decrease in the number of HIV cases reported, while the incidence of 
hepatitis C among IDUs is a cause of concern.  The KPI on the monitoring of the 
incidence of HIV has been dropped and, for the first time, a KPI for the treatment of 
hepatitis C in drug users has been included.  
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Data from the National Drug-Related Deaths Index (NDRDI), set up in line with Action 
67 in the NDS 2001–2008, has shown an increase in drug-related deaths since 1998 
(Lyons, Suzi et al. 2008), and a new action in the NDS 2009–2016 calls for the 
development of a National Overdose Prevention Strategy, and also for a response to 
the increasing numbers of indirectly drug-related deaths.  
 
The Steering Group prioritised the expansion of the availability of detox facilities, opiate 
substitution services, under-18 services and needle-exchange services where required. 
The KPI relating to service provision for under-18s remains the same as in the NDS 
2001–2008, but with a new target of 100% access to treatment within one week (as 
opposed to one month) of assessment by 2012.  While the document states that 
methadone substitution is the cornerstone of opiate treatment and looks for continued 
recruitment of Level 2 GPs,4 a new action calls for the review of the Methadone 
Treatment Protocol to maximise the provision of treatment and to facilitate appropriate 
progression pathways. Additionally, the action calls for alternative opiate substitution 
services. 
 
Noting that there had only been a small increase in the number of residential places 
between 2001 and 2006, the Steering Group called for the development of residential 
care in the context of the four-tier model.  Along with appropriate aftercare services, the 
Steering Group saw residential care as central to the provision of alternative, drug-free 
treatment for problem drug users.  The NDS 2009–2016 includes a new KPI relating to 
residential places, which states that there should be a 25% increase in residential 
rehabilitation places by 2012 based on 2008 figures.   
 
The Steering Group called for the establishment of a drugs intervention programme, 
incorporating a treatment referral option, for those who come to the attention of the 
Garda Síochána because of behaviour caused by substance misuse. It stated that this 
programme would be aimed at young people and young adults.  While many of the 
services needed for this programme are already in place, the Steering Group noted 
that interagency co-ordination needs to be developed. A new KPI specifies that this 
programme should be in place by 2012. 
 
2. Specific groups – further develop engagement with, and the provision of services for, 
specific groups: prisoners, homeless, Travellers, new communities, the lesbian, gay, 
bisexual and transgender (LGBT) community and sex workers. 
 
These specific groups are listed separately in the NDS 2009–2016.  Those with a dual 
diagnosis (both mental health and substance misuse problems) are also mentioned 
specifically.  These groups have been highlighted in order to differentiate their specific 
needs and to tailor services for them.  New issues for prisoners have also been 
identified.  These include the recognition of the high risk of overdose or relapse 
immediately following release from custody and the need for the development of an 
effective and co-ordinated interagency approach to ensure a seamless transition from 
prison back into the community.  The Steering Group noted that not all prisons 
provided substitution treatment, and identified this issue as a key gap.   
 
3. Quality and standards framework - develop a clinical and organisational governance 
framework for all treatment and rehabilitation services. 
 
The Steering Group stated that while progress had been made in introducing standards 
in treatment and rehabilitation services, further measures were necessary. For 
example, currently neither counselling nor psychotherapy services are statutorily 
regulated.  New actions are identified in relation to developing a clinical and 
organisational governance framework for addiction services and developing a 
regulatory framework on a statutory basis for the provision of counselling.  
                                                
4 Under the Methadone Treatment protocol, a level 2 GP is authorised to take up to 35 clients on 
methadone maintenance, and can take on clients without their having to be referred by a treatment clinic. 
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4. Training and skills development – develop national training standards for all those 
involved in the provision of substance misuse services, and co-ordinate training 
provision within a single national substance misuse framework. 
 
The actions relating to training and skills development are more specific in the new 
strategy, as they are seen as a key component in the development of a comprehensive 
addiction service.  The new actions call for the development of national training 
standards, including accreditation, for addiction services (both statutory and voluntary).  
The need for staff training in the use of naloxone in order to prevent fatal overdose is 
specifically mentioned. 
 
Research and information 
 
The NDS 2009–2016 intends to collect information and complete research projects in 
order to inform policy formulation and to develop or enhance responses to the drug 
situation, while the NDS 2001–2008 intended to measure the extent of drug use by 
person, place and time, and describe the characteristics of drug users, but did not state 
how the new information would be used (Table 1.3.2).  
 
Table 1.3.2  Research objectives and KPIs, NDS 2001–2008, and Research and information objectives and KPIs, 
NDS 2009–2016 
 
2001– 2008 
 
                    
2009–2016 
Have valid, timely and comparable data on the extent of 
drug misuse amongst the Irish population and 
specifically amongst all marginalised groups 
 
Ensure the availability of data to accurately inform 
decisions on initiatives to tackle problem substance 
use 
 
Gain a greater understanding of the factors which 
contribute to Irish people, particularly young people, 
misusing drugs 
 
Provide appropriate research to fulfil the 
information needs of Government in formulating 
policies to address problem substance use 
 
Eliminate all major research gaps in drug research by 
end 2003  
 
EMCDDA indicators developed on the extent and 
nature of problem drug use in Ireland  
Publish an annual report on the nature and extent of the 
drug problem in Ireland and on progress being made in 
achieving the objectives set out in the Strategy 
Comprehensive and timely reporting systems in 
place for: treatment, rehabilitation; and on the 
progression of offenders (with drug-related 
offences) through the criminal justice system 
 
 Completion of identified research programme each 
year by the NACD 
 
 
The NDS 2001–2008 was based on a low level of information and the information that 
existed was not collated in a single place or easy to access.  The NDS 2001–2008 
intended to eliminate all research gaps and funded an extensive programme of 
research about the drug situation and the responses to it. The NACD was established 
to co-ordinate the programme of research and advise the Government on its findings.  
The information available on the drug situation has increased dramatically since 2001; 
for example, the NACD published 70 research reports between 2001 and 2008 while 
the HRB published 35 reports during the same period.  All research publications are 
located in a single web-based library known as the National Documentation Centre on 
Drug Use (NDC).   
 
At the time the NDS 2001–2008 was developed, it was not widely understood by those 
working in the drugs area that the EMCDDA required all countries to complete a 
national report on the current drug situation and responses to it each year.  Since 2004, 
the national reports to the EMCDDA have been made available on the NDC website 
and these annual reports are used by policy makers to keep abreast of progress. The 
challenge now is to sustain this level of knowledge and to identify the most efficient 
ways of updating our knowledge. With this in mind, the title of the research pillar has 
being changed to the research and information pillar.  
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In the new strategy NDS 2009–2016, the emphasis, and investment, will be on the 
development of a single information system that will consist of existing data sources 
(such as the CTL, NDTRS, NDRDI, and HPSC) and these information sources will be 
linked using a unique identifier.  This will enable us to document the exact number of 
known problem drug users, and trace their treatment and rehabilitation pathways and 
outcomes. Consent and data protection procedures would be put in place to protect 
individuals’ identities.  
 
The EMCDDA indicators will guide the continuous and periodic data collection process.  
Examples of continuous data collection processes are the CTL, HPSC drug-related 
infectious diseases, NDTRS, NDRDI and PULSE. Examples of periodic data collection 
processes are the survey measuring the prevalence of problem drug use among the 
general population and the estimation of the numbers of problem drug users.  The 
annual programme of research will include projects that could not be achieved through 
routine data collection mechanisms, for example exploring new issues, testing new 
interventions or measuring long-term impact.  The development of an annual rather 
than an eight-year research programme will allow for sudden changes in the situation 
and prioritising of projects in line with available resources.   
 
The seven research-related actions in the NDS 2001–2008 were substantially 
completed. In the NDS 2009–2016 four priorities have been identified, which closely 
link to the KPIs (Table 1.3.3).These priorities have been translated into eight 
associated actions, which identify the agency with lead responsibility for 
implementation together with all other contributing agencies.     
 
Table 1.3.3  Research and information priorities, NDS 2009–2016 
1. Continue to develop indicators and reporting systems on the extent and nature of problem substance use in 
Ireland (seeking to remove barriers to the development of these reporting systems and indicators) 
 
2. Develop a prioritised research programme, to be reviewed annually 
 
3. Continue the Drug Prevalence and the ESPAD surveys 
 
4. Develop a research management framework and disseminate research findings and models of best practice. 
 
 
The critical success factors for Ireland in delivering on the new strategic objectives are 
to ensure that capacity to complete drug-related research is developed further, that 
there is no duplication of research projects or information systems, and that projects 
and interventions are planned using the best practice available within Ireland or in other 
countries.   
 
Inclusion of alcohol in new substance misuse strategy 
 
Announcing the decision to develop a ‘substance misuse’ strategy, including both illicit 
drugs and alcohol, Minister of State with responsibility for the Drugs Strategy, John 
Curran TD, said: ‘A combined strategy will facilitate a more coherent approach to the 
issues and consequences of alcohol and illicit drug use including addictive behaviours. 
We cannot continue to look at these problems in isolation.’ (Curran 2009)  A new 
steering group will be established in autumn 2009 to develop proposals for a strategy 
that will incorporate the already-agreed drugs policy element.  Membership of the new 
steering group will reflect the appropriate statutory, community/voluntary and other 
relevant interests.  The group will be jointly chaired by officials from the Department of 
Health and Children and the Office of the Minister for Drugs and will be asked to report 
by the end of 2010.  
 
The interim drugs strategy contains a number of proposals relating to alcohol. These 
are summarised below. 
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Supply reduction  
 
During the public consultation process, the issue of underage drinking was consistently 
raised, both as a problem in its own right and as a gateway to the use of illicit drugs. 
However, owing to the fundamental legal difference involved in their supply, the focus 
in the interim drugs strategy is on illicit drugs rather than on alcohol, with the exception 
of underage drinking.   
 
Prevention 
 
Alcohol is referenced under this pillar with regard to developing a prevention strategy to 
tackle substance misuse, particularly in relation to under-18-year-olds.  One of the key 
themes to emerge from the consultation process was the perception that drug and 
alcohol use are becoming more widespread and that the age profile of those involved is 
getting younger. Measures to prevent and/or delay drug and alcohol use – especially 
among young people – are, therefore, particularly important and urgent. 
 
Treatment and rehabilitation  
 
The Steering Group endorsed the view of the Working Group on Alcohol and Drug 
Synergies that greater coherence and co-ordination of alcohol and drug issues at  
policy, planning and operational levels are needed.  With respect to treatment and 
rehabilitation, the Steering Group saw the re-orientation of all addiction services 
towards dealing with problem substance use as a key feature of the new strategy.   
 
The Steering Group acknowledged that it was not possible to quantify the number of 
problem alcohol users requiring treatment.  However, the significant difference between 
the number of alcohol-related hospital discharges and the number of reported cases 
receiving treatment for alcohol addiction indicated that there was a considerable cohort 
of problem alcohol users who could benefit from engagement with addiction treatment 
services. 
 
Research and information  
  
The Steering Group recommended the development of a research management 
framework in relation to problem substance use in Ireland.   In relation to alcohol, it 
specifically recommended: 
•  the development of appropriate epidemiological indicators of problem alcohol use, 
and building on existing monitoring systems and prevalence surveys; 
• measuring the impact of alcohol and drugs on the Irish health and justice systems; 
and  
• monitoring problem substance use (including alcohol) among those presenting to 
hospital emergency departments. 
 
Independent reviews of the NDS 2001–2008  
 
In January 2009 the Health Research Board published an overview entitled 
Development of Ireland’s drug strategy 2000–2007 (Pike 2008). The objectives of 
the overview were to gain insights into how the underpinning strategic management 
processes and governance arrangements had supported implementation and might 
have influenced the outcomes, and to explore options for the effective management of 
these elements.  Using Henry Mintzberg’s (Mintzberg 2007) (Mintzberg 1994) five 
‘strategic forms’ as the analytical framework, the overview highlighted four underlying 
tensions.  
 
First, in setting direction, it was apparent that there was an ongoing disconnect 
between the strategic objective and goals, which expressed an aspiration to reduce the 
harm to individuals, families and society from illicit drugs, and the operational 
objectives and key performance indicators, some of which directed effort towards the 
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prohibition of the illicit drug market and the achievement of a drug-free society. Two 
activities were proposed  to help ensure effective management of this ambiguity – the 
formulation of a more rigorous system of performance measurement, for example a 
drug harm index, and more integrated performance through focusing on the 
measurement and evaluation of outputs and outcomes, rather than inputs and 
processes. 
 
Second, with regard to the making of strategic choices, the overview identified two 
broad information types – scientifically derived, or evidence-based, information, and 
public opinion. These two streams of information reflect the rational and the non-
rational aspects of the decision-making process. The overview outlined how 
considerable effort has gone into building up the evidence base, but little 
comprehensive, systematic, scientific investigation of the nature of public opinion and 
the role of the media, has been undertaken. Furthermore, while there have been 
significant strides in building the evidence base, there have been gaps in the use of 
overt analytical, modelling or evaluative methods in policy development. 
 
Third, an exploration of the co-ordination of the NDS 2001–2008, and the allocation of 
responsibilities to individual entities for implementation, had highlighted complex 
governance issues. The recent OECD review of the Irish public service (Organisation 
for Economic Co-Operation and Development 2008) suggested ways of overcoming 
such tensions, for example through adopting networked organisational forms and 
integrated performance management systems.  
 
Fourth, during the lifetime of the NDS 2001–2008, changes in the external environment 
had been amenable to control through means such as project planning, the mid-term 
review of the NDS, and the creation of the Emerging Needs Fund. Other changes, 
however, usually in the wider public policy environment, had had a more oblique 
connection to the NDS. It was not clear whether or how the intention behind initiatives, 
such as shifts in social inclusion policy or the introduction of drug testing in various 
contexts, had been compared with, or assessed against, the intentions behind the 
NDS. The overview canvassed steps to develop a system of strategic control that 
would encompass both emerging and intended strategies.   
 
In conclusion, it was argued that it was essential to recognise that no amount of 
strategic planning and strategic control can eliminate uncertainty entirely. In order to 
realise a strategy as intended, the strategic manager needs to see strategy 
development as a continuous process, based on ‘real-time learning-formation’ rather 
than on ‘prior formulation’. To capture and work with this tendency to complexity and 
instability, it was deemed important that the strategic manager (1) recognise the 
tensions and conflicts inherent in strategy and work with these, rather than seek to 
reduce the instability by focusing on what is amenable to control, and (2) foster and 
encourage continuous and inclusive debate and deliberation on the direction and 
contents of strategy as a means of discovering new options and resolving critical 
strategic tensions. 
 
In March 2009 the Comptroller and Auditor-General published a report Drug addiction 
treatment and rehabilitation (Comptroller and Auditor General and Department of 
Community Rural and Gaeltacht Affairs 2009). The objective of the study was to review 
the value-for-money (VFM) of drug treatment and rehabilitation services. It looked at all 
the main publicly-funded treatment and rehabilitation services provided for persons with 
addiction to illicit drugs. The findings are discussed later in this report (see section 
5.3.1).  
 
With regard to monitoring of and reporting on the NDS 2001–2009, the report found 
that focus had been on the extent to which various actions outlined in the strategy had 
been implemented, rather than on the extent to which planned outputs and outcomes 
had been delivered. It acknowledged that the National Advisory Committee on Drugs 
(NACD) had undertaken research into aspects of drug misuse such as homelessness 
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or family support. However, while this type of study provided benchmarks and context 
measures for performance monitoring and reporting, the authors argued that it did not 
represent a substitute for routine reporting on achievement of outputs and outcomes. 
The authors made several recommendations with regard to monitoring and evaluation: 
 
Service levels established: all treatment and rehabilitation projects should be governed 
by service level agreements that specify the services to be provided and the standards 
to be met. 
 
Outcomes monitored: while a focus on implementing actions is necessary, it needs to 
be supplemented with programme achievement information so that the effect of those 
actions can be gauged. 
 
Costs monitored: there is a need for greater transparency on the cost of treatment and 
rehabilitation services. Performance in terms of both targets achievement, and 
budgetary outcomes, should be reported regularly. 
 
1.3.2 Other drug policy developments e.g. government declaration, civil society 
initiatives 
In 2007 a life-cycle approach to the framing of social inclusion policy was adopted in 
Ireland. Illicit drug misuse fitted into the new life cycle approach under the childhood, 
youth and people of working age stages, and under the additional heading 
‘Communities’ (for full account of change, see Section 1.3.2 of  the 2007 National 
Report   (Alcohol and Drug Research Unit 2007). In October 2008 Ireland’s Economic 
and Social Research Institute (ESRI) hosted an international seminar on the life cycle 
approach to social inclusion. The seminar marked the publication of the ESRI’s 
research into the role that life cycle factors play in shaping patterns of poverty and 
social exclusion in contemporary Irish society (Whelan and Maître 2008b). 
Observing that the life cycle approach had been introduced without any systematic 
effort to link its use to the broader literature on the concept, or any detailed 
consideration of how it should be operationalised, the authors explained (Whelan and 
Maître 2008a) how the life cycle approach to social inclusion marked a shift in 
perceptions of the nature of risk. Traditionally, social policy interventions had focused 
on risks associated with unemployment, disability, and insufficient resources in 
childhood and old age, and had tended to redistribute resources across the life cycle, 
from working age groups to children and to older people. More recently, social policy 
interventions within the life cycle approach had begun to focus on risks faced by 
specific sub-groups at particular stages in their lives, for example risks associated with 
entering the labour market, remaining in the labour market, or managing care 
responsibilities.  
The authors commented that while the life cycle approach offers a set of lenses 
through which to focus on the issues, it does not offer a ready-made set of 
prescriptions: a ‘general analytic framework that accounts for the dynamics and the 
links between events and the appropriate analytic tools’ is needed. To fully understand 
the nature of the dynamic inter-related risks require the mapping of social exclusion 
patterns across the life cycle, and an understanding of the manner in which they 
combine with other socio-economic characteristics. To this end, the authors called for 
longitudinal studies, which would support research into the consequences of various 
policies and interventions for life cycle outcomes, and would play a critical role in 
translating the life cycle perspective into specific forms of policy evaluation and 
prescription.  
1.3.3 Co-ordination 
Compared to the co-ordination arrangements in place for the NDS 2001–2008, those to 
support the implementation of the NDS 2009–2016 are greatly simplified and 
streamlined (see Figure 1.3.2). A new Office of the Minister for Drugs (OMD) will 
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incorporate the work and functions of both the Drugs Strategy Unit (DSU) in DCRGA 
and the National Drugs Strategy Team (NDST) and will report directly to the Cabinet 
Committee on Social Inclusion, Children and Integration (CCSICI). The direct reporting 
line to the CCSICI and use of a ‘networked organisational’ structure in the OMD will 
preclude the need for an Interdepartmental Group on Drugs (IDG), which will be 
reconstituted as an Oversight Forum on Drugs (OFD).   
 
 
 
  
 
    
 
 
 
 
 
 
 
   
   
             
 
 
 
 
 
    
                                             
 
Figure 1.3.2    Co-ordination arrangements for the NDS 2009–2016 (after (Department of Community Rural and 
Gaeltacht Affairs 2009): Table 6.14) 
 
Assessing progress under the NDS 2001–2008, the Steering Group that drafted the 
new NDS found that 20 out of 22 actions to support co-ordination had been 
implemented, the key performance indicators relating to co-ordination reached, and the 
co-ordination arrangements had ‘stimulated and promoted inter-agency working in a 
difficult cross-cutting policy and service area’ (para. 6.7). However, the Steering Group 
also found that there were ‘capacity and structural limitations’, which were limiting 
ability to meet the new challenges including:  
° accounting for expenditure; 
° governance; 
° mainstreaming; 
° capacity of services to meet client needs; and 
° monitoring/evaluation. 
 
The need was identified to establish a structure which would:     
° support and drive the ongoing implementation of the NDS, while respecting the 
various lead roles and statutory responsibilities of the departments/agencies 
involved; 
° provide a more cohesive and integrated framework that promotes closer co-
operation and accountability between the different players, as well as greater 
transparency for expenditure; and 
° provide a clear hierarchy and a greater transparency of the roles from the 
Government and Cabinet Committee on Social Inclusion, Children and Integration to 
the local project level. 
 
Table 1.3.4  Key design features of the new Office of the Minister for Drugs (OMD) 
 
Responsibilities 
 
 
Operating Principles 
 
Resourcing 
° national co-ordination 
° policy development 
° supporting the work of  the 
NACD 
° supporting the community 
and voluntary sectors 
° local responses to local 
need based on local 
planning and decision 
making 
° community representation 
and involvement 
The OMD will be staffed by the 
current staff  of the DSU and the 
NDST. Some 12 officers at 
Assistant Principal level from the 
various government departments 
and state agencies with 
Government 
Cabinet Committee on Social Inclusion, 
Children and Integration (CCSICI) 
Minister/Office of the Minister for 
Drugs (OMD) 
National Advisory 
Committee on 
Drugs (NACD) 
Oversight Forum on Drugs 
(OFD) 
Statutory Agencies Drugs Task Forces (DTFs) 
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Responsibilities 
 
Operating Principles Resourcing 
° co-ordinating Irelands 
input to the EU, UN and 
other international for a 
regarding the rug issues 
° partnership between 
community, voluntary and 
statutory sectors 
° direct linkages between 
local and national 
structures 
° direct linkages between 
local and national policy 
responsibilities under the NDS will 
also be assigned on a half time 
basis for a minimum of three years. 
These staff will work with the OMD, 
and protocols to reflect their 
ongoing roles will be drawn up. 
These staff will also continue to 
work within their parent 
Departments and agencies to seek 
to positively influence policy, 
programme activity and resource 
allocation in regard to drug issues. 
 
The design of the OMD (Table 1.3.4) resembles the networking model promoted in a 
recent OECD review of the Irish public sector (Organisation for Economic Co-Operation 
and Development 2008). The OECD review described the Office of the Minister for 
Children and Youth Affairs (OMCYA), established in 2005, where staff from different 
government departments (including Health, Education and Justice) had been brought 
together in one location (the Department of Health and Children) to work in a 
networked way on issues of strategic national importance with regard to children. The 
review’s observations on the OMCYA may be applied equally to the new OMD: 
 
Policies that cut across the function responsibility of a number of departments 
can lead to difficulties in determining who is the overarching ‘owner’ 
accountable for the service provided. The work to date by the OMC has 
demonstrated that there is value in ensuring that units, such as the Irish Youth 
Justice Services, remain connected to their parent department (Department of 
Justice, Equality and Law Reform). This ensures that they have ongoing 
interaction with, and input to the development of policies targeted at children 
while also ensuring that accountability for the services they deliver remains 
within the remit of their Minister.  This guarantees that historical mismatches 
between children’s policy and youth justice policy can be addressed. (pp. 241–
242)  
 
To support integration, the Steering Group recommended an Oversight Forum on 
Drugs (OFD) to replace the Interdepartmental Group on Drugs (IDG). Comprising the 
same membership, its primary role will be the high-level monitoring of progress being 
achieved across the strategy and agreeing appropriate ways forward where issues are 
blocked or progress is being impeded.  It will also provide a forum for discussion and 
feedback on issues relating to problem drug use that arise in EU and international 
arenas. The Steering Group proposed two additional mechanisms to support the new 
integrative role of the OMD: (1) an Advisory Group of the OMD, comprising 
representatives of the statutory, voluntary and community sectors, to advise the 
Minister on operational and policy matters relating to the NDS; and  (2) twice-yearly 
bilateral meetings between the Minister for Drugs and the Director of the OMD, on the 
one hand and key stakeholders on the other hand. The Steering Group believed these 
meetings would help to keep a focus on drug-related issues and the broader 
implementation of the NDS.   
 
The National Advisory Committee on Drugs (NACD) is to be co-located with the OMD 
and the Director of the NACD is to become a member of the senior management team 
in the OMD. While acknowledging the need for the NACD to be ‘independent’ in regard 
to research, the Steering Group stated that the closer alignment with the OMD will 
‘better address the issue of linkages between policy development and research’. 
Local and regional drugs task forces (DTFs) will now report to the OMD for all activities, 
outputs and expenditures. Priorities for the new OMD with regard to the DTFs will 
include: 
° considering reporting and accountability arrangements for DTF projects with a view 
to simplifying the system; 
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° examining the feasibility of achieving the optimum structure for the employment 
arrangements of DTF personnel; 
° reviewing  and renewing the commitment and participation of all members of DTFs, 
including the position of chairperson; and 
° updating the handbook  for the operation of DTFs to take account of the new 
structural arrangements and include guidelines on mainstreaming. 
 
The NDS notes that the National Drugs Rehabilitation Implementation Committee will 
also be ‘closely linked’ to the OMD. 
 
 
1.4 Economic analysis 
1.4.1 Public expenditures 
 
The most recent information available on public expenditure on drugs in Ireland is for 
the year ended 31 December 2008 (Table 1.4.1). It relates to labelled, that  is directly 
drug-related, public expenditure. It represents a 13 % increase over 2007 labelled 
public expenditure, which, in turn, represents an 8 % increase over 2006 spending.  
 
Table 1.4.1 Public funding directly attributable to drugs programmes, 2006–2008 
Department/Agency Allocation 2006 
(€ million)* 
Allocation 2007 
(€ million)** 
Allocation 2008 
(€ million)*** 
Dept of Community, Rural and Gaeltacht Affairs 43.000 51.518 65.207 
Department of Health and Children 0.978 0.984 1.033 
Health Service Executive 85.053 83.177 101.867 
FÁS (National Training Agency) 18.600 18.700 18.800 
Department of Education and Science 12.140 12.270 12.386 
Dept of Environment, Heritage and Local Govt 0.461 0.481 0.496 
Dept of Justice, Equality and Law Reform 9.530 12.890 8.790 
Irish Probation Service n.a.  n.a.  2.897 
Irish Prison Service 5.000 est.  5.000 est. 5.000 
Garda Síochána  33.400 38.800 38.800 
Revenue’s Customs Service 6.525 8.581 9.000 
Department of Foreign Affairs**** 1.140 1.400 n.a.  
Total 214.687  232.401 264.276 
n.a. = not available 
* Source : (Alcohol and Drug Research Unit 2007) This total excludes expenditure by the Department of Foreign Affairs. 
** Source: (Curran 2008, 3 December)5 This total excludes expenditure by the Department of Foreign Affairs. 
*** Source: National Drugs Strategy 2009–2016: Table 6.3 (Department of Community Rural and Gaeltacht Affairs 2009). This total 
excludes expenditure by the Department of Foreign Affairs. 
**** Source: (Martin 2009, 26 May)6  
 
Preliminary estimates for 2009 indicated that spending across all departments would 
be maintained at the 2008 level (Moloney 2009, 5 March). However, on 6 April 2009, in 
response to the continuing decline of the Irish economy and the need to achieve a 
‘prudent fiscal outturn’ for 2009, the government introduced an emergency budget. This 
reduced expenditures across all government departments and state agencies. Details 
of reductions in drug-related spending across government departments and agencies 
in 2009 are not yet available except in respect of the Drugs Initiative administered by 
the Department of Community, Rural and Gaeltacht Affairs (DCRGA).  DCRGA’s drug-
related budget dropped from €65.207 million in 2008 to €40.611 million in 2009; this 
was attributed in part to the transfer of funding for the Young People’s Facilities and 
Services Fund (YPFSF) to the Office of the Minister for Children and Youth Affairs 
(OMYCA) (Curran 2009, 26 May).  
 
                                                
5 In presenting the figures, Minister of State with responsibility for the Drugs Strategy, John Curran TD, 
explained Curran, J. (2008, 3 December) Parliamentary Debates Dáil Éireann Official Report: Unrevised. 
Vol. 669, No. 3, p. 675, PDF version. Available at www.gov.ie/oireachtas/frame.htm ‘ …there are a number 
of Departments and agencies involved in the implementation of the National Drugs Strategy. However, the 
level of State funding on drug-related issues can be difficult to estimate as the costs associated with 
services provided by An Garda Síochána, the Prison Service, the HSE [Health Service Executive] and 
others deal with drug misuse as part of their wider daily services.’ 
6 This funding represents Ireland’s voluntary contribution to support the work of the United Nations Office 
on Drugs and Crime (UNODC).  
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The UN’s statistical framework COFOG and Peter Reuter’s (Reuter 2004) ‘effects of 
interventions’ framework, first applied to Ireland’s  labelled drug-related public 
expenditure for 2005, as reported in the Selected Issue ‘Public expenditure on drugs’ 
(Alcohol and Drug Research Unit 2007), has not been applied to the 2006–2008 data.  
Although it is believed that it would reveal a similar pattern of drug-related public 
expenditure, the analysis has not been repeated as there were significant gaps in the 
original data that have not yet been filled.  Recent evidence suggests, however, that 
such gaps can be addressed. Specifically:  
 
Budgeting and financial reporting systems: The Selected Issue on public expenditure 
on drugs in Ireland in 2005 (Alcohol and Drug Research Unit 2007) commented that 
many government departments and agencies did not capture and report the necessary 
data. However, the recent VFM study by the Comptroller and Auditor-General 
(Comptroller and Auditor General and Department of Community Rural and Gaeltacht 
Affairs 2009) demonstrated that it is possible to break down drug-related public 
expenditure by service provider and/or function (Table 1.4.2).  
 
Table 1.4.2  Estimated funding of drug addiction treatment and rehabilitation services, 2007* 
Department/Agency €m 
 
€m 
HSE/hospital clinic treatment services  58 
Drug Treatment Centre Board services   10 
Primary care-based methadone treatment   14 
Community and voluntary sector treatment and rehabilitation services   
      Section 65 funding — HSE  12  
      Mainstreamed drug task force projects — HSE  8  
      Interim drug task force projects — DCRGA/HSE/FAS/Probation Service  16  
     Probation service grants  3 39 
Prison drug treatment and rehabilitation  3 
FÁS Community Employment schemes  16 
Total expenditure on drug treatment and rehabilitation  140 
* Source: (Comptroller and Auditor General and Department of Community Rural and Gaeltacht Affairs 2009): Table 8.4  
 
Non-governmental functions: The Selected Issue on drug-related public expenditure 
(Alcohol and Drug Research Unit 2007) noted that, while a large tranche of public 
money (€33.962 million) was voted for the central government function of ‘community 
development’, this same money was then disbursed for expenditure on a range of 
regional or local programmes or projects that would be more accurately coded as 
health-related or education-related functions.  The need to define the nature of these 
disbursements was noted. The Comptroller and Auditor General’s report again 
revealed that it is possible to obtain this type of detail. Thus, with regard to interim-
funded LDTF projects in 2007 administered by DCRGA (€27.2 million), €15.6 million 
was spent on treatment and rehabilitation, and €11.6 million on education, drug 
prevention etc. The Comptroller and Auditor General’s report did not provide a 
breakdown of mainstreamed LDTF projects but responses to recent Parliamentary 
Questions show that individual government departments, which administer the 
‘mainstreamed’ projects, can account for these projects. For example, in 2007 the 
Department of the Environment, Heritage and Local Government funded five 
mainstreamed LDTF projects worth €0.481 million (Finneran 2009, 26 May), while  the  
Department of Education and Science funded  38 projects worth €3.621 million 
(O'Keeffe, B. 2009, 26 May).  
 
In addition to labelled expenditure, there is an unquantified level of unlabelled 
expenditure on the illicit drugs issue in Ireland, that is through programmes not 
specifically targeted at the illicit drugs issue. The Selected Issue on public expenditure 
on drugs in 2005 (Alcohol and Drug Research Unit 2007) did not attempt to estimate 
non-labelled drug-related public expenditure. However, responses to a recent series of 
Parliamentary Questions seeking information on departmental expenditure on tackling 
problematic alcohol and illicit drug use in the past three years yielded information on 
non-labelled drug-related public expenditure over and above the health and criminal 
justice systems. Again, this data demonstrates that the capacity exists to identify 
unlabelled expenditure. 
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° Department of Arts, Sport and Tourism (DAST): Various funding schemes and 
programmes in the sports and arts sectors are believed to assist in tackling the illicit 
drugs problem by encouraging healthy lifestyles through sport and recreation and 
promoting personal and social development. For example, the Code of Ethics and 
Good Practice for Children’s Sport, which has been disseminated to sports clubs 
and in respect of which the Irish Sports Council has organised training courses, 
discourages the use of drugs, alcohol and tobacco. However, it is not deemed 
practicable to estimate the portion of the funding which achieves positive substance 
misuse outcomes (Cullen, M. 2009, 26 May). 
° Department of Education and Science (DES): Its substance misuse prevention 
education contributes to the overall aim of Government policy in relation to drugs. At 
primary level, the Substance Misuse Prevention Programme (SMPP or ‘Walk Tall’ 
Programme) is a national programme, which provides in-service to teachers in 
primary schools in the area of legal and illegal substances. The programme teaching 
and resource materials focus on both alcohol and drugs in an age appropriate 
manner. The programme has an integrated approach to drug education and is a key 
strategy in drug abuse prevention education. Teaching and resource materials 
developed by the ‘Walk Tall’ Programme are made available to all primary and 
special schools nationally. In 2007, it had a budget of €420,557. In addition, 
substance misuse prevention education is implemented as part of SPHE in all 
primary and post-primary schools and is a mandatory part of the curriculum at 
primary and junior cycle in second level. The overall cost of SPHE in 2007 was 
€202,000. It received matching funding from the Health Service 
Executive/Department of Health and Children (O'Keeffe, B. 2009, 26 May). 
° Department of Foreign Affairs (DFA): Under the Emigrant Support Service, the 
government has over the past three years allocated funding totalling over €41 million 
to support Irish communities overseas, including €15.183 million in 2008. The focus 
of this funding is on supporting voluntary sector organisations engaged in the 
delivery of key frontline welfare services to Irish communities abroad. These 
services target the most vulnerable including the elderly, the homeless and those 
suffering addiction. The Minister commented: ‘Many of our most vulnerable 
emigrants experience a range of interlinked challenges, requiring the Government 
funded organisations to provide broad outreach services, which can include 
responses to alcohol or drug abuse. It is not possible, however, to provide specific 
figures on this programme’s annual spend on alcohol and illegal drug use.’ (Martin 
2009, 26 May) 
° Department of Social and Family Affairs (DSFA): The Family and Community 
Services Resource Centre Programme operated by the Family Support Agency, 
which is under the auspices of the DSFA, supports over 100 Family Resource 
Centres (FRCs) nationwide. The 2009 budget for this budget is over €18 million. 
While the FRCs do not have a specific remit to tackle problematic alcohol or drug 
use, providing support to families experiencing such problems is one of the services 
provided (Hanafin 2009, 26 May).  
 
The Steering Group that drafted the NDS 2009–2016 called for a planning and 
reporting system, incorporating both statutory and community and voluntary bodies, 
that will, when implemented, go a long way towards providing the desired detail on 
Ireland’s public expenditure on drugs (para. 6.61):  
° an overall performance management framework to be developed by the OMD, in 
consultation with relevant Departments and agencies, to assess and monitor 
progress across the NDS; 
° a mechanism to be put in place whereby relevant departments and agencies outline 
their proposed budgets for drug-related initiatives to the Minister of State, in the 
context of the annual Estimates process;  
° departments and agencies to report to the OMD on their expenditure, outputs and 
outcomes twice a year, in an agreed format; 
° departments and agencies to incorporate their envisaged contribution to the work of 
the National Drugs Strategy in their Statements of Strategy and Business Plans and 
to report on the associated outputs and outcomes in their annual reports;  
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° DTFs to report to the OMD for expenditure and activity relating to their projects twice 
a year, and to produce an annual statement, in an agreed format, giving an 
assessment of the work and outputs of their projects – and their broader strategic 
and co-ordinating work – in the previous 12 months;  
° the OMD to establish on-going liaison with DTF projects in regard to their overall 
work and activities, as well as their channels of funding; and  
° the OMD to produce an annual report of progress of the services and structures 
under its direct influence, and a report of the progress of the overall strategy every 
two years. 
 
1.4.2 Budget 
The structure of funding arrangements to address the issue of illicit drugs remains the 
same as in previous years and the proportionate levels of allocation are also similar. 
However, there have been several small adjustments that reflect strategic shifts in the 
approach to tackling the drugs issue, specifically among young people and in the way 
that families are supported. 
 
On 1 January 2009 the Young People’s Facilities and Services Fund (YPFSF) was 
transferred from DCRGA, where it was administered by the Drugs Strategy Unit, to the 
OMCYA. The object of the transfer is to assist in ensuring the most strategic use of this 
fund and other youth programmes under the remit of the OMCYA and to provide a 
cohesive and comprehensive response to the needs of all young people, including 
those at risk of drug misuse. The direction, purpose, objectives etc of the fund and the 
administration arrangements remain the same. 
 
At national level, a National Assessment Committee (NAC), currently chaired by the 
Office of the Minister for Children and Youth Affairs, monitors the fund in line with the 
criteria that would apply in relation to approving applications for funding at the level of 
local plans and projects.  The current composition of the NAC includes representatives 
of the departments of Community, Rural and Gaeltacht Affairs, of Justice, Equality and 
Law Reform, and of Environment, Heritage and Local Government; community and 
voluntary representatives; and a representative from Dublin City Council and from City 
of Dublin Youth Services Board (CDYSB).  
 
In recent years the role of families in tackling the drugs problem has become 
increasingly recognised and funding has followed. The mid-term review of the NDS 
2001–2008 (Steering Group for the Mid-Term Review of the National Drugs Strategy 
2005) called for the development of family support services and support for family 
support networks in the areas of information provision and assistance to local family 
support groups. Budget provisions have been made as follows: 
° In 2007 the Family Support Network (FSN), established in 2000 under the auspices 
of Citywide Drugs Crisis Campaign, gained recognition as an autonomous national 
organisation.  Its aim is to improve the situation of families coping with drug use by 
developing, supporting and reinforcing the work of family support groups and 
regional family support networks, by working for positive change in policy and 
practice and by raising public awareness about the problem of drugs for families and 
communities. It is funded through the Drugs Strategy Unit of the DCRGA and the 
Family Support Agency of the Department of Social and Family Affairs.  
° As noted above (Section 1.4.1), over 100 Family Resource Centres (FRCs) 
throughout the country, also funded by the Family Support Agency (€18 million in 
2009), while not having a specific remit to tackle problematic alcohol or drug use, 
provide support to families experiencing such problems (Hanafin 2009, 26 May).   
° In late April 2009, following the emergency budget in early April, the government 
announced the allocation of €1.56 million through the Dormant Accounts Fund for 
substance misuse projects, specifically to support 80 projects intended to expand 
the provision of family support services (Ó Cuív 2009).  
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1.4.3 Social costs 
No studies of the social cost of drug use have been undertaken in Ireland. However, in 
the past decade or so, there have been significant advances in the collection of data 
relating to the drug problem in Ireland, which would yield data relevant to such a study. 
Several one-off studies have also been undertaken, which, in the absence of system-
level data, would help in the estimation of economic values.  
 
Data collection relevant to the social and economic costs of the use of illicit drugs in 
Ireland is most developed in the health sector, with data available on both directly drug-
related treatment and also on comorbidity and trauma associated with drug misuse. In 
recent years initiatives have been taken to collect data on premature mortality and 
morbidity attributable to drug misuse and these data are relevant to estimating the 
economic impacts of illicit drug use on employment and productivity. In relation to drug-
related crime, in 2006 the Central Statistics Office assumed responsibility for the 
compilation of statistics on law enforcement and criminal justice, including drug-related 
offences. However, gaps still exist in these areas.   
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2. Drug Use in the General Population and Specific Targeted 
Groups 
 
2.1 Introduction 
Drug prevalence surveys of the general and school-child population are important 
sources of information on the patterns of drug use, both demographically and 
geographically and, when repeated, can track changes over time. In Ireland such 
surveys are conducted every three to four years. These surveys help to increase our 
understanding of drug use, and to formulate and evaluate drug policies. They also 
enable informed international comparisons provided countries conduct surveys in a 
comparable manner. The four main data collection tools are listed below. 
 
An All Ireland Drug Prevalence Survey was initiated in 2002 by the National Advisory 
Committee on Drugs (NACD) in Ireland and the Public Health Information and 
Research Branch (PHIRB), formerly known as the Drug and Alcohol Information and 
Research Unit (DAIRU), within the Department of Health, Social Services and Public 
Safety (DHSSPS) in Northern Ireland. The main focus of the survey is to obtain 
prevalence rates for key illegal drugs, such as cannabis, ecstasy, cocaine and heroin, 
on a lifetime (ever used), last year (recent use), and last month (current use) basis. 
Similar prevalence questions are also asked of alcohol, tobacco, and other drugs such 
as sedatives, tranquillisers and anti-depressants. Attitudinal and demographic 
information is also sought from respondents.  
 
The questionnaire and methodology for this drug prevalence survey are based on best-
practice guidelines drawn up by the EMCDDA. The questionnaires are administered 
through face-to-face interviews with respondents aged between 15 and 64 normally 
resident in households in Ireland and Northern Ireland. Thus persons outside these age 
ranges, or who do not normally reside in private households, have not been included in 
the survey. This approach is commonly used throughout the EU and because of the 
exclusion of those living in institutions (for example, prisons, hostels) this type of 
prevalence survey is usually known as a general population survey. 
 
The first iteration of this general population drug prevalence survey was undertaken in 
2002/3, and a second iteration in 2006/7. A series of bulletins reporting the findings of 
the 2002/3 iteration have been published, and a second series of bulletins reporting the 
findings of the 2006/7 iteration have also been published.  As with other European 
surveys, people over the age of 64 are excluded from this survey, as they grew up in 
an era when both the use and availability of illegal drugs were very limited. Therefore 
surveys with older people have, to date, shown very low rates of use even on a lifetime 
basis. This situation will change over time as the younger population grows older. 
Hence lifetime prevalence rates are likely to increase for a considerable period of time. 
When examining the data and comparing results over time, last-year use is the best 
reflection of changes as it refers to recent use. Last-month use is equally valuable as it 
refers to current use. 
 
This chapter presents a summary of the survey findings estimating the prevalence of 
drug use among the general population in 2006/7 and compares these findings with 
those of the 2002/3 survey.  One in four people in Ireland used an illicit drug at some 
point in their life in 2006/7 and one in five used cannabis. Cocaine use increased in 
2006/7 compared to 2002/3. The proportion of adults who reported using cocaine 
(including crack) at some point in their lives increased from 3% in 2002/3 to 5% in 
2006/7.  
 
The Survey of Lifestyles, Attitudes and Nutrition (SLÁN) is a national survey of the 
lifestyles, attitudes and nutrition of people living in Ireland. To date surveys have been 
carried out in 1998, 2002 and 2007. Adults aged 18 years and older living in private 
households have been included. SLÁN 1998 and SLÁN 2002 were postal surveys, 
based on samples from the Electoral Register, involving 6,539 respondents in 1998 
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(62% response rate) and 5,992 in 2002 (53% response rate). SLÁN 2007 involved 
10,364 respondents in face-to-face interviews at home addresses, based on samples 
from the GeoDirectory (62% response rate). All three SLÁN surveys have covered 
themes of health and social status, and related health service use.  In April 2008 the 
Department of Health and Children published the report on SLÁN 2007. In general, 
these data are not comparable with the result of the 2006/7 general population drug 
prevalence survey as the SLÁN survey excludes those aged between 15 and 17 years 
and includes those aged over 65 years. 
 
The Health Behaviour in School-aged Children (HBSC) is a cross-national research 
study conducted in collaboration with the WHO Regional Office for Europe. The study 
aims to gain insights into, and increase our understanding of, young people's health 
and well-being, health behaviours and their social context. HBSC was initiated in 1982 
and is conducted every 4 years.  It is a school-based survey with data collected 
through self-completion questionnaires administered by teachers in the classroom.  
 
The Health Promotion Research Centre, National University of Ireland, Galway was 
invited to join the HBSC network in 1994 and conducted the first survey of Irish 
schoolchildren in 1998; the survey has been repeated in Ireland in 2002 and 2006. 
HBSC Ireland surveys school-going children aged 10-18 years. To obtain the Irish 
HBSC participant sample, lists of primary and post primary schools are obtained from 
the Department of Education and Science, and schools across the country are 
randomly selected and invited to participate. The HBSC survey instrument is a 
standard questionnaire developed by the international research network and used by 
all participating countries. Each survey questionnaire contains a core set of questions 
looking at background factors, individual and social resources, health behaviours and 
health outcomes. Questions about smoking, alcohol use and cannabis use are asked 
under the heading of health behaviours.  
 
The 2006 HBSC survey found that,16% of children reported using cannabis during 
their lifetime, compared with 12% in 2002. Cannabis use was highest among those 
aged 15–17, with about one in five in this age group using cannabis in the previous 12 
months.  
 
The European School Survey Project on Alcohol and Other Drugs (ESPAD) is a 
collaborative effort of independent research teams in about 40 European countries. 
Data has been collected every four years since 1995, using a standardised method 
and a common questionnaire.  The fourth data collection was carried out in 35 
countries during the spring of 2007 and the results were published in March 2009. The 
Swedish Council for Information on Alcohol and Other Drugs (CAN) initiated the project 
in 1993. Support has been provided by the Pompidou Group at the Council of Europe, 
the Swedish Ministry of Health and Social Affairs, the Swedish National Institute of 
Public Health and the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). The data collections in the individual countries are funded by national 
sources. The rationale for the survey is that school students are easily accessible and 
are at an age when onset of substance use is likely to occur. (By definition, early 
school leavers, a group known to be vulnerable to alcohol and drug use, are not 
represented.)  
The fourth survey was conducted in 35 European countries during 2007 and collected 
information on alcohol and illicit drug use among 15-16-year-olds; 2,249 students from 
94 randomly-selected schools participated, which represents a response rate of 78%. 
Fewer schools and students participated in 2007 than in 2003.  
 
On 26 March 2009, the findings of the fourth European School Survey Project on 
Alcohol and Other Drugs (ESPAD) were published.  In terms of drug use, the Irish 
data show a marked decrease in lifetime use of any illicit drug between 2003 (40%) 
and 2007 (22%). As the majority of those who have tried any illicit drug have used 
cannabis (marijuana or hashish), the decrease in illicit drug use was influenced by the 
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considerable decrease in the number of students who had tried cannabis at some point 
in their lives, from 39% in 2003 to 20% in 2007 (European average 19%).  
 
 
2.2 Drug use in the general population 
2.2.1 Drug use in the general population, 2006/7: repeat survey 
On 25 January 2008, the National Advisory Committee on Drugs (NACD) and the Drug 
and Alcohol Information and Research Unit (DAIRU) in Northern Ireland published 
jointly the results of the second all-Ireland general population drug prevalence survey 
(National Advisory Committee on Drugs and Drug and Alcohol Information and 
Research Unit 2008a).  
 
The Irish survey followed best practice guidelines recommended by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The questionnaire, based 
on the ‘European Model Questionnaire’, was administered in face-to-face interviews 
with respondents aged between 15 and 64 years normally resident in households in 
Ireland and Northern Ireland. With the exception of two questions and two show cards, 
the questionnaire employed for the 2006/7 survey was the same as that used in 
2002/3. Fieldwork was carried out by MORI MRC during late 2006 and early 2007. The 
final achieved sample was 4,967 in Ireland. This represented a response rate of 65%. 
The sample was weighted by gender, age and region to ensure that it was 
representative of the general population. The main measures of use were lifetime (ever 
used), use in the last year (recent use) and use in the last month (current use). The 
detailed methodological background to the general population survey on drug use and 
the results are presented in Standard Table 1. 
 
The proportion of adults (aged 15–64 years) who reported using an illegal drug in their 
lifetime increased by five percentage points, from 19% in 2002/3 to 24% in 2006/7 
(Table 2.2.1). The proportion of young adults (aged 15–34 years) who reported using 
an illegal drug in their lifetime also increased by five percentage points, from 26% in 
2002/3 to 31% in 2006/7. As expected, more men reported using an illegal drug in their 
lifetime than women.  
 
The proportion of adults who reported using an illegal drug in the last year increased 
marginally, from 6% in 2002/3 to 7% in 2006/7 (Table 2.2.1). The proportion of young 
adults who reported using an illegal drug in the last year increased from 10% in 2002/3 
to 12% in 2006/7. The proportion of adults who reported using an illegal drug in the last 
month remained stable. The findings with regard to cocaine and cannabis are 
discussed in sections 2.2.3 and 2.2.4 below. 
 
Table 2.2.1   Lifetime, last-year and last-month prevalence of illegal drug use in Ireland, 2002/3 and 2006/7 
Illegal  
drug use* 
Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime 18.5 24.0 24.0 29.4 13.1 18.5 26.0 31.4 
Last year  5.6 7.2 7.8 9.6 3.4 4.7 9.7 12.1 
Last month 3.0 2.9 4.1 4.3 1.7 1.4 5.2 4.8 
* Illegal drugs in this context are amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers 
and solvents. 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005c) (National Advisory 
Committee on Drugs and Drug and Alcohol Information and Research Unit 2008a) 
 
Nine per cent of young adults claimed to have tried ecstasy at least once in their 
lifetime in 2006/7 (Table 2.2.2).  
 
 
 
 
 
 
  48
Table 2.2.2   Lifetime, last-year and last-month prevalence of ecstasy use in Ireland, 2002/3 and 2006/7 
Ecstasy use Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 
Lifetime 3.7 5.4 4.9 7.2 2.6 3.6 7.1 9.0 
Last year  1.1 1.2 1.7 1.8 0.5 0.6 2.0 2.4 
Last month 0.3 0.3 0.7 0.5 0.0 0.2 0.6 0.6 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005c) (National Advisory 
Committee on Drugs and Drug and Alcohol Information and Research Unit 2008a) 
 
The considerable increase in the proportions using any illegal drug at some point in 
their lives was influenced by the facts that drug use in Ireland is a recent phenomenon 
and that the population of lifetime and recent drug users in Ireland is relatively young. 
Drug use is measured among adults aged 15–64, and those leaving this age group 
over the next fifteen to twenty years are less likely to have been exposed to drug use 
than those entering the measurement cohort.  
 
When compared to the 19 other countries that completed a general population survey 
on drug use using the European model questionnaire, Ireland ranks seventh highest 
for lifetime use of cannabis, fourth for lifetime use of amphetamines, fourth for use of 
cocaine, third for ecstasy and third for LSD.   
 
2.2.2 Drug use among the general population in regional drugs task force areas 
On 25 June 2008, the NACD published (National Advisory Committee on Drugs 2008) 
a bulletin outlining drug prevalence data for 2006/7 by Regional Drug Task Force 
(RDTF) area.  As expected, the use of illegal drugs was lowest in the north-west and 
highest in the east of the country (Table 2.2.3).  
 
With regard to lifetime use, the following findings are notable: 
° Cannabis was the most commonly reported illegal drug in each of the RDTF 
areas, with proportions ranging between 13% in the North West and 36% in the 
East Coast areas (Table 2.2.4).  
° Ecstasy was among the four most commonly reported drugs in each of the RDTF 
areas, with proportions ranging between 2% in the North West and 11% in North 
Dublin (Table 2.2.5).  
° Cocaine was among the top four drugs ever used by the survey respondents in all 
areas except the North West (Table 2.2.6).  Lifetime cocaine use was highest in 
the North Dublin and East Coast areas. Though the proportions were small, there 
was a significant increase in lifetime use of cocaine in five RDTF areas in 2006/7 
when compared to 2002/3 (Table 2.2.6).  
° Poppers were among the four most commonly used drugs in the North West while 
amphetamines were among the four most commonly used drugs in the South 
East.  
 
Table 2.2.3   Proportion of respondents who reported lifetime, last-year and last-month use of illegal drugs, by 
regional drugs task force area of residence 
 Percentage that used any illegal drugs* 
RDTF area of residence Ever in lifetime In year prior to survey In month prior to survey
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 
East Coast 25.9 38.4† 6.3 12.4† 4.1 5.3 
North Dublin City & County 29.5 32.2 8.4 12.8 5.3 8.2 
South West (Dublin) 24.0 25.6 7.5 7.4 4.3 2.0 
South East  18.5 25.4 6.9 7.9 3.1 3.6 
North Eastern  18.9 22.9 6.4 5.7 2.4 1.1 
Midland  11.0 19.6† 2.8 4.4 1.0 1.7 
Mid West  12.0 18.0 3.2 5.8 1.6 1.4 
Southern  12.1 16.3 4.7 4.9 2.1 2.0 
Western  12.5 23.3† 2.9 4.7 1.9 1.6 
North West  10.6 14.5 2.6 2.9 0.2 0.3 
*Illegal drugs in this context are amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and 
solvents. 
†Significant changes in proportion for the two survey periods 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005a) (National Advisory 
Committee on Drugs 2008) 
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Table 2.2.4   Proportion of respondents who reported lifetime, last-year and last-month use of cannabis, by 
regional drugs task force area of residence 
 Percentage that used cannabis 
RDTF area of residence Ever in lifetime In year prior to survey In month prior to survey 
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 
East Coast  24.5 35.9† 6.1 11.3† 3.8 4.2 
North Dublin City & County  26.9 28.8 7.7 11.9 4.5 7.9 
South West (Dublin) 23.2 24.0 7.3 6.7 3.9 1.8 
South East 16.8 23.3 5.8 5.1 2.1 2.8 
North Eastern 17.8 19.5 5.2 4.6 1.9 0.8 
Midland  10.7 17.0 2.8 4.1 1.1 1.1 
Mid West 10.9 17.0 3.0 4.7 1.6 1.4 
Southern  11.6 15.0 4.4 4.6 2.1 2.0 
Western  12.0 21.0† 2.0 4.3 1.3 1.6 
North West 9.3 12.8 2.2 2.9 0.2 0.3 
†Significant changes in proportion for the two survey periods 
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (Bulletins 2, 2005 & 2008) 
(National Advisory Committee on Drugs 2008) 
 
Table 2.2.5   Proportion of respondents who reported lifetime, last-year and last-month use of ecstasy, by 
regional drugs task force area of residence 
 Percentage that used ecstasy 
RDTF area of residence Ever in lifetime In year prior to survey In month prior to survey
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 
East Coast  5.4 7.6 2.5 2.3 0.9 0.5 
North Dublin City & County 6.5 11.2 1.6 2.9 0.3 1.0 
South West (Dublin) 5.9 4.1 1.3 0.5 0.0 0.0 
South East 4.3 6.5 1.3 1.9 1.3 0.3 
North Eastern  2.6 5.4 0.5 0.9 0.0 0.0 
Midland  2.0 5.8† 0.9 0.9 0.0 0.3 
Mid West  1.7 2.9 0.6 0.8 0.0 0.3 
Southern  2.8 3.5 0.9 0.6 0.2 0.2 
Western  1.8 4.4 0.3 0.9 0.3 0.3 
North West 0.3 2.2† 0.0 0.3 0.0 0.3 
†Significant changes in proportion for the two survey periods 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005a) (National Advisory 
Committee on Drugs 2008) 
 
Table 2.2.6   Proportion of respondents who reported lifetime, last-year and last-month use of cocaine, by 
regional drugs task force area of residence 
 Percentage that used cocaine* 
RDTF area of residence Ever in lifetime In year prior to survey In month prior to survey 
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 
East Coast  6.3 9.1 2.3 3.1 0.5 0.8 
North Dublin City & County 5.2 11.0† 1.7 3.3 0.8 1.4 
South West (Dublin) 5.0 3.8 1.5 0.8 0.6 0.3 
South East 2.5 6.7† 1.7 2.4 0.0 0.9† 
North Eastern 1.2 5.6† 0.0 1.5 0.0 0.0 
Midland  1.3 4.4† 0.3 1.7 0.3 0.9 
Mid West  1.1 2.9 0.6 1.0 0.0 0.0 
Southern  1.9 3.1 0.7 1.1 0.4 0.2 
Western  1.6 3.5 0.7 1.5 0.4 0.4 
North West 0.0 1.6† 0.0 0.3 0.0 0.3 
*Cocaine in this context is cocaine powder and crack. 
†Significant changes in proportion for the two survey periods 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005a) (National Advisory 
Committee on Drugs 2008) 
 
2.2.3 Cannabis use in Ireland 
The third bulletin of results from the 2006/7 all-Ireland general population drug 
prevalence survey focused on cannabis use in the adult population (15–64 years) and 
patterns of cannabis use (National Advisory Committee on Drugs and Drug and Alcohol 
Information and Research Unit 2008c).  
 
Cannabis use increased over the four years since the previous survey in 2002/3 (Table 
2.2.7). The proportion of adults who reported using cannabis at some point in their life 
(ever used) increased from 17% in 2002/3 to 22% in 2006/7. The proportion of young 
adults who reported using cannabis in their lifetime also increased, from 24% in 2002/3 
to 29% in 2006/7.  
 
The proportion of adults who reported using cannabis in the last year (recent use) 
increased from 5% in 2002/3 to 6% in 2006/7. The proportion of young adults who 
reported using cannabis in the last year increased from 9% in 2002/3 to 10% in 2006/7.  
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The proportion of adults who reported using cannabis in the last month (current use) 
remained stable at 3%. 
 
Table 2.2.7  Lifetime, last-year and last-month prevalence of cannabis use in Ireland, 2002/3 and 2006/7 
Cannabis use Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 
Lifetime (ever used) 17.4 21.9 22.4 27.0 12.3 16.6 24.0 28.6 
Last year (recent use) 5.0 6.3 7.2 8.5 2.9 3.9 8.6 10.4 
Last month (current use) 2.6 2.6 3.4 4.0 1.7 1.1 4.3 4.2 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005b) (National Advisory 
Committee on Drugs and Drug and Alcohol Information and Research Unit 2008c). 
 
Half of all cannabis users had first used the drug before they were 18 years old. The 
lifetime prevalence rate was higher for men (27%) than for women (17%).  
 
Over one-quarter (26%) of respondents who had ever taken cannabis reported using 
(or having used) it regularly. The lag time between first use and regular use was two 
years. Of those who were or had been regular users, two-thirds (66%) said that they 
had stopped taking cannabis, 10% said that they had tried to stop but failed and almost 
one-quarter (24%) had never tried to stop. Of those who had stopped, approximately 
one-third (32%) said they had done so because they no longer wanted to take the drug, 
19% said they had health concerns and 17% said it was no longer part of their social 
life. 
 
The majority (62%) of recent cannabis users considered it ‘very easy’ or ‘fairly easy’ to 
obtain the drug within a 24-hour period. Over half (57%) reported obtaining the 
cannabis they had last used at the house of friends, 12% obtained it in the street/park, 
8% in a disco/bar/club and 5% ordered it by phone. The majority (44%) got the 
cannabis they had last used from a family member or friend, 28% had shared it among 
friends and 22% had bought it.  
 
The majority (60%) of current cannabis users reported using a form of cannabis resin. 
Almost two-in-five (38%) reported using a form of herbal cannabis. Approximately 24% 
used the drug daily in the month prior to the survey, a further 10% used it several times 
a week, 28% used it at least once a week and 37% used it less than once a week. Men 
were more frequent users than women. Almost all smoked it, as a joint (93%), in a pipe 
(4%) or in a bong (3%); less than 1% ate the drug. 
 
2.2.4 Cocaine use in Ireland 
The fourth bulletin of results from the 2006/7 all-Ireland general population drug 
prevalence survey (a follow-on from the first such survey in 2002/3) focused on cocaine 
use in the adult population (15–64 years) and patterns of cocaine use (National 
Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 
2008b).  
 
Cocaine use increased in 2006/7 compared to 2002/3. The proportion of adults who 
reported using cocaine (including crack) at some point in their lives increased from 3% 
in 2002/3 to 5% in 2006/7 (Table 2.2.8). The proportion of young adults who reported 
using cocaine in their lifetime also increased, from 5% in 2002/3 to 8% in 2006/7. As 
expected, more men reported using cocaine in their lifetime than women, 7% 
compared to 3.5%.  
 
The proportion of adults who reported using cocaine in the last year (recent use) 
increased from 1% in 2002/3 to 2% in 2006/7 (Table 2.2.8). The proportion of young 
adults who reported using cocaine in the last year increased from 2% in 2002/3 to 3% 
in 2006/7.  
 
The proportion of adults who reported using cocaine in the last month (current use) 
remained stable at under 1%. 
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Table 2.2.8   Lifetime, last-year and last-month prevalence of cocaine use (including crack) in Ireland, 2002/3 
and 2006/7 
Cocaine use Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 
Lifetime 3.0 5.3 4.3 7.0 1.6 3.5 4.7 8.2 
Last year  1.1 1.7 1.7 2.3 0.5 1.0 2.0 3.1 
Last month 0.3 0.5 0.7 0.8 0.0 0.2 0.7 1.0 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2006) (National Advisory 
Committee on Drugs and Drug and Alcohol Information and Research Unit 2008b). 
 
Of the 4,967 survey respondents, 5% had used cocaine powder; crack cocaine use 
was rarely reported (0.6%). Half of all cocaine powder users commenced cocaine use 
before they were 22 years old, while half of all crack users commenced use before they 
were 20 years old.  
 
Of the 25 current cocaine powder users, just over 68% used cocaine less than once 
per week, while 25% used it at least once per week. All of the current cocaine powder 
users reported snorting the drug.  
 
Of the 79 recent cocaine powder users, only 9% obtained their cocaine from a person 
who was not known to them. Cocaine powder was most commonly obtained at the 
home of a friend (43%) or at a disco, bar or club (36%). Almost two-thirds of recent 
cocaine powder users said that cocaine powder was easy to obtain within a 24-hour 
period.  
 
Of the 35 self-defined ‘regular’ cocaine powder users, almost 82% had successfully 
stopped taking cocaine. The most common reasons for discontinuing were: concerns 
about its health effects (28%), could no longer afford it (17%), impact on employment, 
family and friends (11%), did not enjoy it any more (8.7%), attended a rehabilitation 
programme (8.2%) or did not want to continue using it (8.2%).  
 
The findings of this survey should be interpreted with care in view of the small number 
of responses used to describe the patterns of cocaine use. The socially-excluded 
population is unlikely to be represented in a general population survey of this kind; its 
members may not live at fixed addresses or, if listed, may be difficult to locate for 
interview.  
 
2.2.5 Sedative, tranquilliser and anti-depressant use in Ireland 
The sixth bulletin of results from the 2006/7 all-Ireland general population drug 
prevalence survey focused on sedative or tranquilliser and anti-depressant use in the 
adult population (15–64 years) (National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit 2009b) see section 2.2.6.  
 
The proportion of adults who reported using a sedative or tranquilliser at some point in 
their lives was 11% (Table 2.2.9). The proportion of young adults was 6%, while the 
proportion of older adults was higher at 15%. More women (13%) than men (8%) 
reported using a sedative or tranquilliser in their lifetime.  
 
The proportion of adults who reported using a sedative or tranquilliser in the last year 
was 5%, and of older adults 7% (Table 2.2.9).  
 
The proportion of adults who reported using a sedative or tranquilliser in the last month 
was 3%, and of older adults 4% (Table 2.2.9). 
 
Table 2.2.9   Prevalence of sedative and tranquilliser use in Ireland, 2006/7 
 Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
Older adults 
35–64 years 
% 
Lifetime (ever used) 10.5 8.0 13.2 5.9 14.6 
Last year (recent use) 4.7 3.7 5.7 2.5 6.5 
Last month (current use) 3.0 2.4 3.5 1.3 4.4 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2009b). 
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The proportion of adults who reported using an anti-depressant at some point in their 
lives was 9% (Table 2.2.10). The proportion of young adults was 7% while the 
proportion of older adults was higher at 11%. More women (13%) than men (6%) 
reported using an anti-depressant in their lifetime.  
 
The proportion of adults who reported using an anti-depressant in the last year was just 
over 4%, and of older adults 5% (Table 2.2.10).  
 
The proportion of adults who reported using an anti-depressant in the last month was 
3%, and of older adults 4% (Table 2.2.10). 
 
Table 2.2.10   Prevalence of anti-depressant use in Ireland, 2006/7 
 Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
Older adults 
35–64 years 
% 
Lifetime (ever used) 9.2 5.9 12.5 7.1 10.9 
Last year (recent use) 4.3 3.0 5.6 3.2 5.2 
Last month (current use) 3.1 2.3 3.9 2.2 3.9 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2009b). 
 
The average age (among all users) at first use of sedatives or tranquillisers was 29 
years for males and 31 for females. The average age at first use of anti-depressants 
was 34 years for males and 30 years for females.  
 
More than half (57%) of current users of sedatives or tranquillisers, and 91% of current 
users of anti-depressants, took them daily or almost daily.  Most current users got their 
sedatives or tranquillisers (89%) or anti-depressants (100%) on prescription. However, 
11% of sedative or tranquilliser users reported that they had either got them from a 
friend or another source or bought them without a prescription in a pharmacy.  
 
Sedative or tranquilliser and anti-depressant use was more likely among those who 
were dependent on the state long-term, were not in paid employment, had lower levels 
of educational attainment and had left education before the age of 15 years.  
 
Respondents who were separated, divorced or widowed reported higher prevalence 
rates of sedative or tranquilliser and anti-depressant use compared to those who were 
single (never married), co-habiting or married.  
 
2.2.6 New information on polydrug use in Ireland 
The fifth bulletin of results from the 2006/7 all-Ireland general population drug 
prevalence survey focused on polydrug use in the adult population (15–64 years) and 
patterns of polydrug use (National Advisory Committee on Drugs and Drug and Alcohol 
Information and Research Unit 2009a)  
 
For the purpose of Bulletin 5, polydrug use was defined as the use in the last month of 
two or more of the following substances: alcohol, tobacco, any illegal drug or any other 
legal drug (sedatives, tranquillisers or anti-depressants).  
 
Just under one-fifth (19.6%) of the 4,967 survey respondents in Ireland reported that 
they had not used any substance in the last month. Among those who had used drugs 
in the last month, the most common substance combinations were: 
1. 26.5% had used alcohol and tobacco  
2. 3.3% had used alcohol, sedatives or tranquillisers, and anti-depressants  
3. 2.6% had used alcohol and at least one illegal drug  
4. 2.4% had used tobacco and at least one illegal drug  
5. 2.3% had used tobacco, sedatives or tranquillisers, and anti-depressants  
6. 2.2% had used alcohol, tobacco and at least one illegal drug  
7. 1.9% alcohol and sedatives or tranquillisers  
8. 1.9% alcohol and anti-depressants 
9. 1.6% had used alcohol, tobacco, sedatives or tranquillisers, and anti-depressants  
10. 1.5% had used tobacco and anti-depressants  
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The combination of alcohol, tobacco and any illegal drug was more commonly reported 
by men (3.4%) than by women (0.9%). Thirty-one per cent of young adults (15–34 
years) reported that they had used alcohol and tobacco, compared to 23% of older 
adults (35–64 years). The same relationship was observed among users of alcohol, 
tobacco and at least one illegal drug, with 3.8% of young adults and 0.8% of older 
adults reporting this combination.  
 
The results of the polydrug use survey reflected substance use in recreational 
situations, rather than problematic substance use in socially-deprived areas or among 
treated problem drug users. 
 
 
2.3 Drug use in the school and youth population 
2.3.1 Drug data from third SLÁN survey  
On 29 April 2008, the Department of Health and Children published the third SLÁN 
Survey of Lifestyle, Attitudes and Nutrition in Ireland. This survey was completed by 
Morgan and colleagues (Morgan et al. 2008) at the Royal College of Surgeons in 
Ireland. 
 
The survey involved 10,364 face-to-face interviews with adults resident in Ireland, 
which represented a 62% response rate. The sample was drawn from the 
GeoDirectory, using a multi-stage probability procedure, and was stratified by 
townland, urban–rural location, age and social class.  
 
Respondents were asked a number of questions about their drug use. The responses 
were weighted for age, gender, marital status, country of birth and ethnicity. The 
authors noted that the findings must be interpreted with caution because of the change 
in sample selection and data-collection methods in 2007 compared to those used in 
2002 and 1998, as shown in Table 2.3.1. 
 
Table 2.3.1   Summary of SLÁN methods, 1998, 2002 and 2007 
 SLÁN 1998 SLÁN 2002 SLÁN 2007 
Population Adults aged 18+ Adults aged 18+ Adults aged 18+ 
Sampling frame Electoral register Electoral register GeoDirectory 
Sample Multi-stage sample, drawn by 
electoral division 
Multi-stage sample, drawn by 
electoral division 
Multi-stage probability sample 
Stratification Percentage distribution 
across each of 26 counties, 
locality and gender 
Percentage distribution 
across each of 26 counties, 
locality and gender 
Percentage distribution 
across townlands, age 
groups, social classes and 
urban–rural location 
Methods Self-completion questionnaire 
and self-completion of Food 
Frequency Questionnaire 
Self-completion questionnaire 
and self-completion of Food 
Frequency Questionnaire 
Face-to-face interview and 
self-completion of Food 
Frequency Questionnaire 
Obtained sample 6539 5992 10364 
Response rate 62% 53% 62% 
Source: (Morgan et al. 2008) 
 
In the 2007 survey, respondents were asked about their use of illegal drugs in the last 
year (Table 2.3.2). Six per cent reported that they had used an illegal drug in the year 
prior to the survey; the reported use of such drugs was higher for men (9%) than for 
women (4%). As expected, cannabis was the most commonly-used drug. The 
percentage of those who used cocaine in the last year was surprisingly low at 1%.  
 
Table 2.3.2   Last-year prevalence of illegal drug use in Ireland  
 Adults 18 years or over Males 18 years or over Females 18 years or over 
 % % % 
Illegal drug use* 6.0 9.0 4.0 
Cannabis 5.0 8.0 3.0 
Ecstasy 1.0 1.0 <1.0 
Cocaine 1.0 2.0 <1.0 
* Illegal drugs in this context are amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers 
and solvents. 
Source: (Morgan et al. 2008) 
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In general, these data are not comparable to the results of the 2006/7 general 
population survey by the NACD as the SLÁN survey excluded those aged between 15 
and 17 and included those over 65 years. In addition, the use of confidence intervals 
would allow commentators to rule out sampling variation when comparing the SLÁN 
surveys, both over time and with other surveys completed at the same time.  
 
2.3.2 Fourth ESPAD survey on substance use among young people 
 
On 26 March 2009, the fourth European School Survey Project on Alcohol and Other 
Drugs (ESPAD) was published (Hibell, B et al. 2009).  
 
ESPAD surveys have been conducted every four years since 1995, using a 
standardised method and a common questionnaire. The rationale for these surveys is 
that school students are easily accessible and are at an age when onset of substance 
use is likely to occur. (By definition, early school leavers, a group known to be 
vulnerable to alcohol and drug use, are not represented.) ESPAD survey information is 
valuable in planning prevention initiatives.  
 
The fourth survey was conducted in 35 European countries during 2007 and collected 
information on alcohol and illicit drug use among 15–16-year-olds; 2,249 students from 
94 randomly-selected schools participated, which represents a response rate of 78%. 
Fewer schools and students participated in 2007 than in 2003.  
 
In terms of drug use, the Irish data showed a marked decrease in lifetime use of any 
illicit drug between 2003 (40%) and 2007 (22%), a fall of 18 percentage points (Table 
2.3.3). As the majority of those who have tried any illicit drug have used cannabis 
(marijuana or hashish), the decrease in illicit drug use was influenced by the 
considerable decrease in the number of students who had tried cannabis at some point 
in their lives, from 39% in 2003 to 20% in 2007 (European average 19%). Lifetime use 
of solvents/inhalants decreased from 18% in 2003 to 15% in 2007, but remained higher 
than the European average (9%). In the case of both amphetamines and cocaine 
powder, the proportions reporting lifetime use increased marginally above the 
European average of 3%. In 2007, one in ten of the survey participants reported that 
they had taken prescribed tranquillisers or sedatives at some point in their lives; the 
use of such drugs had decreased marginally since 1999.  
 
Table 2.3.3   Proportions of school-going children (15–16 years) in Ireland who reported lifetime use of drugs in 
the ESPAD surveys of 1995, 1999, 2003 and 2007 
 
 
1995 
% 
1999 
% 
2003 
% 
2007 
% 
Lifetime use     
Any illicit drug* 37 32 40 22 
Cannabis 37 32 39 20 
Inhalants (solvents) n.a. 22 18 15 
Ecstasy 9 5 5 4 
Cocaine powder 2 2 3 4 
Amphetamines 3 3 1 3 
Prescribed tranquilisers or sedatives n.a. 11 10 10 
Non-prescribed tranquilisers or sedatives 7 5 2 3 
*includes amphetamines, cannabis, cocaine, crack, ecstasy, heroin and LSD or other hallucinogens 
n.a. = not available 
Sources: (Hibell, B. et al. 1997) (Hibell, Björn et al. 2000) (Hibell, Björn et al. 2004) (Hibell, B et al. 2009) 
 
In another national study, the HBSC (Health Behaviour in School-aged Children) 
survey, lifetime cannabis use among 15–17-year-olds was 29% in 2006 compared to 
26% in 2002 and 25% in 1998 (S Nic Gabhainn, personal communication, 2008). The 
HBSC survey shows a steady marginal increase in cannabis use between 1998 and 
2007, whereas the ESPAD survey shows a large increase between 1999 and 2003 and 
a larger, unexpected decrease between 2003 and 2007 (Figure 2.3.1). It is important 
that in the future the reasons for the change in cannabis use reported in the ESPAD 
surveys be investigated; it could represent a genuine decrease in the use of cannabis 
or a change in the sample chosen or the way the questionnaire was administered.   
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Figure 2.3.1   Trends in lifetime cannabis use, as reported by the ESPAD and HBSC surveys at three time points 
 
Drug and solvent use among national school children in mid-western Ireland 
 
In 1997, the Mid-Western Health Board undertook a baseline study to examine health 
status and behaviours of adolescents in the region i.e. counties Clare, Limerick, North 
Tipperary and Limerick City, and completed a follow-up study in 2002. The latter study 
found that a minority of children aged 13 years or under reported regular substance 
use. The present study (Houghton et al. 2008) was completed in 2004 to examine the 
current extent of tobacco, alcohol and drug use among national (primary) school 
children aged 11 to 14 years in Limerick City, Limerick County, Clare and North 
Tipperary (the Mid-West Region).  
 
The survey questions about drug and glue/solvent misuse were drawn from the Health 
Behaviour in School-aged Children (HBSC) survey. The study population was selected 
from fifth and sixth class pupils (years seven and eight) attending national schools in 
the region. Fifty schools were randomly selected from a geographically stratified 
sample, with a quarter of the schools selected from each area. A total of 43 schools 
participated in the survey. The response rate, calculated inclusive of children in the 
non-participating schools, was 76.2%. 
 
Of the 1,254 questionnaires analysed, 573 were from males and 681 from females. 
Participants ranged in age from 10 to 14 years (although only two were aged 14), with 
47% (588) coming from fifth class and the remainder from sixth class. The mean age of 
the participants was 11.5 years (SD = 0.73).  
 
Of the respondents, 1% (n = 12) reported that they had used cannabis at least once in 
their life, of whom eight were male and four were female. Only two children reported 
having used cannabis three or more times. 
 
A total of 1.3% (n = 16) of respondents reported having ever taken ‘any other drug’. 
Thirteen of these had done so ‘once or twice’ and the remaining three had done so 
three or more times. Of the children who had ever taken ‘any other drug’, 13 were male 
and three were female.  
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Fifty-three (4.2%) children had used glue/solvents at least ‘once or twice’ in their lives. 
Forty-four out of the 53 replied that they had only ever done this ‘once or twice’. Thirty-
three were male and 20 were female. 
This survey indicates that use of cannabis and of solvents starts at a young age in 
Ireland.  
 
Drug and alcohol-related knowledge, attitudes and behaviours of early school 
leavers aged 15–20 years in the west of Ireland.  
 
Redmond (Redmond 2008) explored the drug and alcohol-related attitudes, knowledge 
and behaviours of early school leavers in the west of Ireland.  
 
The data were collected using three methods: questionnaires, focus groups and 
PhotoVoice. The participants included 47 males and 59 females, aged 15–20 years, 
who answered the questionnaires; 22 young people (14 males and 8 females; average 
age 16 years) in three focus groups, one per county (Galway, Mayo and Roscommon); 
and five males (aged 15–16 years) who participated in a PhotoVoice project. 
 
The use of most substances was higher among early school leavers compared to their 
school-going contemporaries. Early school leavers were more likely to use cannabis, 
cocaine, ecstasy and speed. Solvents were used by both groups. Alcohol use was 
widespread and accepted, with knowledge of the harms from alcohol coming from lived 
experience. Parental attitudes were identified as an important influence on a young 
person’s respect for alcohol. A lack of understanding of the link between drugs and 
addiction was evident. It was particularly common for respondents to link cocaine use 
and addiction. Dissatisfaction with current drugs education, or lack of it, was apparent 
and the knowledge level varied considerably among participants. 
 
The author concluded that consistent and appropriate means must be used to 
challenge young people’s attitudes to substance use, to enhance knowledge, to 
positively impact behaviour and to utilise normative education. A link must be made to 
parenting practices, as parents have significant influence in developing resilience, self-
esteem, and motivation to be involved in non-substance-using activities. Emphasis 
must also be placed on providing a range of youth services to meet the needs and 
diversity of young people, and the education system as it stands requires a creative 
approach to become more holistic in achieving better mental, social and emotional 
health.  
 
Drug and alcohol use among adolescents in south-eastern Ireland 
 
Van Hout (Van Hout 2009b) completed semi-structured interviews with a random 
sample of 220 15–17-year-old students from schools and youth training centres in the 
south-east of Ireland.  
 
Just under one-quarter of the respondents reported ever using an illicit drug, and the 
majority who had tried drugs were boys. Almost all respondents said that they had 
been offered drugs and that drugs were easily available in urban areas. The majority of 
respondents believed that drug use would increase in the future in the area. They said 
that the police or schools did not take action to stop dealing or drug use in public. 
Drugs were purchased over the phone and could even be delivered to the schoolyard.  
Cannabis was the most common illicit drug used and was the first drug used. A small 
number reported that ecstasy or amphetamine was their first drug. Alcohol was usually 
consumed alongside illicit drugs. Cannabis was perceived as a safe drug, while 
cocaine, heroin and speed were perceived as dangerous drugs. Most respondents took 
drugs because they were curious, bored or their friends were taking them. Some 
respondents said that drugs helped them to relax or gave them a buzz. Respondents 
said that on the first occasion they had not planned to take drugs, but that the 
opportunity arose. Just under half felt ill after taking the drug but this did not deter them 
from further drug taking.  The majority were aged between 10 and 15 years when they 
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took their first drug, and the drug was usually given by a friend or older sibling. A small 
number reported that they clubbed together with friends to buy drugs. Some 
respondents reported that they controlled their drug use to prevent addiction, overdose, 
or other physical symptoms. Some of the older drug-using respondents reported that 
they had ceased illicit drug use because drugs had lost their appeal, they had 
experienced negative effects or they preferred alcohol. Very few drug-using 
respondents were worried about the legal consequences of illicit drug use.  
 
The respondents who had never taken drugs gave the following reasons as to why they 
were not interested in drugs: drugs were dangerous, they had observed the side effects 
of drugs, or drug use was difficult to control. Some respondents were afraid of their 
parents’ reaction if they found out.  
 
The author concluded that the attitudes towards drug use of both adolescent users and 
abstainers have become more liberal and 'normalised' and this is against the backdrop 
of rising drug use in the community. 
 
Volatile inhalant use among young people in south-eastern Ireland  
 
Van Hout and O’Connor (Van Hout and Connor 2008) explored practices, social 
dynamics and effects of solvent or volatile inhalant use and suggested methods to 
deter or stop use among young people. This inquiry was part of a much larger study on 
drug use. The authors interviewed 20 young people (average age 13.2 years) living in 
the south-east of Ireland using a semi-structured questionnaire. Eleven males and nine 
females participated in this aspect of the study. The first time the child used a solvent 
was opportunistic and in the company of peers. The average age of first solvent use 
was 10.3 years and most stopped using solvents by the age of 13 years. Most children 
reported that they ‘fainted’ or felt ‘sick’ the first time they used these substances. The 
frequency of subsequent solvent use was sporadic and opportunistic. Subsequent use 
of solvents was in a more controlled fashion to reduce side effects. Half of the solvent 
users also smoked cigarettes despite the obvious danger. Solvent use was followed by 
initiation into alcohol use (average age of first use 12.5 years) and subsequently a 
small number experimented with cannabis. Most used solvents outdoors with their peer 
group and during the long summer holidays. There were some reports of solvent use 
during school breaks. The type of solvent used was determined by cost, access and 
place of residence. Children who lived in rural areas used a limited number of products, 
namely, wood glue, diesel and petrol, whereas children in urban areas used a wide 
variety of products including Pritt Stick, methylated spirits, hairspray, deodorant, 
chrome paint, butane, nitrous oxide and Vick’s nasal inhalant. Some products were 
inhaled using a plastic bag, others by placing the spray nozzle in their mouth or nostril, 
and others by pouring the product on a damp cloth and placing it over the face. The 
participants reported a variety of reasons for continuing to use solvents, such as be 
part of the peer group, relieve boredom, experience a high, deal with stress or escape 
from reality. They reported a variety of physical effects such as fainting, vomiting, 
inflamed nostrils or headache. Following use, some participants reported taking actions 
that they would not normally do, such as having sex, being involved in vandalism or 
completing dares. All respondents knew someone who had died as a result of solvent 
use. In general, the children reported that teachers were uncomfortable delivering 
information about drug use.  
 
Service providers’ views of youth alcohol and drug use in south-eastern Ireland 
 
Van Hout (Van Hout 2009a) explored the views of 78 service providers based in the 
south-east of Ireland on youth substance use and current service provision. The 
service providers worked in one of the following services: youth, community, addiction, 
education or health.  
 
The service providers believed that illicit drugs and drug use had become a normal 
aspect of society in the area. They said that illicit drug use had increased because the 
  58
availability of drugs had increased, young people had more disposable income, they 
had greater freedom and parental monitoring was lacking. According to the service 
providers, young people had a positive attitude to alcohol use and a facilitating attitude 
to drug use and this encouraged experimentation. In addition, children had better 
knowledge about the effects of individual drugs and the effects of mixing them. They 
said that teachers were trying to control drug dealing and use in the schoolyard.  
 
The respondents reported that children are introduced to alcohol at a young age and 
observe their parents and siblings drinking to excess. They cited poor parental 
monitoring and unstructured leisure time as contributing factors. Young people were 
observed purchasing and sharing drugs among close peers or best friends. Drug and 
alcohol use occurred in fields, on the streets or at friends’ houses. The service 
providers reported that drug use could start as young as 10 years of age and that boys 
were more likely than girls to experiment. Young people had developed an informal 
hierarchy of drugs, according to the perceived level of harm, with heroin at the top of 
the scale and cannabis at the bottom. Young people thought that heroin was safe if 
smoked and that cannabis was as safe as cigarettes.     
 
The service providers said that most children experimented with drug use and matured 
out of it, but that children experiencing family problems and disruption were more likely 
to develop problem drug or alcohol use. Drug use included use of solvents and 
inappropriate use of prescription medication. 
 
According to the service providers, adolescent diagnostics and services are based on 
adult models. The author suggested that adolescent services should be developed 
using age- and situation-appropriate models of care.  
 
Parents' views of youth alcohol and drug use in south-eastern Ireland  
 
Van Hout (Van Hout 2009b) provided an exploratory account of rural parents’ views on 
alcohol and illicit drug use among youth in the south-east of Ireland.  
 
Facilitated by school completion officers, convenience sample of parents (34 mothers 
and 21 fathers) with adolescent children was selected at a parent–teacher evening at 
three rural schools. Semi-structured interviews were conducted, which included 
questions relating to the parents’ perceptions of youth drug and alcohol use (both in 
terms of recreational and problematic use in their communities), drug availability, 
perceptions of risk, types of settings for adolescent substance use, service provision 
and drug information. The parents were not questioned about their own children but 
about youth in general. Following transcription of the interviews, a content and thematic 
analysis was conducted.  
 
The results suggested parental concern with regard to increased exposure to drugs 
among youth in local rural communities. The majority of parents were aware of youth 
alcohol use, they were concerned about all drugs, they were not aware of specific 
differences in drug-related risk and had difficulty comprehending harm-reduction 
principles. Most parents recognised the need for greater parental monitoring through 
improving accountability for free time, improving parent–child interaction, and visibility 
of services.  
 
The author observed that life in contemporary rural Ireland is influenced by dominant 
social changes in terms of  seeing the normalisation of alcohol and drug use in youth 
subcultures. This is facilitated by increasing fragmentation of traditional rural family 
norms and values, emerging acceptability of alcohol and drug use in recreation time 
and the increasing availability of alcohol and drugs. The author suggested there is a 
need to provide drug education, service visibility and family support for those 
experiencing problem substance use.  
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2.4 Drug use among targeted groups/settings at national and local level 
(university students and conscript surveys, migrants, music 
venues, gay clubs, gyms) 
Substance use among Irish women expecting their first baby 
 
Between April 2003 and May 2004, Donnelly and colleagues (Donnelly et al. 2008) 
interviewed 1,011 Caucasian women attending a maternity hospital in Dublin’s city 
centre to determine their use of illegal drugs, tobacco and alcohol. The definition of 
illegal drugs used in the survey was not given in the paper. The study participants were 
expecting their first baby, were less than 20 weeks pregnant and were aged between 
16 and 40 years. Women were interviewed at private, semi-private and public antenatal 
clinics. The study response rate was very high at 95%. 
 
Of the 1,011 women interviewed, 235 (23.5%) respondents reported that they had 
taken an illegal drug at some point prior to this pregnancy. As expected, cannabis was 
the most commonly-used illegal drug, with 214 (21.2%) respondents reporting that they 
had used this drug at some point prior to this pregnancy. Seventy (6.9%) respondents 
had used ecstasy at some point prior to this pregnancy while 64 (5.8%) had used 
cocaine. Ninety women (8.9%) had used more than one illegal drug. Eleven women 
(1.1%) had used an illegal drug during this pregnancy.  
 
In relation to tobacco use, 574 (56.7%) of the women interviewed reported that they 
had smoked cigarettes at some point in their lives; 282 (28.8%) reported that they were 
current smokers, of whom 87 (30.8%) smoked more than 10 cigarettes a day.  
 
In relation to alcohol use, 545 women (53.9%) said that they had drunk alcohol on at 
least one occasion since their first positive pregnancy test, and, of these, 500 (91.7%) 
had drunk between one and four units, 33 (5.1%) between five and 10 units and 12 
(2.2%) more than 10 units.  
 
Alcohol consumption and cigarette smoking were associated with illegal drug use: 
smokers were 2.8 times more likely to use illegal drugs than non-smokers, while 
women who drank alcohol were 1.8 times more likely use illegal drugs than non-
drinkers. The type of clinic attended or the level of education achieved were not found 
to be associated with the use of illegal drugs.  High levels of alcohol use among 
pregnant women in Ireland has been reported elsewhere.  
 
This survey does not report confidence intervals so it is not possible to estimate the 
use among the population of primigravid women.  
 
Substance use in the Traveller community in the WRDTF area 
 
The Western Region Drugs Task Force (WRDTF) has published a report on the nature 
and extent of substance use, and use of services, by members of the Traveller 
community in the west of Ireland (Van Hout 2009a).This is the second in a series of 
three reports on substance use in the region commissioned by the WRDTF. 
 
Data were collected from 57 focus groups that included both adult and younger 
members of the Traveller community. Interviews and consultations were held with 45 
service providers, including services dealing specifically with substance use among 
Travellers. The fieldwork was complemented by prior consultation with stakeholders, 
desktop research and a literature review.  
 
Service providers reported a marked increase in problematic drug and alcohol use 
among Travellers in the last 10 years in the west of Ireland. Substance use was mainly 
seen as an escape from depression, poor health, difficulties with employment and 
strained relationships with the settled community. In terms of risk, older Travellers 
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reported a fear of drugs and potential overdose, with younger Travellers indicating an 
acceptance of the use of drugs such as cannabis and ecstasy as relatively normal. 
 
Alcohol  
According to service providers, alcohol remains the substance of most concern in this 
community, and increasing levels of use were reported among Traveller men and more 
recently among single Traveller women. Some Travellers were aware of ‘drink 
problems’ in their community, and reported that such problems were usually dealt with 
within the family. Service providers felt that because Travellers are discriminated 
against in certain pubs, they buy cheap alcohol from supermarkets, which contributes 
to high levels of consumption in the home and at halting sites.  They reported that high 
levels of alcohol use can contribute to violence in the home and when a family break-
up occurs and ‘the head of the house’ (usually the male) leaves the family home, the 
women often resort to alcohol and prescribed medication.  
 
Drugs  
Travellers commented that there have been visibly ‘more drugs’ in urban areas in the 
west in the past two years, and that drugs are increasingly available in the region as a 
whole in comparison to the situation 10–15 years ago. Ecstasy, speed, hash and 
cocaine are the drugs most commonly used. Polysubstance use is common, most often 
in the following combinations: alcohol and hash/cannabis; alcohol and 
benzodiazepines; benzodiazepines and Solpadeine; Solpadeine and alcohol; cocaine 
and alcohol; Red Bull and Anadin; Zamadol and Coca-Cola; Anadin and Coca-Cola 
and painkillers and alcohol. According to service providers, Traveller males use hash, 
cocaine and ecstasy and Traveller women tend to use prescription medication. Despite 
some anecdotal reports of heroin (smoking), crack cocaine and cocaine use, the 
majority of service providers reported little direct evidence to suggest that these 
substances were widely used.  
 
Levels of illicit drug use among young Traveller women were perceived to be lower 
than those reported by young women in the general population. This was often 
attributed to the degree of monitoring, parental control and restriction of income of 
young women in Traveller communities. However, there were reports that young 
Traveller women use night sedation medication and benzodiazepines. 
 
Drug dealing 
Mixed views existed on the nature and extent of drug dealing in the Traveller 
community. The general consensus was that it exists but is not widespread and that 
users tend to obtain their drugs through their own families and have little contact with 
dealers in the settled community. Some Travellers were concerned that both Traveller 
and settled drug dealers were recruiting young Travellers to act as ‘runners’ and were 
therefore also providing them with an introduction to drugs and a context for use. 
 
Drug awareness and information  
Travellers felt the level of drug awareness within their community was quite low. Older 
Travellers viewed illicit drugs as a sensitive and ‘taboo’ topic. The majority of Travellers 
who had participated in drug awareness training felt that it was not suitable for a 
Traveller group, as it was not based on their values and beliefs. The most pervasive 
theme was the importance of involving the Travellers in drug education and prevention, 
and taking into consideration their norms and cultural values in the delivery of such 
services and educational materials. It was remarked that Travellers ‘would prefer 
information from Travellers’. 
 
This research is welcome and builds on what is already known about substance use in 
the Traveller community. The main findings are similar to those of a 2006 study 
(Fountain 2006), and show that levels of illicit drug use among Travellers are low 
compared to those in the general population, particularly in the case of Class A drugs 
such as heroin and cocaine. This research shows the influence of the informal ‘social 
controls’ that pertain in some Traveller communities. These informal mechanisms are 
  61
often credited with reducing the use of illicit drugs among young Traveller women, but 
appear to be less effective in reducing the use of prescription and over-the-counter 
drugs by young women.  
 
Substance use in new communities in the WRDTF area 
 
A report commissioned by the Western Region Drugs Task Force (WRDTF) explored 
substance use among new communities in the west of Ireland and identified barriers to 
effective use of services (Kelly, C. et al. 2009). New communities included migrant 
workers, refugees, asylum seekers, and migrants who had been granted citizenship. At 
the time of the 2006 census, there were 48,387 non-nationals living in the west of 
Ireland.  
 
The authors stated that members of new communities in Ireland came from countries 
where the rates of substance use among adults were generally lower than in this 
country. They noted that Irish research and informal reports from service providers 
suggested that migrant workers and refugees and asylum seekers were not accessing 
health services in Ireland because of the high cost of these services, lack of insurance, 
unfamiliarity with the health system and poor English language skills.  
 
The authors reported that risk factors for substance use in new communities were 
generally the same as those in other communities, and included mental health issues, 
social isolation, poor education levels and unemployment. For some members of new 
communities, post-traumatic stress disorder could interact with experiences of 
discrimination and social exclusion to increase the risk of substance use. Other factors 
included the strain of being undocumented, having illegal status, and anxiety about 
being discovered. Having limited access to medical services except in the case of an 
emergency could impede access to frontline services such as GPs where substance 
use might be identified as a problem and treated early.  
 
According to this report, adolescents in new communities could experience isolation 
owing to low levels of supportive peer relationships in school. Additional strain could 
occur for these young people when they learned a new language and cultural practices 
reflecting the norms of the indigenous population. This might result in a clash with the 
value system and cultural practices of their family. Taken together, these factors could 
increase the risk of substance use among young people as they tried to fit in with the 
indigenous culture and deal with social isolation.   
 
The authors interviewed by phone 18 statutory and voluntary groups involved in the 
support of new communities or the provision of substance use services, to explore their 
views on substance use in these communities. Almost all those contacted had no 
specific or specialist information on the issue, nor did their organisations have policies 
or strategies to address the issue.  
 
This research included an analysis of regional press coverage of substance use issues 
in the west, and particularly in new communities, between 8 and 14 December 2008. 
The results suggested that there was more media interest in alcohol-related issues 
than in other drug issues and that there was more ambivalence about alcohol (which is 
presented as both potentially dangerous and positive and worthy of promotion) than 
other drugs (which are presented entirely negatively). In relation to the issue at hand, 
only five articles were identified where members of new communities and alcohol or 
other drugs were explicitly linked, and just three of those cases concerned drug 
possession or public drunkenness. 
 
This report mentioned a small number of studies on appropriate responses to 
substance use in new communities. These were highlighted as potential ‘starting 
points’ for communication among service providers and, according to the authors, were 
‘in a sense pragmatic and in some cases “best guesstimates” of what could work’.  
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The authors uncovered little evidence of substance use as a substantial problem, or 
one that required immediate action, among new communities in the west of Ireland. 
However, the reluctance of members of new communities to access health services, as 
acknowledged in this report, suggests that the views of service providers as to the 
extent of substance use may not reflect the true situation in the communities. 
Alternative methods of collecting primary data, such as training people from new 
communities to undertake in-depth fieldwork, including interviews and observation, may 
yield a different picture to that conveyed here. A 2004 study using these methods found 
that heroin and cocaine use were becoming a problem among some sections of new 
communities in Ireland (Corr 2004).   
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3. Prevention 
3.1 Introduction 
Drug prevention has been a key pillar in Ireland’s National Drugs Strategy 2001–2008 
and the new National Drugs Strategy (interim), 2009–2016 will continue to focus on 
developing drug prevention policy and practice (Department of Community Rural and 
Gaeltacht Affairs 2009). Drug prevention is delivered in schools through the Walk Tall 
(primary schools) and the Social, Personal and Health Education (post-primary 
schools) programmes. Drug prevention interventions are also provided in the 
community in different settings, including youth clubs and youth cafés, and by means of 
a number of diversion activities provided by the statutory, voluntary and community 
sectors. Young people and their families are the main target groups for drug prevention 
activities, which consist mainly of universal and selective prevention, with little focus on 
indicated prevention.  
 
 
3.2 Universal prevention 
3.2.1 School 
Environment in secondary schools in Ireland compared to other OECD countries  
 
Fostering a positive, safe and supportive school environment can be an important 
protective factor against substance use (Meyer and Cahill 2004). Data from the latest 
OECD Teaching and Learning International Survey (TALIS) show some interesting 
findings regarding the nature of the school climate in Ireland and its possible impact on 
teachers and students (Organisation for Economic Co-Operation and Development 
2009). Irish secondary school students are more likely to arrive late for school, be 
absent from school, engage in intimidation or verbal abuse of other students and 
teachers, and use/possess alcohol and/or drugs compared to the OECD average 
(Table 3.2.1). In addition, Ireland has quite a high level of teacher absenteeism (43%) 
compared to the OECD average of 25.8%. These data reflect the challenges that 
pertain in schools and which adversely impact on pedagogical instruction and the 
personal and social development of students.  
 
Table 3.2.1  Percentage of teachers of lower secondary education whose school principal considered the 
following student behaviours to hinder instruction ‘a lot’ or ‘to some extent’ in their school, Ireland and OECD 
average 
 Ireland OECD average 
Student factor % % 
Arriving late for school 57.7 39.4 
Absenteeism 70.9 45.8 
Classroom disturbance 53.6 60.2 
Cheating 2.9 20.9 
Profanity/Swearing 21.6 36.5 
Vandalism 10.6 27.1 
Theft 4.7 15.3 
Intimidation or verbal abuse of other 
students 36.6 34.6 
Physical injury to other students 4.3 15.9 
Intimidation or verbal abuse of 
teachers or staff 17.9 16.8 
Use and/or possession of alcohol 
and/or drugs 15.0 10.7 
Source: Adapted from (Organisation for Economic Co-Operation and Development 2009) 
 
The findings from the TALIS study suggest that there is a strong perception among 
principals and teachers in Ireland that students are engaged in a number of activities 
that may compromise their educational development and threaten their bonding with 
the educational system. Poor levels of bonding with social institutions is considered a 
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risk factor for early school leaving and poor academic performance and can lead to 
substance use and related behaviours in students. The provision of substance 
prevention programmes in schools and their potential impact on reducing demand for 
alcohol and drugs among students are likely to be compromised in settings where the 
school climate is less than supportive to both staff and students.  
 
The views of secondary school students on substance use education 
 
The Social, Personal and Health Education (SPHE) programme is the main vehicle 
through which substance use prevention interventions are implemented in secondary 
schools. The programme aims to improve social and personal competencies in 
students so they can understand and counter the many social influences that are seen 
as contributing to their use of drugs and alcohol.  
 
The curriculum for Social, Personal and Health Education (SPHE) in the junior cycle of 
secondary school is presented in ten modules, each of which appears in each year of 
the three-year cycle. 
° Belonging and integrating 
° Self-management: a sense of purpose 
° Communication skills 
° Physical health 
° Friendship 
° Relationships and sexuality 
° Emotional health 
° Influences and decisions 
° Substance use 
° Personal safety 
 
Nic Gabhainn et al. (Nic Gabhainn et al. 2008) examined the contribution of the SPHE 
curriculum to the experience of junior cycle students and to the junior cycle curriculum. 
A random sample of 12 schools was drawn representing different combinations of 
school characteristics, including school type (secondary, community comprehensive, 
vocational), size, location, status (disadvantaged or not) and pupil gender.  
 
Data collection 
° 49 members of staff in the 12 schools were interviewed. 
° 57 parents participated in the nine focus groups. 
° 713 students participated in workshops representing three classes from each 
school.  
° 686 of the workshop students returned self-completed questionnaires. 
° 911 parents completed and returned questionnaires. 
 
Findings from a thematic analysis 
Quality and value of SPHE provision 
° SPHE is challenging and worthwhile. 
° Quality teaching is essential for the successful delivery of SPHE. 
° Insufficient time is given to SPHE. 
° Sufficient and relevant resources are essential for the delivery of a high-quality 
SPHE programme. 
° Many parents lack sufficient knowledge and commitment. 
° SPHE is regarded as valuable and helpful. 
° SPHE suffers from timetabling pressures and there are difficulties with curriculum 
overload that influence SPHE provision. 
° SPHE has a lack of status in comparison to examination subjects. 
The contribution of SPHE to health attitudes, health behaviours and educational 
experience of junior cycle students 
° SPHE contributes positively to students’ attitudes to health, especially in their future 
lives. 
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° SPHE helps students to think about and discuss health issues relevant to their age 
group. 
° SPHE provides opportunities for the development of personal and social skills 
among students. 
° It is difficult for staff to evaluate the influence of SPHE on health behaviours among 
students. 
° There is agreement that SPHE has the potential to improve the health behaviours 
of students. 
° Most parents and students are satisfied with the support SPHE offers in relation to 
keeping healthy. 
° There is consensus that SPHE enhances the educational experiences of students. 
All groups are enthusiastic about the educational potential of the subject. 
° Students are more ambivalent than their parents about the influence SPHE has on 
their education. 
° Students express the view that SPHE is helpful to them in dealing with difficult 
situations. 
Implementation of SPHE 
° SPHE staff, particularly those who choose to teach it and have been trained, enjoy 
the experience. 
° The majority of the students enjoy learning during SPHE classes. 
° The importance of continuity in relation to teaching SPHE to the same class over a 
period of years is stressed by teachers. 
° Support and training for the teachers are regarded as essential for success of 
SPHE. 
° SPHE is included in the planning process in fewer than half the schools. 
° Schools are keen to include SPHE in whole-school planning. 
° Almost all schools have policies and structures that support the running of the 
SPHE programme. 
° The role of the SPHE co-ordinator is seen as pivotal to success. 
° Members of the SPHE team who feel valued and supported express a strong sense 
of satisfaction in their work. 
° More than half of parents think that schools need more support in their delivery of a 
successful SPHE programme. 
Stakeholder involvement 
° There is little engagement with parents in the planning and development of SPHE. 
° Parents who do comment are enthusiastic and encouraging about the SPHE 
programme. 
° Many parents feel unable to comment due to their lack of knowledge of SPHE. 
° Some of the parents’ comments indicate that they would like to know more about 
the SPHE programme and to feel more involved in this aspect of their child’s 
education. 
 
Ten of the twelve schools in this study were in favour of the continuation of SPHE into 
the senior cycle. However, a minority of parents and students did not support this view. 
 
During the recent review of the National Drugs Strategy 2001–2008, (Department of 
Community Rural and Gaeltacht Affairs 2009) the effectiveness of SPHE at second 
level was consistently questioned in particular by students themselves. The 
commitment given to SPHE by individual schools, and the support teachers receive to 
deliver the programme, were also mentioned as key concerns during the consultation. 
These concerns had already been raised during the mid-term review of the National 
Drugs Strategy (Steering Group for the Mid-Term Review of the National Drugs 
Strategy 2005).  
 
Although it is widely accepted that substance prevention programmes in secondary 
schools in Ireland are well designed and follow best practice guidelines, i.e. they adopt 
a social influence approach in combination with competence enhancement, the 
emerging consensus from the latest drugs strategy review suggests that the SPHE 
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programme is unevenly delivered across and within schools. The uneven delivery has 
been attributed in the past to an overcrowded curriculum, lack of positive status for 
SPHE and limited engagement with parents (Geary and McNamara 2003). In the 
National Drugs Strategy (interim) 2009–2016 (para. 3.67) the steering group calls for 
improved delivery of SPHE in primary and post-primary schools, encompassing the 
implementation of the recommendations of the recent SPHE evaluation in post-primary 
schools (Nic Gabhainn et al. 2008) and the development of a ‘whole of school’ 
approach to substance use education in the context of SPHE. 
 
Kerry Life Education project: an evaluation  
 
The Kerry Life Education (KLE) project is delivered from a fleet of mobile buses called 
‘Life Education’ classrooms that visit primary schools in Co Kerry in the south west of 
Ireland. The project includes a mix of health promotion and information and covers diet, 
self-esteem, peer dynamics, bullying, and alcohol and substance use. It has been 
visiting schools since 2004 and is estimated to reach between 5,000 and 7,000 
students per year. An evaluation of the KLE project has recently been published and 
the methods used and key findings are summarised below (Jackson et al. 2008). 
 
Methods of evaluation 
This was a process evaluation aimed at uncovering the perspectives of schools, 
parents and professionals on the operation and relevance of the KLE project. A survey 
questionnaire was sent to 68 schools that had participated in the project; the response 
rate was 84%. The principal of each school was asked to complete the questionnaire 
using a consensus view between principal, teachers and parent representatives. A 
different survey questionnaire was sent to eight key professionals in the fields of health 
promotion and education; six responded. In addition, data from the Health Behaviour in 
School-aged Children (HBSC) dataset for 2006 were analysed and comparisons on a 
number of variables were made between students in KLE schools and students from 
comparison schools in County Kerry.  
 
The perspective of schools 
The majority of schools (89%) reported the teaching, content and presentation of KLE 
to be excellent and appropriate for children, and 95% wanted the project to continue. 
Ninety per cent reported that KLE was good or excellent at supporting individual 
components of the SPHE programme, including learning about the body, making 
decisions and relating to others. Ninety-three per cent reported having a substance use 
policy, with 94% reporting that KLE provided either good or excellent support to the 
development of substance use policies. Only 46% reported that parents had received 
input from the KLE project. Ninety-six per cent perceived the impact of the project on 
students to be good or excellent, with the same figure anticipating the potential impact 
over time to be good or excellent.  
 
The perspective of key professionals 
Three of the six professionals who responded were not familiar with the work of KLE 
prior to being surveyed. When they did learn of the project, respondents reported 
mixed views. Public health professionals expressed cautious optimism that KLE could 
provide consistent information on substance use, contribute to a holistic approach to 
health promotion and increase the number of health promotion sites available to young 
people. In contrast to the view of the majority of schools, the two education 
professionals expressed concern that KLE was short-term and did not reinforce the 
consistent approach taken in SPHE that seeks to develop life skills during school-going 
years.  
 
Comparison of KLE student data with HBSC data 
The evaluators compared data for Fifth and Sixth Class students who participated in the 
KLE project with HBSC 2006 data from comparison schools in Kerry. Lifetime 
consumption of alcohol was lower among Fifth Class KLE students than among 
students in comparison schools. Differences favouring KLE students were noted on a 
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number of other variables, including being satisfied with life, taking more frequent 
exercise, consuming fewer soft drinks, snacks and chips and being less likely to be 
involved in bullying.  
 
When interpreting these favourable results for KLE students it is important to note that 
the sample was small and was 75% female. In addition, the differences observed 
between KLE students and students not receiving the intervention cannot be attributed 
solely to the intervention of KLE, as any number of factors may explain these changes. 
Further research under more controlled conditions is needed before any substantive 
conclusions can be reached. Nonetheless, the KLE project is popular among school 
personnel and parents in Kerry. Evidence shows that short-term interventions delivered 
on a once-off basis are not very useful in making drug education effective in young 
people’s lives (McGrath et al. 2006).  However, when used in conjunction with a 
comprehensive programme such as SPHE, they can enhance understanding of the 
issues being addressed and contribute to a perception in the community that potential 
substance use among young people is being tackled. Such a perception can 
undermine the belief among young people that substance use is ‘normalised’ and 
tolerated by the community.  
 
3.2.2 Family 
Crosscare, a social care agency working in Dublin, has produced a useful booklet that 
aims to support parents and guardians in dealing with drug and alcohol issues in the 
family. The booklet, Don’t lose the head, contains 64 pages and uses cartoon 
characters and speech bubbles to convey important messages about drugs (Crosscare 
2008). The booklet is based on an extensive review of the literature undertaken by an 
independent researcher (Clerkin 2008). The review examined the most cited 
international studies in the field of drug prevention and abstracted key information on 
‘what works’ and ‘how it works’. This evidence was then transferred into a ‘family-
friendly’ format in the shape of the booklet and was complemented by extensive 
consultations with national representatives from the voluntary and community sectors 
who brought their expertise to the process. Consultations were also undertaken with 
parents and young people on their information needs and appropriate ways of 
disseminating this information in a useable format for all stakeholders. The process 
also drew on the experience of staff at Crosscare who provide the Drugs and Alcohol 
Programme (DAP) and the Teen Counselling intervention.  
 
The booklet contains chapters on talking to children about drugs, dealing with drugs in 
the family, factual information about drugs and a list of services to support families. It 
draws on the social influence model to discuss the key influences on human behaviour, 
i.e. parents, peers and the media. Families are encouraged to develop skills in 
communication and decision-making to help them understand and respond to the 
influences of the media and the peer network. The focus on peers is important in this 
regard; research has shown that young people tend to be introduced to drugs by peers 
and, in some cases, come to see drug-using behaviour as ‘normal’ and assume that 
the majority of young people are using drugs (Mayock, Paula 2000).  
 
By advocating a social influence model to understand the factors leading to drug use 
and the development of social skills to address these factors, the booklet highlights the 
key components of the current evidence base on drug prevention. It aims to help 
families discuss drugs in a reasoned manner, without using scare tactics, and this 
approach can be useful in ‘blowing the myth’ that drug use is a normal activity among 
peers. The booklet also includes a number of quizzes that families can use to generate 
discussion about drugs; this is a useful technique based on evidence that interactive 
discussion is more effective than instructional delivery in drug prevention.  
 
One of the few large-scale studies of parents’ support needs in Ireland was based on a 
survey of 1,000 parents (Riordan 2001). In that survey, the most frequently identified 
sources of parenting information or knowledge were the family, natural instinct and 
books, magazines and newspapers, which suggests that parents use a number of 
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information sources to improve their parenting skills and that the Crosscare booklet is 
appropriate to their needs. Respondents identified the three main concerns they had in 
relation to their children as: (i) exposure to drugs, (ii) negative influence of media, and 
(iii) the ability to maintain good relationships with their children. The contents, layout 
and theoretical approach of the Crosscare booklet can address these concerns and 
help parents to develop positive parenting skills.  
 
3.2.3 Community 
Since the emergence of the local drugs task forces (LDTFs) in the 1990s, and more 
recently the regional drugs task forces (RDTFs), as mechanisms for co-ordinating 
service provision to individuals, families and communities affected by drugs, the role of 
the community in helping to reduce demand for drugs has grown. The community and 
voluntary sector, in partnership with the statutory sector, has developed and 
implemented a number of prevention interventions in both school and non-school 
settings. The active role of the community sector has been particularly helpful in 
addressing local concerns about the impact of locating services in communities.  
 
In late 2008, to dovetail with the national awareness campaign on cocaine use, ‘The 
Party’s Over’ (for an account of this campaign, see Section 3.3.1 of last year’s National 
Report (Alcohol and Drug Research Unit 2008), funding of €500,000 was allocated 
from DCRGA for cocaine awareness campaigns at local and regional level, to be 
delivered through the local and regional drugs task forces.  
 
In outlining this extension of the national campaign, Minister for Drugs John Curran TD 
observed: ‘The Task Forces, through their interaction with communities and groups on 
the ground, are considered best placed to deliver meaningful, appropriate and 
focussed campaigns. A workshop was also held with the Drugs Task Forces to share 
learning and information and to assist them in planning their individual campaigns. In 
addition, many of the Drugs Task Forces already have in place a number of valuable 
initiatives, including events such as “Awareness Weeks”.  Such initiatives have proven 
to be effective as many of them focus on the issues particular to their own localities’ 
(Curran 2009, 4 March). 
 
 
3.3 Selective prevention in at-risk groups and settings 
3.3.1 At-risk groups  
Strategies to reduce early school leaving in disadvantaged communities 
 
The NDS 2001–2008 included four actions targeting early school leaving. Action 29 
referred to the embedding of the government’s DEIS Action Plan (Delivering Equality of 
Opportunity in Schools), which is aimed at identifying and tackling levels of 
disadvantage and provides the basis for school supports, in schools in LDTF areas. 
DEIS incorporates the School Completion Programme, which targets children most at 
risk of early school leaving, and the Department of Education and Science (DES) has 
developed a strategy to tackle educational disadvantage and early school leaving in the 
Traveller community.  
 
There is a lack of information regarding the effectiveness of DEIS in reducing early 
school leaving in disadvantaged areas, especially in local and regional drugs task force 
areas (Department of Community Rural and Gaeltacht Affairs 2009).However, recent 
research by the Economic and Social Research Institute (ESRI) on behalf of Barnardos 
provide a snapshot of the operation of DEIS and assess the views of stakeholders on 
its likely effectiveness (Smyth and McCoy 2009). The research was based on 
interviews with parents, children and principals from DEIS schools, and with key 
professionals working in the area, and a national postal survey of school principals.  
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School principals responding to the postal survey highlighted their concerns that the 
current economic uncertainty is having a direct impact on the children of disadvantaged 
families by adding to the stress already experienced. This was seen as potentially 
contributing to higher levels of drug use, and in the long term, unemployment and drug 
use would lead to higher levels crime.  
 
Regarding the operation and effectiveness of DEIS, respondents had a number of 
positive remarks to make about the programme. These included the view that by 
providing additional funding to subsidise a range of measures, including reducing class 
sizes, emphasising literacy, providing healthy school meals and offering vocational 
alternatives, the School Completion Programme could yield significant benefits to 
children and their families in the long run. However, a separate report published by 
Barnardos, which integrated the findings of the ESRI report, made the point that 
children attending DEIS schools were already disadvantaged relative to their peers 
when starting school and that DEIS was not capable of solving all the problems that 
shaped this disadvantage (Barnardos 2009).  
 
The ESRI report made a useful distinction between DEIS and non-DEIS schools, and 
in doing so highlights some of the more acute problems that shape and contribute to 
the socio-economic disadvantage of pupils in DEIS schools. As well as catering for 
students from disadvantaged backgrounds, DEIS schools have disproportionate 
numbers of groups of students requiring extra support, including newcomers, Travellers 
and children with learning disabilities.   
 
This report has been a useful addition to the debate on how to respond to the 
educational and developmental needs of children in disadvantaged communities. On 
the one side, as the authors pointed out, the DEIS programme has the advantage of 
being a targeted intervention delivered in communities that have been identified as 
having higher than average scores on a number of indices used to assess the extent of 
disadvantage. This targeted approach can in theory deal with problems more directly 
than the universal approach.   
 
On the other hand, the evidence in the ESRI report indicated that the problems faced 
by children attending DEIS schools were so great in number and intensity that the 
number of families that might benefit from the DEIS programme could be quite small. 
The authors made the point that concentrating children from socio-economically 
deprived communities who also have acute learning and behavioural needs in selected 
schools may lead to an increasing ghettoisation of these schools. Future evaluations of 
the DEIS programme need to consider both sides of this debate.  
 
A new direction for tackling the mental health needs of young people in Ireland 
 
Headstrong, the National Centre for Youth Mental Health in Ireland, is a non-
governmental organisation (NGO) that commenced work in 2006 against a background 
of national concern about increasing youth suicide rates, youth drug and alcohol abuse, 
and media coverage of anti-social and high-risk behaviour among youth, which led 
some to believe that the mental health needs of young people were being neglected. 
Headstrong commenced a programme of work that included extensive data-collection 
exercises with youth, service providers and community leaders over a two-year period 
to understand the nature and scope of the mental health challenges facing young 
people in Ireland. In addition, a review of national and international research and policy 
was undertaken to ascertain best practice in working to improve young people’s mental 
health.  From this work Headstrong has drawn a number of key conclusions, which are 
included in its recent report and paraphrased below (Bates et al. 2009).  
° Every young person has coping capacity and can make their community a better 
place. 
° Young people are assets in a community and should not be viewed in problematic 
terms. 
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° The developmental needs of young people in Ireland have been historically and are 
currently neglected.  
° Communities have substantial untapped resources which can be developed without 
great cost. 
° Young people need to be involved in the planning and implementation of policy and 
practice in all sectors pertaining to their development.  
° Communities need assistance to become more scientific and systematic in 
developing, implementing and monitoring their local plans and strategies around 
community development. 
° The absence of mental illness is not mental health; the absence of problems does 
not always indicate you are prepared for challenges. 
° All young people have mental health needs, not just those in distress or at risk. 
 
Based on these conclusions, Headstrong has developed an innovative support service 
model called Jigsaw. Headstrong’s vision is that Jigsaw will provide a framework of 
systemic change that will lead to young people being connected to their communities 
and having the resilience to meet the challenges of their own mental health 
development. Jigsaw has been formulated using ecological systems theory which 
considers the ecology of human development and the developing person in relation to 
the social environment. Thus, Jigsaw is about re-engineering systems of services and 
supports. The challenge for Headstrong in designing Jigsaw was not just to consider an 
expansion of current services and supports, but rather to think differently about how to 
address the unique needs of young people in Ireland. The objective of Jigsaw is 
systems transformation.  
 
The Headstrong research revealed a clear picture of the core needs that young people 
must satisfy in order to experience a quality of mental health that will enable them to 
withstand the social changes that envelop their lives at an apparently increasing rate. 
These needs are summarised below: 
° personal and social development assets, e.g. personal talents, role models and 
family support; 
° capacity to form secure bonds with others; 
° social, emotional, cognitive and moral competencies; 
° self-determination and self-efficacy; 
° positive sense of identity; and 
° social and community values and contributions to others. 
 
The research also revealed that young people are not engaging with services; supports 
and services are inaccessible; and services are inappropriate to the needs of young 
people.  
 
According to the authors, one of the reasons for the mismatch between the types of 
services available and what young people want is that there is an almost exclusive 
focus on specialist services, rather than on the broader range of community-based 
services and supports that is required. Headstrong’s experience has been that many of 
the resources required to accomplish a more balanced and responsive system already 
exist in the community. These need to be identified, enhanced, and integrated. 
Headstrong believes that it is critical to involve young people in the planning process. 
Young people want respect, confidentiality and a safe, accessible and supportive 
environment appropriate to their age and needs.  
 
As part of its research programme, Headstrong recently undertook a national baseline 
survey of adolescent mental health with 1,070 adolescents aged 12–18 years. It plans 
to extend the scope of its survey to include around 10,000 young people aged 12–25. 
A preliminary analysis of the data already collected reveals that:  
° one in five reported having no one to talk to about their problems, with over 25% 
reporting that if they had problems with depression, they had no one to turn to;  
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° nearly one in ten reported having serious problems but did not seek professional 
help;  
° only 64% had an adult they could trust always available to them; this percentage 
was lower for males (56%) than for females (70%); 
° one in five had been in trouble with the police authority. Levels of personal risk 
behaviour was high in the 14–16-year age category, with one in five drinking weekly 
(up to 50% monthly), and over one in 10 bingeing weekly (nearly one in three 
monthly). 
° only 40% felt they could cope well with their problems, and over one in three felt 
they were generally not happy. 
 
Evaluation of work with marginalised youth 
 
The Office of the Minister for Children and Youth Affairs (OMCYA) established an 
Inclusion Programme in December 2007 aimed at engaging marginalised young people 
in ‘youth participation structures and processes’. Seven organisations were allocated 
funding to support such involvement by the young people they represented.  An 
independent evaluation of the first year of the Inclusion Programme has now been 
published (McEvoy 2009).  
 
The seven participating organisations and the number of participants from each 
organisation involved in the Inclusion Programme and other youth participation projects 
are shown in Table 3.3.1. Grants were offered to these organisations so that they could 
help young people become involved in structures such as the Children and Young 
People’s Forum (CYPF) and Comhairle na nÓg. These structures provide a 
mechanism whereby the views of young people can be gathered on issues relevant to 
them, such as recreation policy and youth cafés. 
 
Table 3.3.1  Number of young people involved in the Inclusion Programme and other youth participation 
structures, by participating organisation 
 Inclusion 
Programme 
Other 
participation 
structures 
Total 
Barnardos 2 0 2 
BeLonG To Youth Service (an organisation for lesbian, gay, 
bisexual and transgendered (LGBT) young people) 1 2 3 
Ferns Diocesan Youth Service (FDYS) 37 10 47 
Inclusion Ireland (National Association for people with an 
intellectual disability) 2 0 2 
Irish Association of Young People in Care (IAYPIC) 4 0 4 
Irish Wheelchair Association (IWA) 12 1 13 
Pavee Point (Traveller organisation) 10 5 15 
Total 68 18 86 
Source: (McEvoy 2009) 
 
Site visits were made to six of the organisations and the evaluator conducted face-to-
face interviews and a number of telephone interviews with key stakeholders in all 
seven organisations, including 21 young people, and 11 adults who were youth 
leaders, project leaders, steering committee representatives or directors of the 
organisations. Each organisation submitted two progress reports during the first year of 
operation.  
 
Sixty-eight young people were involved in projects specifically relating to the Inclusion 
Programme and a further 18 were involved in other youth participation structures. More 
than half of the total number is accounted for by the high numbers attending the Ferns 
Diocesan Youth Service in Wexford. The evaluator stated that the numbers involved 
were a ‘simple and important criterion’ of success; however, it must be noted that in 
most cases the numbers were small. This may reflect the ‘bedding down’ time it takes 
to initiate this type of intervention and to attract marginalised young people.  
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The young people interviewed identified the benefits of participation in the Inclusion 
Programme and other youth participation projects in terms of opportunities – to get 
involved; to have a voice; to make new friends and understand different points of view; 
to improve personal skills, such as communication, confidence and team working; and 
to feel a sense of achievement.  The evaluation noted that the personal stories of the 
young people were testament to a programme that was well organised, well supported 
and meaningful and the ultimate benefit was that young people felt empowered and 
valued in the projects, as reflected in comments such as: ‘you are not judged on your 
background’ and ‘people don’t treat you differently’. 
 
The evaluator stated that the achievements of this programme represented progress in 
a short space of time. However, continued commitment and drive were required from 
the OMCYA and participating organisations to ensure that young marginalised people 
continued to benefit from engaging in youth participation structures, and that such 
structures benefit from integrating the views of young people on issues affecting their 
lives.  
 
3.3.2 At-risk families 
See National Report 2008 for most recent information (Alcohol and Drug Research 
Unit 2008). 
 
3.3.3 Recreational settings 
See National Report 2008 for most recent information (Alcohol and Drug Research Unit 
2008). 
 
3.4 Indicated prevention  
3.4.1 Children at risk (e.g.  children with AD(H)D, children with externalising or 
internalising disorders) 
 
No new information available 
 
3.5 National and local media campaigns 
The Steering Group that drafted the National Drugs Strategy (interim), 2009–2016 
(Department of Community Rural and Gaeltacht Affairs 2009) noted the evidence from 
the evaluation of the national drug awareness campaign mounted between 2003 and 
2005 (Sixsmith and Nic Gabhainn 2007), which concluded that stand-alone mass 
media campaigns were less effective than multi-component, multi-level interventions 
that reflect the complex nature of drug prevention and harm reduction.  
 
The Steering Group considered that a series of awareness campaigns should be 
developed that would (para. 3.48):  
° ensure that local and regional campaigns complement and add value to national 
campaigns;  
° optimise the use of ICT in drugs awareness initiatives (e.g. through internet search 
engines and social network websites);  
° ensure a co-ordinated approach by all key players to the development and 
implementation of a designated drug awareness week/day with agreed themes and 
methodologies; and  
° through the engagement with services users, representatives or services working 
with the following communities, target third-level educational institutions, 
workplaces and recreational venues; at-risk groups (Travellers, new communities, 
lesbian, gay, bi-sexual, transgender community (LGBTs), homeless people, 
prisoners and sex workers); and education/awareness among drug users to 
minimise the levels of usage and to promote harm reduction measures. 
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4. Problem Drug Use (PDU)  
4.1 Introduction 
This chapter provides an overview of developments and trends in the prevalence and 
characteristics of problem drug use in Ireland ranging from data for 2006 relating to the 
prevalence and incidence estimates of PDUs, to more recent studies relating to data on 
problem drug users from non-treatment sources and on varieties of problematic drug 
use.  
 
It is not possible to estimate the number of injecting drug users or problem cocaine 
users in Ireland as the National Drug Treatment Reporting System (NDTRS) does not 
have a unique identifier and this is the most reliable source of such data. This issue 
has been raised in a number of strategy submissions and it is hoped that this issue will 
be addressed in the forthcoming health information bill. A national 3-source capture-
recapture study, to provide statistically valid estimates on the prevalence of opiate drug 
use in the national population during 2006, was commissioned by the National Advisory 
Committee on Drugs (NACD).  The three data sources used in the study were the 
Central (methadone) Treatment List (CTL), the Hospital In-Patient Enquiry (HIPE) 
database and Garda PULSE data. The findings were published in 2009 (Kelly, A. et al. 
2009); they update a similar study for 2000–2001 (Kelly et al. 2003), which, in turn, 
update a Dublin-only study for the year 1996 (Comiskey, C.M. 1998).The new study 
indicates that use has increased since the previous survey.   
 
The National Registry of Deliberate Self Harm is a national system of population 
monitoring for the occurrence of deliberate self harm. It was established, at the request 
of the Department of Health and Children, by the National Suicide Research 
Foundation. Reported on Section 6.3.1 below is the sixth annual report from the 
National Registry of Deliberate Self Harm, based on data collected on persons 
presenting to hospital emergency departments as a result of deliberate self harm in 
2006 and 2007 in the Republic of Ireland. The Registry had near complete coverage of 
the country’s hospitals for the period 2002-2005. In 2006-2007, for the first 
time, all general hospital and paediatric hospital emergency departments in the 
Republic of Ireland contributed data to the Registry. Thus, for 2006-2007 the Registry 
achieved complete national coverage of hospital-treated deliberate self harm. 
 
The Registry defines deliberate self harm as: ‘an act with non-fatal outcome in which 
an individual deliberately initiates a non-habitual behaviour, that without intervention 
from others will cause self harm, or deliberately ingests a substance in excess of the 
prescribed or generally recognised therapeutic dosage, and which is aimed at realising 
changes that the person desires via the actual or expected physical consequences’. All 
methods of deliberate self harm are recorded in the Registry, including drug overdoses 
and alcohol overdoses, where it is clear that the self harm was intentionally inflicted. All 
individuals who are alive on admission to hospital following a deliberate self harm act 
are included. Not considered to be cases of  deliberate self harm are, among other 
things, accidental overdoses, e.g. an individual who takes additional medication in the 
case of illness, without any intention to self harm; alcohol overdoses alone where the 
intention was not to self harm; accidental overdoses of street drugs, i.e. drugs used for 
recreational purposes, without the intention to self harm; and individuals who are dead 
on arrival at hospital as a result of suicide. 
 
The EMCDDA (2004) defines PDU as ‘injecting drug use or long duration/regular use 
of opiates, cocaine and/or amphetamines’.  
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4.2 Prevalence and incidence estimates of PDU 
4.2.1 Indirect estimates of PDU 
Estimation of the numbers of problem opiate user in Ireland using capture-re-
capture 
 
In 2006 Dr Alan Kelly and colleagues in Trinity College Dublin (TCD), on behalf of the 
National Advisory Committee on Drugs (NACD), repeated the three-source capture-
recapture study undertaken in 2000–2001 (Kelly et al. 2003) (Kelly, A. et al. 2009). The 
three data sources employed to generate the estimate were the Central (methadone) 
Treatment List (CTL), Hospital In-Patient Enquiry (HIPE) Scheme and Garda PULSE 
data.  
 
The three sources of data indicated that there were 11,807 opiate users aged 15–64 
years known to services in Ireland in 2006 and an estimated 8,943 users not known to 
the services (hidden population) (Table 4.2.1). The estimate indicated that there were 
between 18,136 and 23,576 problem opiate users in Ireland in 2006; the point estimate 
was 20,790 (Table 4.2.2). Twenty-eight per cent (5,886) resided outside Dublin and 
72% (14,904) resided in Dublin (Table 4.2.3).  The authors reported that the estimate 
was likely to be inflated because the population was not closed, that is, it continued to 
recruit people into treatment (in Dublin and outside Dublin) and police custody (outside 
Dublin). In addition, the overlap between the three population sources was small. 
These two factors are known to inflate estimates obtained through the capture-
recapture method. The respective population rates for Dublin and the Rest of Ireland 
are 17.6 per 1,000 and 2.9 per 1,000. 
 
The point estimate for Ireland has increased by 44%, from 14,452 in 2001 to 20,790 in 
2006. The point estimate for Dublin increased by 21% while the point estimate for the 
rest of Ireland (excluding Dublin) increased by 164%; of note, the estimate of opiate 
users living outside Dublin was relatively small in 2001. In Dublin, the rate of opiate use 
per 1,000 of the 15–24 year old population decreased by 62%, from 18.7 in 2001 to 7.2 
in 2006 and this indicates that the number of younger people commencing opiate use 
has decreased. The rate of opiate use per 1,000 of the 15–64 year old population 
residing outside Dublin increased from 0.5 in 2001 to 1.5 in 2006 and this indicates that 
opiate use has increased outside Dublin. In an unpublished study, Kelly and colleagues 
report that retaining opiate users in treatment reduces their likelihood of being in 
contact with the gardaí (Dr A. Kelly, personal communication, 2009). For example, only 
12% of males aged 25–34 years who were attending treatment services between 2001 
and 2006 and known to the gardaí in 2001 continued committing crime in 2006. This is 
in line with findings from the ROSIE study and indicates that methadone treatment 
reduces the incidence of crime. The detailed results are presented in Standard Table 7.  
 
Table 4.2.1 Number of known opiate users, estimated hidden number, prevalence estimate and population rate 
in Ireland, in Dublin and in the Rest of Ireland, 2006 
 Age 
group 
Known 
number 
Estimated hidden 
number 
Estimated 
prevalence 
Rate/1,000 
population 
Ireland 15–64 11807 8983 20790 7.2 
Dublin 15–64 9442 5462 14904 17.6 
Rest of 
Ireland 
 
15–64 
 
2365 
 
3521 
 
5886 
 
2.9 
Source: Unpublished data from Kelly et al. 2009, TCD. 
 
Table 4.2.2 Estimated prevalence of opiate use in Ireland, in Dublin, and in the rest of Ireland, 2001 and 2006 
 2001 2006
 Estimate Lower 
bound 
Upper 
bound 
Rate/1000 
population 
Estimate Lower 
bound 
Upper 
bound 
Rate/1000 
population 
Ireland 14493 13453 16336 5.6 20790 18136 23576 7.2 
Dublin 12268 11519 13711 15.9 14904 13737 16450 17.6 
Rest of 
Ireland 2225 1934 2625 
 
1.2 5886 4399 7126 
 
2.9 
Source: (Kelly et al. 2003) and unpublished data from Kelly et al. 2009, TCD. 
Numbers using the sumative method 
 
  75
In 2006, 28% (5,886) resided outside Dublin and 72% (14,904) resided in Dublin (Table 
4.2.3). Seventy-one per cent were male. One in five was between 15 and 24 years old 
and half were between 25 and 34 years old.  
 
Table 4.2.3 Prevalence estimate of opiate users by age, gender and place of residence, 2006 
Gender 
Age 
group Ireland Dublin 
Rest of 
Ireland 
All 15–64 20790 14904 5886 
     
Males 15–64 14787 10395 4392 
 15–24 3150 1892 1258 
 25–34 7238 5172 2066 
 35–64 4399 3331 1068 
     
Females 15–64 6003 4509 1494 
 15–24 1159 701 458 
 25–34 3298 2605 693 
 35–64 1546 1203 343 
     
Source:  Unpublished data from Kelly et al. 2009, TCD. 
 
The prevalence rate for men 15 to 24 years old in Ireland was relatively stable in 2006 
compared to 2001 while the prevalence rates for older men increased (Table 4.2.4). 
This indicates that the rate of entry by men to opiate use may have stabilised though 
the overall rate of opiate use has increased. It is important to note that opiate 
dependence is a chronic condition.  
 
Table 4.2.4 Prevalence estimates and rates of opiate users for males by age, 2001 and 2006  
  Prevalence estimates Rate/1,000 population 
Region Age band 2001 2006 2001 2006 
Ireland 15–24 3194 3150 9.5 9.8 
 25–34 4376 7238 14.7 19.7 
 35–64 2228 4399 3.3 5.6 
      
Dublin 15–24 2735 1892 29.3 19.9 
 25–34 3740 5172 36.3 43.0 
 35–64 1803 3331 9.9 16.3 
      
Rest of Ireland α 
15–24 N/A 1258 N/A 5.6 
25–34 N/A 2066 N/A 8.4 
 35–64 N/A 1068 N/A 1.8 
 15–64 1688 4392 1.8 4.2 
      
α In 2001 there were insufficient numbers outside of Dublin to provide reliable estimates by individual age bands. 
Source: (Kelly et al. 2003) unpublished data from Kelly et al. 2009, TCD. 
 
The prevalence rate for women 15 to 24 years old in Ireland decreased in 2006 
compared to 2001 while the prevalence rates for the older women increased. This 
indicates that the rate of entry by women to opiate use may have decreased (Table 
4.2.5). 
 
Table 4.2.5 Prevalence estimates and rates of opiate users for females by age, 2001 and 2006 
  Prevalence estimates Rate/1000 population 
Region Age band 2001 2006 2001 2006 
      
Ireland 15–24 1999 1159 6.2 3.7 
 25–34 1941 3298 6.6 9.3 
 35–64 714 1546 1.1 2.0 
      
Dublin 15–24 1766 701 18.7 7.2 
 25–34 1784 2605 16.2 21.9 
 35–64 628 1203 3.2 5.7 
      
Rest of Irelandα 15–24 N/A 458 N/A 2.1 
 25–34 N/A 693 N/A 2.9 
 35–64 N/A 343 N/A 0.6 
 15–64 537 1494 0.6 1.5 
      
α In 2001 there was insufficient numbers outside of Dublin to provide reliable estimates by individual age bands. 
Source: (Kelly et al. 2003) and unpublished data from Kelly et al. 2009, TCD. 
 
4.2.2 Estimates of incidence of problem drug use 
There are no estimates of the incidence of problem drug use in Ireland. 
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4.3 Data on PDU from non-treatment sources (police, emergency, 
needle exchange) 
4.3.1 Description of clients attending harm reduction 
 
There is up-to-date national data on drug users attending needle exchanges (Robinson 
et al. 2008). This is presented in standard table 10 and structured questionnaire 23. 
Overall, between 10% and 30% of clients attending needle exchanges were female in 
2007. The youngest clients were aged between 16 and 20 years. Twenty-five services 
were open to any person aged over 18; five of these also dealt with 16–18-year-olds. 
Two services catered for women and sex workers; two served residents only; and two 
operated specific services for ethnic minorities. Twenty-nine services reported that a 
significant minority of their clients were homeless.  
 
Twenty-nine services reported heroin as the drug most commonly used by clients; 18 
services reported cocaine as the most common. As expected, injecting was the most 
common route of administration (reported by 19 services). Benzodiazepine injecting 
was reported as a common practice by 11 services. Nineteen services reported that 
clients attending their service injected steroids.  
 
4.3.2 National Registry of Deliberate Self-Harm annual report 2008 
 
The seventh annual report from the National Registry of Deliberate Self Harm was 
published in July 2009 (National Registry of Deliberate Self Harm Ireland 2009).  
According to the report there were 11,700 presentations of deliberate self-harm, 
involving 9,218 individuals, to hospital A&E departments in 2008. Reviewing data 
collected by the Registry for the six-year period 2002–2007, the report indicated that 
the rate of presentation of deliberate self-harm was relatively stable. However, a 6% 
increase was noted in the national person-based rate of deliberate self-harm, from 188 
per 100,000 in 2007 to 200 per 100,000 in 2008. 
 
The biggest rise in deliberate self-harm was observed in men, an increase of 11% from 
2007, resulting in the highest rate since the Registry was established in 2002. Men 
represented 45% of deliberate self-harm episodes in 2008 and women accounted for 
55%. 
 
Concordant with previous reports, deliberate self-harm was largely confined to the 
younger age groups.  Almost half of all presentations (46.5%) were by people aged 
less than 30 years. The peak age range for females and males presenting was the 
same as previous reports at 15–19 years for females and 20–24 years for males. The 
report showed an increase in the number of persons presenting with deliberate self-
harm aged 10–14 years. 
 
Rates were higher in urban settings, with the highest rate (17%) in Dublin North East 
Hospital Group. The number of deliberate self-harm presentations was highest on 
Mondays and Sundays, accounting for one in three of all presentations. Over 40% of 
the total number of presentations were made between the hours of 8pm and 3am. 
 
Repetition of deliberate self-harm accounted more than one in five (21%) of all 
presentations in 2008 and the highest proportion of repeated acts was among the 30–
40 years age group.   
  
Drug overdose was the most common form of deliberate self-harm, representing 72% 
of all such episodes reported in 2008. Overdose rates were higher among females 
(79%) than among males (64%). On average, at least 31 tablets were taken in 
episodes of drug overdose. The total number of tablets taken was known in 74% of 
cases. Forty-one per cent of all drug overdoses involved a minor tranquilliser, 23% 
involved paracetamol-containing medicines and 22% involved anti-depressants/mood 
stabilisers. According to the report, although the analgesic, distalgesic, was withdrawn 
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from the Irish market in January 2005, distalgesic was involved in 29 cases of 
deliberate self-harm in 2008, this compared to approximately 400 cases reported 
annually between 2002 and 2005.  
 
There was evidence of alcohol consumption in 42% of all episodes of deliberate self-
harm, emphasising the strong association between alcohol consumption and suicidal 
behaviour. Illicit drugs such as cocaine and heroin were involved in 3.8% of all 
overdose acts. 
 
Attempted hanging was more often used as a method of deliberate self-harm in 2008 
than in previous years, accounting for 16% of all self-harm acts in the 10–14 years age 
group. Self-cutting was the only other method of deliberate self-harm, representing 
21% of all episodes, and was more common among males (25%) than among females 
(18%). 
 
The emergency department was the only treatment setting for more than half (57%) of 
all deliberate self-harm patients, that is, they did not proceed to further treatment. 
 
The report recommended the following measures to reduce the incidence of deliberate 
self-harm: 
° continued support for the national mental health awareness campaign and 
evidence-based mental health promotion initiatives and implementation of more 
intensified prevention and intervention programmes at national level; 
° development and implementation of initiatives to increase awareness of mental 
health issues among the general public and service providers supporting the 
unemployed or people experiencing financial difficulties; 
° development of a system to enable deliberate self-harm data to be linked with 
suicide mortality data to improve the understanding of risk factors associated with 
suicide; 
° prioritisation of evidence-based mental health programmes for children and 
adolescents in addition to specialist mental health services; 
° development of more uniform assessment procedures and evidence-based 
interventions targeting people who repeatedly self-harm; 
° restriction or withdrawal from the market of highly lethal drugs; and 
° confirmation of the effectiveness of interventions such as cognitive behavioural and 
problem-solving treatments among men presenting with deliberate self-harm. 
 
 
4.4 Intensive, frequent, long-term and other problematic forms of use 
4.4.1 Description of the forms of use falling outside the EMCDDA’s PDU 
definition (in vulnerable groups) 
 
Drug-using sex workers  
 
A large-scale qualitative study has highlighted the need for adequately-resourced 
support structures to reduce the risk of harm to drug-using sex workers in Ireland. The 
first of its kind, this study by the NACD (Cox and Whitaker 2009) explored the local risk 
environment within which drug-using sex workers in Dublin live and work.  The authors 
concluded that wider social and situational factors, such as poverty, housing, health, 
educational needs and employment prospects are as fundamental to reducing risk of 
harm in this vulnerable group as addressing drug use. 
In-depth interviews were conducted with 35 drug users currently or formerly engaged in 
sex work, and biographical, drug use and offending behaviour data were collected by 
means of brief questionnaires.  In addition, interviews were held with 40 professionals 
across community, voluntary and statutory sectors whose work either directly or 
indirectly impacted on drug-using sex workers.  This intensive, qualitative approach 
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revealed that there was a range of behaviours associated with drug use and its 
accompanying lifestyle which placed individuals at particular risk of harm.  
For the most part, participants in the study grew up in communities associated with 
social and economic marginalisation and high levels of unemployment. They moved 
more or less continuously through drug and alcohol services, homeless hostels, the 
judicial system and other social care agencies.   Participants used a range of strategies 
to reduce danger, yet their perception of risk was relative to their situation, thus leading 
them to treat some risks as acceptable or necessary.  Current harm reduction 
interventions tend to focus on individual risk behaviour, often overlooking the wider 
social contexts in which members of this group live and work. 
Arising from analysis of the research, the NACD recommended:   
° continued and adequate funding of existing services that deal with this client group; 
expansion of outreach services (particularly out of hours) to target existing and 
developing street sex markets, and development of peer outreach to areas of the 
city with known networks of drug-using sex workers; 
° continued funding of programmes (such as specialist Community Employment (CE) 
schemes for drug users) aimed at getting drug users back to work;  
° provision of flexible hostel accommodation for drug-using sex workers who are 
homeless, ranging from low-threshold facilities to accommodation that assists 
recovery and rehabilitation;  
° recognition of the role of drug services in identifying male and female clients 
involved in sex work and in providing advice on safer sex practices in order to 
reduce sexual risk in personal intimate relationships and commercial sex 
transactions. 
In terms of policy, the authors recommended that ‘harm reduction be explicitly stated 
as a guiding principle of the new National Drugs Strategy’ (p.26), and that the strategy 
must also outline a continuum of harm-reduction activities, a ‘model package’ of 
interventions, minimum standards for services and optimal levels of service coverage. 
 
Drug tests in Irish prisons 
 
Information on drug testing in prisons in 2008 was obtained from the Irish Prison 
Service. These data indicated that more than 20,000 voluntary tests were carried out to 
monitor drug use and responses to treatment. These tests included those carried out 
on committals (new entries) as well as those carried out on existing inmates. It may be 
assumed therefore that some of the positive test results related to drugs or alcohol 
consumed outside the prison. Between one-third and one-half of those screened tested 
positive for at least one drug. The common metabolites detected indicated use of 
cannabis, benzodiazepines and opiates (Table 4.4.1). It is not clear whether the 
numbers of positive cases excluded prisoners who were prescribed benzodiazepines; if 
they do not, these figures overstate the extent of unregulated use of benzodiazepine in 
prisons. Cocaine and alcohol were detected in a small number of tests. The profile of 
positive opiate and benzodiazepine tests indicated moderate use of such drugs among 
prisoners tested in Mountjoy, Wheatfield, Limerick, Midland and Cloverhill prisons.  
The proportion of positive tests was low in St Patrick’s Institution and in Castlerea and 
Cork prisons. It would be useful if the test results of prisoners who were tested at 
committal interview could be removed from this analysis, as this would provide a more 
accurate assessment of drug use in Irish prisons. 
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Table 4.4.1   Number of tests, by prison, and number (%) of positive tests, by prison and by drug type, 2008 
Prison
No. of
tests Cannabis
Benzodiaz
epines Methadone Opiates Cocaine Alcohol Amphetamines
Number (%)
Mountjoy Male 3279 1491 (45) 1619 (49) 3075 (94) 1714 (52) 46 (1) 12 (0.4) 22 (0.7)
Dochas Centre 2933 772 (26) 1692 (58) 2433 (83) 816 (28) 179 (6) 58 (2) 8 (0.3)
Training unit 2849 31 (1) 17 (0.6) 0 (0) 23 (1) 2 (0.1) 14 (0.5) 8 (0.3)
Wheatfield 2552 1026 (40) 782 (31) 1886 (74) 913 (36) 18 (0.7) 15 (0.6) 3 (0.1)
Cloverhill 3191 853 (27) 1265 (40) 2292 (72) 1179 (37) 333 (10) 87 (3) 24 (0.8)
St Patrick’s Inst. 2457 133 (5) 71 (3) 300 (12) 27 (1) 0 (0.0) 12 (0.5) 1 (0.04)
Castlerea 164 43 (26) 55 (34) 11 (7) 21 (13) 6 (4) 3 (2) 3 (2)
Loughan House 567 157 (28) 105 (19) 2 (0.4) 21 (4) 2 (0.4) 8 (1) 2 (0.4)
Shelton Abbey 887 214 (24) 118 (13) 7 (0.8) 38 (4) 5 (0.6) 23 (2.6) 9 (1)
Limerick 496 155 (31) 211 (43) 425 (86) 187 (38) 2 (0.4) 2 (0.4) 1 (0.2)
Cork 153 2 (1) 20 (13) 0 (0.0) 5 (3) 0 (0.0) 0 (0.0) 0 (0.0)
Midland 3452 785 (23) 892 (26) 3063 (89) 1423 (41) 58 (2) 14 (0.4) 11 (0.3)
Portlaoise 18 4 (22) 10 (56) 4 (22) 3 (17) 1 (6) 0 (0.0) 1 (6)
Arbourhill 46 6 (13) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Source: Irish Prison Service  
 
The normalisation of substance abuse among young Travellers in Ireland 
 
Van Hout and Connor (Van Hout 2009a) explored the nature and extent of drug use 
among a group of 12–18-year-old Travellers in the south east of Ireland. In terms of 
drug use and attitudes, young Travellers demonstrated similar trends to ‘settled’ 
adolescents. However, they reported poor levels of health awareness and knowledge 
of drug services. The authors concluded that the social exclusion of young Travellers 
puts them at risk of problem drug use, owing to issues of poor literacy levels, family 
crises, discrimination, poor knowledge of service provision relating to drug education 
and treatment, and the location of halting sites in areas of high drug usage.  
 
4.4.2 Prevalence estimates of intensive, frequent, long-term and other 
problematic forms of use, not included in the PDU definition 
 
Crack cocaine in the Dublin region 
 
The HRB conducted research into crack cocaine in Dublin over a nine-month period 
beginning in August 2007, using a rapid situation assessment technique developed by 
the World Health Organization (Connolly et al. 2008). This involved a multi-method 
approach which brought together existing research, and drug treatment and criminal 
justice data, supported by interviews with key informants such as drug users, gardaí, 
outreach workers and treatment specialists.  
 
The report indicated that the number of people using crack in Ireland was low, with 
current users representing just 1% of drug users presenting for treatment and 0.1% of 
the general population. However, the report also made the point that, despite targeted 
garda interventions, crack use had increased and availability had spread throughout 
the Dublin region. The report highlighted the need to remain vigilant.  
 
Crack cocaine is produced from powder cocaine using readily available chemicals such 
as ammonia and baking soda.  A number of factors may explain the rise in crack 
cocaine use in Dublin – the increased availability of powder cocaine; the presence of 
problematic opiate users who have used crack cocaine elsewhere and have resumed 
use while living in Dublin; and the presence of non-Irish nationals who have access to 
cocaine supply routes and experience of preparing crack cocaine.  
 
Most crack users used more than one drug; opiates (mainly heroin) were the most 
common drugs used alongside crack. Smoking was the main route of administration. A 
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proportion of intravenous users made a transition from injecting powder cocaine to 
smoking crack cocaine because of the physical harms of injecting. Frequency of use 
ranged from daily to weekly and was largely dependent on financial resources.  
 
The north inner city was the primary crack market in Dublin; the market was dominated 
by non-Irish national dealers who imported small amounts of cocaine via couriers. 
However, a growing number of Irish dealers were reported to be involved in the 
distribution of crack throughout the Dublin region, and prepared crack had been 
available throughout the city since 2006. Findings indicated that the crack market was 
a closed market, meaning dealers did not sell to strangers, exchanges were arranged 
using mobile phones, and buyers were directed to exchange points outside the inner 
city. The price of crack was relatively stable and uniform, with prepared quantities or 
‘rocks’ being sold for €50 or €100. Crack houses were reported as locations where 
crack was used and in some cases prepared in exchange for free crack; they were not 
reported as venues for crack dealing or as sites for sex work.  
 
A high proportion of crack users were homeless, unemployed and did not have formal 
educational qualifications. According to data from treatment services, the majority of 
crack users were male and half were aged between 20 and 29 years. However, 
females involved in sex work and single mothers were reported to develop the most 
chaotic addiction. Common physical side-effects of crack use are breathing problems, 
heart problems and rapid weight loss, and the most common psychological 
consequences are paranoia, aggressiveness and depression. Compulsive crack users 
reported neglecting their children, often diverting their financial resources towards 
buying crack. Shoplifting, burglary and robbery were reported as means of supporting 
the crack cocaine habit. Service providers reported an increase in the numbers of 
women returning to or beginning sex work to fund their crack use.  
 
Identifying new drugs and new drug trends with the help of drug helplines 
 
In July 2009 the European Foundation of Drug Helplines (FESAT) published the results 
from the 15th (Evenepoel 2009b) and 16th data collections for its monitoring project 
(Evenepoel 2009a). Since the beginning of 2001 FESAT has been collecting 
information every six months on the types of person contacting helplines, the content of 
these calls and how this has changed compared to the previous six months. According 
to the author, the main objective of this monitoring is to identify the emergence of new 
drugs and new drug trends; the data cannot quantify the size of any such changes.  
 
Of the 34 relevant FESAT helplines, 14 helplines in 11 countries, including Ireland, 
participated in the project in the first half of 2008. This article outlines some of the main 
changes reported for the first half of 2008 when compared to the second half of 2007, 
and presents some unpublished information from the Drugs/HIV Helpline in Ireland.  
 
The smallest of the 14 participating helplines in Europe answered less than one call per 
day, and the largest, more than 60 calls per day. Seven helplines answered 10 calls or 
fewer per day; six helplines answered 11 to 30 calls; one helpline answered 31 to 60 
calls and one helpline answered 61 or more calls. Half of the helplines answered 13 or 
more calls per day. The Drugs/HIV Helpline in Ireland answered an average of 14 calls 
per working day, though this figure included calls about sexual health. There were 
1,805 calls between January and June 2008, which represented an 8% decrease when 
compared to the preceding six-month period. This decrease was expected owing to the 
fact that there was an increase in the number of calls during the pharmacy strike in 
October 2007 (Aileen Dooley, personal communication, 2009). 
 
The FESAT report noted a decline in the numbers of helplines reporting calls about 
crack (9 helplines), heroin (6 helplines), ecstasy (6 helplines), cocaine (4 helplines) and 
hash (4 helplines) across Europe in the first half of 2008 when compared to the second 
half of 2007, and an increase in the number of helplines reporting calls about alcohol 
(10 helplines), medications (other than opiates and benzodiazepines) (7 helplines) and 
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benzodiazepines (4 helplines). There were mixed reports about cocaine and cannabis 
across Europe, with some helplines reporting increases and some reporting decreases.  
 
In Ireland, there were large decreases in the number of calls to the Drugs/HIV Helpline 
about hashish and painkillers containing opiates in the first half of 2008 when 
compared to the second half of 2007. There were large increases in the number of 
calls about alcohol, cocaine, ecstasy and smoking heroin (Aileen Dooley, personal 
communication, 2009). 
 
During the first half of 2008, a number of helplines in Europe received calls about drugs 
that had not been reported to them before. Helplines in Belgium and in Germany 
reported calls about the ‘spice’ products which are used to induce the same effect as 
cannabis. A helpline in Belgium received calls about ‘space shuttles’, which are in the 
form of mushrooms or herbs. A helpline in Norway received its first call about 
mescaline, a hallucinogenic drug. 
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5. Drug-related Treatment: treatment demand and treatment 
availability 
 
5.1 Introduction 
Two broad philosophies underlie the approaches to treatment: medication-free therapy 
and medication-assisted treatment. Medication-free therapy uses models such as 
therapeutic communities and the Minnesota Model, though some services have 
adapted these models to suit their particular clients’ needs. Medication-assisted 
treatment includes opiate detoxification and substitution therapies, alcohol and 
benzodiazepine detoxification, and psychiatric treatment. Various types of counselling 
are provided through both philosophies of treatment and independent of either type of 
treatment. Alternative therapies, such as acupuncture, are provided through some 
community projects.  
 
On 1 January 2005, the 10 health boards managing the health services in Ireland were 
replaced by a single entity, the Health Service Executive (HSE), which manages 
Ireland’s public health sector. The HSE’s Addiction Services, including both illicit drugs 
and alcohol, are delivered through Social Inclusion Services, which is part of the 
Primary, Community and Continuing Care (PCCC) directorate.  Treatment is provided 
through a network of statutory and non-statutory agencies.  
 
In 1998, the same year as the CTL was established, a Methadone Treatment Protocol 
(MTP) was introduced.  Prior to the introduction of the MTP only a small number of 
GPs were prescribing methadone. This resulted in a large number of drug misusers 
travelling long distances from all parts of Dublin in search of methadone. This affected 
the communities in which the prescribing GPs practised. There was also anecdotal 
evidence that a large quantity of methadone and physeptone was available for sale on 
the black market. The MTP was to ensure that treatment for opiate misuse could be 
provided wherever the demand existed.  Locally-based methadone treatment for opiate 
misusers is now provided through drug treatment clinics, satellite clinics or through 
general practitioners in the community. 
 
Under the MTP general practitioners are contracted to provide methadone treatment at 
one of two levels – Level 1 or Level 2.  Level 1 qualification under the programme 
allows GPs to maintain methadone treatment for misusers who have previously been 
stabilised on a methadone maintenance programme. Each GP qualified at this level is 
permitted to treat a maximum of 15 stabilised misusers. Level 2 qualification allows 
GPs both to initiate and maintain methadone treatment. Each GP qualified at this level 
may treat up to a maximum of 35 misusers. Practices where two qualified level 2 GPs 
are practicing are permitted under the protocol to treat a maximum of 50 misusers.  
 
Under the Community Pharmacy Contractor Agreement the HSE can agree with 
individual pharmacies to dispense methadone mixture DTF1mg/ml to opiate dependent 
persons in their local areas on a special methadone prescription form. The involvement 
of the community pharmacists in the dispensing of methadone also emsures that a 
large number of opiate dependent persons may be treated in their own local area.  
 
National data collection tools 
 
The National Drug Treatment Reporting System (NDTRS) is a national epidemiological 
database which provides data on treated drug and alcohol misuse in Ireland. The 
NDTRS collects data from both public and private outpatient services, inpatient 
specialised residential centres and low-threshold services.  For the purposes of the 
NDTRS, treatment is broadly defined as ‘any activity which aims to ameliorate the 
psychological, medical or social state of individuals who seek help for their substance 
misuse problems’.  The NDTRS is a case-based, anonymised database. The NDTRS 
is co-ordinated by staff at the Alcohol and Drug Research Unit (ADRU) of the Health 
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Research Board (HRB) on behalf of the Department of Health and Children. Significant 
improvements in the NDTRS’s data collection processes and procedures mean that the 
HRB is now able to report on the information collected from treatment centres on a 
more regular basis. The number of drug treatment services participating in the NDTRS 
continues to increase (Standard Table TDI 34).  Although treatment is provided within 
the Irish Prison Service, it was only in 2009 that counsellors working in the prison 
service began to return information to the NDTRS.   
 
The Central Treatment List (CTL) was established under Statutory Instrument No 225 
following the Report of the Methadone Treatment Services Review Group 1998 
(Methadone Treatment Services Review Group 1998). This list is administered by the 
Drug Treatment Centre Board on behalf of the HSE and is a complete register of all 
patients receiving methadone (for treatment of opiate misuse) in Ireland and provides 
all data on methadone treatment nationally. 
 
The Research Outcome Study in Ireland (ROSIE) was the first prospective study of 
treatment outcomes for opiate users to be conducted in Ireland. The objective was to 
evaluate the effectiveness of treatment and other intervention strategies for opiate use. 
The study recruited 404 opiate users entering treatment between September 2003 and 
June 2004. Three treatment modalities, provided through both inpatient and outpatient 
settings, were the focus of attention – methadone maintenance, structured 
detoxification, and abstinence-based treatment programmes. In addition, a sub-sample 
of individuals was recruited from needle exchange interventions. Participants were 
interviewed at treatment intake, or as soon as possible thereafter, and again at 6 
months, 12 months and 3 years after the baseline interview. Data were collected by 
means of a structured interview. The interview instrument contained a comprehensive 
set of outcome measures detailing the social and psychological characteristics of the 
cohort, and a range of treatment process factors in relation to treatment outcomes. 
Between September 2006 and October 2008 seven papers in the ROSIE Findings 
series, concentrating on particular aspects of the study, were published; in June 2009 a 
report on outcomes at 1-year and 3 years for the whole population and the ‘per 
protocol’ population, i.e. participants who completed all three interviews, was published 
(Comiskey, Catherine M et al. 2009). 
 
 
5.2 Strategy/policy 
5.2.1 Plans for drug and alcohol services in Ireland in 2009 
 
The Health Service Executive’s National Service Plan 2009 (NSP) contains the 
agency’s plans in the drugs and alcohol area during 2009 (Health Service Executive 
2008). Table 5.2.1 summarises the key result areas for 2009 together with the outputs 
delivered in 2008 and the deliverables for 2009.  
 
‘Key result areas’ are a new element in the HSE’s annual service plan. They have 
resulted in a rationalisation and reduction in the number of action lines in the addiction 
services area. Just three key result areas are identified: enhancement of addiction 
services, development of the new National Drugs Strategy, and the and supporting the 
drugs task forces model. 
 
Table 5.2.1 Addiction Services in 2009  
Key result area Output 2008 Deliverable 2009 
Enhancement of addiction 
services 
(Progress implementation 
of the recommendations of 
the 2007 report of the 
Working Group on Drugs 
Rehabilitation) 
 
Regional addiction plans 
developed 
 
Recruitment of Rehabilitation Co-
ordinator under way 
 
Development of National 
Rehabilitation Implementation 
Committee under way  
Further development of multi-disciplinary teams for 
provision of services to under-18 year-olds. This will 
facilitate the further development of harm reduction 
services, including needle exchange and 
methadone services.  
 
Implementation of the Rehabilitation Strategy (to 
include appointment of co-ordinator) 
 
Addiction services training programme 
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Key result area Output 2008 Deliverable 2009 
 
Development of new 
National Drugs Strategy 
(NDS) 
HSE / Department of Health and 
Children submission to NDS 
review. 
Planning undertaken for implementation of HSE 
components of the new National Drugs Strategy 
2009 – 2013  
 
National Drugs Task Force  
 
 
Mainstreaming process agreed 
with the Departments of 
Community, Rural and Gaeltacht 
Affairs and Health and Children 
Progression of mainstreaming of 169 local drugs 
task forces (LDTFs) as appropriate, starting from 
April onwards. 
Source: (Health Service Executive 2008) 
 
The performance information framework used in the HSE has also been refined. In the 
addiction services area, one measure of ‘activity’ and two indicators of ‘performance’ 
have been identified. The figures indicate that, nationally, the level of activity in the 
addiction services area increased in 2008 and this new level is due to be maintained in 
2009, but the level of performance is expected to remain static at 2007 levels. The 
2009 performance target for treatment of substance misusers aged under 18 is based 
on baseline data collected in 2008.   
 
Activity – the average number of clients in methadone treatment per month per area: In 
2008 the national target was to maintain throughput at the 2007 level of 7,000 clients. 
In the event, throughput in 2008 reached 7,636 and the HSE expects to reach this level 
of activity again in 2009.  
 
Performance – the number and percentage of substance misusers for whom treatment, 
as deemed appropriate, commenced within one calendar month: In 2008 the national 
target was to exceed the 84% (n=1,406) performance level achieved in 2007. In the 
event, the 2007 level was attained but not exceeded, and this same level of 84% has 
been set as the target for 2009. 
 
Performance – the number of substance misusers under 18 years of age for whom 
treatment, as deemed appropriate, commenced within one calendar month: No target 
was set for this indicator in 2008 as the staff to develop services for under–18s were 
only appointed during 2008. However, data collected in 2008 showed that 88% (n=106) 
of substance misusers under the age of 18 commenced suitable treatment within a 
calendar month. This performance level has been set as the target for 2009. 
 
The breakdown of performance by HSE region, also published in the plan, reveals 
variations, with the regions around Dublin performing below par. Regarding 
commencement of treatment for substance misusers in 2008, the Southern Region 
exceeded the national target by over 10% at 96% (n=547), while the combined 
Dublin/North East and Dublin/Mid-Leinster regions only achieved a performance level 
of 64% (n=510). Regarding commencement of treatment for under-18s, the target 
timeframe of one calendar month was achieved 100% by both the Southern (n=53) and 
Western (n=30) regions, but the combined Dublin/North East and Dublin/Mid-Leinster 
regions only achieved a level of 62% (n=23). These regional performance targets have 
been rolled over for 2009.  
 
Under the heading of ‘Improving our infrastructure’, the service plan lists two capital 
works in the Dublin/Mid-Leinster Region, which, it states, are to be commissioned and 
in place before the end of 2009 and which can be funded within the HSE’s 2009 
allocation: 
° Clondalkin: new purpose-built addiction centre providing psychiatry, GP, 
counselling, pharmacy, nursing, psychology and family therapy services; and  
° Pearse Street: refurbishment and upgrade of the Drug Treatment Centre.  
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5.2.2 RDTF strategies and treatment 
 
An assessment of treatment needs in the North Eastern Regional Drugs Task 
Force Area 
 
The North Eastern Regional Drugs Task Force (NERDTF) commissioned a needs 
assessment study in order to:  
° assess the number and profile of drug-users; 
° assess in-patient and out-patient drug treatment services; 
° explore needs of drug treatment service users and their families; 
° identify gaps in service provision; and 
° make recommendations for future service development and resources required. 
 
The study examined available quantitative data and also carried out qualitative 
interviews with a wide range of stakeholders, including staff working in addiction 
services, community and voluntary groups, drug users and family support groups 
(Watters 2008). The NERDTF covers the counties of Louth, Meath, Cavan and 
Monaghan. The main results are summarised below. 
 
The study found that drug use in the region had increased in recent years. National 
prevalence data showed that almost one in four people in the region reported using an 
illicit drug at some point in their life, and one in three in the 15–34-year age group.  
 
The report did not include all data available at the time from the NDTRS; Table 5.2.2 
presents the complete figures for 2001 to 2006, showing a 27% increase in the total 
number of cases over the six years. This was mainly due to the increase in new cases 
seeking treatment.  
 
Table 5.2.2 Number (%) of cases entering treatment in the former North Eastern Health Board area, 2001–2006  
 2001 2002 2003 2004 2005 2006 
All cases 370 306 387 374 365 471 
Previously treated cases 125 (33.8) 99 (32.4) 146 (37.7) 130 (34.8) 125 (34.2) 149 (31.6) 
New cases 221 (59.7) 186 (60.1) 229 (59.2) 236 (63.1) 224 (61.4) 303 (64.3) 
Treatment status unknown 24   (6.5) 21   (6.9) 12   (3.1) 8   (2.1) 16   (4.4) 19   (4.0) 
    Source: (Reynolds et al. 2008) 
 
According to the NDTRS, the incidence of treated drug use in the region for 2001–2006 
was 91.3 per 100,000, an increase on the 1998–2002 rate of 50.1 per 100,000. 
 
The main problem drugs identified by the study were cocaine, cannabis, alcohol, heroin 
and prescription drugs. The main problem drugs among those entering treatment 
between 2001 and 2006 were cannabis (54%), opiates (27%) and cocaine (10%). 
 
Most of the respondents interviewed felt that drug use was a growing problem in the 
region. Other issues raised included the normalisation of cannabis use to the point 
where it was considered equivalent to consuming alcohol. Heroin use was associated 
with social deprivation and rural areas, while cocaine was perceived as being used by 
all social classes, with use starting in the late teens. Increased polydrug use was also 
commented on. Increased consumption of alcohol by teenagers was reported.  
 
The report noted that services varied in type, quality and availability throughout the 
region. There was a range of outpatient services, but no dedicated inpatient facility for 
drug treatment and detoxification. Underdevelopment of the services was suggested as 
a factor in some of the weaknesses in service provision. Other issues raised included 
insufficient staff resources in HSE Addiction Services, limited collaboration between 
statutory and voluntary services, lack of a clear focus on polydrug use and lengthy 
waiting lists.  
 
Recommendations of the report are summarised below: 
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° provide services for residential detoxification, out-of-hours treatment, crisis and 
early intervention, and treatment for under-18s; 
° provide clear access pathways and accessible information on the types of service 
and treatment available; 
° move to a continuity of care model, with a case management approach, and 
systems to monitor progress and outcomes; 
° widen the scope of treatment services to cover holistic care for the client and their 
family, and improve the support services; 
° develop a set of standards/guidelines to improve the appropriateness/location of 
services; 
° adjust treatment approaches to respond to polydrug use, including alcohol, and 
increase harm reduction approaches, including needle exchange, health education 
and easy access to low-threshold treatment; 
° improve collaboration and communication between statutory and community 
services. 
 
Launch of Dublin 12 Local Drugs Task Force strategic plan 
 
The Minister of State with responsibility for drugs strategy, John Curran TD, launched 
the Dublin 12 Local Drugs Task Force Strategic Plan 2009–2013 on 12 May 2009 
(Dublin 12 Local Drugs Task Force 2009). The launch was followed by workshops on a 
number of themes, including the availability of treatment, rehabilitation, education and 
prevention initiatives, and families dealing with drug issues. The plan was the product 
of extensive consultation with stakeholders in the catchment areas of Crumlin, 
Drimnagh, Kimmage and Walkinstown. Specific aims and objectives in the new 
strategy include: 
° Treatment – continue to develop the cross-task force harm reduction/needle 
exchange service and increase collaboration between drug treatment and alcohol 
services.   
° Rehabilitation – lobby for a rehabilitation/integration service (RIS) and increased 
rehabilitation options, and develop forums and networks such as the D12 Service 
Users Forum. 
° Education – consolidate and develop interventions aimed at young people at risk, 
develop links with schools and provide accredited addiction studies courses locally. 
° Supply control – work towards implementing initiatives such as the Joint Policing 
Committees and the Dial to Stop Drug Dealing campaign, and develop the 
Community Safety Partnership with the gardaí and other community stakeholders. 
° Research – strengthen data collection systems, commission local research to 
inform service planning, and participate in national-level studies. 
° Family support – re-establish family support groups and support the development of 
childcare facilities for drug-using families. 
° Alcohol – develop a plan to address alcohol misuse, identify local alcohol services 
and form stronger relationships with them.  
 
5.3    Treatment systems 
5.3.1 Organisation and quality assurance 
 
Audit of drug treatment in Ireland 
 
The Comptroller and Auditor General (CAG) published a report entitled Drug treatment 
and rehabilitation on 6 June 2009 (Comptroller and Auditor General and Department of 
Community Rural and Gaeltacht Affairs 2009). The drug treatment services examined 
in this report were those caring for people with addiction to illegal drugs (mainly 
cannabis, cocaine, ecstasy and heroin). The report reviewed: 
° the extent to which the demand for drug treatment and rehabilitation services was 
being met; 
° the timeliness of access to drug treatment; 
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° the extent to which the effectiveness of drug treatment and rehabilitation services 
was evaluated; and 
° the effectiveness of the arrangements for co-ordination of drug treatment and 
rehabilitation at an individual case level, and nationally. 
 
Treatment for problem opiate use 
It has been estimated that there were between 12,884 and 15,883 problem opiate 
(mainly heroin) users in Ireland in 2001. Up to 2000, opiate use was concentrated in 
the greater Dublin area, but at the time of this report there was evidence that it had 
spread throughout the country. Methadone substitution treatment is the main form of 
treatment for opiate addiction in Ireland. At the end of 2007, just over 8,000 people 
were receiving methadone treatment. Around one-third of those receiving methadone 
treatment were cared for by private general practitioners. Needle-exchange services 
were provided in some areas, with the aim of reducing the risks associated with the 
sharing of injecting equipment. According to this report, there was some increase in the 
provision of needle-exchange services between 2001 and 2009, but gaps in service 
provision remained. The authors reported that in the period under review the numbers 
of opiate users who received detoxification treatment and the numbers who attended 
follow-on rehabilitation treatment were very low when compared with the numbers who 
received methadone treatment. They estimated that the extent of detoxification 
treatment provision was in the region of 100 courses of treatment per year. While the 
authors acknowledged that long-term methadone maintenance is likely to be the best 
outcome that can be achieved for a significant proportion of opiate users, they 
suggested that the HSE set targets for rates of progression through the various forms 
of treatment.  
 
Treatment for problem drug use (excluding opiates)  
The prevalence of cannabis and cocaine use among the general population increased 
between 2002/3 and 2006/7. The authors assumed that the habitual use of a number of 
other drugs was also on the increase between the two surveys. The authors reported 
that, despite this, there did not appear to have been a commensurate increase in the 
number of cases treated for problem use of cannabis over the life of the National Drugs 
Strategy 2001–2008. The findings of the review indicated that changes in the pattern of 
drug misuse (e.g. heroin addiction outside of Dublin and cocaine addiction in Dublin) 
created a challenge that service providers and planners found difficult to address. The 
review noted that many clients reported multiple addictions. The current pattern of drug 
use suggested that there were, in effect, two separate client groups for whom drug 
treatment needed to be provided: 
° those with a largely opiate-based addiction problem, with more than three in five 
reporting multiple drug use, and concentrated in certain marginalised and poor 
sectors of society; and 
° those with problem use of drugs such as cannabis, cocaine or ecstasy, spread 
more widely across social groups and geographic areas. 
 
Although the prevalence of illegal drugs such as cannabis and cocaine was higher in 
Dublin than in the rest of the country, the rate at which users of these drugs entered 
treatment appeared to be significantly lower in Dublin than elsewhere. The authors 
noted that there was a risk that the uptake of addiction treatment reflected the available 
services in a geographical area rather than the needs of the people living in the area.  
 
Demand for treatment 
Accurate information about the level of demand for treatment for problem drug use is 
very important for service planning purposes. The National Drug Treatment Reporting 
System (NDTRS), relies on treatment service providers to collect details on each 
individual who presents for treatment. The information is transmitted to the HRB, 
without personal identification details (e.g. name or address) of the individuals 
receiving treatment. The result is that while the number of courses of treatment 
delivered can be identified, it is not possible to track the progression of an individual 
from one service provider to another. The review noted that ‘the NDTRS has the 
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potential to generate better estimates of demand for treatment, but greater compliance 
by service providers with the NDTRS data input rules would be required if this is to be 
achieved.’ The review recommended that ways of recording treatments being sought 
and provided be on an individual basis and in a manner that ensures security of the 
information.  
 
Access to treatment 
This review reported that the NDTRS data may underestimate the extent of waiting for 
assessment. In some areas recording of information for NDTRS purposes starts only at 
the time of assessment, rather than at the time of initial presentation or referral. Some 
service providers also operate ‘informal’ waiting lists, and call those on the informal list 
only when an assessment appointment becomes available. In addition, where drug 
users are aware of long waiting times for access to local services, they may be 
deterred from presenting for assessment. The HRB provides a protocol defining the 
terms referral, assessment and treatment, but needs to put more emphasis on ensuring 
that all service providers record information completely and accurately so that the true 
extent of waiting for treatment may be gauged. Subject to these limitations, analysis of 
NDTRS data indicated an estimated 82% of those beginning methadone treatment in 
2007 commenced treatment within the one-month target following assessment. In 
almost all cases treated for cannabis, cocaine or other stimulants, treatment was 
provided within the one-month target.  
 
While a high proportion of individuals commenced treatment within the one-month 
target, approximately 460 people were recorded as waiting for methadone treatment in 
April 2008. The average waiting time for those on the lists in some areas was over a 
year.  
 
A target of carrying out an assessment within three days of presentation (or referral) for 
treatment has been set. Of the opiate cases recorded by the NDTRS for 2007, an 
estimated 61% were reported to have been assessed within three days of presentation. 
Almost one in eight of those assessed was reported to have waited more than a month 
for their assessment. For persons presenting for assessment for problem cocaine use 
in 2007, 56% were recorded as having been assessed within the three-day target. Of 
those presenting for assessment for cannabis or stimulant use, less than 40% were 
assessed within the target time. 
 
Effectiveness of treatment 
Observing that evaluation of treatment effectiveness is complex, the report described 
the ROSIE (Research Outcome Study in Ireland) as sound and informative work in 
relation to treatment of opiate addiction in Ireland. It commented that the effectiveness 
of treatment for problem use of drugs other than opiates needs to be evaluated. 
 
ROSIE – opiate treatment outcomes 
 
On 9 October 2008, the NACD published a summary of opiate treatment outcomes in 
Ireland at one year and at three years after entry to treatment (Comiskey, C. et al. 
2008). 
 
At baseline, the 404 opiate users recruited to the study were entering treatment for the 
first time, or were returning to treatment after a period of absence, at any one of 54 
services nationwide. Of these, 289 individuals completed all three interviews – at 
baseline (2003/4), at one year (2004/5) and at three years (2006/7). These individuals 
(the per-protocol population) were asked the same questions at the three time points. 
The interview schedule examined key outcome measures, including: 
° drug use in the 90 days preceding the interview – specifically type, frequency, 
quantity and cost; 
° harmful practices and consequences; 
° health status, using a self-rated physical and psycho-social health assessment; 
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° social functioning, including accommodation, employment, and involvement in 
crime; and 
° mortality, using information obtained from the participants’ contacts and the 
General Mortality Register. (Six of those who entered treatment died during the 
three-year period.) 
 
The proportion of participants who reported using heroin in the 90 days preceding data 
collection fell from 81% at intake to 47% at one year, and was sustained at 47% at 
three years. The average frequency of heroin use in a 90-day period reduced from 42 
out of 90 days at intake to 15 out of 90 days at one year, but increased to 20 out of 90 
days at three years. The average quantity of heroin consumed each day over a 90-day 
period decreased from 0.9 grams at intake to 0.3 grams at one year, and this lower 
consumption rate was sustained at three years. There was a corresponding reduction 
in the average amount spent on heroin on a typical day, from €75 at intake to €24 at 
one year; the average spend at three years was not reported.  
 
There were reductions in the proportions of participants who reported use of non-
prescribed methadone, cocaine powder, crack cocaine, cannabis, alcohol and non-
prescribed benzodiazepines at one year compared to the baseline interview. The 
reduced levels were maintained between one-year and three-year follow-up for all 
drugs except benzodiazepines. 
 
The proportion of participants who reported use of more than one drug decreased from 
78% at intake to 50% one year later and to 45% three years after intake. 
 
The proportion of participants who reported injecting drug use in the 90 days preceding 
data collection decreased from 46% at intake to 29% at one year and 27% at three 
years. There was a small overall decrease in the proportion reporting an overdose, 
from 7% at intake to 4% at one year, to 5% at three years. 
 
In relation to mental health symptoms experienced in the three months prior to each 
interview, there was no reduction at three years in the proportion who reported 
symptoms of anxiety but some reduction in the proportion who reported three of five 
symptoms of depression.  
 
The proportion of participants living in unstable accommodation decreased from 25% at 
intake to 21% at one year and 18% at three years. The proportion attending training 
courses in the six months prior to interview increased from 15% at intake to 29% at one 
year and 33% at three years. The proportion currently employed increased from 15% at 
intake to 20% at one year and 31% at three years. The most progress between one 
and three years was in the areas of housing, training and employment.  
 
The proportion of participants who reported involvement in acquisitive crime decreased 
from 31% at intake to 14% at one year and this decrease was sustained at three years. 
In addition, the proportion who reported selling or supplying drugs reduced from 31% at 
intake to 11% at one year and this decrease was sustained at three years. 
 
At the time of entry to treatment, 7% of the 289 participants were not using drugs; the 
proportion had improved to 29% at one year and was sustained at 29% at three years.  
Of those for whom treatment status at three years was reported, 201 (70%) were still in 
treatment, of whom 173 were in methadone treatment.    
 
GPs’ attitudes to the Methadone Treatment Protocol 
 
Almost one-third (32%) of opiate users prescribed methadone substitution are cared for 
in private general practice in Ireland. In light of this information, the Irish College of 
General Practitioners (ICGP) conducted a postal survey in 2006 to determine the 
attitudes of Irish GPs to the Methadone Treatment Protocol (MTP) (Delargy 2008). 
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A questionnaire was sent to 600 GPs who were recorded on the ICGP’s drug misuse 
database as having received training in the management of methadone clients. Just 
under 35% (207) responded.  It is notable that 247 GPs had patients on the Central 
Treatment List at the time of the study.  
 
Almost half of the GPs who responded were aged between 46 and 60 years and 29% 
were female. Two out of every three practices were situated in an urban area. Just over 
two-fifths of the GPs said that illicit drugs were a major problem in their practice area; 
the majority of these GPs practised in an urban location. Ninety-two per cent confirmed 
that they had attended special training in methadone treatment. 
 
Of the 207 GPs who completed the questionnaire, 72% were providing patients with 
methadone treatment at the time of the survey. Over half had 10 or fewer patients. 
Only 35 prescribing doctors or their staff did not want any more patients. Forty-six GPs 
were willing to take more patients, which suggests that there is capacity to support the 
transfer of suitable clients to a normal health care environment.  
 
The vast majority of GPs thought that the MTP was beneficial to patients, though some 
said that methadone was addictive and difficult to get off (Figure 5.3.1). It was also 
noted that patients who attended daily might be unable to take up employment.   
 
 
Figure 5.3.1  General practitioners’ attitudes to methadone treatment, 2006 (Source (Delargy 2008)) 
 
Only 3% of GPs reported that their training was not sufficient to stabilise patients 
receiving methadone substitution. One-third reported that their training was not 
sufficient to manage the complications of drug use. Over two-fifths reported that their 
training was not sufficient to manage patients who continued to use illicit drugs. Just 
under two-thirds reported that their training was not sufficient to manage patients with 
alcohol problems, while over half reported that their training was not sufficient to 
manage patients with benzodiazepine problems.  
 
The types of training that GPs considered most useful to them were small locally based 
continuing education networks, individual mentoring, and distance learning.  
 
The additional services most desired by GPs were addiction counselling, in-patient 
detoxification and rehabilitation beds, and employment schemes. 
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GPs’ role in methadone treatment  
 
According to the NDTRS and the CTL the total number of cases receiving methadone 
treatment increased by 32% between 2002 and 2007 (Table 5.3.1). The number 
receiving treatment in private general practice increased by 36% during the same 
period. In each of the six years, at least 30% of cases who received methadone 
treatment were treated in private general practice.   
 
Table 5.3.1   Total cases in methadone treatment, and number, treatment status and percentage of cases 
treated in private general practice, 2002–2007  
 Cases in methadone treatment 2002 2003 2004 2005 2006 2007 
Total cases  7419 7736 8800 9354 9675 9769 
Cases treated in general practice 2323 2494 2699 2827 2890 3161 
Cases continuing in treatment in general practice 
from the previous year* 1875 2113 2292 2488 2642 2872 
Cases entering treatment in general practice during 
the reporting year† 448 381 407 339 248 289 
Cases treated in general practice as a percentage of 
total cases  31% 32% 31% 30% 30% 32% 
*Numbers obtained from the Central Treatment List 
†Numbers obtained from the National Drug Treatment Reporting System 
 
The proportion of cases continuing in methadone treatment each year was higher 
among those attending private general practice than among those attending other 
treatment providers (Table 5.3.2). The cases attending general practice were older 
than those attending other treatment providers. There was no difference in the gender 
profile.  
 
Table 5.3.2  Proportion of cases in methadone treatment in Ireland, by treatment status, gender and age group, 
2002–2007 
  
Treatment service 
General 
practice Other 
% % 
Cases continuing in treatment from the previous year 87 75 
Cases entering treatment (either new or returning)  13 25 
Male  69 67 
Female 31 32 
Age group   
10–14 years 0 0 
15–19 years 1 2 
20–24 years 13 18 
25–29 years 31 32 
30–34 years 24 24 
35–39 years 15 13 
40–44 years 9 7 
45–49 years 5 3 
50–54 years 2 1 
55–59 years 1 0 
60–64 years 0 0 
65 years or over 0 0 
 
Illicit methadone use among young people  
 
A paper was published in 2008 on illicit methadone use and abuse among young 
people accessing treatment for opiate dependence in Ireland (Roche, A. et al. 2008). At 
the time of publication, no research into methadone diversion had been conducted in 
Ireland. This study examined illicit use of methadone in a group of clients aged 25 and 
under attending a treatment programme for opiate dependence in the Drug Treatment 
Centre Board clinic in central Dublin in May 2005.  
 
Data were obtained through a structured interview covering demographic information, 
family background, treatment history, current and prior drug use, current and prior 
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reasons for illicit methadone use, details of methadone supply, and experiences of 
selling methadone.  
 
Of the 81 people interviewed, the average age was 22 years, and 51% were female. 
The average age of first drug use was 13 years, and 70% of participants reported 
cannabis as the first illicit drug used.  
 
More than half of the participants (51%) reported that other family members had also 
used heroin. Thirty-one per cent of participants were homeless or living in a hostel.  
 
The average age of first use of heroin was 15; one participant reported never having 
used heroin. The majority (91%) reported smoking as the first route of administration of 
heroin, while the remaining 9% reported injecting as their first route of administration. 
Almost four-fifths (79%) reported having injected heroin at some point in their lives.  
 
The average prescribed daily methadone dose reported by participants was 66mg. 
Almost one-third (31%) reported that this dose did not control the symptoms of heroin 
withdrawal.   
 
More than half of participants reported the use of illicit methadone both prior to and 
during treatment. Counteraction of opiate withdrawal symptoms was the most common 
reason given. During treatment, failure to attend the clinic was the most common 
reason for withdrawal symptoms.  Forty per cent obtained illicit methadone in order to 
do their own detox or maintenance. One-third reported using methadone for hedonic 
effects prior to commencing treatment. Participants reporting the misuse of 
benzodiazepines were more likely to report use of illicit methadone.  
 
Despite strict controls, 73% of participants reported that illicit methadone was easy to 
obtain. The most commonly-listed marketplace was outside the treatment clinic, while 
other locations included the participants’ local areas, the quays, and outside city centre 
train stations.  
 
Of those buying methadone, 42% reported having a regular source. The majority of 
participants (82%) reported the supplier as someone on a methadone maintenance 
programme. The vast majority (93%) of participants who had received their methadone 
prescription as take-aways in the past reported being asked to sell it on; only 6% 
reported having done so.  
 
Emergency department doctors' and nurses' knowledge and attitudes 
concerning substance use and substance users 
 
The aim of this study was to determine emergency department doctors' and nurses' 
knowledge and attitudes regarding problematic substance use and substance users 
(Kelleher and Cotter 2009).  
 
Data were collected using an adapted survey questionnaire and the Substance Abuse 
Attitude Survey (SAAS). By means of convenience/opportunistic sampling, all 
emergency department doctors and nurses (n = 145) working in three university 
teaching hospitals in Ireland were asked to fill out the knowledge and attitudes 
questionnaire.  
 
A relatively low response rate of 46% (66) was achieved. Results indicate that 
participants' current level of knowledge about alcohol and drug misuse in general was 
satisfactory. Knowledge deficits were noted in relation to drugs such as 
benzodiazepines and amphetamines, and intervention strategies for alcohol and 
opiates. The majority of participants had never received any specific training regarding 
substance use and the authors suggested that substance-using patients might be 
managed inadequately. The SAAS results indicated that participants exhibited near-
optimal attitudes for constructive working with substance-using patients. The majority of 
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respondents disagreed with the legalisation of drug use but understood that young 
people might experiment with drugs. The majority of service providers agreed that 
addiction was a treatable condition and were aware of the factors that facilitated 
successful treatment. The majority of service providers did not stereotype drug users, 
but a minority did admit that they were difficult patients to treat. 
 
5.3.2 Availability and diversification of treatment 
 
See section 7.3 for harm reduction responses to prevent drug-related infectious 
diseases 
 
‘Quasi-compulsory’ treatment  
 
Quasi-compulsory treatment (QCT) refers to any form of drug treatment that is ordered, 
motivated or supervised by the criminal justice system.  The Council of Europe’s 
Pompidou Group (Criminal Justice Platform) commissioned a survey to ascertain what 
existing guidelines were employed by various jurisdictions when making QCT orders or 
recommendations for adult drug-dependent offenders (McSweeney 2008).  Of the 35 
Council of Europe states requested to participate, 22 countries (including Ireland) 
provided responses.  
 
The primary form of QCT available in Ireland is that offered by the Irish Drug Treatment 
Court (DTC). The DTC, established as a permanent court in 2006 after a five-year pilot 
phase,  deals with offenders who have either pleaded guilty or been convicted of minor 
crimes committed as a consequence of drug abuse. Addressing a European 
conference on QCT and other alternatives to imprisonment in October 2007, Judge 
Bridget Reilly of the DTC said: ‘Despite the low graduation numbers, the progress and 
improvement in quality of life for the participants is seen to be very significant by the 
DTC team, considering the background of low literacy skills, low educational 
participation, and often difficult social and family history (Connolly 2007).The DTC was 
due to be expanded to other areas under the National Drugs Strategy 2001–2008, 
which is currently under review.   
 
Overall, the results of the survey were deemed encouraging but the variety of 
approaches among member states suggested the need to develop a transnational set 
of guidelines on QCT practices. It was also concluded that there was scope for 
legislation in the six responding countries (including Ireland) where legislation was 
absent. Of these countries, several had prison systems operating at or above capacity. 
 
Drug Treatment clinical policy in the Irish Prison Service 
 
In January 2008, the Irish Prison Service (IPS) produced their comprehensive drug 
treatment clinical policy document (Irish Prison Service 2008b).  It covers a wide range 
of issues around drug treatment. 
 
There is an extensive section on methadone treatment, outlining the background and 
rationale for methadone treatment, as well as the clinical management of a prisoner on 
methadone and the logistics of dispensing. The policy document covers: 
° clinical interdisciplinary care planning; 
° methadone treatment guidelines;     
° assessment – treatment plans and treatment goals (induction, maintenance and 
detox); 
° criteria for treatment priority;  
° use of methadone – ordering and dispensing;  
° administration and recording of methadone.    
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The document also outlines in some detail the processes necessary for methadone 
treatment, whether a prisoner is already on methadone on admission, or treatment is to 
be initiated in prison, and for planned release of a prisoner on methadone.   
 
Issues around blood-borne viruses, including testing, clinical management and 
immunisation, are also addressed in the policy. 
 
The document states that the misuse of benzodiazepines is an endemic problem in the 
Irish prison population and recommends policies and guidelines around assessment of 
dependence, prescribing and detoxification.   
 
The Lofexidine detoxification and alcohol withdrawal guidelines have been modified 
from The Maudsley protocols.  Guidelines for the use of Naltrexone, as part of an 
overall programme of addiction treatment along with psycho-social support, are 
outlined in the document.  The guidelines state that Naltrexone should only be 
prescribed by a medical person experienced in its use. The use of injectable 
Naltrexone for reversing accidental opiate overdose is not covered.   
 
The document states that an interdisciplinary team will provide treatment for problem 
cocaine use on an individual basis.  There is a range of treatments available including 
counselling and cognitive behavioural therapy, along with appropriate referrals to 
medical or psychiatric services as necessary. 
 
It is the policy of the IPS, in accordance with the community standard, to develop a 
dual diagnosis service for those patients with addiction problems and mental health 
problems. 
 
Pregnant women are specifically mentioned in the document.  The objectives of the 
care of pregnant women are:  
° stabilisation of mother’s drug use; 
° retention of mother in obstetric and drug treatment service and ensuring adequate 
support and through care in the community; 
° delivery of a full-term baby with healthy birth weight; 
° avoidance of in utero exposure to HIV/hepatitis; 
° minimisation of the occurrence of neonatal abstinence syndrome; 
° promotion and support for positive physical, mental health and social wellbeing 
thoughout and after pregnancy. 
 
Suboxone study 
 
The Department of Health and Children established an expert group to examine the 
use of buprenorphine/naloxone (suboxone) as a treatment for opiate dependency. The 
group recommended that a feasibility study on the use of buprenorphine/naloxone 
treatment as an alternative to methadone be established.  The study began in July 
2009 and is being conducted at several specialist addiction centres in Dublin and a 
number of Level II GP practices in Dublin and around the country.  The aim is to enrol 
up to 80 problem opiate users who agree to treatment and are suitable (40 in specialist 
centres and 40 in the community).  The Drug Treatment Centre Board is maintaining 
electronic records on those taking part in the study.  The protocol for prescribing and 
dispensing buprenorphine/naloxone is similar to that for methadone.  If the problem 
opiate user is pregnant, then she will be prescribed buprenorphine, without naloxone, 
as the latter drug is contra-indicated in pregnancy.  Buprenorphine/naloxone is 
provided free of charge.  The study is to be reviewed after eight months with a view to 
deciding if it will be offered to all drug treatment clients.  The evaluation of the study will 
be conducted according to agreed evaluation criteria and using a recognised audit tool. 
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Physical fitness intervention during residential adolescent addiction treatment in 
the south east 
 
Van Hout (Van Hout 2008) assessed the perception of social context and activity 
scales of adolescent substance abusers following participation in a physical activity 
intervention during residential drug treatment. The increase in perception of social 
context value was measured by increased social interaction, group identification, trust, 
co-operation and social growth. The increase in perception of activity value was 
measured by increased enjoyment, self-efficacy, skill acquisition and confidence. The 
sample (n=47) was assessed on entry to treatment, on completion of treatment; six 
weeks post residential treatment and six months after treatment using mean, standard 
deviation, and t-tests.  
Sixty-three per cent of the participants were male and the participants were between 12 
and 20 years old. In general, the overall mean scores for perception of social context 
increased from entry to completion of the treatment programme, decreased marginally 
six weeks after treatment, and returned to baseline levels after six months in aftercare. 
A small significant positive difference was recorded between entry to treatment and six 
weeks after treatment (p = 0.04). The results relating to perception of activity increased 
from entry to completion of the treatment programme, increased at six weeks after 
treatment, and decreased to below the baseline level after six months in aftercare. 
Positive significant differences were recorded between entry and six weeks post-
treatment (p = 0.02) and between completion of treatment and six months in aftercare 
(p = 0.03). This research illustrates the positive potential of physical activity as part of 
an adolescent residential treatment programme and in the six-week follow-up period. 
The research highlights that it was difficult to maintain the long-term positive benefits 
and approaches to doing so need to be explored.  
 
5.4 Characteristics of treated clients (TDI data included) 
Cases treated for problem cocaine and opiate use, 2002–2007 
 
Two papers, one on problem cocaine use (Bellerose et al. 2009)  and one on problem 
opiate use (Carew et al. 2009), based on data reported to the NDTRS for the six-year 
period 2002–2007, were published in 2009. It is important to note that the NDTRS 
collects data on episodes of treatment, rather than the number of individual people 
treated each year. This means that individuals may appear more than once if they 
attend more than one treatment service in a year, and may reappear in subsequent 
years.  
 
The main findings of the paper on treated problem cocaine use are: 
° One-fifth (10,764) of all cases treated for problem drug use between 2002 and 2007 
reported cocaine as a problem substance. The annual number of cocaine cases 
increased by 177%, from 954 in 2002 to 2,643 in 2007. This increase was in line 
with increases in cocaine seizures, cocaine use among the general population and 
cocaine-related deaths during the same time period. 
° The number of cases who reported cocaine as their main problem drug increased 
by 502%, from 128 in 2002 to 770 in 2007. The number of cases who reported 
cocaine as an additional problem drug increased by 128%, from 826 in 2002 to 
1,885 in 2007.  
° The higher rates of new cases treated for cocaine as their main problem drug were 
in the north-eastern, south eastern and southern counties.  The incidence of treated 
problem cocaine use was lower than expected in Dublin due to the fact than many 
problem cocaine users in Dublin also used opiates, and the opiate was categorised 
as their main problem drug while cocaine was categorised as an additional problem 
drug. 
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° Almost four out of five cases who reported cocaine as their main problem drug used 
more than one drug. Cocaine was used alongside opiates, cannabis, alcohol and 
ecstasy. 
° Cocaine users entering treatment appeared to fit one of two profiles, those who use 
opiates alongside cocaine and those who use combinations of alcohol, cannabis 
and/or ecstasy alongside cocaine. 
° The majority of cases who reported cocaine as their main problem drug used it on 
two to six days per week, indicating that cocaine may be used as a week-end drug 
or during a binge. 
° Half of the cases were under 27 years old, 83% were men and 33% were 
employed. The proportion of treated cocaine cases in employment was higher than 
the proportion of opiate cases in employment, 35% versus 13%, indicating that 
treated cocaine users were from a mix of social backgrounds. 
° The majority (69%) of cases were treated in outpatient services in 2007.  
° There is a wide variety of interventions provided to cocaine cases, though until 
there is national data on treatment outcomes it is difficult to comment on the 
effectiveness of these interventions.  
 
The main findings of the paper on treated problem opiate use are: 
° The number of cases who reported an opiate (mainly heroin) as a problem drug 
increased by 29%, from 8,804 in 2002 to 11,392 in 2007. This increase in treatment 
provision is explained by a combination of factors– an increase in the number of 
treatment places, an increase in opiate use among the population and an increase 
in reporting to the NDTRS.  
° This increase in treated problem opiate use was in line with increases in heroin 
seizures in 2005 and 2006, problem opiate use among the population and heroin-
related deaths during the same time period. 
° The rate of increase in new opiate cases was highest outside Dublin, and in 
particular in the midland, north eastern, and south eastern counties.  
° The proportion of cases treated for opiates as a main problem drug who reported 
use of more than one drug decreased from 69% in 2002 to 63% in 2007. Between 
2002 and 2007, cannabis, benzodiazepines and, in more recent years, cocaine 
were the most common additional problem drugs used alongside opiates. The use 
of additional drugs alongside opiates makes it more difficult to treat the addiction 
successfully.  
° Of the 3,575 cases who entered treatment and reported opiates as their main 
problem drug in 2007, 52% smoked it, 40% injected it, and 4% consumed it orally.  
° Between 2003 and 2007 decreasing proportions of cases reported that injecting 
was their primary route of administration, while correspondingly increasing 
proportions reported smoking opiates. This indicates that harm reduction messages 
are being heard and the transmission of blood-borne viruses will be reduced among 
this cohort.  
° The majority of cases who reported an opiate as their main problem drug used it 
daily, indicating the addictive nature of the drug.  
° In 2007, the vast majority (75%) of opiate cases entering treatment were cared for 
in outpatient services.  
° There is a wide variety of interventions provided to opiate cases including 
counselling, methadone maintenance, brief intervention, and medically assisted 
opiate detoxification.  
 
Cases entering treatment for cannabis use in Ireland, 2001–2007 
 
Analysis of data from the NDTRS for the seven-year period 2001–2007 (Long 2009a) 
indicates that the number of treated cases reporting cannabis as a main problem drug 
decreased from 1,384 in 2003 to 958 in 2007 (Table 5.4.1), of whom 74% used one or 
more additional drugs. The number of cases reporting cannabis as an additional 
problem drug increased from 1,383 in 2001 to 1,630 in 2007 (Table 5.4.2). The drugs 
associated with cannabis use were alcohol, ecstasy, amphetamines and cocaine 
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(Table 5.4.3).  These data indicate that only a small proportion of cannabis users are 
seen at treatment services, and that the majority of those use more than one drug.  
 
Table 5.4.1   Cases entering treatment for cannabis as a main problem drug, 2001–2007 
 2001 2002 2003 2004 2005 2006 2007 
 
  
Number (%) 
All cases entering 
treatment 4797 4948 5054 4506 4877 5191 5684 
Cases reporting  
cannabis as main 
problem drug 
1136 
(23.7) 
1336 
(27.0) 
1384 
(27.4) 
991 
(22.0) 
1039 
(21.3) 
1096 
(21.1) 
958 
(16.9) 
Of whom:        
   New cases 781 924 955 736 794 809 694 
   Previously treated   
cases 299 349 401 224 219 260 255 
   Treatment status    
not known 56 63 28 31 26 27 9 
Source: Unpublished data from the NDTRS 
 
Table 5.4.2  Cases entering treatment who reported cannabis as an additional problem drug, 2001–2007  
  2001 2002 2003 2004 2005 2006 2007 
 
  
Number (%) 
All cases reporting an 
additional problem drug 3459 3582 3760 3157 3401 3692 3816 
Cases reporting  
cannabis as an  
additional problem drug 
1383 
(40.0) 
1362 
(38.0) 
1445 
(38.4) 
1239 
(39.2) 
1417 
(41.7) 
1579 
(42.8) 
1630 
(45.5) 
Of whom:   
   New cases 540 511 556 449 527 583 681 
   Previously treated cases 797 797 842 757 844 925 904 
   Treatment status not 
known 46 54 47 33 46 71 45 
Source: Unpublished data from the NDTRS 
 
Table 5.4.3   Main problem drug and associated additional drugs used by new cases entering treatment,  
2001–2007 
New cases 4708 769 1064 99 228 160 4999 
 Main problem drug 
 Opiates Ecstasy Cocaine 
Amphet-
amines 
Benzo-
diazepines 
Volatile 
inhalants Cannabis 
Additional problem 
drug(s) used* Number (%) 
Opiates 751 (16.0) † 16 (2.1) 78 (7.3) 1 (1.0) 36 (15.8) 2 (1.3) 128 (2.6)
Ecstasy 447 (9.5) 394 (37.0) 49 (49.5) 32 (14.0) 11 (6.9) 1897 (37.9)
Cocaine 1029 (21.9) 206 (26.8) 12 (1.1)† 25 (25.3) 37 (16.2) 3 (1.9) 865 (17.3)
Amphetamines 89 (1.9) 183 (23.8) 109 (10.2) 4 (1.8) 2 (1.3) 528 (10.6)
Benzodiazepines 1029 (21.9) 20 (2.6) 67 (6.3) 2 (2.0) 9 (3.9)† 1 (0.6) 117 (2.3)
Volatile inhalants 17 (0.4) 15 (2.0) 5 (0.5) 1 (1.0) 3 (1.3) 8 (5.0)† 118 (2.4)
Cannabis 1866 (39.6) 489 (63.6) 611 (57.4) 60 (60.6) 56 (24.6) 47 (29.4) 6 (0.1)†
Alcohol 466 (9.9) 341 (44.3) 497 (46.7) 36 (36.4) 103 (45.2) 57 (35.6) 2389 (47.8)
* By cases reporting use of one, two or three additional drugs 
† Additional problem drug(s) used may be a form of drug in the same family as the main problem drug. 
Source: Unpublished data from the NDTRS 
 
Of the 958 cases treated in 2007 who reported cannabis as their main problem drug, 
99% smoked it, and 1% ate it. Use by these 958 cases in the month prior to treatment 
was reported as follows: 49% used it daily, 22% used it between two and six days per 
week, 8% used it once per week or less and 19% had not used it. As expected, the 
frequency of cannabis use among treated cases was considerably higher than among 
the general population.  
 
Of these 958 cases, half had commenced cannabis use before they were 14 years old, 
and 86% were men.  Of the total number, 109 (11%) lived in Dublin and 849 (89%) 
lived elsewhere in Ireland. The numbers reflect the greater availability of treatment for 
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cannabis, cocaine and other non-opiate drugs in Dublin, rather than use among the 
general population.  
 
Cases presenting for treatment for sedative or tranquilliser use in Ireland, 2001–
2007 
 
According to NDTRS data for 2001 to 2007 (Long and Lyons 2009), the annual number 
of treated cases reporting sedatives or tranquillisers as a main problem drug fluctuated 
between 78 and 171 (Table  5.4.4). The total for the period was 778 cases, of whom 
87% reported a benzodiazepine as their main problem drug.  Of the 778 cases, 76% 
used one or more additional drugs. 
 
Of the 171 cases treated in 2007 who reported sedatives or tranquillisers as their main 
problem drug, 98% ate them and 0.5% injected them. Use by these cases in the month 
prior to treatment was reported as follows: 66% used them daily, 12% used them 
between two and six days per week, 5% used them once per week or less and 11% 
had not used them. Half had commenced use before they were 19 years old; 66% were 
men; and 61% lived in Dublin.  
 
Table 5.4.4    Cases entering treatment for sedatives or tranquillisers as a main problem drug, 2001–2007 
 2001 2002 2003 2004 2005 2006 2007 
Number (%) 
All cases  4797 4948 5054 4506 4877 5191 5684 
Cases reporting sedatives or 
tranquillisers as  
main problem drug 
115 (2.4) 104 (2.1) 97 (1.9) 108 (2.4) 78 (1.6) 105 (2.0) 171 (3.0) 
Of whom:    
New cases 55 39 37 50 44 55 91 
Previously treated cases 52 60 60 52 31 44 74 
Treatment status not 
known 8 5 0 6 3 6 6 
Source: Unpublished data from the NDTRS 
 
The number of cases reporting sedatives or tranquillisers as an additional problem drug 
exceeded 1,000 per year between 2001 and 2007 (Table 5.4.5). The main drugs 
associated with sedative or tranquilliser use by new cases entering treatment were 
cannabis, alcohol, stimulants, cocaine and opiates (Table 5.4.6). 
 
Table 5.4.5  Cases entering treatment who reported sedatives or tranquillisers as an additional problem drug,  
2001–2007  
 
Source: Unpublished data from the NDTRS 
 
Table 5.4.6   Main problem drug and associated additional drugs used by new cases entering treatment, 
 2001–2007 
New cases 5741 1526 981 371 14 184 5693 
 Main problem drug 
 Opiates Cocaine Stimulants 
Sedatives/ 
tranquillisers Hallucinogens 
Volatile 
inhalants Cannabis 
Additional 
problem 
drug(s) used* Number  
  2001 2002 2003 2004 2005 2006 2007 
 Number (%) 
All cases reporting an 
additional problem drug 3459 3582 3760 3157 3401 3692 3816 
Cases reporting sedatives 
or tranquillisers as an 
additional problem drug 
1107  
(32.0) 
1155 
(32.2) 
1050 
(28.3) 
1009 
(32.0) 
1110 
(32.6) 
1200 
(32.5) 
1155 
(30.3) 
Of whom:   
New cases 252 264 214 176 206 269 273 
Previously treated 
cases 786 826 791 685 747 771 681 
Treatment status not 
known 32 43 26 31 26 21 14 
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New cases 5741 1526 981 371 14 184 5693 
 Main problem drug 
 Opiates Cocaine Stimulants 
Sedatives/ 
tranquillisers Hallucinogens 
Volatile 
inhalants Cannabis 
Opiates 848† 102 26 52 2 4 151 
Cocaine 1278 14† 272 59 3 3 1056 
Stimulants 606 669 257† 62 9 14 2655 
Sedatives/ 
tranquillisers 1267 110 39 27† 0 2 251 
Hallucinogens 47 25 37 1 1† 1 165 
Volatile inhalants 19 7 16 5 0 9† 127 
Alcohol 2209 847 605 109 9 53 10 
Cannabis 652 706 422 171 4 62 2719† 
* By cases reporting use of one, two or three additional drugs 
† Additional problem drug(s) used may be a form of drug in the same family as the main problem drug. 
Source: Unpublished data from the NDTRS 
 
According to NDTRS data for the years 2001 to 2007, only 10 treated cases reported 
anti-depressants as a main problem drug, of whom half used one or more additional 
drugs. In the seven-year period, 56 cases reported anti-depressants as an additional 
problem drug. The drugs associated with anti-depressant use were opiates and 
sedatives. Of the 66 cases treated who reported anti-depressants as a problem drug, 
53% were men, and 58% lived in Dublin (Figure 5.4.1).  
 
 
 
Figure 5.4.1  Rates of psychiatric first admission of cases with a diagnosis of drug disorder (using the ICD-10 
three character categories) per 100,000 of the population in Ireland and reported to the National Psychiatric 
Inpatient Reporting System, 1990–2007 (Daly, Antoinette and Walsh 2003; Daly, A. et al. 2005; Daly, A et al. 
2007; Daly, A et al. 2008; Daly, Antoinette et al. 2004; Daly, Antoinette et al. 2006) 
 
 
5.5 Trends of clients in treatment (incl. numbers) 
5.5.1 Drug treatment demand 
 
Figures from the NDTRS for treated problem drug use in Ireland for 2007 show that 
13,620 cases were treated in 2007, of which 5,977 entered treatment in that year 
(Lyons, S 2009). The majority of cases attended outpatient services.  An opiate (mainly 
heroin) was the most common main problem drug reported by cases entering treatment 
in 2007.  The majority of cases treated in 2007 reported problem drug use of more than 
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one substance (67.1%), which was slightly lower than in 2006 (71.1%).  Alcohol was 
reported as an additional problem substance in 40% of all treated cases.  Many 
problem drug users in treatment were young and male, had low levels of education and 
were unlikely to be employed.  Almost 14% of all new cases treated in 2007 were aged 
under 18 years of age, a slight increase from 2006. Almost 3% of previously -treated 
cases were aged under 18 years, similar to 2006.  
 
The prevalence of treated problem drug use among 15–64-year-olds living in Ireland 
expressed per 100,000 of the population increased by 4%, from 426 in 2006 to 445 in 
2007.  New cases entering treatment are an indirect indicator of recent trends in 
problem drug use.  The incidence of treated problem drug use among 15–64-year-olds 
per 100,000 of the population living in Ireland increased from 75 in 2006 to 80 in 2007.   
 
Preliminary analysis of 2008 data shows that 6,247 cases entered treatment, the 
majority for problem heroin use.  Of those who entered treatment, the majority attended 
outpatient services (4,837, 77.4%). These figures do not include cases who reported 
alcohol as their main problem drug but used other additional drugs. 
  101
6. Health Correlates and Consequences 
6.1 Introduction 
Problematic drug use can be associated with a number of other health conditions or 
lead to a range of health consequences, including drug-related infectious diseases, 
drug-related overdoses, a range of chronic illnesses and acute conditions, and 
psychiatric comorbidity. Information on these various health correlates and 
consequences is collected in a variety of information systems. 
 
The Health Protection Surveillance Centre (HPSC) is Ireland’s specialist agency for the 
surveillance of communicable diseases.  Part of the Health Service Executive, the 
HPSC endeavours to protect and improve the health of the Irish population by collating, 
interpreting and disseminating data to provide the best possible information on 
infectious disease. The HPSC has recorded new cases among injecting drug users of 
HIV since 1982, hepatitis B since 2004, and hepatitis C since 2006.  
 
HIPE (Hospital In-Patient Enquiry) is a computer-based health information system, 
managed by the Economic and Social Research Institute (ESRI) in association with the 
Department of Health and Children and the Health Service Executive, that collects 
demographic, medical and administrative data on all admissions, discharges and 
deaths from acute general hospitals in Ireland. It was started on a pilot basis in 1969 
and then expanded and developed as a national database of coded discharge 
summaries from the 1970s onwards. Each HIPE discharge record represents one 
episode of care; each discharge of a patient, whether from the same or a different 
hospital, or with the same or a different diagnosis, gives rise to a separate HIPE record.  
The scheme, therefore, facilitates analyses of hospital activity rather than of the 
incidence of disease. HIPE does not record information on individuals who attend 
accident and emergency units but are not admitted as inpatients. Data relating to 14, 
770 cases of non-fatal overdoses for a three-year period, 2005–2007, are analysed in 
Section 6.3.1 below. 
 
The National Poisons Information Centre (NPIC), located in Beaumont Hospital, 
provides a national telephone information service on the toxicity, features and 
management of cases of poisoning. This 24-hour service is offered mainly to doctors 
and other health care professionals. Queries are dealt with by poisons information 
officers at the Centre between 8 am and 10 pm, while out-of-hours calls are 
automatically diverted to the UK National Poisons Information Service (NPIS). Data 
from this source provide indications of the pattern of human cases of poisoning, 
including age, gender and agent. 
 
The data collected by the Primary Care Re-imbursement Service (PCRS), previously 
called the General Medical Services Payments Board and usually referred to as the 
GMS, is another source of information on the health correlates and consequences of 
problematic drug use among those who have medical cards, which are means-tested.  
Medical-card holders receive certain health services, including approved prescribed 
drugs and medicines, free of charge. Operated by the HSE, the PCRS administers 
payments to doctors, pharmacists and dentists who provide services under the PCRS 
scheme. A study, conducted in July 2008, of morbidity among medical-card holders 
who were opiate users in methadone treatment is reported on in Section 6.3.2 below.  
 
The National Psychiatric In-Patient Reporting System (NPIRS), administered by the 
HRB, is a national psychiatric database that provides detailed information on all 
admissions to and discharges from 56 inpatient psychiatric services in Ireland, 
recording data on cases receiving inpatient treatment for problem drug and alcohol 
use. NPIRS does not collect data on the prevalence of psychiatric comorbidity in 
Ireland. Every year the HRB publishes an annual report on the data collected in 
NPIRS.  
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Problematic drug use can also lead to premature death. Death can occur as a result of 
overdose (both intentional and unintentional), actions taken under the influence of 
drugs, medical consequences or incidental causes. While illicit drugs are involved in 
many cases of drug-related death, licit (prescribed) drugs are also frequently involved 
in such deaths (alone or in conjunction with an illicit drug). Alcohol has been reported 
as the third greatest risk factor for ill health and premature death in Europe. 
Established in 2005, the National Drug-Related Death Index (NDRD), which is 
maintained by the HRB, is an epidemiological database which records cases of death 
by drugs poisoning, and deaths among drug users Ireland, extending back to 1998; the 
NDRDI has also recorded data on alcohol-related deaths, deaths among alcoholics, 
and deaths from alcohol-related diseases, extending back to 2004. 
 
The number of deaths as a result of poisoning fluctuated between 1998 and 2003; 
however, since 2003 the number of cases has risen from 107 cases to 169 cases in 
2007. The rise is attributed to cocaine opiates and/or poly-substance use. 
 
 
6.2 Drug-related infectious diseases 
 
6.2.1 HIV/AIDS and viral hepatitis 
 
HIV surveillance in 2008 
 
Voluntary linked testing for antibodies to HIV has been available in Ireland since 1985. 
According to the most recent report of the HPSC (O'Donnell, K. et al. 2009), at the end 
of 2008 there were 5,186 diagnosed HIV cases in Ireland, of which 1,417 (27%) were 
probably infected through injecting drug use.  
 
Figure 6.2.1 presents the number of new cases of HIV among injecting drug users 
reported in Ireland, by year of diagnosis; data from 1982 to 1985 were excluded from 
the figure as these four years were combined in the source records. Figure 6.2.1 is 
based on data reported to the Department of Health and Children, the National Disease 
Surveillance Centre and its successor, the HPSC. There was a fall in the number of HIV 
cases among injecting drug users between 1994 and 1998, with about 20 cases per 
year, compared to about 50 cases each year in the preceding years. There was a 
sharp increase in the number of cases in 1999 (69 new cases), which continued into 
2000 (83 new cases). Between 2001 and 2008 there was an overall decline in the 
number of new injector cases (38, 50, 49, 71, 66, 57, 54 and 36 respectively) when 
compared to 2000. It was difficult to interpret the trend owing to the relatively small 
numbers diagnosed each year, so a smoother curve (grey broken plot line in Figure 
6.2.1) was calculated using a rolling centred three-year average. This curve presents a 
new baseline of between 45 and 65 cases each year.  
 
Of the 36 new HIV cases among injecting drug users reported to the HPSC in 2008, 27 
were male and nine were female, and the average age was 33 years. Twenty-two of 
the 34 cases with a known address lived in the HSE Eastern Region (Dublin, Kildare 
and Wicklow).  
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Figure 6.2.1   Actual number and rolling average number of new cases of HIV among injecting drug users, by 
year of diagnosis, reported in Ireland, 1986–2008. Source: Unpublished data reported to DoHC, National Disease 
Surveillance Centre and HPSC.  
 
Hepatitis B surveillance in 2008 
 
Hepatitis B is a vaccine-preventable disease which is transmitted through contact with 
the blood or body fluids of an infected person. The main routes of transmission are 
mother-to-baby, child-to-child, sexual contact and unsafe injections. The number of 
cases notified to the HPSC increased each year between 1996 and 2005. In 2006 the 
number decreased by 7% (to 810) and then increased steadily in 2007 and 2008 
(Table 6.2.1). There were 949 cases in 2008, of whom 765 had a chronic infection, 82 
had an acute infection and the disease status of 102 cases was unknown. The 
surveillance system has recorded risk factor data since 2004 and the number of cases 
notified to the HPSC that include data on risk factors has increased from 30% in 2006 
to 59% in 2008. In 2008 59% (557) of all cases had risk factor data reported, of whom 
seven (1.3%) reported injecting drug use as their main risk factor. The number of such 
cases remained consistently low between 2005 and 2008, indicating the effectiveness 
of routine administration of the hepatitis B vaccine. 
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Table 6.2.1    Number (%) of acute and chronic hepatitis B cases reported to the HPSC, by risk factor status, 
2005–2007 
  Hepatitis B status 
  2006 2007 2008 
Risk factor 
status 
Acute Chronic Unknown Acute Chronic Unknown Acute Chronic Unknown 
  N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) 
Total number 
of cases 93 655 62 52 706 105 82 765 102 
% of cases by 
status 11.5 80.9 7.7 6.0 81.8 12.2 8.6 80.6 10.7 
Cases with 
reported risk 
factor data  61 177 6 44 315 16 73 428 56 
% of cases 
with risk factor 
data 65.6 27.0 9.7 84.6 44.6 15.2 89 55.9 54.9 
       Of which:                 
       Injecting 
drug users  0 (0) 3 (1.7) 1 (16.7) 1 (2.3)  4 (1.3) 1 (6.3) 0 (0) 6 (1.4) 1 (1.8) 
                 
Cases without 
reported risk 
factor data  32 478 56 8 391 89 9 337 46 
% of cases 
without risk 
factor data 34.4 73.0 90.3 15.4 55.4 84.8 11 44.1 45.1 
Total 810 863 949 
Source:  Unpublished data from the HPSC 
 
Hepatitis C surveillance in 2008 
 
Hepatitis C is one the most common blood-borne viral infections among injecting drug 
users and is transmitted through contact with the blood of an infected person. The main 
routes of transmission are mother-to-baby, unsafe injections, transfusion of blood and 
blood products, and unsterile tattooing and skin piercing. The HPSC reported that there 
were 1,537 cases of hepatitis C reported in 2008 (Table 6.2.2), compared to 1,128 
cases in 2004, and 85 cases of hepatitis ‘type unspecified’ in 2003.  
 
Table 6.2.2   Number of cases and age-standardised notification rates (ASR) per 100,000 population for hepatitis 
C, 2004–2008 
Year Number of cases Age standardized rate per 100,000 
2004 1128 26.6 
2005 1415 33.4 
2006 1219 28.8 
2007 1556 36.7 
2008 1537 36.3 
Source:  Unpublished data from the HPSC 
 
An enhanced surveillance system for hepatitis C was introduced in Ireland in 2007. 
Enhanced surveillance is essential to identify risk factors and for planning prevention 
and treatment strategies. In 2008, 38% of newly-reported hepatitis C cases had risk 
factor status reported (Table 6.2.3). As expected, the majority of these cases (76.9%) 
reported injecting drug use as the main risk factor. Four per cent of cases said that they 
were recipients of blood or blood products at some time in the past and according to 
the HPSC were late reports to the system (N Murphy, HPSC, personal communication, 
2009).  
 
Table 6.2.3   Number (%) of hepatitis C cases reported to the HPSC, by risk factor status, 2007 and 2008 
 Hepatitis C Hepatitis C
 2007 2008
Risk factor status 
 
Total number of cases 1556 1537 
   
Cases with reported risk factor data  664 (42.7%) 581 (37.8%) 
       Of which:   
       Injecting drug users  503 (75.8%) 447 (76.9%) 
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 Hepatitis C Hepatitis C
 2007 2008 
Risk factor status   
   
       Recipients of blood/blood products 34 (5.1%) 24 (4.1%) 
       Other risk factors 90 (13.6%) 77 (13.3%) 
       No known risk factor could be identified by patient or doctor 37 (5.6%) 33 (5.7%) 
   
Cases without reported risk factor data  892 (57.3%) 956 (62.2%) 
Source:  Unpublished data from the HPSC 
 
In 2007, 85% of cases reporting injecting drug use as their main risk factor were 
notified by services in Dublin, Kildare and Wicklow and the remainder by services in 
HSE areas outside these counties (Table 6.2.4). Seventy-one per cent were male and 
62% were under 35 years old.  
 
Table 6.2.4   Number (%) of hepatitis C cases who reported injecting drug use as their risk factor by age, gender 
and place of residence, 2007 and 2008 
 Hepatitis C Hepatitis C
 2007 2008 
Risk factor status   
   
Total number of known injector cases 503 447 
   
Gender    
       Male 339 (67.4%) 319 (71.4%) 
       Female  163 (32.4%) 126 (28.2%) 
       Unknown 1 (0.2%) 2 (0.4%) 
   
Age   
       Mean (in years) 32.7 33.3 
       Median(in years) 31 32 
       Under 25 years 49 (9.7%) 45 (10.1%) 
       25 to 34 years 282 (56.1%) 233 (52.1%) 
       More than 34 years 170 (33.8%) 165 (36.9%) 
       Unknown 2 (0.4%) 4 (0.9%) 
   
Place of residence   
      Dublin, Kildare and Wicklow 445 (88.5%) 379 (84.8%) 
      Elsewhere in Ireland 58 (11.5%) 68 (15.2) 
   
Source:  Unpublished data from the HPSC 
 
Burden of hepatitis C infection in Ireland 
 
The data provided in this section are abstracted from a paper written by Murphy and 
Thornton and published in EPI-Insight in July 2008 (Murphy and Thornton 2008). 
 
Central Statistics Office mortality data 
For 288 people between 1994 and 2005 the underlying cause of death was reported to 
be primary liver cancer. According to an international review by staff at the HPSC, 
approximately one third of primary liver cancer cases are due to hepatitis C. 
 
Hospital In-patient Enquiry (HIPE) Scheme data 
Between 1999 and 2004, when HIPE coverage of acute hospitals was 95%, there were 
3,060 discharges with a principal diagnosis of ‘other specified viral hepatitis without 
mention of hepatic coma’. Most of these are likely to have been due to hepatitis C. A 
further 778 discharges were associated with a principal diagnosis of primary liver 
cancer. 
 
Liver transplants 
The liver unit in St Vincent’s University Hospital, Dublin, carried out 311 liver 
transplants between 2000 and 2006. Twenty-five of these were known to be a 
consequence of HCV infection and a further 17 were known to be due to hepatitis C 
plus another indication such as alcoholic liver disease or hepatocellular carcinoma. 
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6.2.2 STI’s and tuberculosis 
The surveillance data available in Ireland does not identify drug use as a risk factor for 
these infections. 
 
6.2.3 Other infectious morbidity (e.g. abscesses, sepses, endocarditis, wound 
botulism) 
Botulism is a rare but serious illness caused by botulin toxin. The toxin is produced by 
the bacteria Clostridium botulinum. The HPSC was informed of four cases of wound 
botulism – all affecting injecting drug users – in late November 2008 (Long 2009b). The 
condition is caused by bacteria that are commonly found as spores in soil or gravel and 
can be acquired if a wound is contaminated by such material. The bacteria grow in skin 
abscesses as a result of injecting heroin but the bacteria can also reproduce in the 
nasal passages as a result of snorting cocaine. Symptoms of botulism usually develop 
about 12–36 hours after exposure to the toxin and normally begin with blurred vision, 
difficulty swallowing, difficulty speaking and occasionally breathing problems. Diarrhoea 
and vomiting can also occur and the disease can progress to paralysis. In recent years 
this type of botulism has been most commonly reported among chronic drug users, in 
Ireland and elsewhere. Most people (90–95%) with botulism will recover with treatment. 
 
6.2.4 Behavioural data 
There is no new information available.  
 
 
6.3 Other drug-related health correlates and consequences 
6.3.1 Non-fatal overdoses and drug-related emergencies 
Data used in the following analysis were extracted from the Hospital In-Patient Enquiry 
(HIPE) scheme.  There were 14,902 overdose cases in the period 2005 to 2007. Of 
these cases, 132 died in hospital and have been excluded from this analysis. A total of 
14,770 cases were included in the following analysis. 
 
Age Group 
Figure 6.3.1 shows that the 15–24-year-old age group is at highest risk, with the 
incidence of overdose decreasing with age.  The pattern remains the same for each of 
the years reported. 
 
Figure 6.3.1   Incidence of overdose by age group by year, 2005–2007 (n=14,770)   
Source:  Unpublished data from the HIPE 
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Area of residence 
Figure 6.3.2 shows the number and area or residence of recorded overdose cases 
between 2005 and 2007.  Seventy-nine cases were resident outside of Ireland and 28 
cases were recorded as having no fixed abode; these 107 cases were excluded from 
this analysis of area of residence. From 2005 to 2006 there was an increase (176, 
20.4%) in overdose cases among persons resident in Dublin (city and county), followed 
by a decrease in 2007 (94, 9.1%). The opposite trends were reported for cases 
resident outside Dublin.  Overall, almost one fifth of cases were among persons 
resident in Dublin. 
 
Figure 6.3.2   Area of residence of overdose cases, 2005–2007 (n=14,770)   
Source:  Unpublished data from the HIPE 
 
Gender 
There were more overdose cases among females than among males. There was a 
slight decrease (189, 6.8%) in the number of females cases in 2006, but this followed 
by an increase (86, 3.3%) in 2007 (Figure 6.3.3). 
 
Figure 6.3.3   Incidence of overdose by gender, 2005–2007 (n=14,770)   
Source:  Unpublished data from the HIPE 
 
Drugs involved 
Table 6.3.1 presents all drugs and other substances involved in cases of overdose 
reported by HIPE from 2005 to 2007. Over two thirds (69.5%, 10,259) of all overdose 
cases in the reporting period involved nonopioid analgesics, 11.1% (1,647) involved 
narcotics or hallucinogens and 8.2% (1,207) involved psychotropic medication. There 
was evidence of alcohol consumption in 13.9% (2,066) of all overdose cases.  
 
Table 6.3.1 Category of drugs involved in overdose cases, 2005–2007 (n=14,770)   
Drug category *Number % 
Nonopioid analgesics 10259 69.5 
2005 2006 2007
Dublin (city and county) 862 1038 944
Outside Dublin 4109 3769 3941
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Table 6.3.2  Category of drugs involved in intentional overdose cases, 2005–2007 (n=9,240)   
Drug category *Number % 
Nonopioid analgesics 7877 85.2 
Alcohol 1360 14.7 
Psychotropic  1007 10.9 
Narcotics or hallucinogens 810 8.8 
Benzodiazepines 727 7.9 
Antiepilepic/Sedative/Antiparkinson 535 5.8 
Autonomic nervous system 269 2.9 
Systemic and haematological  169 1.8 
Systemic antibiotics 161 1.7 
Cardiovascular 130 1.4 
Gastrointestinal 121 1.3 
Other chemicals and noxious substance 121 1.3 
Diuretics  108 1.2 
Hormones  83 0.9 
Muscle and respiratory 43 0.5 
Anaesthetics 36 0.4 
Other gases and vapours 36 0.4 
Topical agents 10 0.1 
Antiinfectives/antiparasitics 8 0.1 
Other and Unspecified Drugs 1574 17.0 
*Total number differs from total number of cases as individual cases may have more than one drug or substance involved in 
their overdose 
Source:  Unpublished data from the HIPE 
 
Narcotics or hallucinogens 
Narcotic or hallucinogen drugs were involved in 11.1% (1,647) of the total number of 
overdose cases for the reporting period.  The number of overdoses involving narcotic 
or hallucinogenic drugs decreased by 4.6% (25) from 2005 to 2006, but increased by 
13.7% (71) between 2006 and 2007.  
 
The specific drug(s) involved is known for 45.0% (742) of these cases. In 8.5% (63) of 
cases more than one drug within this category of drugs was used in the overdose, 
therefore total figures may exceed 100%. Opiates accounted for 60.8% (451); other 
hallucinogens accounted for 18.3% (136); and cocaine accounted for 16.3% (121) 
(Figure 6.3.5). 
 
 
Figure 6.3.5   Drug type within narcotics and hallucinogens drug category, 2005–2007 (n = 742) 
Source:  Unpublished data from the HIPE 
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More than one quarter more males than females overdosed using narcotic or 
hallucinogen-type drugs during the period 2005 to 2007.  The majority of cases (39.6%, 
653) were in the 15–24-year-old group, and the incidence decreased in successive age 
groups between 25 and 95 years (Figure 6.3.6).  A quarter (25.4%, 419) of overdose 
cases involving a narcotic or hallucinogen -type drug were resident in the Dublin region 
(city and county).  
 
 
Figure 6.3.6   Age group within narcotics and hallucinogens drug category, 2005–2007 (n = 1647) 
Source:  Unpublished data from the HPSC 
 
National Poisons Information Centre (NPIC) – 2007 report 
 
According to its annual report (Poisons Information Centre of Ireland 2008), NPIC 
received 11,011 enquiries in 2007, a decrease of 7.5% on the 2006 figure. Of these, 
2,459 were dealt with by NPIS in the UK and are not included in the analysis presented 
in the report. Of the 8,552 calls answered by NPIC, 8,277 (96.8%) were about human 
toxicology. The remaining calls concerned poisoning in animals (1.2%) and non-
emergency requests for information (2.0%).  
 
Of the 8,552 calls dealt with by NPIC, the highest proportion were from the HSE 
Eastern Region (28.4%), of which 79.8% were from Dublin city and county.  
 
The most frequent enquiries were from hospitals (35.1%), general practitioners (34.9%) 
and members of the public (23.0%). The other sources of enquiries were community 
pharmacists, carers, vets, industry/manufacturers, schools, emergency services, 
media, and government agencies. The increased use by Irish emergency departments 
of TOXBASE, the online clinical toxicology database of the UK NPIS, is reflected 
in a 2.2% drop in the proportion of enquiries from hospitals since last year.  
 
More than half of the enquiries about cases of poisoning in humans concerned children 
under 10 years of age (Table 6.3.3). The main agents involved in these cases were 
household products, cosmetics and personal hygiene products, and plants. The 
majority (88.5%) of all human poisoning incidents occurred in the home. 
 
Table 6.3.3  Age and gender of enquiries about human cases of poisoning, recorded by NPIC, 2007 
Age group Gender Total % 
 Male        Female Unknown   
<1 159 152 114 425 5.1 
1–4 1921 1588 66 3575 43.2 
5–9 208 160 7 375 4.5 
10–14 80 109 4 193 2.3 
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Age group Gender Total %
 Male        Female Unknown   
15–19 136 241 3 380 4.6 
20–49 706 726 9 1441 17.4 
50–69 159 206 3 368 4.4 
>70 91 112 1 204 2.5 
Unknown 434 499 383 1316 15.9 
      
Total 3894 3793 590 8277  
Source: NPIC 
The enquiries about human toxicology involved 13,538 agents, mainly drugs, industrial 
chemicals and household products. The most common enquiry concerned substances 
containing paracetamol (1,082). Alcohol was next most common (376), and in the 
majority of cases was ingested with other substances. The third most common agent 
was ibuprofen (363).  Only a small proportion of cases (395, 4.8%) were followed up. 
Although most recovered completely, 21 cases suffered adverse effects, a further 17 
cases died, while the outcome of 68 cases could not be determined. 
 
National Registry of Deliberate Self-Harm – annual report 2008  
 
See section 4.3.2 
  
6.3.2 Other topics of interest 
Morbidity among opiate users in methadone treatment  
 
Cullen and colleagues (Cullen, W. et al. 2009) completed a study of problem opiate 
users attending general practice for methadone treatment to estimate the prevalence of 
chronic illness and examine patterns of health service utilisation among this group 
compared with matched controls in July 2008. The cases and controls were matched 
for practice, age, gender and general medical service (GMS) status. Data were 
collected on a sample of 114 patients attending three general practices: 57 cases 
attending for methadone treatment (19 per practice) and 57 controls attending for 
primary care (19 per practice).  
 
Illness among opiate users in methadone treatment 
The average age of cases was 37.2 years; 42 (74%) were male; 41 (72%) had GMS 
cover; all were Irish nationals; and 56 (98%) were documented as living in stable 
accommodation. Considerable lifetime contact with the practice was observed: 16 
patients (28%) had been attending the practice for less than five years, 21 (37%) for 
between five and 10 years, and 20 (35%) for more than 10 years. There were three 
reasons for initial contact with the general practice: registration for general medical 
care (20 patients), treatment of illicit drug use (20 patients), and referral by specialist 
addiction treatment services for methadone treatment (17 patients). All patients had 
been prescribed methadone by specialist addiction services prior to attending the 
general practice for methadone treatment, and 14 (25%) had been referred back to 
specialist addiction services since commencing methadone treatment at the practice 
(six in the previous year). The average dose of methadone prescribed (based on the 
last issued prescription) was 66 mg daily.  
 
Fifty-two patients (91%) had one or more chronic illnesses (in addition to opiate 
dependence) documented in their clinical record. Hepatitis C (38, 66%), depression 
(20, 35%), asthma (14, 25%), HIV/AIDS (8, 14%) and DVT/varicose veins/thrombo-
phlebitis (4, 7%) were the most common chronic illnesses recorded. Thirty-nine 
patients (68%) were on regular prescribed medication in addition to methadone. Thirty-
one patients (54%) had had at least one acute condition during the previous three 
months, of which the most common were: upper respiratory tract infection (10, 18%), 
insomnia, anxiety or depression (4, 7%), abdominal pain (4, 7%), urinary tract infection 
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(3, 5%) and ear wax (3, 5%). Tobacco use was noted in the records of 39 patients, of 
whom 37 were recorded as smokers. Twenty-five patients (44%) had been prescribed 
at least one time-limited medication (in addition to methadone) for the treatment of an 
acute illness during the previous three months. In the previous six months, patients had 
attended their GP for issues other than their addiction care an average of four times, 
and 27 patients (47%) had either been referred to or attended secondary care. 
 
Comparison with a matched control group 
The average age of controls was 37.2 years, 42(74%) were male, 41(72%) had GMS 
cover, all were Irish nationals and 38 (67%) were documented as living in stable 
accommodation. Morbidity and health service utilisation rates were high among this 
group also (Figure 6.3.7). Patients attending for methadone treatment were significantly 
more likely to have a chronic illness, to be prescribed recurrent medications and to 
attend a general practice.  
 
 
Figure 6.3.7   Comparison of morbidity profile and health service utilisation among patients on methadone and 
matched controls attending inner city general practices in Dublin, July 2008. 
Source: (Cullen, W. et al. 2009) 
 
An unusual medical complication of heroin abuse, a case report 
 
O’Conor and McMahon (O'Connor and McMahon 2008) reported a case of atraumatic 
rhabdomyolysis in a 21-year-old man who presented to the emergency department in 
St James's Hospital by ambulance. He was found collapsed at home by his uncle, 
complaining of severe pain and swelling in his left lower leg, with reduced sensation to 
his left foot. He was hepatitis C positive from intravenous drug use, and had used both 
heroin and cocaine five days previously on his release from prison.  
 
Musculo-skeletal exam showed extensive swelling of his left lower leg, with tense calf 
compartments. Initial laboratory results showed a raised creatine kinase of more than 
155,000 IU/l. Urine toxicology was positive for methadone, heroin and 
benzodiazepines, whereas urinary dipstick was positive for blood, which subsequent 
laboratory analysis confirmed to be myoglobin. Atraumatic rhabdomyolysis is a 
syndrome characterised by injury to skeletal muscle with subsequent release of 
intracellular contents, that is, myoglobin and creatine kinase. Drugs have direct toxic 
effects, but may also cause coma-induced rhabdomyolysis, owing to unrelieved 
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pressure on gravity-dependent body parts. Diagnosis is made with history (i.e. recent 
heroin or cocaine use), elevated serum CK, plus the possible presence of 
myoglobinuria.  
 
Aggressive intravenous rehydration remains the mainstay of treatment. If there is any 
evidence of compartment syndrome, urgent fasciotomy is required. Electrolyte 
imbalances should be corrected, unless very mildly abnormal. A high index of suspicion 
and thereby early recognition is crucial to prevent complications in intravenous drug 
users presenting with unusual symptoms and signs. 
 
Alcohol use among opiate users in methadone treatment in general practice 
 
Ryder and colleagues (Ryder et al. 2009) estimated that 35% (95% CI = 28%–41%) of 
a sample of current or former heroin users attending general practice for methadone 
treatment were problem alcohol users, and that 14% of the sample were dependent 
users. According to data from the National Drug Treatment Reporting System, 24% of 
opiate users entering opiate treatment reported alcohol as an additional problem drug, 
which is lower than the estimate presented here. 
 
The authors surveyed 196 patients, which represented 8% of those on the Central 
Treatment List, 31% of those selected in the sample of current or former heroin users 
attending general practice for methadone treatment, and 71% of those sampled who 
were invited by their general practitioner to participate. The response rate was lower 
than desired – an indication of the difficulty than can be associated with doing research 
among patients attending private general practitioners in Ireland. The authors used a 
survey questionnaire which included the Alcohol Use Disorders Identification Test 
(AUDIT) to assess participants’ alcohol use, and also collected data on socio-
demographic, medical and substance use characteristics. 
  
The median age of the 196 participants was 32 years, 68% were male, 79% said that 
they had used one or more illicit drugs in the previous month, and 76% had ever 
injected drugs. Of those who knew their blood-borne viral status, 55% said that they 
were hepatitis C positive and 5% said that they were HIV positive. Other research 
indicates that self-reported hepatitis C and HIV status can both over- and under-
estimate the prevalence of these infections and should be interpreted with caution.  
 
The cases classified as problem alcohol users were significantly more likely to have 
attended a local emergency department in the previous year and less likely to have 
attended a hospital clinic in the previous year compared to those who were not problem 
alcohol users. Among the 107 respondents who reported that they were hepatitis C 
positive, those who were problem alcohol users were significantly less likely to have 
attended a specialist hepatology clinic than their counterparts.  
 
The authors concluded that problem alcohol use has a high prevalence among current 
or former heroin users attending primary care for methadone treatment, and that 
interventions that address this issue should be explored as a priority.  
 
Trends in drug admissions to psychiatric facilities 
 
Activities of Irish psychiatric units and hospitals 2007, the annual report published by 
the Mental Health Research Unit of the Health Research Board in December 2008, 
shows that the total number of admissions to inpatient care has continued to fall (Daly, 
A et al. 2008).  
 
In 2006, 724 cases were admitted to psychiatric facilities with a drug disorder, of whom 
265 were treated for the first time (Daly, A et al. 2008). The report does not present 
data on drug use and psychiatric co-morbidity, so it is not possible to determine 
whether or not these admissions were appropriate. Figure 6.3.8 presents the rates 
between 1990 and 2007 of first admission of cases with a diagnosis of drug disorder, 
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per 100,000 of the population. The rate increased steadily between 1991 and 1995, 
with a dip in 1996 and 1997, and further annual increases between 1998 and 2001. 
The rate was almost three times higher in 2001 than it was in 1990.  Notable dips in the 
rate occur in the census years 1996 and 2002, and can be partly explained by the 
increased population figure used as the denominator in calculating the rate for those 
years.  
 
The overall increase in the rate of drug-related first admissions between 1990 and 
2001 reflects the increase in problem drug use in Ireland and its burden on the 
psychiatric services.  The overall decrease in the rate since 2001 possibly reflects an 
increase in community-based specialised addiction services during this period. The 
increased rate in 2005 may be accounted for by the use of the 2002 census figure in 
calculating the rate. The decrease to 5.9 in 2006 reflects the new census figure used 
as denominator. The rate increased marginally to 6.3 in 2007. Of the 776 discharges 
with a drug disorder, 51% spent less than one week in hospital and just under 13% 
spent more than one month in hospital.   
 
 
Figure 6.3.8   Rates of psychiatric first admission of cases with a diagnosis of drug disorder (using the ICD-10 
three character categories) per 100,000 of the population in Ireland and reported to the National Psychiatric 
Inpatient Reporting System, 1990–2007  
Source: (Daly, Antoinette and Walsh 2003; Daly, A. et al. 2005; Daly, A et al. 2007; Daly, A et al. 2008; Daly, Antoinette et al. 2004; 
Daly, Antoinette et al. 2006) 
 
6.4       Drug-related deaths and mortality of drug users 
The first analysis of data from the NDRDI was published in 2008 (Lyons, Suzi et al. 
2008).  It reported on directly drug-related deaths (poisonings) in Ireland between 1998 
and 2005. These data were reported in the 2008 National Report (Alcohol and Drug 
Research Unit 2008). Data on directly drug-related deaths (poisonings) in 2006 and 
2007 have now been have been collected and analysed and these new data, which 
have not yet been published in a separate national-level report, are described below in 
Section 6.4.1.  
 
The first national report on non-poisoning deaths among drug users in Ireland was 
published in November 2009.  It describes trends in non-poisoning deaths (deaths due 
to traumatic or medical causes) among drug users between 1998 and 2005. These 
data are described below in Section 6.4.2. 
 
6.4.1 Drug-induced deaths 
The number of poisonings recorded in Ireland (as per Selection D) has been rising 
steadily in the last four years, from 108 in 2003 to 181 in 2006 and to 185 in 2007 
(Table 6.4.1, also see Standard Table 6).   
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Table 6.4.1  Poisonings (Selection D) by year, 1998 to 2007 (N=1328) 
  1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
Selection D 104 115 113 107 126 108 126 163 181 185 
Source: Unpublished data NDRDI 
 
In the last two years for which data have recently become available, 2006–2007, over 
three-quarters of cases have been male (287, 78.4%). The majority of cases (258, 
70.5%) have been aged between 20 and 40 years (Figure 6.4.1) and the median age 
has been 31 years.  Forty-four percent (162) of all poisonings have been aged 30 years 
or less.  This is a very similar profile to that of poisoning deaths reported in Ireland 
between 1998 and 2005 (Lyons, Suzi et al. 2008) and in other countries during the 
same period (Ghodse et al. 2007). 
 
 
Figure 6.4.1  Age group of poisonings in Ireland (selection D), 2006 to 2007 (N=366) 
Source: Unpublished data NDRDI 
 
Of the 366 cases of poisoning recorded in 2006 and 2007, heroin and unspecified 
opiates accounted for 84 (23.0%)  cases, while methadone alone accounted for 20 
(5.5%).  This pattern is similar to that reported for the period 1998 to 2005 (Lyons, Suzi 
et al. 2008). Almost half of all deaths owing to poisoning (180, 49.2%) were attributable 
to polysubstances including an opiate, which is slightly lower than in previous years 
(Lyons, Suzi et al. 2008).   
 
In 2007, 74.1% of fatal overdoses were associated with opiate use. Deaths as a result 
of poisoning from cocaine, alone or with another drug, accounted for 28.6% (n=53) of 
poisoning deaths in 2007. 
 
From a national perspective, alcohol and other drugs, including benzodiazepines, non-
benzodiazepine sedatives, antidepressants, other prescription medication and over-
the-counter medication contribute significantly to the burden of drug-related deaths in 
Ireland but are not presented in this national report for the EMCDDA.  For further 
information on the national situation, see the most recent publication at 
http://www.hrb.ie/uploads/tx_hrbpublications/HRB_Trend_Series_4_01.pdf. 
 
6.4.2 Mortality and causes of deaths among drug users 
See Section 6.4.1 and  Section 6.4.3 
 
6.4.3 Specific causes of mortality indirectly related to drug use 
 
A total of 885 non-poisoning deaths among drug users were recorded between 1998 
and 2005.  Of those with a known cause of death (n=746), 476 (63.8%) were due to 
trauma and 270 (36.2%) were due to medical causes.   
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The number of drug users who have died from hanging or from drowning supports the 
argument that substance misuse is related to suicide.  There is a need for increased 
awareness and education around this issue, especially for those with a dual diagnosis 
of mental health and substance misuse problems who are already in treatment and 
those who present at emergency rooms with non-fatal drug- or alcohol-related injuries.  
 
The number of drug users who were driving at the time of their death and had a 
positive toxicology is further evidence of the need for more reliable statistics on 
drink/drug driving.  There is a need for expansion of the forensic analysis programme 
to ascertain the true incidence of driving while under the influence of drugs and/or 
alcohol.  However, there is currently no reliable system of road-side test for the 
presence of drugs in the body (European Monitoring Centre for Drugs and Drug 
Addiction 2009). 
 
The correlation of toxicology and drug-use history with the type of death recorded 
supports the argument that drug use is contributing to the premature death of drug 
users in Ireland.  More effective measures are required to educate drug users about 
the health consequences of drug use, particularly the cardio-toxic effects of cocaine. 
 
The continuing upward trend in drug-related deaths reflects the increasing numbers in 
the population who are consuming drugs and taking risks and who have acquired 
infections or developed medical conditions associated with drug use.  
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7. Responses to Health Correlates and Consequences 
7.1 Introduction 
This chapter presents new data on preventing drug-related mortality, the management 
of blood-borne viral infections, and responses to co-morbidity. The public and voluntary 
sector institutions that have been engaged in the various initiatives described in the 
following sections are briefly described here. 
 
In May 2008 the Joint Oireachtas (Parliamentary) Committee on Health and Children 
formed a sub-committee to consider the high level of suicide in Irish society, and in 
particular to monitor the implementation of recommendations made in the Joint 
Oireachtas Committee on Health and Children’s 7th Report on The High Rates of 
Suicide in Irish Society, which had been published in July 2006. The report of this sub-
committee, published in June 2009, is described in this chapter. (A joint Oireachtas 
committee comprises the Select Committees of both Houses of Parliament (Senate 
and Dáil) sitting and voting together.) 
 
The Health Service Executive (HSE) is responsible for managing and delivering health 
and personal social services in Ireland. It operates through three areas of service 
delivery – Primary Community and Continuing Care (PCCC), National Hospitals Office 
(NHO), and Population Health (PH) – and supports numerous responses to the health 
correlates and consequences of problematic drug use. 
 
The National Immunisation Advisory Committee (NIAC) is a Standing Committee of the 
Royal College of Physicians of Ireland (RCPI). It advises the Department of Health and 
Children in the area of immunisation procedures and related matters. It prepares and 
maintains the Immunisation Guidelines for Ireland with the assistance of an active 
committee from associated disciplines in paediatrics, infections diseases, general 
practice and public health.   
Community Response is a partnership of statutory, voluntary and community interests 
concerned with issues of problem drug use, drug-related hep C, HIV/AIDS and drug-
related crime in the south inner-city area of Dublin. Its aim is to develop and devise 
practical and effective ways of tracking problem drug use and its effects in Dublin’s 
south inner city, and to work with the local community to determine its own solutions to 
drug-related issues. Its services include training, education, family support, health 
promotion, referrals and information-giving.  It offers a one-year part-time course 
leading to a Certificate in Addiction Studies, which is accredited by NUI Maynooth. Its 
team of community development workers offer a range of workshops which explore 
such complex issues as Domestic Violence, Drug and Alcohol use, Prejudice and 
Discrimination. 
The Ana Liffey Drug Project (ALDP) is a voluntary organisation offering a low-threshold 
harm-reduction service in north inner-city Dublin. It works with people experiencing 
addiction, to minimise the harm that problematic drug use causes them, their families 
and the wider community. It provides a range of services including a drop-in service, 
outreach service, family care and case management service, peer-support group and 
literacy tutoring.  
 
 Merchants Quay Ireland (MQI) is a voluntary organisation providing services to people 
who are homeless and for drug users. Its drug-related services include open access, 
day support services and settlement and integration services, residential drug 
treatment, and training, research and policy development services 
The Mental Health Commission (MHC) is an independent statutory body established 
under the Mental Health Act 2001. It is tasked with promoting high standards in the 
delivery of mental health services in Ireland and ensures the interests of those 
involuntarily admitted to ‘approved centres’ are protected. 
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7.2 Prevention of drug-related emergencies and reduction of drug-
related deaths 
A Joint Oireachtas sub-committee was established in 2005 to examine in detail the 
issue of suicide in Irish society; to engage with those who work in suicide prevention; 
and to hear evidence from those involved in post-suicide counselling and support.  
According to the World Health Organization, suicide is among the three leading causes 
of death worldwide among people in the 15–44-year-old age bracket.  In 2004, there 
were 27.1 deaths/100,000 population among men in Ireland, compared to 6.1 in 
England.  For females the rate was 2.9/100,000 population, compared to 1.7 in 
England.  Youth suicide rates in Ireland are the fifth highest in the European Union.     
 
The sub-committee’s report, The high level of suicide in Irish society, was published in 
2006 and accepted for implementation (Joint Committee on Health and Children 2006).  
It provided detailed information on the extent of suicide in Ireland and made 33 
recommendations on how to address the problem.  A report by a new sub-committee, 
published in June 2009, reviewed the extent to which these recommendations had 
been implemented, and identified the obstacles that had prevented their 
implementation (Joint Committee on Health and Children 2009) (Table 7.2.1).      
 
Table 7.2.1   Recommendations, and progress on their implementation 
Oireachtas report recommendations 2006 Progress 
Appoint a suicide prevention officer Very limited progress 
Establish a health and education liaison group Very limited progress 
Appoint a national co-coordinator for the education sector No significant progress 
Set up an evidence-based health promotion programme for transition year students No significant progress 
Develop national training programmes in suicide prevention for teachers, voluntary 
organisations, primary care teams, hospital staff and mental health service staff Very limited progress 
Organise a consultation with young people Some progress 
Develop anti-stigma and positive mental health promotion media campaign Some progress 
Standardise support and information provided by primary care services to those bereaved 
by suicide Some progress 
Pilot a fast-track referral system from primary care to mental health services for suicidal 
individuals  Almost complete 
Standardise pre-discharge and transfer planning from or between mental health services Very limited progress 
Develop staff guidelines for people presenting to hospital following self harm No substantial progress 
Conduct study to compare different models of service provision to those presenting to 
emergency departments with self-harm 
Very limited progress 
 
Determine the risk of suicide associated with being in a marginal group, review services 
and develop new ones as needed Very limited progress 
Develop inpatient units for children with mental health problems and integrate adult and 
child services administratively Very limited progress 
Implement recommendations from the Inspectorate of Mental Health services within 5 
years or Minister or Inspector to resign No substantial progress 
Implement recommendations of alcohol task force; establish screening protocol for 
intervention of problem alcohol use; establish a range of effective, accessible, appropriate 
and integrated alcohol treatment services in each HSE area with explicit pathways of care 
for those seeking treatment for problem alcohol use 
Some progress from the 
Dept. of Justice but very 
little else 
Review and develop a national policy on current alcohol and addiction treatment services No substantial progress 
Evaluate psychological support services for those in prisons Very limited progress 
Provide training for gardaí and prison officers in supporting suicidal individuals Very limited progress 
Review and develop a service plan for bereavement services Complete  
Formally co-ordinate the various voluntary agencies working in the area of suicide 
bereavement support 
No substantial progress 
 
Develop and implement protocols for health service response in the event of suicide 
clusters No substantial progress 
Facilitate communication between the gardaí, coroners and suicide resource officers so 
that in the event of a suicide families and others can be provided with information on 
bereavement support services Very limited progress 
Develop evaluation criteria for a pilot mental health promotion and support initiative for 
young men Very limited progress 
Evaluate the risk of suicide associated with over-the-counter medications and develop and 
implement guidelines No substantial progress 
Enable the safe disposal of unused and unwanted medicines Very limited progress 
Examine whether certain Irish places are associated with suicide and implement ways of 
making these places safer No substantial progress 
Appoint coroner’s officers to act as links between the coroner service and the public Very limited progress 
Establish a technical group to link and exchange data between relevant national 
information systems including the National Drug Treatment Reporting System and the 
National Drug-related Deaths Index No substantial progress 
Establish a national confidential enquiry into deaths from unnatural causes, including 
suicide No substantial progress 
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Oireachtas report recommendations 2006 Progress 
Establish a national ethics committee to oversee suicide-related research No substantial progress 
Agree a national programme of research into self-harm, suicide and suicide prevention No substantial progress 
Publish suicide research guidelines for donors providing funding No substantial progress 
 
It appears that many of the recommendations outlined in 2006 have not been 
progressed at all.  In addition, the few recommendations that have been completed or 
mostly completed now need financial resources and political support in order to 
develop and implement their findings.  The report concluded that immediate change is 
required to properly address the ongoing serious problem of suicide in Ireland. The 
National Office for Suicide Prevention needs adequate and sustained funding, a higher 
level of interagency collaboration, and the requisite political support if it is to have any 
chance of fully implementing the recommendations made in the 2006 Oireachtas 
report. 
 
7.2.1 Nursing assessment of episodes of deliberate self-harm 
In January 2008 a research study Accident & Emergency Nursing Assessment of 
Deliberate Self Harm was released by the HSE South and the National Suicide 
Research Foundation Ireland (Lamb et al. 2008). It reported on a pilot study exploring 
‘the impact of introducing a suicide education programme and a suicide intent scale 
into A&E/MAU [Medical Assessment Unit] nursing practice’. The study was based on 
the concern that inadequate assessment of deliberate self-harm (DSH) patients may 
result in failure to diagnose treatable underlying conditions such as alcohol and drug 
dependence. Key findings of the study were that (a) the provision of training was 
associated with a significant increase in nurses’ confidence in dealing with DSH 
patients and positive changes in their attitudes towards suicidal behaviour and its 
prevention, and (b) the use of a suicide intent scale is potentially valuable in referring 
DSH patients presenting at A&E/MAU to the appropriate service.  
 
 
7.3 Prevention and treatment of drug-related infectious diseases 
7.3.1 Strategy to deal with hepatitis C 
In January 2007, the HSE established a working group on hepatitis C. The brief of this 
group is to build on a 2004 unpublished report on hepatitis C carried out by the then 
Eastern Regional Health Authority. Unlike the 2004 report, the 2007 initiative has a 
national brief. It is examining how Ireland can best respond to hepatitis C in the areas 
of surveillance, education and treatment. The working group will comment on how the 
recommendations of the 2004 report have been progressed. It will bring forward costed 
and prioritised recommendations. The group has completed its report and is waiting to 
present it to HSE senior management (J Barry, personal communication, July 2009).  
 
7.3.2 Inclusion of hepatitis B vaccine in the Irish Childhood Immunisation 
Programme 
The National Immunisation Advisory Committee and the Department of Health and 
Children recommended significant changes to Ireland’s national childhood 
immunisation programme in 2008 (National Immunisation Advisory Committee 2008). 
These changes, which were published in the revised Immunisation guidelines for 
Ireland 2008, include the addition of hepatitis B vaccine to the routine childhood 
programme. The 5-in-1 childhood vaccine was to be replaced with a 6-in-1 vaccine 
which includes hepatitis B vaccine. In the Immunisation guidelines for Ireland 2002, 
hepatitis B vaccine was recommended for several high-risk groups rather than the child 
population; prisoners and injecting drug users were two of the high-risk groups named 
(National Immunisation Advisory Committee 2002).  
 
7.3.3 World Hepatitis Day 
On 19 May 2008, the Blood Borne Virus Forum marked World Hepatitis Day with an 
Open Day at Community Response, Carman’s Court, Dublin 8. The purpose of the 
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open day was to raise awareness about hepatitis and in particular about hepatitis C. 
Attention was drawn to the fact that almost 20,000 Irish people could be infected with 
hepatitis C and most do not know that they are infected. Information on the symptoms 
of hepatitis C, its routes of transmission and testing and treatment procedures was 
provided using educational posters, leaflets and interactive activities.  
 
Two short films were shown - Hidden I and Hidden II – both of which were produced by 
Community Response Drama Group and developed through improvisation and role-
play. Hidden I is an educational drama about drug use, pregnancy and hepatitis C, 
while Hidden II continues the story and educates the viewer about testing and 
treatment for hepatitis C.  
 
A new hepatitis C awareness board game and DVD were launched at the open day. 
The board game can be played by up to 10 people and requires players to answer a 
possible 29 questions about hepatitis C. Postcards which provide information on the 
risk factors for hepatitis C infection were also launched. The postcards were to be 
made available in cafés nationwide.  
 
7.3.4 Innovative  outreach work  
 
In August 2008, the Ana Liffey Drug Project (ALDP) adopted assertive street-based 
outreach work  in which staff seek to engage people who are based on the streets of 
Dublin's inner city and who may experience problem drug use and/ or homelessness. 
According to the project, there are a number of reasons people may not wish to access 
centre-based services; by conducting outreach they can ensure that these people are 
not excluded from ALDP and other services. In many ways, the assertive outreach 
function is an extension of the ALDP's drop-in work – ‘we can provide friendly, non-
judgmental advice and support on the streets’. Services provided include advocacy, 
phone calls, referrals to ALDP (and other services) and brief solution-focused 
interventions.  
 
In November 2008, ALDP launched peer-led outreach, disseminating information about 
keeping safe on the streets, created by the ALDP peer group - Duck, Dive and Survive. 
ALDP asked the peer group what they felt was inappropriate and appropriate behaviour 
on the street. Based on their discussion, the ALDP supported them to create a durable 
leaflet with a few handy tips for staying safe on the street. The leaflets also promoted 
the ALDP freephone number. 
 
In March 2009 the Dublin City Business Improvement District (DBID) announced a 
long-term partnership with the ALDP to help improve the quality of life and conditions of 
its service users and ultimately assist them in finding greater structure in their lives. 
Rooted in the 'Continuum of Care' principle, the partnership will operate at both a 
strategic level and also on the ground where its team of 12 street ambassadors will 
provide information and refer potential clients to the ALDP. As the first step, the DBID 
announced its contribution towards the purchase of an eight-seater van to support the 
ALDP Outreach Programme which includes advocacy, referrals, and interventions on 
the streets of Dublin City Centre.  
In June 2009 the ALDP used a bursary, awarded for coming first in the New Initiatives 
category of the Crystal Clear MSD Health Literacy Award 2009[1] for its Duck, Dive and 
Survive series, to establish an SMS text messaging service for its service users. 
Named ‘Survive’ SMS Texting Service for people who use drugs, it uses mobile phone 
technology to communicate with one of Dublin's most marginalised groups. Information 
provided by SMS includes: 
° any change to opening times to key services, 
° advice on overdose risks and prevention, 
° new trends and dangers relating to illicit drug use, and  
° information from service users.  
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The ALDP work with the Service Users 'Peer Group' to identify key messages to be 
sent to their peers via this service. An example of a group text message sent to people 
who attended the ALDP during June 2009 is: ‘OVERDOSE: Don't panic. Put them in 
the recovery position, dial 999, ask for an ambulance and stay with them until the 
ambulance arrives. Ana Liffey: 1800786828’. Tony Duffin, the ALDP Director, 
commented: ‘There is a high rate of mobile telephone use among the people who use 
ALDP's services. This innovative approach will reach many people in their day-to-day 
lives and offer real time information on reducing the risks associated with drug use. 
During June 2009 over 50 service users signed up to the Duck, Dive and Survive SMS 
service, and the feedback has been very positive.’  
 
In a separate initiative, also in June 2009, Dublin-based ambient advertising 
specialists[2] Captive agreed to provide pro bono ambient advertising for Ana Liffey 
Drug Project. The Duck, Dive and Survive poster that promotes ALDP’s freephone was 
placed in 20 city-centre locations.  
 
7.3.5 Information leaflet on needle-exchange services 
 
In July 2009, the HSE East Coast Area needle-exchange service launched an 
information leaflet for people who inject drugs (John Craven, personal communication, 
2009).  The aim of the leaflet is to encourage injectors not to share and never to re-use 
injecting equipment.  
 
The leaflet includes advice about safer injecting practices and provides guidance on 
how to look after veins and limit vein damage.  It stresses the importance of never 
sharing drug-taking equipment in order to help prevent the transmission or acquisition 
of hepatitis and HIV.  While the main focus is on injecting drug use, the leaflet states 
that blood-borne viruses can also be transmitted or acquired by sharing snorting 
equipment.  
 
Service users are encouraged to seek further advice from needle-exchange services, 
which are listed in the leaflet, with their opening hours and contact details. Information 
is also provided on services providing HIV/AIDS prevention, drug treatment and 
counselling, and the community addiction teams, in the East Coast area. For people 
seeking treatment and counselling services in other areas, a helpline number is given. 
 
7.3.6 MQI safer injecting guide 
On 3 April 2008 Merchants Quay Ireland (MQI) launched the booklet Safer injecting at 
a seminar focused on reducing the harm associated with injecting drug use (Merchants 
Quay Ireland 2008).    
 
This safer injecting guide was produced for people who inject drugs. The booklet 
includes advice about safer injecting practices and different types of injecting – into a 
vein or muscle, or under the skin (skin popping).  The importance of washing one’s 
hands prior to injecting to reduce the risk of infection is a simple and important point 
highlighted in the guide.  Advice is provided about how to look after veins and decrease 
vein damage.  Readers are encouraged to seek medical attention if they experience 
any health issues associated with injecting.  A full description of the necessary injecting 
equipment is provided, along with the important statement that ‘single-use syringes are 
the safest as water and/or bleach will not destroy all viruses’.  Overdose prevention 
techniques and responses are described, along with information on the increased risk 
of overdose owing to polydrug use.  The necessity for protection against the acquisition 
and transmission of blood-borne viruses is also discussed.  
 
7.3.7 Profile of needle exchange services in Ireland 
 
Needle and syringe exchange services were first provided in Ireland in 1989, when five 
exchanges were established. There are now 34 exchanges in the country, operating 
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three models of service: fixed-site exchanges, home visit exchanges, and exchanges in 
public locations. Peer-based, pharmacy, prison-based or vending machine exchange 
services are not available in Ireland. 
 
The Health Research Board collated information to profile 31 needle and syringe 
exchange services operating between November 2007 and February 2008 in Ireland 
(Robinson et al. 2008).  A service-inventory questionnaire was used to collect the data. 
The questionnaire comprised six sections: administrative details, profile of target 
population, profile of staff and volunteers working in the service, activities, 
management issues and new phenomena in relation to drug use (Working Group on 
Data Collection within the Correlation Network 2008). The 31 services provided 
exchanges at fixed sites (28), on home visits (3) and in public locations (2); two 
services provided exchanges in two settings. 
 
Of the exchanges surveyed, 17 were operated by government, 11 by a partnership of 
government and non-government organisations, and 3 by non-government 
organisations. Two services provided social and medical care; six provided social care 
only and four provided medical care only. All provided services without charge to the 
client.  
 
Weekly opening times ranged from 24 and three-quarter hours over five days in one 
service to one hour on one day in three services. Twenty of the services were open on 
one day a week for 1–2½ hours. One service was open on seven days a week for one 
hour each day; this was the only service that operated at weekends. Eight of the 
services were open after 5 pm on one night a week.  
 
Of the 31 services, 20 provided services in urban locations, 12 in inner city locations 
and 3 in rural locations; some services operated in more than one location. The 
majority reported a dispersed open drug scene and/or a hidden scene in their areas.  
 
Seven of the services had no formal data-collection procedures, and two services were 
not open for all of 2007. A total of 22 services reported 7,069 client attendances in 
2007.  
 
Overall, between 10% and 30% of clients were female. The youngest clients were aged 
between 16 and 20 years. Twenty-five services were open to any person aged over 18; 
five of these also dealt with 16–18-year-olds. Two services catered for women and sex 
workers; two served residents only; and two operated specific services for ethnic 
minorities. Twenty-nine services reported that a significant minority of their clients were 
homeless.  
 
Twenty-nine services reported heroin as the drug most commonly used by clients; 18 
services reported cocaine as the most common. As expected, injecting was the most 
common route of administration (reported by 19 services). Benzodiazepine injecting 
was reported as a common practice by 11 services. Nineteen services reported that 
clients attending their service injected steroids.  
 
Thirty services reported that the outreach workers had an academic (but not a 
professional) qualification. The remaining service reported that staff did not have formal 
qualifications. Thirty services were operated by two or more staff during a session; 15 
had a general assistant present. Six services provided on-site access to health 
services, usually provided by a nurse; four provided on-site access to counsellors.  
 
All 31 services reported that staff received training in the assessment of clients’ sexual 
risk practices and injecting practices, and on emergency responses such as overdose 
prevention techniques. Twenty-six services had a written document about staff training.  
 
A variety of policy and procedural documents have been developed to guide the 
operation of needle and syringe exchange services in Ireland. A written document for 
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service providers in relation to health and safety issues was available in all services. A 
written document in relation to the health and safety of clients was available in 20 
services. Thirty services offered staff vaccination against hepatitis A and B, and seven 
offered staff vaccination against tetanus. 
 
All 31 services completed an assessment when a client accessed the service for the 
first time. The majority of services recorded clients’ drug use, drug history and sexual 
health practices in the past year. The majority also recorded the blood-borne viral 
(BBV) infection status of their clients as well as their BBV test and treatment history. 
The amount of information recorded at the initial visit depended on how comfortable the 
client was in divulging this information. In some cases, service providers recorded 
basic client information (such as name, date of birth, drug of choice and mode of 
administration) at the initial visit and obtained additional details at subsequent visits. No 
service developed a written care plan for clients. However, 28 services reported 
reviewing clients’ needs after a number of visits – in some services after every two 
visits and in others after every 10 visits.  
 
The majority of services recorded the following data at each return visit: date, used 
injecting equipment returned, sterile equipment received, client’s sharing of injecting 
equipment (since last visit), drug(s) used (since last visit), condoms received, and 
length of visit.  
 
Information was recorded on client assessment forms in 30 services and on a 
computer system in 19 services; some services recorded the data in both ways. Of the 
services recording data on computer, 16 used the Drugs/Aids Information System 
(DAIS), two used Microsoft Excel and one used a specially designed client-information 
system.  
 
Services provided a range of sterile injecting equipment and materials. All 31 services 
provided different sizes and types of needle and syringe, as well as alcohol swabs and 
citric or acetic acid. All services also provided condoms. Thirty services provided 
stericups or cookers and sterile water; 28 provided non-toxic foil (for smoking heroin); 
11 provided syringe identifiers; and seven provided tourniquets. No service provided 
single-use injecting packs, crack pipes or straws.  
 
All 31 services provided information on safer injecting practices, overdose prevention 
and blood-borne viruses; 29 provided information on safer sexual health. All services 
discussed with clients the importance of safely disposing of needles and syringes. 
 
All 31 services reported either providing social care and crisis counselling services on 
site or referring clients to other services that provided the necessary interventions. 
Accompanied referrals to either social care or health care services occurred 
infrequently in the majority of services. However, accompanied referrals to an 
emergency department were provided if a client presented to the service in a suicidal 
state.  
 
Some services provided facilities in addition to needle and syringe exchange: 11 had a 
drop-in club, lounge or open-access service, of which five had tea and coffee making 
facilities, nine provided meals (a sandwich at minimum), seven had leisure facilities 
(games, television), nine had telephone facilities and three had internet facilities 
available to service users.  
 
Day-bed facilities were not provided by any service, though two provided night-bed 
facilities, with 17 and 20 beds available respectively. Lockers for personal belongings 
were available in two services. Eight services had personal hygiene facilities available 
to service users, of which seven had bath or shower facilities, seven had laundry 
facilities and four had clothes distribution facilities.  
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7.3.8 Methadone and HCV treatment 
Relatively few patients infected with the hepatitis C virus through intravenous drug 
abuse receive effective antiviral therapy. A study was undertaken to determine if 
supervised treatment in a drug treatment centre could improve compliance with 
antiviral therapy (McCormick et al. 2008). A pilot study of supervised anti-viral 
treatment in a community non-residential drug treatment facility was conducted. 
Thirteen patients infected with hepatitis C virus genotype 2 or 3 were identified in a 
drug treatment clinic. Six patients agreed to treatment. A full treatment course was 
administered to all six, with sustained viral response being observed in five of the six. 
This study demonstrated that effective treatment penetration could be improved for this 
patient group by shared care with drug treatment services and without significantly 
increasing the resources needed. The number in the study was small but the findings 
were in line with other research in this area and supported linking HCV and methadone 
treatment.   
 
7.3.9 Management of mycotic femoral pseudoaneurysms in intravenous drug 
abusers 
Mycotic aneurysms are caused by microorganisms in the vessel wall. The most 
commonly-reported cause of mycotic aneurysms today is intravenous drug abuse. The 
diagnosis should be considered whenever a mass is encountered over a major artery 
(a blood vessel which carries oxygenated blood) in an intravenous drug abuser. The 
clinical findings often include a tender, pulsatile mass overlying an artery. The single 
best diagnostic test is the arteriogram. Mycotic femoral pseudoaneurysms, particularly 
in the drug-abusing population, pose a difficult problem to the vascular surgeon. The 
treatment is based on early exploration with debridement of all necrotic and infected 
tissue, effective drainage, ligation of the artery and appropriate antibiotic coverage.  
 
A study was undertaken reviewing the management of mycotic femoral 
pseudoaneurysms in intravenous drug abusers presenting to an inner city tertiary 
referral center in Dublin (Peirce et al. 2009). Between 2001 and 2006, nine patients 
were treated, two patients were treated twice. The average age was 30.7 years with a 
male-to-female ratio of 1:2. Five patients had a positive viral status for both HIV and 
hepatitis C, three patients had hepatitis C only and one had HIV only. A combination of 
groin pain and swelling were the most common symptoms reported when help was 
sought. Two patients presented with significant bleeding. The diagnosis was confirmed 
by ultrasound in the majority of cases. Nine cases were managed with arterial ligation 
and removal of the dead tissue. One case was successfully managed with ultrasound-
guided injection to dissolve the clot and another had an arterial puncture closure. On 
follow-up, one patient required a below-knee amputation following re-injection into the 
postoperative wound site. Another patient underwent an amputation of his toe due to 
lack blood supply to it.  
 
The data indicate that ligation and removal of dead tissue are well tolerated in the 
majority of drug-abusing patients diagnosed with mycotic femoral pseudoaneurysms. 
 
 
7.4 Responses to other health correlates among drug users 
On 14 May 2009 the Mental Health Commission Annual Report 2008 including the 
report of the inspector of Mental Health Services 2008 (Mental Health Commission 
2009) was published. In his national review, the Inspector of Mental Health Services, 
Dr Patrick Devitt, expressed concern over failure to implement some of the 
recommendations in A Vision for Change (Expert Group on Mental Health Policy 2006), 
which proposed a framework for mental health service delivery in Ireland. For example, 
the subsuming of mental health in the Primary and Continuing Community Care 
directorate of the HSE, rather than in a separate mental health directorate, has resulted 
in specialist mental health services not having an adequate focus and being regarded 
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as of secondary importance. The concept of a national network of comprehensive, 
community-based, multidisciplinary mental health teams is still far from realisation.  
 
 With regard to addiction psychiatry, the Inspector wrote: ‘Substance abuse or 
dependence can give rise to certain behaviours mimicking those of mental illness and, 
in addition, can be a cause of mental illness. Moreover, the use of substances can 
exacerbate existing mental illnesses and make rehabilitation more difficult. There is a 
strong need for mental health professionals to become and remain well versed in the 
problems associated with substance dependence and identify and refer to the addiction 
services those patients where this is the primary problem. We have not had the 
opportunity in the past to inspect in detail these services, but look forward to doing so 
in the future’.  The Inspector hopes to be in a position in the future to examine and 
made recommendations for these services.  
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8. Social Correlates and Social Reintegration 
8.1  Introduction 
Social reintegration for drug users is gaining in importance in Ireland, according to 
recent reviews of policy and practice (Comptroller and Auditor General and 
Department of Community Rural and Gaeltacht Affairs 2009); (Department of 
Community Rural and Gaeltacht Affairs 2009); (Working Group on Drugs Rehabilitation 
2007). Social reintegration includes providing support with accommodation, education 
and training and employment, and is aimed at empowering individuals to plan 
alternative activities to those that they engaged in during their active drug use. 
 
8.2 Social exclusion and drug use 
The links between social exclusion and drug use in Ireland have been well established 
(Keane 2007). Problem drug users in treatment tend to be young and male, have low 
levels of education and are unlikely to be employed. For a small proportion, around 
10%, homelessness and insecure accommodation are persistent problems. In recent 
times there has been a modest increase in the proportion of other nationalities seeking 
treatment (Reynolds et al. 2008). Research also shows that there are problems with 
illicit drug use among socially-excluded groups such as sex workers, homeless people 
and new communities. The research and information presented in this section suggest 
that services to tackle the needs for accommodation and education, training and 
employment are as important as services to tackle people’s addiction problems and 
their use of illicit drugs. For example, a recent study on sex work and drug use 
illustrated that many participants growing up in poverty and disadvantaged 
communities were exposed to an escalating and changing drug scene where peers 
shared drugs and introduced others to the sex work industry. These narratives 
conveyed the corrosive effect of social exclusion on the lives of participants from an 
early age (Cox and Whitaker 2009).  
 
8.2.1 Social exclusion among drug users 
The Research Outcome Study in Ireland (ROSIE) is a national, prospective, 
longitudinal, multi-site drug treatment outcome study. The study recruited and followed 
404 opiate users entering treatment and documented their progress after six months, 
one year and three years. Recently published results included information on outcomes 
in terms of social functioning at the three time points (Comiskey, Catherine M et al. 
2009).  
 
Homelessness and insecure accommodation have been closely linked with problematic 
drug use and are indicative of social exclusion. The proportion of ROSIE participants 
who reported being homeless at intake or follow-up interviews, or in the 90 days prior 
to interview, are shown in Table 8.2.1. These data indicate that at least 10% of opiate 
users in drug treatment are likely to be experiencing episodes of homelessness on a 
frequent basis and, despite the gains that might be expected from being in treatment, it 
appears that moving to secure accommodation is not feasible for them within the 
current model of treatment. The ‘housing first’ approach, which seeks to place people 
in secure accommodation and then deal with their other needs, may be a more 
effective policy response to this group (see section 8.3.1 on social reintegration for a 
discussion on this new policy direction).  
 
Table 8.2.1  ROSIE study participants who reported being homeless at or prior to intake and follow-up 
interviews, or in the 90 days prior to interview 
 At intake At 1-year follow-up At 3-year follow-up 
 n % n % n % 
Currently homeless  33 8.3 34 11.3 37 10.4 
Homeless within past 
90 days 
58 14.7 36 11.8 40 11.2 
Source: (Comiskey, Catherine M et al. 2009) 
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8.2.2 Drug use among socially excluded groups 
This section includes information on the use of drugs and related issues among a 
number of groups that experience social exclusion, including sex workers, homeless 
people, Travellers and members of new communities.  
 
For information on substance use in the Traveller community, see section 2.4.1 
 
Drug use and the experience of risk in the lives of sex workers 
 
Recent research on behalf of the NACD aimed to gain an understanding of the local 
risk environment (i.e. the physical, social, economic and policy environment) within 
which problem drug-using sex workers in Dublin lived and worked and how they 
perceived and responded to risk (Cox and Whitaker 2009).  
 
Sampling and recruitment 
Accessing eligible study participants proved difficult and sampling and recruitment 
methods included using key informants to access initial interviewees and then snowball 
sampling with interviewees to continue the chain referral network. Posters and 
postcards were placed in sites believed to be frequented by drug-using sex workers 
and, combined with websites and a magazine, were used to highlight the study and 
invite potential participants to make contact. Fieldworkers were ‘on call’ via mobile 
phones to speak with service providers and/or potential study participants. Despite 
intense efforts to find problem-drug-using male sex workers, the final number achieved 
was only four. 
 
Data collection methods 
In-depth interviews were carried out with 35 drug-using sex workers (31 female and 4 
male); the average age was 32 and the majority were parents. Biographical data and 
data on recent drug use were collected with a short questionnaire. Interviews were held 
in service providers’ premises, prison, hostels, respondents’ cars and coffee shops. 
Forty professionals who worked either directly or indirectly with drug-using sex workers 
were interviewed in private rooms in services.  
 
Data analysis 
The analysis was undertaken using the constant comparative method to identify the 
main concepts and themes in the data. This approach facilitated a number of 
categories and conceptual schema to emerge which provided a basis for establishing 
the relations within the data that formed the core for middle-ground theoretical 
development.  
 
Findings and interpretation 
Participants grew up in inner-city, working-class poverty-stricken communities, where a 
well-established heroin market exposed them to a range of substances from an early 
age. The majority used drugs from an early age, usually in the company of older peers. 
Peers and social networks were the dominant route into sex work; economic necessity 
to cater for their opiate habits the main reason. Involvement in sex work often led to an 
escalation in drug use, which was paid for with the extra cash.  
 
A profile of participants’ self-reported use of drugs revealed that two-thirds reported 
recent heroin use, over a quarter reported recent cocaine use, 15% reported recent 
crack cocaine use.  Overall, rates of self-reported recent drug use were highest among 
those actively involved in sex work at the time of interview. Eighty-eight per cent were 
receiving prescribed methadone and one in four was homeless at  the time ofinterview. 
Among the study participants (and the professionals interviewed), injecting cocaine 
was considered particularly risky; it was associated with frantic, high-frequency 
injecting, binge use, extensive vascular and tissue damage and risk of blood-borne 
viral infection from sharing of used injecting equipment and paraphernalia. While all the 
participants reported using needle exchanges to access sterile injecting equipment, 
most also admitted knowingly and/or inadvertently engaging in unsafe injecting 
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practices in the past. The majority used a range of strategies in an effort to reduce the 
risk of harm associated with their drug use.  The professionals were of the opinion that 
changes in the local drugs market, most notably the increased availability and use of 
cocaine, in particular cocaine injecting, had led to an increase in drug-using risk 
behaviour among this client group. 
 
This research is one of the few in-depth studies undertaken in Ireland to examine the 
links between drug use and sex work and the risks involved. The findings show that the 
majority of people grew up in disadvantaged communities where the use of drugs was 
prevalent. Finding the money to sustain a drug habit was a key reason for entering sex 
work and often drug use and risky practices around taking drugs occurred when people 
were engaged in sex work. Heroin, cocaine and crack cocaine use was prevalent in the 
daily lives of these sex workers.  
 
Drug use among young homeless people 
 
A report on Phase II of a qualitative longitudinal study on homelessness among young 
people in Dublin city was published in 2008 (Mayock, P et al. 2008). The research 
aimed to generate in-depth understanding of the process of youth homelessness, with 
particular focus on movement into, through and out of homelessness.   
 
Research methods 
Phase II data were collected between September 2005 and August 2006. Information 
was obtained about the living situations of 37 of the 40 young people (23 males and 17 
females) recruited in Phase 1 and follow-up interviews were conducted with 30 (16 
males and 14 females) using the life history interview approach.  
 
Findings  
In analysing the narratives of the 30 young people re-interviewed at Phase II, the 
researchers were able to categorise three pathways from homelessness: 
 
° Independent exits from homelessness 
° Dependent exits from homelessness 
° Continued homelessness 
 
Independent exits 
Six of the young people had moved home and one had moved to private rented 
accommodation. Those who had continued contact with and support from their families 
throughout the homeless experience made a smoother transition home and were more 
likely to view their move home in positive terms. Among those for whom drug use was 
an issue, continued family and parental support was almost always contingent on the 
young person seeking drug treatment and quitting use. This often involved breaking 
ties with past friends and associates within both street and drug scenes and 
establishing new social networks. 
 
Dependent exits 
Ten of the young people had either moved to transitional/supported housing (n=7) or to 
a residential care setting (n=3). They were helped to make this move by support from 
family members and professional sources, and by participation in education or training.  
For those who reported drug problems, seeking treatment was a critical enabler in the 
transition to supported housing. Most felt that it was important to distance themselves 
from former peer networks and attempted to establish and maintain positive and 
enabling social relationships. Some experienced financial difficulties as well as 
problems with everyday household chores and responsibilities. A number reported 
feelings of loneliness and depression.  
 
Continued homelessness 
Thirteen of the young people (11 males and two females) remained homeless, that is, 
they continued to access emergency hostel accommodation, sleep rough or live in 
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other temporary or unstable situations. Nine were aged 19 years or under. Most had 
left school early, reported short-lived attempts at a return to education/training, had 
limited participation in the labour market and weak family ties. All had a history of drug 
misuse and two also reported heavy alcohol use; nine reported heroin use.  
 
Housing instability had a discernible impact on these young people’s drug-using 
behaviour. Moving between temporary living places brought them into contact with 
other drug users and also cultivated an acceptance of the use of ‘hard’ drugs. Their 
entry to adult hostels was a point of particular vulnerability owing, in large part, to the 
sense of despair many experienced at this juncture. Escalating drug consumption 
impacted on their physical and mental health, and negatively influenced their ability to 
maintain meaningful ties with society. A number had tried to address the matter of their 
drug consumption and several had sought treatment at some time.  
 
This research shows that there are pathways out of homelessness for young people 
whose contact with their families has remained strong; they receive support in 
accessing treatment for their substance use and in making the transition to supported 
living conditions. The research also shows that there are young people who remain 
trapped in homelessness and substance use. They tend to have weak ties with family, 
poor education skills and problems related to drug and alcohol use. Despite many 
making efforts to ‘get clean’, their experience of housing instability and exposure to 
adult hostels and the street drug scene can elevate the risk of them escalating their 
substance use and continuing to be homeless.  
 
Drug use in new communities  
 
The third in a series of three research reports commissioned by the Western Region 
Drugs Task Force (WRDTF) explored substance use among new communities in the 
west of Ireland and identified barriers to effective use of services (Kelly, C. et al. 2009). 
New communities include migrant workers, refugees, asylum seekers, and migrants 
who have been granted citizenship. At the time of the 2006 census, there were 48,387 
non-nationals living in the west of Ireland.  
 
The authors stated that members of new communities in Ireland came from countries 
where the rates of substance use among adults were generally lower than in this 
country. They noted that Irish research and informal reports from service providers 
suggested that migrant workers and refugees and asylum seekers were not accessing 
health services in Ireland because of the high cost of these services, lack of insurance, 
unfamiliarity with the health system and poor English language skills.  
 
The authors reported that risk factors for substance use in new communities were 
generally the same as those in other communities, and included mental health issues, 
social isolation, poor education levels and unemployment. For some members of new 
communities, post-traumatic stress disorder could interact with experiences of 
discrimination and social exclusion to increase the risk of substance use. Other factors 
included the strain of being undocumented, having illegal status, and anxiety about 
being discovered. Having limited access to medical services except in the case of an 
emergency could impede access to frontline services such as GPs where substance 
use might be identified as a problem and treated early.  
 
According to this report, adolescents in new communities could experience isolation 
owing to low levels of supportive peer relationships in school. Additional strain could 
occur when these young people learned new language and cultural practices reflecting 
the norms of the indigenous population. This might result in a clash with the value 
system and cultural practices of their family. Taken together, these factors could 
increase the risk of substance use among young people as they tried to fit in with the 
indigenous culture and deal with social isolation.   
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The authors interviewed by phone 18 statutory and voluntary groups involved in the 
support of new communities or the provision of substance use services in order to 
explore their perspective on substance use in these new communities. Almost all those 
contacted had no specific or specialist information on the issue, nor did their 
organisations have policies or strategies to address the issue.  
 
This research included an analysis of regional press coverage of substance use issues 
in the west, and particularly in new communities, between 8 and 14 December 2008. 
The results suggested that there was more media interest in alcohol-related issues 
than in other drug issues and that there was more ambivalence about alcohol (which 
was presented as both potentially dangerous and positive and worthy of promotion) 
than other drugs (which were presented entirely negatively). Only five articles explicitly 
linked members of new communities and alcohol or other drugs, and just three of those 
cases concerned drug possession or public drunkenness. 
 
This report mentioned a small number of studies on appropriate responses to 
substance use in new communities. These were highlighted as potential ‘starting 
points’ for communication among service providers and, according to the authors, were 
‘in a sense pragmatic and in some cases “best guesstimates” of what could work’.  
 
The authors uncovered little evidence of substance use as a substantial problem, or 
one that required immediate action, among new communities in the west of Ireland. 
However, the reluctance of members of new communities to access health services 
suggested that the views of service providers as to the extent of substance use might 
not reflect the true situation in the communities. Alternative methods of collecting 
primary data, such as training people from new communities to undertake in-depth 
fieldwork, including interviews and observation, may yield a different picture to that 
conveyed here. A previous study using these methods found that heroin and cocaine 
use were becoming a problem among some sections of new communities in Ireland 
(Corr 2004).  
 
The Health Behaviour in School-Aged Children (HBSC) Specific sub-groups 
 
The second report of the 2006 Health Behaviour in School-Aged Children (HBSC) 
survey was published in 2008 (Molcho et al. 2008). The report dealt with four specific 
sub-groups: Travellers, immigrants, children with a disability/chronic illness and 
children from schools that had been designated as disadvantaged. The data were 
collected from a representative sample of primary and post-primary schools in Ireland 
as part of a cross-national study, in collaboration with the World Health Organization 
(WHO), to gain new insights and increase understanding of health-related issues in 
school-going children aged 10–17 years. The first three sub-groups were matched with 
a sub-group from the general population on socio-demographic characteristics for 
comparative purposes. The schools that had been designated as disadvantaged were 
matched with other schools for size, type and location.  
 
Children from the Traveller community 
Traveller students were more likely to report that they were current smokers, had drunk 
alcohol in the last month, had been ‘really drunk’ at least once in their lives and had 
used cannabis in the last 12 months (21%) compared to the matched group (12%). 
However, the number of children from the Traveller community in the total sample was 
small (n=233, 2%).  
 
Children from schools designated as disadvantaged 
Boys in disadvantaged schools were more likely to be current smokers and to have 
been ‘really drunk’ than were boys in the matched group. Boys in disadvantaged 
schools were less likely to report positive perceptions of school: fewer reported that 
they liked school, that students in their classes enjoyed being together, and that 
students in their classes were kind and helpful.  
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8.3 Social reintegration 
This section examines recent policy proposals to improve housing and accommodation 
for homeless people, including drug users, and presents recent information on 
education and training among people in drug treatment, and employment outcomes 
from the ROSIE study.  
 
8.3.1 Housing 
The Comptroller and Auditor General (CAG) recently undertook an examination of the 
publicly-funded treatment and rehabilitation services for people with drug addictions 
(Comptroller and Auditor General and Department of Community Rural and Gaeltacht 
Affairs 2009). The report looked at the current and future provision of accommodation 
and related services for drug users within the overall framework of the 2001–2008 
national drugs strategy. It noted that responsibility for providing accommodation 
services for drug users was shared between the local authorities, responsible for 
providing accommodation, and the Health Service Executive (HSE), which is 
responsible for providing health and social care services. The report included a 
recommendation that separate accommodation be provided for drug users in treatment 
and for those who have completed treatment and wish to pursue a drug-free lifestyle; 
this would support recovering drug users by reducing the risk of relapse. The report 
highlighted the role of step-down facilities in this regard and noted that the HSE funded 
29 step-down beds for people recovering from drug addiction. It also noted that 
demand for accommodation places for recovering drug users far exceeded the number 
of beds available.  
 
An evaluation of one of the HSE step-down projects showed the positive outcomes that 
can be achieved by recovering drug users (Juniper Consulting 2008). Of 12 former 
clients who completed the programme, six were living independently, two were living 
with a family member or a partner and four were living in further transitional housing. 
Self-reporting by these clients and their key workers suggested that they were no 
longer abusing drugs and were in education, training and employment. The provision of 
step-down facilities is clearly beneficial for some recovering drug users. This report 
highlighted the importance of collecting data on the percentage of people using step-
down facilities who progress to independent living. It called for the national monitoring 
of waiting times for access to transitional or long-term accommodation by those 
undergoing rehabilitation.  
 
The importance of providing accommodation for homeless people with drug problems 
was highlighted by the Steering Group established to develop the strategy 2009-2016. 
The provision of appropriate housing was seen as the critical need that must be 
addressed if treatment and rehabilitation services were to achieve sustained successful 
outcomes among this cohort (Department of Community Rural and Gaeltacht Affairs 
2009): para. 4.98.  
 
The Steering Group did not discuss the issue of accommodation for drug users in any 
depth and there is no evidence of building on the work of the CAG’s report mentioned 
above. However, it did list as a priority the implementation of the recommendations of 
the report of the Working Group on Drugs Rehabilitation (Working Group on Drugs 
Rehabilitation 2007). One of the recommendations of this Working Group was that local 
authorities and drug treatment services should work together to identify and provide a 
range of accommodation supports for recovering drug users  
 
The Steering Group proposed that the recommendations of the Working Group on 
Rehabilitation be incorporated into a comprehensive integrated national treatment and 
rehabilitation service using a four-tier model approach similar to that used in the United 
Kingdom. However, the UK model is a mix of generic and specialist addiction and 
mental health interventions provided in a range of settings targeting drug users and 
their families. It does not make explicit how the accommodation needs of drug users 
can be addressed.  
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A recurring theme in the reports mentioned above is the need to build on and develop 
existing examples of inter-agency working to provide a coherent package of services to 
recovering drug users, including accommodation supports. The Homeless Agency has 
been identified as a key player in this regard and it has been instrumental in developing 
a strategic response to tackle the overall problem of homelessness in Dublin. The 
Department of the Environment, Heritage and Local Government (DEHLG) and the 
HSE jointly fund the non-statutory Homeless Agency to plan, manage and co-ordinate 
services to tackle homelessness in the Dublin area. The Agency undertook a 
comprehensive review of the problem and of responses, and made a detailed 
submission to government that included a number of recommendations for action 
within the overall implementation of the new national strategy on homelessness, The 
way home (Department of the Environment Heritage and Local Government 2008). The 
submission is referred to as ‘a new blueprint for change’ and is about creating the 
conditions for change to realise the aim of eliminating long-term homelessness and the 
need to sleep rough in Dublin; it was included in a recently-published evaluation of 
homeless services (Brooke and Associates 2008). 
 
As part of the evaluation of homeless services, the Homeless Agency administered a 
needs survey to homeless people using services in order to assess their long-term 
accommodation needs. The results showed that, of the 1,531 homeless households 
that completed the survey, 1,049 (69%) needed mainstream housing with either no 
support (259, 17%), short-term support (391, 26%), or long-term support (399, 26%); 
449 (29%) required residential supported housing with varying degrees of support. 
According to the Agency, this finding ran counter to the frequently expressed view that 
most homeless people need long-term high-support residential accommodation. In 
addition, the Homeless Agency stated that the unit costs of mainstream housing with 
housing support were considerably lower than the unit costs of supported housing. 
According to the Agency, the high percentage of households that were assessed as 
requiring mainstream housing rather than supported housing strongly supported a 
‘housing first’ approach (Brooke and Associates 2008). 
 
The findings from the evaluation of homeless services and a review of the international 
literature on effective responses to the problem of homelessness form the basis of a 
reorientation of homeless services towards a ‘pathways to housing’ approach. This 
approach, also known as the ‘housing first’ policy, was designed to end homelessness 
and improve overall well-being among homeless people with concurrent mental health 
and addiction needs in New York City. The housing first policy contends that homeless 
people with high-risk needs are entitled to be accommodated first, without having to 
meet criteria such as being sober and clean. This runs contrary to the expectations of 
those who insist on sobriety-contingent and medication-contingent models of housing 
people. The evaluation report of the Homeless Agency cites a number of studies from 
the United States which compare the housing first approach with alternative 
approaches. The housing first approach consistently shows better outcomes for 
homeless people across a number of social and health variables; they retain 
accommodation and improve their overall health and social functioning.  
 
However, the Homeless Agency pointed out in its report that the housing first policy did 
not mean ‘housing only’: a variety of services were needed to promote housing stability 
and individual well-being, using means such as the assertive community treatment 
model or case management. These supports can be delivered to the majority of service 
users through an adapted ‘floating support’ model that is aimed at supporting people to 
retain their accommodation first and then address their other needs. In addition, the 
Agency stated that the housing first approach only works if affordable housing is 
available and accessible. One of the principal barriers to the resolution of 
homelessness in Ireland has been the lack of affordable housing.  
 
As part of the same Homeless Agency evaluation of services, 101 households that had 
experienced homelessness or were still in accommodation for the homeless were 
interviewed. The 101 households comprised 85 single people, one couple without 
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children, and 15 families with children (nine one-parent and six two-parent 
households). Thirty-five interviews with managers of homeless services in the Dublin 
area were also undertaken; these comprised seven statutory service workers and 28 
working in non-governmental organisations (NGOs). Six focus groups comprising staff 
from the services being evaluated were also undertaken.  
 
Four factors stood out as contributing to the single people interviewed becoming 
homeless: relationship and family breakdown (34 respondents), physical and mental 
health issues (20 respondents), alcohol issues (19 respondents), and drug issues (13 
respondents). A number of research studies undertaken in Ireland between 1999 and 
2006 had found that the same four factors had contributed to people becoming 
homeless in the first instance (Keane 2007). 
 
Among the families interviewed, drug issues (five families), relationship breakdown 
(four families) and having to leave social or private rented accommodation (four 
families) stood out as the main reasons for initially becoming homeless.  
 
Sixty-six respondents, including nearly everyone who answered the question in the 
service user interview, said that homeless services staff, especially key workers, had 
been the main help in moving out of homelessness. This positive view of homeless 
service providers is complemented by service users’ views that friendly and helpful 
staff are among the best features of homeless services. 
 
In addition, 14 people mentioned their own personal motivation and concern for their 
dignity as the main driving force in their exiting homelessness, while nine respondents 
mentioned social workers, GPs and other health staff in this context. These responses  
were taken as demonstrations of the value of personal support to homeless individuals 
and families.  
 
Responses to questions about difficulties encountered in getting out of homelessness 
revealed four issues: lack of information about services (16 respondents), difficulty in 
accessing private rented accommodation (12 respondents), addiction to alcohol or 
drugs (11 respondents) and the stigma attached to being homeless (11 respondents). 
Respondents across the different homeless services (including emergency 
accommodation, private emergency accommodation, transitional housing and 
residential supported housing) also highlighted the problem of open drug use in these 
services. Over half of the 35 managers interviewed cited the lack of detoxification and 
rehabilitation services for those with either alcohol or drug addiction as the main 
obstacle to moving out of homelessness. The lack of housing and sustainable move-on 
options for homeless people and the lack of access to mental health services were also 
cited by managers as key obstacles to exiting homelessness.  
 
The views expressed by service users and providers in this evaluation of homeless 
services demonstrated that initial exposure to homelessness was brought about by a 
combination of personal and social factors that included addiction, mental health issues 
and the severing of ties with families. Homelessness and exposure to an active ‘drug 
scene’ in the vicinity of current services, combined with pre-existing addiction and 
mental health issues, can effectively trap people in homelessness. The presence of 
these factors in the lives of homeless people has traditionally been tackled while 
maintaining them in insecure accommodation. The shift to a housing first policy will 
help to reintegrate them while also addressing their other problems. This evaluation 
revealed that service users saw friendly and helpful staff as key motivating agents who 
can help effect major changes to their accommodation status. The housing first 
approach uses the skills of experienced and professional staff to implement key actions 
and, in this regard, the Homeless Agency has been to the forefront in developing a 
number of training and development programmes for staff working in the sector.  
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8.3.2 Education, training 
The ROSIE study of treatment outcomes found significant increases at one year and at 
three years in the number of participants undertaking training courses (Comiskey, 
Catherine M et al. 2009). At three years, 11% (40) of the participants were attending 
some sort of vocational training, 8% (30) were in placements under the community 
employment (CE) scheme, 8% (29) were attending a personal development and life 
skills course and 4% (15) were in further education. In many cases, these figures were 
more than double those reported at intake.  Although the numbers are small, the 
findings demonstrate that engaging in drug treatment can improve opportunities for 
vocational rehabilitation.  
 
The CE scheme for drug users operates through local projects primarily in LDTF areas 
and is sponsored by community and voluntary groups. FÁS, the national training and 
employment authority, provides funding for 1,000 places and the project sponsors are 
required to sign a service agreement that outlines the work programme and the target 
outcomes. The primary objective of CE is to prepare participants for entry into the 
active labour force, although in reality the outcomes outlined by most projects tend to 
be ‘softer’ than finding employment.  Outcomes include personal development, 
improved literacy skills and education capital, and supported progression to more 
specialised training and education. An evaluation of the scheme in 2004 revealed that 
for the majority of clients on CE placements, moving on to employment was not a 
realistic outcome; this was in part explained by the lack of focus on vocational 
development in the projects (Bruce 2004). 
 
Since the introduction of the special CE scheme there has been a constant shortfall in 
the uptake of places, and the latest figures show a decline in the number of places 
being used, from 90% in 2004 to 83% in 2007. The reasons for this decline are not 
clear and, as pointed out by the CAG, the decline ‘occurred at a time when the 
numbers in drug treatment were increasing’ (Comptroller and Auditor General and 
Department of Community Rural and Gaeltacht Affairs 2009). However, as the majority 
of CE places are available in projects in Dublin and a large part of the increase in the 
numbers presenting for drug treatment came from outside Dublin (where the number of 
CE places is much lower), the decline in uptake of places in Dublin remains to be 
explained.  
 
The recent review of the national drugs strategy 2001–2008 acknowledged the CE 
scheme for helping recovering drug users to develop their personal and employment 
skills and find a pathway back to work. The Steering Group that drafted the new 
national drugs strategy 2009–2016 proposed that the implementation of the Individual 
Learner Plan (ILP) would help to identify participants’ needs and design progression 
routes towards labour market reintegration.  The development of targeted programmes 
by FÁS was seen to be essential and should be an integral part of the national drugs 
strategy in the future, with a commitment to ensuring that such initiatives are available 
to recovering drug users in all parts of the country (Department of Community Rural 
and Gaeltacht Affairs 2009).  
 
8.3.3 Employment 
The Research Outcome Study in Ireland (ROSIE) (Comiskey, Catherine M et al. 2009) 
reported that the number of people currently employed increased significantly between 
intake and three-year follow-up, with figures rising from 16% (64) to 29% (102). The 
number of participants deemed ‘not working’ decreased from 43% (171) at intake to 
31% (109) at three years. Regarding main sources of income, the proportion reporting 
drug dealing and other crime as a main source of income had reduced significantly at 
one year and at three years in comparison to intake. Income from family/partner had 
also dropped significantly at one year, and at three years. Furthermore, the proportion 
of participants who reported social welfare as a main source of income was 
significantly smaller at three years than at one year. It is interesting to note that the 
proportion reporting a wage/salary as a main source of income was significantly higher 
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at three years than at intake and at one year.  These figures indicate that participants 
were becoming more self-sufficient.  
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9. Drug-related crime, prevention of drug-related crime and  
prison 
9.1 Introduction 
Until 2006, the principal source of information on drug offences was the annual reports 
of the Garda Síochána. In 2006, responsibility for reporting crime statistics was 
transferred to the Central Statistics Office (CSO). The CSO data are derived from the 
Garda Síochána computerised PULSE system (Police Using Leading Systems 
Effectively). The latest data available from the CSO is for 2007 (Central Statistics 
Office 2008) (Central Statistics Office 2009).  
 
The vast majority of drug offences reported come under one of three sections in the 
Misuse of Drugs Act (MDA) 1977: section 3 – possession of any controlled drug 
without due authorisation (simple possession); section 15 – possession of a controlled 
drug for the purpose of unlawful sale or supply (possession for sale or supply); and 
section 21 – obstructing the lawful exercise of a power conferred by the Act 
(obstruction). Other MDA offences regularly recorded relate to the importation of drugs 
(section 5), cultivation of cannabis plants (section 17) and the use of forged 
prescriptions (section 18).  
 
Driving under the influence of drugs has been a statutory offence in Ireland since the 
introduction of the 1961 Road Traffic Act. The principal legislation in this area is 
contained in the Road Traffic Acts 1961 to 2002. Section 10 of the Road Traffic Act 
1994 prohibits driving in a public place while a person is under the influence of an 
intoxicant to such an extent as to be incapable of having proper control of the vehicle. 
Intoxicants are defined as alcohol or drugs and any combination of drugs or of drugs 
and alcohol. Although penalties for driving under the influence of alcohol are graded 
according to the concentration of alcohol detected, the law does not set prohibited 
concentrations for drugs. Neither does it distinguish between legal and illegal drugs. 
Tests to identify the level of impairment can only take place where there is a 
reasonable suspicion that an offence is being committed. 
 
 
9.2 Drug-related crime 
9.2.1 Drug law offences 
Figures 9.2.1 and 9.2.2 show trends in proceedings for drug offences from 2003 to 
2007. As can be seen from Figure 9.2.1, criminal proceedings for the possession of 
drugs for personal use (simple possession) have more than doubled during this period. 
Proceedings for drug supply have increased marginally, from 1,715 proceedings in 
2003 to 2,654 in 2007. The upward trend in total drug offence proceedings during the 
five-year period is largely accounted for by the increase in simple possession offences. 
In 2007, of the total drug offences (n = 11,647), almost 72% were for simple 
possession.  
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2003 2004 2005 2006 2007
Total drug offences 5324 5798 8290 8924 11647
Drug possession for personal use 3276 3761 5864 6107 8352
Drug possession for supply 1715 1654 1983 2291 2654
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Figure  9.2.1  Trends in relevant legal proceedings for total drug offences, drug possession for personal use 
and for supply, 2003–2007 (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
Figure 9.2.2 shows trends in legal proceedings for a selection of other drug offences 
between 2003 and 2007.  The offence of obstructing the lawful exercise of a power 
conferred by the Misuse of Drugs Act (s21) clearly represents the largest category, 
with obstruction offences totalling more than the other offences combined in every 
year. Obstruction offences often involve an alleged offender resisting a drug search or 
an arrest or attempting to dispose of drugs to evade detection. Obstruction offences 
increased from 208 offences in 2003 to 407 in 2007, an increase of 96%. The number 
of other offences has remained low, with the offences of forging or altering a 
prescription and importation remaining relatively stable during the period. Since 2005, 
however, drug cultivation or manufacture offences have more than trebled, increasing 
from 29 offences in 2005 to 109 in 2007. 
 
2003 2004 2005 2006 2007
Obstruction 208 239 290 349 407
Forged/altered prescriptions 51 85 95 91 90
Cultivation or manufacture 50 32 29 54 109
Importation 24 27 29 32 35
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Figure  9.2.2 Trends in relevant legal proceedings for selected drug offences, 2003–2007 (Central Statistics 
Office 2008) (Central Statistics Office 2009) 
 
Figure  9.2.3 shows trends in proceedings for possession of cannabis-type substances 
relative to proceedings for possession of all drug types from 2003 to 2007. In every 
year except 2006, cannabis-related proceedings represented more than 50% of the 
total of all drug types.  
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2003 2004 2005 2006 2007
All substances 9035 9363 13059 14001 17539
Cannabis-type substances 4805 4943 7750 6947 9126
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Figure  9.2.3 Trends in proceedings for possession of all drug types and cannabis-type substances, 2003–2007 
(Central Statistics Office 2008) (Central Statistics Office 2009) 
 
Figure 9.2.4 shows trends in proceedings for possession by drug type for a selection of 
drugs excluding cannabis. In 2006, the number of cocaine-related proceedings 
exceeded heroin-related proceedings for the first time. In 2007, the number of heroin-
related proceedings again overtook cocaine-related prosecutions but only marginally. 
Prosecutions for possession of both heroin and cocaine have continued their upward 
trend since 2003. Ecstasy-related proceedings have also continued to rise since 2005, 
following a slight decline since 2003.  
2003 2004 2005 2006 2007
Ecstasy-type substance* 1529 1331 1105 1499 1800
Cocaine 1015 1348 1967 2442 2878
Heroin 995 1201 1601 2364 3113
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Figure  9.2.4 Trends in proceedings for possession of a selection of drugs, 2003–2007 (Central Statistics Office 
2009). 
*Also contains MDMA, DMEA, DOB and methylamphetamine 
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Drugs and driving 
2003 2004 2005 2006 2007
Number of prosecutions 51 51 70 70 197
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Figure  9.2.5 Trend in prosecutions for driving/in charge of a vehicle while under the influence of drugs, 2003–
2007  (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
Figure 9.2.5 shows the trend in prosecutions for driving under the influence of drugs 
(DUID) between 2003 and 2007. Between 2003 and 2007 the number of prosecutions 
for DUID increased slightly from 51 in 2003 to 70 in 2006. In the following year there 
was a marked increase in DUID prosecutions, up to 197 prosecutions, a growth of 
almost 60%. It is unclear why this increase occurred in 2007. It could possibly reflect an 
increase in targeted police activity in this area. 
 
9.2.2 Other drug-related crime 
 
Drug-related intimidation of drug users and their families 
 
In early 2009 the Family Support Network (FSN) published the findings of research into 
the issue of intimidation of the families of drug users by those involved in drug dealing 
(O'Leary 2009).7 Through its work with families the FSN became aware of a large 
number of families experiencing intimidation by drug dealers as a result of a family 
member’s drug-related debts. The research consisted of a postal survey of 91 family 
support workers or facilitators. The response rate for the survey was 55%. 
 
 A general finding of the research was that no locality or region that responded was 
untouched by intimidation. Nearly all family support services indicated that their clients, 
mostly family members of drug users, had experienced debt-related intimidation. About 
35% of the cases of intimidation related to debts of between €100 and €500. The 
largest debts were between €10,000 and €20,000; one case involved €60,000. Many of 
those in debt belonged to families surviving on very low incomes and families were 
often only given days to repay the debt. Drug users themselves often resorted to 
criminal activity to repay debts to dealers. Many agreed to deal drugs themselves or to 
hide, hold or transport drugs for the dealer to whom they owed money. Others engaged 
in violent activity, including murder in one case, as a method of repayment. Other 
violent activity included the holding or concealment of firearms on behalf of the drug 
dealer. Many female drug users engaged in prostitution to repay their debts.  
 
Respondents were asked to list the types of intimidation experienced by families they 
encountered. These included verbal threats, physical violence and damage to their 
home or other property. In seven cases individual family members had experienced 
sexual violence or threats of such violence. Of 112 cases of intimidation reported, in 35 
                                                
7 The FSN was established in 2000 to support the development of family support groups throughout 
Ireland. There are currently over 70 family support groups affiliated to the FSN. 
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cases mothers were the target. The next highest category was the siblings of drug 
users (23 cases), fathers (21 cases), grandparents and children (17 cases) and 
partners and others (10 cases).  
 
The report identified a number of issues complicating both the impact of intimidation 
and the responses available to families. As a person working for the dealer normally 
collects the debt, it is not always easy for families to know to whom the money is owed 
or whether the money is being given to the correct person. Whether or not the 
intimidation stops is an important factor considered by a family when deciding whether 
or not to pay a debt as ‘many families are caught in a recurrent cycle of debt, 
intimidation, repayment and further debt, (p. 22). Fear often stems from knowledge of 
the perpetrators and their capacity to follow through on threats. Fifty-one per cent of 
respondents stated that sometimes threats were carried out, 33% stated that threats 
were always carried out and 4% said they were never carried out. 
 
Table 9.2.2 shows the various ways that families source money to pay a debt on behalf 
of a family member. In the case of social welfare payments, including children’s 
allowances and disability payments, in some cases intimidators waited outside social 
welfare offices on collection days to collect the debt. 
 
Table 9.2.2 Sources of funds used by families to pay a drug debt 
Funding sources No. of cases % 
Salary/wages 25 50 
Credit union loan 36 72 
Bank loan 9 18 
Money lender 21 42 
Re-mortgage home 11 22 
Selling personal property 17 34 
Social welfare payments 22 44 
Borrowing from family/friends 33 66 
Other 3 6 
Not applicable 6 12 
Total 183 N/A 
 Source: (O'Leary 2009) p 23 
 
The study also identified a number of themes through a case study analysis of reported 
incidents of intimidation. These included the following: 
° Threatening behaviour included verbal threats, intimidation at the workplace, 
harassment, death threats, threats of shooting, beatings or ‘knee-capping’, and live 
bullets posted through letter boxes. 
° Personal property - houses and cars vandalised and burnt out. 
° Physical violence included two drug users murdered, one user carried out a murder 
because of a debt owed, shootings through doors and windows of family home, 
hospitalisation due to beatings, burning of a drug user. 
° Physical/sexual violence against women included drug users and partners forced 
into prostitution to protect family from violence, two minors less than 18 years of 
age forced into prostitution, one dealer threatened to rape daughter of a drug user. 
° Fear in the community of reprisal from drug dealers prevented them from raising 
awareness of the issue. 
° Children might be encouraged by dealers to deal to friends or other children so as 
to create debt and force them into further dealing; they were often present when 
family members were beaten; and their mothers may be engaged in prostitution in 
the family home as a means of debt repayment. 
° Garda reaction - family members too fearful to approach gardaí in relation to 
intimidation; many believed gardaí powerless to act; in one case gardaí advised 
family to pay the debt, while in another they provided protective custody to a family 
and a drug user. 
° Women -  perpetrators of intimidation targeted female drug users for debt 
repayment, and they were also forced, either directly or indirectly, into prostitution; 
a high proportion of families targeted were headed by a female lone parent; 
average weekly earnings of females were significantly less than their male 
counterparts and women were more likely to be out of the workforce; women often 
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concealed intimidation and payment from their husbands/partners owing to fear that 
they might not be willing to pay.  
° Forced emigration - in many cases drug users had been forced to move or emigrate 
and were unable to return home. 
 
The report concluded with a series of recommendations. The need to incorporate the 
issue of intimidation of families in the National Drugs Strategy 2009-2016 was 
highlighted. The report also called for a pilot initiative to be established whereby the 
gardaí would identify a member of staff to liaise with families experiencing intimidation. 
A safe reporting and advice provision procedure for families willing to report the issue 
was also called for. The report recommended that gardaí needed closer liaison with 
local family support services. Ways of addressing the fear of reprisal of those willing to 
pursue the issue of intimidation through the legal system also needed to be put in 
place. The report concluded that other initiatives that would enable community 
members to work together to tackle the fear they experience in their locality should also 
be investigated. 
 
 
9.3 Prevention of drug-related crime 
9.3.1 Addressing crime and anti-social behaviour in Limerick 
 
The Fitzgerald Report submitted to the Cabinet Committee on Social Inclusion 
addressed social exclusion, crime and disorder issues in the Moyross and Southill 
communities and other disadvantaged areas in Limerick city (Fitzgerald 2007). The 
report advocated a strategic response including:  
° interventions to address the issue of serious criminality;  
° economic and infrastructural regeneration; and 
° co-ordination between local authorities, gardaí and community and voluntary sector 
agencies to tackle entrenched disadvantage. 
 
The report used evidence from a variety of sources which highlighted the decreasing 
quality of life in these communities. In particular, it pointed to statistics compiled by the 
CSO indicating that these areas ‘are among the most deprived in the country’ (p. 5). 
Additional evidence collected by the author and his team indicated that members of 
these communities had suffered violent intimidation and damage to personal and 
council property from so-called ‘criminal elements’. Other concerns included the 
number of young people involved in anti-social behaviour and drug distribution. 
 
The report emphasised that economic and social regeneration could not happen 
without ‘intensive policing arrangements’ (p. 8). It stated that ‘dealing with the serious 
(although relatively small in number) criminal elements … will be fundamental to 
creating the conditions for real progress to be achieved on all other fronts’ (p. 6). This 
policing initiative should occur in the context of a five-year programme, the objective of 
which should be to ‘normalise and stabilise these areas’ (p. 8). Specific 
recommendations included: 
° targeting the assets of criminals by establishing a local Criminal Assets Bureau 
operation;  
° maintaining a highly visible Garda presence in the area, which would involve 
dedicating up to 100 gardaí to these communities to restore public order and deal 
with criminal activity; 
° empowering Limerick City Council to evict tenants involved in criminal or anti-social 
behaviour. 
 
It was proposed that two new geographically-defined development agencies (Limerick 
Southside and Limerick Northside) be established to co-ordinate the delivery of 
economic and social regeneration. With these structures in place, the report 
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recommended a number of economic and social initiatives to address disadvantage, 
including: 
° the attraction of commercial investment into these communities via fiscal incentive 
schemes;  
° the development of transport infrastructure and access to these communities; 
° the total regeneration of housing stock in these estates, including a mix of social 
and private housing.  
 
It was recommended that special teams be established to co-ordinate the efforts of 
existing bodies to provide intensive and targeted interventions to local residents and 
families. These teams would be multi-disciplinary and include educational welfare 
officers, family support workers, local drugs taskforce and HSE representatives and 
community gardaí. Particular emphasis was to be placed on the provision of activities 
and amenities for young people in the evenings and summer holidays. 
 
In terms of drug abuse, Limerick city currently falls within the remit of the Mid-Western 
Regional Drugs Task Force. However, the report recommended that Limerick city 
would  benefit from local intervention initiatives including prevention and education 
initiatives, given that ‘the problems of drug abuse in Limerick city are particularly acute’ 
(p. 12).  
 
In October 2008, following a process of consultation with a range of stakeholders, the 
Limerick Regeneration Agencies launched their regeneration plan to implement the 
recommendations of the Fitzgerald report (Limerick Regeneration Agencies 2008). The 
plan identifies three key ‘pillars’ – social regeneration, economic regeneration and 
physical regeneration – around which the entire plan will be built.  
 
° Social regeneration is identified as the most important of these pillars. The pillar is 
broken down into four parts: education, children, youth and family support, health 
and people and neighbourhoods.  
° The economic regeneration pillar seeks to address the serious unemployment 
levels in the area.  
° The physical regeneration element seeks to radically reform the appearance and 
physical environment of the area.  
 
The regeneration agencies intend to put in place an ongoing assessment of risks 
relating to the implementation of the plan and incorporate these into an annual report. 
This will be aligned with an evaluation process which will produce a comprehensive 
and clear relevant set of benchmarking data. Included in the data for the social 
objectives will be participation in education, health status and participation in sport. The 
proposed timeline for the programme is 2009 to 2018. 
 
9.3.2 Drug treatment and crime 
Research Outcome Study in Ireland (ROSIE) 
 
In October 2008 the National Advisory Committee on Drugs published a summary of 
opiate treatment outcomes at one year and at three years after entry to treatment 
(Comiskey, C. et al. 2008). At baseline, the 404 opiate users recruited to the study 
were entering treatment for the first time, or were returning to treatment after a period 
of absence, at any one of 54 services nationwide. Of these 404 individuals, 289 
completed all three interviews – at baseline (2003/4), at one year (2004/5) and at three 
years (2006/7). These individuals (the per-protocol population) were asked the same 
questions at the three time points. The interview schedule examined key outcome 
measures, including: 
° drug use in the 90 days preceding the interview – specifically, type, frequency, 
quantity and cost; 
° measures of harmful practices and consequences; and 
  144
° social functioning, including accommodation, employment, and involvement in 
crime. 
 
The proportion of participants who reported using heroin in the 90 days preceding data 
collection fell from 81% at intake to 47% at one year, and was sustained at 47% at 
three years. The average frequency of heroin use in a 90-day period reduced from 42 
out of 90 days at intake to 15 out of 90 days at one year, but increased to 20 out of 90 
days at three years. The average quantity of heroin consumed each day over a 90-day 
period decreased from 0.9 grams at intake to 0.3 grams at one year, and this lower 
consumption rate was sustained at three years. There was a corresponding reduction 
in the average amount spent on heroin on a typical day, from €75 at intake to €24 at 
one year; the average spend at three years was not reported.  
 
The proportion of participants who reported involvement in acquisitive crime decreased 
from 31% at intake to 14% at one year and this decrease was sustained at three years. 
In addition, the proportion who reported selling or supplying drugs reduced from 31% at 
intake to 11% at one year and this decrease was sustained at three years.  
 
 
9.4 Interventions in the criminal justice system 
Dial to Stop Drug Dealing  
 
In September 2008 the Dial to Stop Drug Dealing campaign was launched. Individuals 
and communities affected by drug dealing were urged to pass on information relating to 
drug dealing in their local communities by dialling a confidential telephone number. 
Individual names or numbers were to be neither requested nor recorded. Calls were to 
be routed to call centres staffed by non-locals, separate from Garda stations. All 
information was to be passed on to the Garda Síochána.  
 
The campaign was funded by the Dormant Accounts Fund, the Department of 
Community, Rural and Gaeltacht Affairs and the Department of Justice at a total cost of 
€450,000 for a three-phase campaign over nine months. Phase one ran from 1 
November 2008 in communities in the areas of Tallaght Local Drugs Task Force 
(LDTF), Blanchardstown LDTF, South West Regional DTF, North Inner City LDTF, and 
Dublin North East LDTF. In the second phase, rolled out in January 2009, the initiative 
was promoted throughout the country. It was strongly emphasised that, though the 
initiative would be promoted only within the Greater Dublin Area initially, all calls would 
be answered regardless of location and all information would be passed on to the 
Garda Síochána. 
 
The project had already reported success in Blanchardstown LDTF where it was 
launched in 2006 as a part of the Blanchardstown LDTF’s supply reduction programme 
(Connolly, Johnny 2006b). An evaluation of the Blanchardstown pilot initiative revealed 
that over 296 calls were received over the six-week period, over two-thirds of which 
were regarded as useful by the Garda Síochána. The website for the initiative can be 
found at http://www.dialtostopdrugdealing.ie 
 
In June 2009, in response to questions in Dáil Éireann, John Curran TD, minister for 
State with special responsibility for the Drugs Strategy, stated that, owing to financial 
constraints, the initiative was soon to come to an end. He described the impact the 
initiative had had:  
 
‘Overall, the campaign has proved to be very successful. To date, there have 
been in excess of 3,300 calls to the phone-line that have generated over 920 
information reports to the Gardaí. It should also be noted that from the outset 
the Dial-to-Stop Drug Dealing Campaign was to run over a discrete period of 
time. This was based on the findings from the initial pilot project in 
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Blanchardstown which found that the vast majority of calls were received early 
in the campaign following its launch.’ (Curran 2009, 17 June) 
 
In September 2009, however, in his speech to launch the National Drug Strategy 
2009–2016, Minister Curran stated that the scheme was to be extended. This was, he 
said, because ‘the initiative has proven its worth and has been lauded by many’ 
(Curran 2009, 10 September).  
 
Customs activity 
 
Customs drugs law enforcement reports a range of activities undertaken during the 
reporting year (CDLE personal communication, July 2009). These include: 
° Continued participation in MAOC-N, the maritime analysis and operation 
centre based in Lisbon  
° Acquisition of a second customs cutter in 2009 
° Acquisition of an additional scanner for scanning large containers 
° One new dog handler and one new detector drug dog to be added to the dog unit 
during 2009 
 
Operation Resolute is a joint Customs and Garda Síochána project aimed at building 
up intelligence on organised crime groups. The initial pilot phase of the operation was 
conducted in selected locations throughout the country. The operation was regarded as 
highly successful by both agencies. Revenue now plan to extend this operation 
nationwide. 
 
9.4.1 Alternatives to prison 
The Irish Drug Treatment Court  (DTC) was established in Dublin in 2001on a pilot 
basis. A recent report by the Comptroller and Auditor General has highlighted the low 
number of offenders progressing through the court (Comptroller and Auditor General 
and Department of Community Rural and Gaeltacht Affairs 2009). When the DTC was 
established, it was envisaged that it would handle around 100 cases during the 12-
month pilot period. In practice, 37 offenders were admitted to the programme during 
the pilot. From January 2001 to July 2008, an average of 22 offenders a year were 
admitted to the programme, just over one fifth of the initial annual target. The 
Department of Justice, Equality and Law Reform is currently examining the DTC to 
determine the reasons behind the relatively low numbers of persons being dealt with in 
the court and to consider if measures can be taken to improve its operation. This 
review will determine whether a further expansion of the court will take place. 
 
9.4.2 Other interventions in the criminal justice system 
Community policing 
 
Pilot Joint Policing Committees (JPCs) have been established under the provisions of 
the Garda Síochána Act 2005 (Connolly, Johnny 2006a). JPCs bring together public 
representatives, representatives of local authorities, the Garda Síochána and 
representatives of the voluntary and community sector to assess levels of crime and 
anti-social behaviour, including that related to alcohol use and illicit drug use, and to 
make recommendations as to how to prevent and address such problems. The JPC 
pilot was evaluated in early 2008 and final guidelines were issued to enable the 
establishment of JPCs in all local authority areas throughout the state. Further 
guidelines are due to be published in the latter half of 2009 enabling the establishment 
of Local Policing Fora in local drug task force areas as provided for in Action 11 of the 
National Drugs Strategy 2001–2008. 
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9.5 Drug use and problem drug use in prisons 
Supply control 
 
The Irish Prison Service (IPS) annual report for 2007 detailed developments in drug 
supply reduction measures in Irish prisons (Irish Prison Service 2008a).  
 
Section 36 of the Prisons Act 2007, which came into operation in May 2007, makes it 
an offence for prisoners to have unauthorised possession or use of mobile phones. 
Phones are viewed by the prison authorities and the Garda Síochána as contributing to 
illegal activity outside the prison. It is reported that by the end of 2007 more than 2,124 
mobile phones had been seized in Irish prisons.   
 
Other supply reduction measures reported included: 
° new prison visiting arrangements whereby only identified and known persons are 
allowed to visit prisoners, ‘reducing the likelihood of visitors attempting to pass 
drugs, and of prisoners being coerced into receiving visits from persons not known 
to them to facilitate the passing of drugs’ (p.25); 
° enhanced perimeter security involving improved netting and closer co-operation 
with the Garda Síochána to arrest and prosecute persons attempting to convey 
drugs into prisons; 
° improved technology for searching cells and prison property; 
° the introduction of drug detection dogs; 
° the establishment of an Operational Support Group dedicated to developing 
expertise in searching and intelligence gathering. 
 
9.6 Responses to drug-related health issues in prisons (and other 
custodial settings) 
According to the IPS annual report for 2007, sentenced committals for drug offences 
increased by 34%, from 395 (6.5% of total offences) in 2006 to 530 (8.2% of total 
offences) in 2007.  These figures do not include people who were imprisoned for drug-
related offences, such as economic acquisitive crimes committed to support a drug 
habit. Given the clear link between drug use and economically-motivated crime, it may 
be assumed that many of those imprisoned for property offences were problematic 
drug users. Of the 530 offenders sentenced for drug offences in 2006, 267 received 
prison sentences of up to one year, 241 received sentences from one to 10 years and 
22 received sentences of more than 10 years 
 
9.6.1 Drug treatment 
The IPS annual report for 2007 described developments in rehabilitation and treatment 
services for prisoners during 2007. Measures advanced during 2007 to enhance drug 
rehabilitation included the awarding of a contract for the provision of addiction 
counsellor services, and the allocation of additional nurse officers and prison officers to 
dedicated drug treatment teams. 
 
The IPS also reported that ‘Considerable work was undertaken during the year in 
consultation with practitioners at local prison level to draft a Drug Treatment Clinical 
Policy document to provide guidance to practitioners regarding various clinical issues 
that may arise in treating addiction in a prison context’ (p. 26). 
 
As shown in Table 9.6.1, nine prisons provided methadone substitution treatment to 
1,840 prisoners in 2007, of whom 185 were receiving methadone for the first time. It is 
noteworthy that methadone treatment was not provided in two large prisons, namely 
Cork and Castlerea. 
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Table 9.6.1   Numbers of individuals receiving methadone treatment* in Irish prisons in 2007 
Prison Total patients 
during 2007 
New patients in 2007 Patients  at  
31 December 2007 
Cloverhill Prison 710 124 176 
Dochas Centre 225 26 38 
Limerick Prison 10 0 3 
Midlands Prison 90 8 30 
Mountjoy Main Prison 474 9 112 
Mountjoy Prison Medical Unit 120 8 53 
Portlaoise Prison 3 1 1 
St Patrick’s Institution 15 0 6 
Wheatfield Prison 193 9 90 
Total  1840 185 509 
*Methadone treatment in this context is either substitution or detoxification. 
Source: (Irish Prison Service 2008a) 
 
9.6.2 Prevention and reduction of drug-related harm 
In 2007, the allocation of additional nurse officers and prison officers were allocated to 
dedicated drug treatment teams. 
 
The IPS also reported that ‘Considerable work was undertaken during the year in 
consultation with practitioners at local prison level to draft a Drug Treatment Clinical 
Policy document to provide guidance to practitioners regarding various clinical issues 
that may arise in treating addiction in a prison context’ (p. 26). 
 
9.6.3 Prevention, treatment and care of infectious diseases 
 
No new Information available. 
 
9.6.4 Prevention of overdose-risk upon prison release 
The  IPS annual report for 2007 also stated that funding was provided to community 
groups to provide addiction counselling and support to prisoners while in prison and on 
their release in the community. 
 
 
9.7 Reintegration of drug users after release from prison 
Numerous studies in Ireland have shown that problematic drug users tend to have high 
rates of prison recidivism (Connolly, J. 2006). The first detailed study into prison 
recidivism was conducted by the Institute of Criminology at University College Dublin 
(O'Donnell, I. et al. 2007). The geographical distribution of prisoners released in 2004 
was mapped to set out what is known about the community contexts from which 
prisoners are drawn and to which they are likely to return. The research was conducted 
using data from the new IPS computer-based records system, Prison Records 
Information System (PRIS), to track and map the known addresses of 5,057 prisoners 
(out of a possible 5,588) who were released in 2004. Although the study focused not 
only on drug-related offenders, some of its findings highlighted the links between 
problematic drug use, crime and recidivism. 
 
Method of mapping  
The known addresses of released prisoners were coded to the appropriate electoral 
division (ED) and these divisions were assigned a social deprivation rating according to 
a deprivation index. This index was computed using census data relating to 
unemployment, car ownership, overcrowding, local authority housing and social class. 
A further analytic dimension was provided by the calculation of a standardised prisoner 
ratio for each ED. This is the ratio of the observed number of prisoners in an ED to the 
expected number, given the age and gender profile of the ED population.  
 
Findings of the research 
More than 25% of offenders are re-incarcerated within 12 months of release and 
approximately 50% within four years. The most deprived areas in the country had 
145.9 prisoners per 10,000 population, compared to 6.3 in the least deprived areas. 
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The authors stated that ‘the magnitude of this difference is startling and demonstrates 
unequivocally that it is the areas already marked by serious disadvantage that must 
bear the brunt of social problems that accompany released prisoners’ (p. 4). Most 
prisoners came from city areas – 28.6 per 10,000 population overall, compared to 6.3 
from rural areas. Thirty-eight per cent of prisoners released in 2004 had Dublin 
addresses. The following Dublin suburbs had high standardised prisoner ratios for all 
crime sub-categories: Finglas, Ballymun and Darndale on the north side of the city; 
Fettercairn and Jobstown in Tallaght; Cherry Orchard, Rowlagh, Moorfield, 
Palmerstown and Mulhuddart in the south west; Summerhill, Ballybough and Sherriff 
Street in the north inner city; and Dolphin’s Barn, the Coombe and the Liberties in the 
south inner city. Deprived suburban areas in Cork, Limerick and Galway also had 
higher prisoner ratios. However, a number of very deprived areas did not have any 
prisoners, particularly in Donegal, Kerry, Galway and Mayo. 
 
Drugs and deprivation 
This study clearly highlights the link between drugs and poverty: in the most deprived 
areas there were 57.8 prisoners per 10,000 released after serving a sentence for a 
drug-related crime, compared to 1.8 in the least deprived areas. In terms of the 
geographic distribution of drug-related crime, Dublin, followed by the mid-west region 
(Clare, Limerick and North Tipperary) was more likely to have higher numbers of 
prisoners convicted for drug-related crimes. While the distribution of violent offenders in 
Dublin was spread evenly between the suburbs and the inner city, prisoners serving a 
sentence for drug offences and, to a lesser degree, for property offences were more 
likely to come from the inner city than the suburbs. 
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10. Drug Markets 
10.1 Introduction 
There is no systematic, comprehensive information available on illicit drug markets in 
Ireland. However, new research relating to Irish drug markets is described in this 
chapter. Data published by the Central Statistics Office (CSO) also assists us in 
understanding aspects of the operation of the illicit drug market in Ireland (Central 
Statistics Office 2008) (Central Statistics Office 2009). This chapter also reports on 
drug seizures by Customs Drug Law Enforcement and the Garda Síochána. 
 
 
10.2 Availability and supply 
10.2.1 Perceived availability of drugs, exposure and access to drugs 
The third bulletin of results from the 2006/7 all-Ireland general population drug 
prevalence survey (National Advisory Committee on Drugs and Drug and Alcohol 
Information and Research Unit 2008c) (a follow-on from the first survey in 2002/3) 
focused on cannabis use in the adult population (15–64 years) and patterns of 
cannabis use. The majority (62%) of recent cannabis users considered it ‘very easy’ or 
‘fairly easy’ to obtain the drug within a 24-hour period. Over half (57%) reported 
obtaining the cannabis they had last used at the house of friends, 12% obtained it in 
the street/park, 8% in a disco/bar/club and 5% ordered it by phone. The majority (44%) 
got the cannabis they had last used from a family member or friend, 28% had shared it 
among friends and 22% had bought it. 
 
The fourth bulletin of results from the 2006 all-Ireland general population drug 
prevalence survey (National Advisory Committee on Drugs and Drug and Alcohol 
Information and Research Unit 2008b) focused on cocaine use in the adult population 
(15–64 years) and patterns of cocaine use. Of the 79 recent cocaine powder users, 
only 9% obtained their cocaine from a person who was not known to them. Cocaine 
powder was most commonly obtained at the home of a friend (43%) or at a disco, bar 
or club (36%). Almost two-thirds of recent cocaine powder users said that cocaine 
powder was easy to obtain within a 24-hour period. 
 
The latest issue of European Addiction Research contains a paper on illicit methadone 
use and abuse among young people accessing treatment for opiate dependence in 
Ireland (Roche, A. et al. 2008). Despite strict controls, 73% of participants reported that 
illicit methadone was easy to obtain. The most commonly listed marketplace was 
outside the treatment clinic, while other locations included the participants’ local areas, 
the quays, and outside city-centre train stations. Of those buying methadone, 42% 
reported having a regular source. The majority of participants (82%) reported the 
supplier as someone on a methadone maintenance programme. The vast majority 
(93%) of participants who had received their methadone prescription as take-aways in 
the past reported being asked to sell it on; only 6% reported having done so. 
 
The fourth European School Survey Project on Alcohol and Other Drugs (ESPAD), 
published on 26 March 2009 (Hibell, B et al. 2009), gave some indication of perceived 
availability of some illicit substances. In response to the question “How difficult do you 
think it would be for you to get each of the following (cannabis, amphetamine, 
ecstasy)?”, 43% of Irish students said marijuana or hashish would be ‘fairly easy’ or 
‘very easy’ to obtain, 25% said the same for amphetamine (ESPAD average 15%) and 
31% for ecstasy (ESPAD average 18%).  
  
10.2.2 Drugs origin: national production versus imported 
The origins of drugs vary according to drug type. Although there has been no specific 
research conducted on trafficking routes into Ireland, its proximity to the UK renders it 
vulnerable to transit from there, and the proximity of the southern coast of Ireland to 
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the Iberian peninsula exposes it to the supply of cannabis resin originating in Morocco 
and cocaine originating in the Andean peninsula. Both cannabis resin and cocaine , 
according to the UNODC, sometimes enter Western Europe through Ireland. It is 
widely reported by gardaí and the media that many known Irish drug dealers are 
resident in Spain, which also facilitates the development of links between suppliers of 
cannabis and cocaine and drug dealers resident in Ireland (O'Keeffe, C. 2005). Finally, 
Ireland’s long western Atlantic coastline renders it vulnerable to trafficking from the 
south and central Americas. It is also important to recognise that seizures made in Irish 
waters are sometimes not destined for the Irish market but are destined for the UK or 
elsewhere in mainland Europe. In recent years some of the largest cocaine seizures in 
Europe have been made off the south-western coast of Ireland (Burke 2008). 
 
The following information with regard to individual drugs was supplied by Customs 
Drugs Law Enforcement (CDLE personal communication, July 2009). 
 
Cannabis 
 South Africa continues to be the main source for herbal cannabis with Amsterdam and 
Belgium being the main transit hubs for the majority of seizures during 2008. There 
have also been a number of eastern European individuals identified transporting herbal 
cannabis into the state.  In all sectors local profiling and national /international 
intelligence continue to be the dominant triggers.  
 
Customs also reports an increase in domestic cultivation of cannabis. Since the start of 
2008 there has been a ‘noticeable increase in detections of sapling cannabis plants 
and seeds’. This has led to a number of joint operations between Customs and the 
Garda Síochána. 
 
Cocaine 
Although South America continues to be the main source for cocaine, there is growing 
evidence of West African countries, e.g. Benin and Senegal, becoming distribution 
hubs for the European market.  In the case of the airfreight seizure of cocaine from the 
United States, Canadian/US organised crime groups are suspected of being involved. 
In corpore concealments are still being encountered at the main airports. 
 
Romanian couriers, bringing cocaine through Dublin airport, have been intercepted. A 
major seizure of over 1.2 tonnes of cocaine was seized in Romania in February 2009 
suggesting that it has become a hub for cocaine trafficking. 
 
Heroin 
With regard to heroin, the use of both commercial vehicles and groupage loads as 
concealment methods is reported. Heroin, it is reported, ‘continues to be high risk 
through our ports with a multi kilo seizure in Dublin Port, routing from Holland via the 
UK and onward to Dublin. The trend of utilising deep concealment methods continues.’ 
 
Methamphetamine 
A significant supply of Methamphetamine was seized in July 2008.  Two separate 
amounts were discovered over a two-day period from deep concealments. The drugs 
were loaded in Lithuania and detected as a result of a joint operation between 
Customs and the Garda National Drugs Unit. This is the first significant detection of 
Methamphetamine (also known as Meth or Crystal Meth or Ice) in the history of the 
State. 
 
10.2.3 Trafficking patterns, national and international flows, routes, modi 
operandi; and organisation of domestic drug markets 
Drug offence data published by the CSO can assist in understanding aspects of the 
operation of the illicit drug market in Ireland (Central Statistics Office 2008) (Central 
Statistics Office 2009). With regard to the so-called middle market level, which involves 
the importation and internal distribution of drugs, data on drug supply offence 
prosecutions by Garda division are a possible indicator of national drug distribution 
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patterns. While these data primarily reflect law enforcement activities and the relative 
ease of detection of different drugs, they may also provide an indicator of national drug 
distribution trends. These data can be compared with other sources such as drug 
treatment data, for example, to show us trends in market developments throughout the 
State. Such data can also indicate trafficking patterns by showing whether there is a 
concentration of prosecutions along specific routes. 
 
The upward trend since 2005 in relevant legal proceedings for drug supply continued 
until 2007, the latest year for which figures are available (Figures 10.2.1 and 10.2.2). 
The majority of such proceedings were in the Dublin metropolitan region (DMR). The 
number of supply offences in the DMR increased steadily from 846 in 2004 to 1,477 in 
2007. This represents just over 55 % of the total number of supply offences throughout 
the State in 2007.  
2003 2004 2005 2006 2007
Ireland (total) 1715 1654 1983 2291 2654
Dublin Metropolitan Region 856 846 1027 1254 1477
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Figure 10.2.1  Trends in relevant legal proceedings for possession of drugs for sale or supply, nationally and in 
the Dublin Metropolitan Region (DMR), 2003–2007 (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
As Figure 10.2.2 shows, the proportion of the total number of supply offences outside 
the DMR has increased in most regions since 2005. Relevant legal proceedings for 
drug supply increased in the southern region by 60% and by 40% in the south-eastern 
region, 44% in the eastern region and 70% in the western region. Supply offence 
prosecutions decreased slightly in the northern region during 2007.  
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2003 2004 2005 2006 2007
Southern region 234 258 314 310 412
South eastern region 232 179 218 235 251
Eastern region 214 211 269 276 304
Northern region 91 89 85 111 89
Western region 88 71 70 105 121
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Figure 10.2.2  Trends in relevant legal proceedings for possession of drugs for sale or supply, by region, 
excluding the DMR, 2003–2007 (Central Statistics Office 2008) (Central Statistics Office 2009). 
 
Drug dealing in Clondalkin, west Dublin  
 
A research report was commissioned by the Clondalkin Local Drugs Task Force 
(CLDTF) in order to clarify the nature and extent of drug use in the area (Breen 2008). 
 
Both qualitative and quantitative research methods were used, including a survey of 
150 drug users by nine peer research assistants, and focus groups with problematic 
drug users, family members and community members. Available relevant statistics 
were also collated, such as Garda crime statistics and drug treatment figures. The 
report covered a wide range of drug-related issues, including information relating to 
availability, prevalence, profile of users and patterns of use, drug-related health issues 
and risk behaviours, drug treatment and drug-related crime.  
 
With regard to drug-related crime, the research found that as drug consumption had 
become less visible, the wider community’s concern had centred on drug-related crime 
and the normalisation of such crime. A greater amount and variety of illegal drugs has 
become available in recent years. Drug dealing has become more open, frequently 
being conducted in public places, and is seen as an attractive and lucrative ‘career 
option’ for a proportion of young people living in Clondalkin. The report highlighted a 
belief that law enforcement focuses too much on breaking up high-level drug 
distribution networks rather than on disrupting the activities of local dealers.  
 
Study on Dublin crack cocaine market 
 
In October 2008 the Alcohol and Drug Research Unit of the Health Research Board 
(HRB) launched Crack cocaine in the Dublin region: an evidence base for a crack 
cocaine strategy (Connolly et al. 2008). The research was commissioned by the 
Intersectoral Crack Cocaine Strategy Group, which was established by the late Tony 
Gregory TD, in response to a number of seizures of crack cocaine made by the Garda 
Síochána in the north inner city.  
 
The report indicated that the number of people using crack in Ireland remained low, 
with current users representing just 1% of drug users who presented for treatment and 
0.1% of the general population. However, the report also made the point that, despite 
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targeted Garda interventions, crack use had increased and availability had spread 
throughout the Dublin region. Launching the report, Minister of State John Curran TD 
said: ‘It is good news that the crack cocaine market has not taken hold in Ireland to the 
extent it has in other countries. However the report highlights the need to remain 
vigilant to ensure that this remains the case.’ The Minister also stated that the report 
would be central to the development of a timely strategic response through the new 
National Drugs Strategy.  
 
The HRB conducted the research over a nine-month period beginning in August 2007, 
using a rapid situation assessment technique developed by the World Health 
Organization. This involved a multi-method approach which brought together existing 
research, and drug treatment and criminal justice data, supported by interviews with 
key informants such as drug users, gardaí, outreach workers and treatment specialists.  
 
The emergence of crack cocaine 
A number of factors may explain the rise in crack cocaine use in Dublin. These include 
the increased availability of powder cocaine; the presence of problematic opiate users 
who have used crack cocaine in the UK or in Europe and have resumed crack 
consumption while living in Dublin; and the presence of non-Irish nationals, primarily of 
West African origin, who have access to cocaine supply routes and experience of 
preparing crack cocaine.  
 
Drug-using characteristics of crack users 
The majority of crack users used more than one drug, with opiates (mainly heroin) 
being the most common drugs used alongside crack. Smoking was the predominant 
route of administration. A proportion of intravenous users made a transition from 
injecting powder cocaine to smoking crack cocaine because of the physical harms of 
injecting. Frequency of use ranged from daily to weekly and was largely dependent on 
availability of financial resources.  
 
Dublin crack market 
The north inner city was the primary crack market in Dublin; the market was dominated 
by non-Irish national dealers who were importing small amounts of cocaine via 
couriers. However, a growing number of Irish dealers were reported to be involved in 
the distribution of crack throughout the Dublin region, and prepared crack had been 
available throughout the city since 2006. Findings indicated that the crack market was 
a closed market, meaning that dealers did not sell to strangers, exchanges were 
generally arranged using mobile phones, and buyers were directed to exchange points 
outside the inner city. The price of crack was relatively stable and uniform, with 
prepared quantities or ‘rocks’ being sold for €50 or €100. Crack houses were reported 
as locations where crack was used and in some cases prepared in exchange for free 
crack; they were not reported as major venues for crack dealing or as sites for sex 
work.  
 
Social profile of crack users and consequences of crack use  
A high proportion of crack users were homeless, unemployed and did not have formal 
educational qualifications. According to data from treatment services, the majority of 
crack users were male and half were aged between 20 and 29 years. However, 
females involved in sex work and single mothers were reported to develop the most 
chaotic addiction. Common physical side-effects of crack use are breathing problems, 
heart problems and rapid weight loss, and the most common psychological 
consequences are paranoia, aggressiveness and depression. Compulsive crack users 
reported neglecting their children, often diverting their financial resources towards 
buying crack. Shoplifting, burglary and robbery were reported as common means for 
users to sustain their crack cocaine habit. Service providers also reported an increase 
in the numbers of women returning to or beginning sex work to fund their crack use.  
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Intervention strategies 
International evidence indicates that effective intervention strategies are those which 
combine attempts to disrupt local markets, making them less predictable to buyers and 
sellers, with attempts to divert drug offenders into treatment services. The most 
successful approaches to reducing or ceasing crack use are psychosocial interventions 
such as cognitive behavioural therapy. However, these interventions can only be 
successful if the user is attracted to and retained in treatment. 
 
Study of Illicit drug market in Ireland 
 
The first comprehensive study of the Irish illicit drug market is currently being carried 
out by the Health Research Board. The aims of the study are to: 
° examine the nature, organisation and structure of Irish drug markets, 
° examine the various factors which can influence the development of local drug 
markets, 
° examine the impact of drug dealing and drug markets on local communities, and 
° describe and assess interventions in drug markets with a view to identifying what 
further interventions are needed. 
 
Commissioned by the National Advisory Committee on Drugs, the study employs a 
range of research methods and is due for publication in 2010. 
 
 
10.3 Seizures 
10.3.1 Quantities and numbers of seizures of all illicit drugs 
The number of drug seizures in any given period can be affected by such factors as 
law enforcement resources, strategies and priorities, and by the vulnerability of 
traffickers to law enforcement activities. However, drug seizures are considered indirect 
indicators of the supply and availability of drugs.  
 
Cannabis seizures account for the largest proportion of all drugs seized. Figure 10.3.1 
shows trends in cannabis-related seizures and total seizures between 2003 and 2007; 
drug seizures have continued to increase since 2005. Of the 10,444 reported drug 
seizures in 2007, 5,176 (49.6%) were cannabis-related.  
 
2003 2004 2005 2006 2007
All seizures 6377 5299 6362 8417 10444
Cannabis-type substances 3705 2860 3555 4243 5176
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Figure 10.3.1  Trends in the total number of drug seizures and cannabis seizures, 2003–2007 (Central Statistics 
Office 2008) (Central Statistics Office 2009) 
 
Figure 10.3.2 shows trends in seizures for a selection of drugs, excluding cannabis, 
between 2003 and 2007. There has been a continuous steady rise in cocaine and 
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heroin seizures since 2005. In 2007, there were 1,749 cocaine seizures and 1,698 
heroin seizures. The number of ecstasy-type substances seized has also continued to 
rise, following a decline from 2003 to 2005. The number of ecstasy seizures has 
exceeded the 2003 level. 
 
2003 2004 2005 2006 2007
Ecstasy-type substances* 1083 806 689 858 1173
Heroin 660 612 763 1254 1698
Cocaine 566 753 1045 1500 1749
Amphetamines 211 145 125 277 235
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Figure 10.3.2  Trends in the number of seizures of selected drugs, excluding cannabis, 2003–2007 (Central 
Statistics Office 2008) (Central Statistics Office 2009) 
* Includes MDMA, MDEA, and DOB  
 
Table 10.3.1 shows the particulars of all drugs seized in 2007 that were reported by the 
Forensic Science Laboratory (FSL). Not all drugs seized by law enforcement (the 
Garda Síochána and Customs Drug Law Enforcement), are necessarily analysed and 
reported by the FSL. For example, if no individual is identified in relation to the drug 
seizure, and no prosecution takes place, the drugs may not be sent for analysis and 
may be destroyed.  Alternatively, there may be some large cannabis/cannabis resin 
cases without a suspect where no analysis was conducted and no quantification (purity 
determination) was carried out. 
 
Table 10.3.1  Particulars of drugs seized during 2007, and analysed by the Forensic Science Laboratory (Central 
Statistics Office 2009) 
Drug Type Quantity Cases 
Alprazolam 217 tablets 16 
Amphetamine 58,217 grams, 10,471 tablets 235 
BZP**  203 tablets, 1.4 grams 43 
Cannabis 763,120 grams 1910 
Cannabis resin 1,235,352 grams 3166 
Cannabis plants* 1,272 plants 100 
2 C-B 2 tablets 1 
Cocaine 1,751,802grams 1749 
CPP*** 57,420 tablets 12 
Diamorphine  (Heroin) 146,586 grams 1698 
Diazepam 71,483 tablets, 1,988 gram 166 
Dihydrocodeine 358 tablets, 0.2 grams 16 
DOB 5 tablets 1 
Ecstasy MDMA 204,799 tablets, 13,253 grams  1171 
Ecstasy MDEA 7 tablets 2 
Ephedrine 695 tablets, 47 capsules, 3.2 grams 11 
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Drug Type Quantity Cases 
Flunitrazepam (Rohypnol) 76 tablets 4 
Flurazepam 3,608 capsules 24 
Ketamine*** 52.1 grams 2,082 tablets 28 
Khat Plant samples 2 
LSD 140 units 13 
Methadone 6,022 millilitres, 900 tablets 21 
Methandienone*** 4,094 tablets 18 
Methylamphetamine 40.9 grams 9 
Oxycodone 283 capsules, 263 tablets 2 
Temazepam 4 tablets 3 
Zopiclone*** 2,218 tablets 23 
*The number of cannabis plants does not reflect the total number detected as only a sample of the plants are sent for analysis. 
** BZP was added to the list of controlled drugs during 2008 
*** These drugs are not controlled under the Misuse of Drugs Acts, 1977 & 1984 
 
10.3.2 Quantities and numbers of seizures of precursor chemicals used in the 
manufacture of illicit drugs 
 
See Section 10.4 of National Report 2008, for most recent information on price and 
purity. 
 
10.3.3 Number of illicit laboratories and other production sites dismantled; and 
precise type of illicit drugs manufactured there 
 
See selected issue chapter 11 in relation to cannabis plants. No new information in 
relation to other drugs. 
 
 
10.4 Price/purity 
 
See Section 10.4 of National Report 2008, for most recent information on price and 
purity. 
 
10.4.1 Price of illicit drugs at retail level 
No update is available on the information reported in Ireland’s National Report 2008 
(Alcohol and Drug Research Unit 2008), where it was reported that, ‘The Garda 
Síochána are currently developing a more robust method to ascertain drug prices 
(GNDU, personal communication, May 2008).’ 
 
10.4.2 Price/potency of illicit drugs 
In support of the ‘Drugs Markets’ study currently being conducted in a number of 
locations in Ireland (Section 10.2.3), the FSL is carrying out a study, analysing drugs 
samples seized for purity and potency. The FSL has been provided with additional 
resources to undertake this special initiative. The drugs market study is due to be 
published in 2010.  
 
10.4.3 Composition of illicit drugs and drug tablets 
No update is available on the information reported in Ireland’s National Report 2008 
(Alcohol and Drug Research Unit 2008), where it was reported that, ‘The Forensic 
Science Laboratory (FSL) reported that the average wholesale purity of heroin in 2007 
was 41% while the average retail purity was 40%. The average wholesale purity of 
cocaine was reported as 27% with the average retail purity 10%. (Forensic Science 
Laboratory, personal communication, September 2008) 
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In 2005 Connolly (Connolly 2005) stated: ‘Drug purity data are not collated in a 
systematic way at different market levels in Ireland. The primary function of the 
Forensic Science Laboratory (FSL) in this area relates to supporting the criminal justice 
system, and not to research. Only a very small proportion of drugs seized are tested to 
ascertain the percentage purity. Research should be conducted in the FSL to ascertain 
the purity levels of different drugs and for different-sized seizures, i.e. both street-level 
and larger seizures. Such research should be conducted on a national basis. Also, 
analysis of the various dilutants used to bulk up drugs for street sale could be useful in 
identifying the health implications for drug users, (pp. 19–20). 
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Part B: Selected Issues 
Summary of selected issues 
11. Cannabis markets and production 
• Drug seizure data, survey findings and law enforcement operations in recent 
years (2006–2008) suggest that commercial domestic cannabis production is 
gaining momentum in Ireland. 
• There is limited evidence available to ascertain the size and growth of domestic 
cannabis production. 
• There has been an increase in ‘grow shops’ nationwide since 2000. Grow 
shops are generally referred to as ‘head shops’ in Ireland. Information on the 
extent of the head shop industry is not reliable as there is no official register of 
head shops in Ireland. 
• According to media reports, the first head shop in Ireland opened in 2000 and 
by 2007 there were at least 24 head shops operating nationwide. 
• Two recent all-Ireland general population drug prevalence surveys (2002/3 and 
2006/7) highlight cannabis use patterns in the adult Irish population. The 
majority (60%) of current cannabis users reported using a form of cannabis 
resin. Almost two-in-five (38%) reported using a form of herbal cannabis. 
• No research studies have been conducted in Ireland on the nature of the Irish 
drug market. Research currently being completed by the Health Research 
Board will look at the organisation and structure of Irish illicit drug markets. A 
number of books have been written by investigative journalists about specific 
criminals or organised crime groups involved in the trade in illicit drugs 
including cannabis. 
• Wholesale prices for cannabis are not currently available in Ireland. 
• As part of ‘Operation Vacuum’, the Garda Síochána targeted domestic 
production of cannabis in 2008. Several large scale ‘cannabis factories’ were 
uncovered nationwide. Many were located indoors, both in private residences 
and commercial premises. The largest production facility successfully targeted 
by police in January 2009, had 1,200 cannabis plants, using the water based 
hydroponic system of cultivation. 
• Morocco is the major producing country of cannabis resin, the principal form of 
the drug used in Ireland. According to Customs Drug Law Enforcement ‘South 
Africa continues to be the main source for herbal cannabis with Amsterdam and 
Belgium being the main transit hubs for the majority of seizures during 2008.  
• Drug seizure data highlight increasing numbers of both cannabis plants and 
herbal cannabis seizures. Although drug seizures are seen as an indirect 
indicator of drug availability, it is important to remember that they can also 
merely reflect changes in police emphasis or priorities. There has been a sharp 
increase in cannabis herb seizures, from 609 seizures in 2006 to 1,910 in 2007. 
The number of cannabis plants seized more than doubled from 47 seizures in 
2006 to 100 seizures in 2007. 
• Trend data for proceedings for possession of herbal cannabis in the Dublin 
Metropolitan Region (DMR) and Nationally from 2003 to 2007 show that there 
has been a steady upward trend in proceedings in the DMR since 2004. The 
steep upward trend in such proceedings nationally since 2006 in particular, is 
due to the upward trend in all garda regions since 2004 and a sharp rise in the 
South Eastern region during 2007 where proceedings for the possession of 
herbal cannabis increased from 218 in 2006 to 472 the following year. 
 
12. Treatment for older drug users 
• The proportion of drug users aged 40 and over in treatment has increased from 
3.1% of the total in 1998 to 9.4% of the total in 2008. 
• The biggest increase was observed in the age group 40–49, increasing from 
2.7% in 1998 to 8.0% in 2008. 
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• The proportion of treated clients aged over 60 is very low and remained almost 
constant for all years between 1998 to 2008. 
• Between 1998 and 2007, one-fifth (22%) of the total deaths due to poisonings 
recorded in Ireland (as per Selection D) were among individuals aged 40 and 
over.  
• The number of deaths in the older age groups increased steadily from 18 cases 
in 1998 to 28 cases in 2004, after which there was a jump in the number of 
deaths to 45.  Since 2005, the number of deaths in this age group has fallen 
slightly. 
• In the older age groups, the majority of deaths due to poisonings occurred 
among those aged 40 to 49.  The majority of older drug-related deaths were 
male.   
• Nearly two thirds of poisonings among older drug users were due to more than 
one substance.  Of these, almost all included an opiate-type drug. 
• The proportion of drug users aged 40 and over in methadone maintenance 
treatment has increased from 4% in 1994 to 19% in 2008. 
• Only a very small proportion (less than 0.5%) of treated clients started their 
drug use after the age of 40.  The proportion did not change over the 10 years 
under review. 
• Overall, heroin is the main problem drug reported by all older drug users. 
• Only a small proportion of older drug users reported cocaine as their main 
problem drug. Very few drug users aged over 50 years reported cocaine as 
their main problem drug. 
• The small number of drug users aged 50 and over makes inferences about 
these older groups more difficult. 
• In 2008, almost one in ten clients entering drug treatment were aged 40 years 
or older.  The majority of these older users were aged between 40 and 49.   
• In 2008, the majority of older drug users reported using heroin.  Lower 
proportions of older drug users reported cocaine as their main problem drug 
compared to younger users. 
• In 2008, benzodiazepines and other opiates were the main problem drugs for 
clients aged 60 or over. However, the small numbers make inferences difficult.   
• Older drug users have not been identified as a vulnerable or high-risk group in 
Ireland who need dedicated services. No specific research has been done on 
this group, but as the cohort ages this may need to be re-evaluated.  
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11. Cannabis markets and production 
11.1 Introduction 
Law enforcement data and survey data suggest that there has been a recent growth in 
domestic cannabis cultivation in Ireland. Several large-scale ‘cannabis factories’ have 
been detected as a result of targeted police activity. There has also been an increase 
in the number of ‘grow shops’ (also referred to as ‘head shops’) since 2000. These 
shops sell paraphernalia associated with the production and use of cannabis products. 
The majority of cannabis users reported finding it relatively easy to obtain cannabis and 
many reported originally obtaining cannabis from a family member or friend, indicating 
a culture of exchange and gifts associated with the use of cannabis. 
 
11.2. Markets 
Drug seizure data, survey findings and law enforcement operations in recent years 
(2006–2008) suggest that commercial domestic cannabis production is gaining 
momentum in Ireland. Customs also reports an increase in trends in domestic 
cultivation of cannabis. 
 
11.2.1 Cannabis domestic production 
 
There is limited evidence available to ascertain the size and growth of domestic 
cannabis production. Survey data from the 2006/7 all Ireland general population drug 
prevalence study indicates that 16.1% of current herbal cannabis smokers knew that 
their cannabis was grown in Ireland, 32.7% were not sure and 51.2 % were certain 
their cannabis was grown outside Ireland (National Advisory Committee on Drugs and 
Drug and Alcohol Information and Research Unit 2008c).  
 
There has been an increase in ‘grow shops’ nationwide since 2000. Grow shops are 
generally referred to as ‘head shops’ in Ireland. Information on the extent of the head 
shop industry is not reliable as there is no official register of head shops. Unlike outlets 
that sell alcohol, there is no requirement for a special retail licence to open a head 
shop.  According to media reports, the first head shop in Ireland opened in 2000 and 
by 2007 there were at least 24 head shops operating nationwide (Clarke 2007, 16 
December). In addition to selling legal substances such as herbal cigarettes and, until 
recently, BZP and ‘magic mushrooms’, many of these head shops sell rolling papers, 
pipes, grinders, seeds, lights and propagators and other items associated with the 
cultivation and use of cannabis. The Irish Association of Head Shops represents the 
interests and concerns of its members to government and the media and monitors the 
legislative agenda to inform and advise its members of possible ramifications. 
 
11.2.3 Consumer-market share of different cannabis products  
 
Two recent all-Ireland general population drug prevalence surveys (2002/3 and 2006/7) 
highlight cannabis use patterns in the adult Irish population (National Advisory 
Committee on Drugs and Drug and Alcohol Information and Research Unit 2005b) 
(National Advisory Committee on Drugs and Drug and Alcohol Information and 
Research Unit 2008c). The majority (60%) of current cannabis users reported using a 
form of cannabis resin. However, almost two-in-five (38%) reported using a form of 
herbal cannabis. 
 
11.2.4 Distribution of cannabis at national level  
 
No research studies have been conducted in Ireland on this subject. Research 
currently being completed by the Health Research Board will look at the organisation 
and structure of Irish illicit drug markets. 
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Investigative journalists have written books about specific criminals or organised crime 
groups involved in the trade in illicit drugs including cannabis (Mooney 2001) (Williams 
2001). No studies have been conducted on middle-market drug distribution in Ireland 
(Connolly 2005). Research on the middle-market level seeks to describe, for example, 
how drugs are moved from importation to street level and by whom. The Garda 
Síochána believe that the distribution of drugs within Ireland is organised by networks 
of criminal gangs. In some cases these gangs involve members of the same family 
(Moran et al. 2001). Journalist Paul Williams (Williams 2001) who focused on the gang 
involved in the murder of crime correspondent Veronica Guerin in 1996 suggested the 
significant involvement of both international and national organised crime networks in 
the Irish cannabis trade. He also suggested that the same gang was involved in the 
importation of cannabis, cocaine, firearms and ammunition. The book described 
regular trips by gang members to Holland to organise cannabis shipments. It 
suggested that a second level of gang members then sold the drugs to a network of 
dealers in Ireland, who did not appear to be members of the primary gang, for onward 
local distribution. 
 
11.2.5 Cannabis wholesale prices, 2004–2008 
 
Wholesale prices for cannabis are not currently available in Ireland. The Garda 
National Drugs Unit (GNDU), in its report for the government’s annual submission to 
the United Nations Office on Drugs and Crime (UNODC) for 2002, reported that the 
price of one kilogram (35.27 oz) of cannabis resin at wholesale level in that year was 
€3,250, with the price per gram at street level ranging from €10 to €15.  
 
11.2.6 Typology of retail outlets for cannabis sale 
 
The 2006/7 all-Ireland general population drug prevalence study examined the 
availability of cannabis products for users (National Advisory Committee on Drugs and 
Drug and Alcohol Information and Research Unit 2008c). The majority (62%) of recent 
cannabis users considered it ‘very easy’ or ‘fairly easy’ to obtain the drug within a 24-
hour period. Over half (57%) of recent users reported obtaining the cannabis they had 
last used at the house of friends, 12% obtained it in the street/park, 8% in a 
disco/bar/club and 5% ordered it by phone.  
 
11.2.7 Cannabis sources and transactions 
 
A study conducted in 2002 by the Garda Research Unit among second-level students 
in the Garda divisions of Waterford/Kilkenny and Kerry found that cannabis was the 
first drug taken by 89% of those who reported having used drugs. In 70% of cases 
friends had supplied the drugs (Sarma and Ryan 2002). In a study conducted in 2003 
Hibell (2004) (Hibell, Björn et al. 2004) found that, of the 40% of students who had 
used illicit drugs, 19% had received the drug for the first time from a friend or sibling, 
15% had shared it in a group. The 2006/7 all-Ireland general population drug 
prevalence study also examined the sources of cannabis products for users (National 
Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 
2008c). Forty-four per cent got the cannabis they had last used from a family member 
or friend, 28% had obtained it through sharing with friends and 22% had bought it. This 
suggests a culture of exchange of cannabis as gifts between family and friends.  
 
 
11.3 Seizures 
11.3.1 Supply reduction organisation and activity 
Customs Drug Law Enforcement (CDLE) is based within the Revenue Commissioners 
and is primarily responsible for enforcing the law in relation to the importation of illicit 
drugs into Ireland via sea and air ports. It is also responsible for intercepting illicit 
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substances distributed via the Irish postal system. The Garda Síochána is the national 
police force and has primary responsibility for enforcing and prosecuting offences 
against Irish drug laws. Over the past 18 months CDLE reports that there has been a 
‘noticeable increase in detections of sapling cannabis plants and seeds’. This has led 
to a number of joint operations between Customs and the Garda Síochána’.  
 
11.3.2 Seizures of plantations, 2006–2008 
As part of ‘Operation Vacuum’, the Garda Síochána targeted domestic production of 
cannabis in 2008. Several large-scale ‘cannabis factories’ were uncovered nationwide. 
Many were located indoors, both in private residences and commercial premises. The 
largest production facility successfully targeted by police in January 2009, had 1,200 
cannabis plants, using the water-based hydroponic system of cultivation (Roche, B. 
2009, 28 January) (McGreevy 2008, 28 July) (Brady 2008)  
 
11.3.3 Origin of cannabis products seized, 2004-2008 
The data provided in this section is drawn from an overview completed in 2005 
(Connolly 2005), with an update on the origin of herbal cannabis obtained in 2009. 
 
Cannabis resin 
 
Morocco is the major producing country of cannabis resin, the principal form of the 
drug used in Ireland. The main supply route for cannabis resin is from Morocco via 
Spain, the Netherlands or the UK to Ireland. The bulk of cannabis resin seized by 
customs in 2003 was concealed in freight consignments from North Africa. Large 
quantities of cannabis resin have also been seized along the south coast of Ireland, 
being smuggled by yachts, small craft or converted fishing vessels. 
 
Cannabis herb 
 
The cannabis herb seized in Ireland originates primarily in South Africa and Thailand. It 
comes to Ireland via different countries, including France, Germany, the UK, the 
Netherlands and Belgium. In 2001 there was a large increase in cannabis herb 
seizures. This was reported as being due to Ireland’s being targeted as a transit 
country for supplying cannabis herb to the UK market. In 2001, the Garda National 
Drugs Unit estimated that 47% of the cannabis herb seized in Ireland was for the Irish 
market and 53% for the UK market. Customs seized over 19 tonnes of cannabis herb 
in the years 2001/2 and the vast bulk of this was detected in a small number of very 
large seizures in maritime freight (18 tonnes), the bulk of the balance being detected in 
passenger baggage at the airports. ‘The majority of these (seizures) have been seized 
from freight consignments originating in Spain, South Africa and Thailand. One 
significant consignment which was seized during 2002 involved the smuggling of 
nearly six tonnes of herbal cannabis, worth nearly €25 million, concealed within 
concrete garden furniture which had originally been shipped from Thailand’. It is 
believed that this consignment was destined for the UK market.  
 
According to CDLE ‘South Africa continues to be the main source for herbal cannabis 
with Amsterdam and Belgium being the main transit hubs for the majority of seizures 
during 2008.  In all sectors local profiling and national /international intelligence 
continue to be the dominant triggers’ for detection. (CDLE personal information, July 
2009) 
 
11.3.4 Breakdown of cannabis seizures by product and amount seized, 2008 
Drug seizure data highlight increasing numbers of both cannabis plants and herbal 
cannabis seizures. Although drug seizures are seen as an indirect indicator of drug 
availability, it is important to remember that they can also merely reflect changes in 
police emphasis or priorities. Data presented in this section relates to the period 2003–
2007; data for 2008 is not yet available. 
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Cannabis resin had represented the bulk of all cannabis seizures from 2003 to 2006 
when 85% to 91% of all cannabis seizures consisting of cannabis resin. However, as 
shown in Figure 11.3.1, this decreased dramatically in 2007 when resin only accounted 
for 61% of all cannabis seizures. At the same time, there has been a sharp increase in 
cannabis herb seizures, from 609 seizures in 2006 to 1,910 in 2007. The number of 
cannabis plants seized more than doubled from 47 seizures in 2006 to 100 seizures in 
2007. 
 
 
Figure 11.3.1  Trends in the number of seizures of cannabis resin, herbal cannabis and cannabis plants and 
total cannabis-related seizures, 2003–2007, reported by the CSO (Central Statistics Office 2008) (Central 
Statistics Office 2009) 
 
The number of individual seizures is a more reliable indicator of trends than the 
quantity seized as in any one year a very large individual seizure can distort the 
picture. Although there is generally no clear relationship between the number of 
seizures and the quantity of the drug seized, Figure 11.3.2 shows that following a 
sharp increase in the quantity of cannabis resin seized in 2005 and 2006, there was a 
significant drop in the quantity of cannabis resin seized in 2007. The quantity seized 
decreased from 6,972kg in 2006 to 1,235 kg in 2007. 
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Figure 11.3.2  Trends in the number and quantity of seizures of cannabis resin, 2003–2007, reported by the CSO 
(Central Statistics Office 2008) (Central Statistics Office 2009) 
 
2003 2004 2005 2006 2007
Total seizures 3705 2860 3555 4243 5176
Cannabis resin 3366 2610 3260 3587 3166
Cannabis herb 309 223 279 609 1910
Cannabis plants 30 27 16 47 100
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Figure 11.3.3 shows trends in the number and quantity of herbal cannabis seizures 
from 2003 to 2007. Both the number and quantity of herbal cannabis seized increased 
together fairly consistently.  
2003 2004 2005 2006 2007
Quantity (kg) 202 104 151 315 763
Seizures 309 223 279 609 1910
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Figure 11.3.3  Trends in the number and quantity of seizures of herbal cannabis, 2003–2007, reported by the 
CSO (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
With regard to Figure 11.3.4, we can also see a sharp increase in the quantity of 
cannabis plants seized in 2006 and 2007. As mentioned in section 11.3.2 above, 
although there has been a doubling in the number of seizures, the large quantity 
seized may reflect the discovery during this period of a number of cannabis factories 
producing high yields of cannabis plants. 
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Figure 11.3.4  Trends in the number and quantity of seizures of cannabis plants, 2003–2007, reported by the 
CSO (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
11.4 Offences - cannabis supply-related offences reported by the police  
Data is not available with regard to the type of substances involved in supply offences. 
The following data is derived from the Garda Síochána PULSE IT system and is 
reported by the Central Statistics Office (Central Statistics Office 2008) (Central 
Statistics Office 2009). It provides trends in prosecutions for possession for personal 
use (s3 Misuse of Drugs Act) by cannabis type. 
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Figure 11.4.1 shows trends in possession offences for cannabis resin at a national 
level and in the Dublin Metropolitan Region. A larger number of such proceedings 
takes place in the Dublin region relative to other garda regions. Generally it can be 
seen that national trends closely mirror trends in Dublin. In 2007 however, there was 
an upward trend in the DMR while the national total declined slightly. 
2003 2004 2005 2006 2007
Ireland (total) 4120 4315 6842 5368 5216
Dublin Metropolitan 
Region 1115 1110 2109 1729 2068
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Figure 11.4.1  Trends in proceedings for possession of cannabis resin nationally and in the Dublin Metropolitan 
Region (DMR), 2003–2007, reported by the CSO (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
Figure 11.4.2 shows trends in possession offences for cannabis resin for the other 
garda regions throughout the state, from 2003 to 2007.  Proceedings for possession of 
cannabis resin have declined quite significantly in the Southern, Eastern and South 
Eastern regions since 2005 when they were at their peak. Proceedings for possession 
in the Northern and Western regions have remained relatively stable. 
 
2003 2004 2005 2006 2007
Southern Region 968 1198 1623 1216 754
South Eastern Region 833 763 1011 863 783
Eastern Region 592 649 1329 787 821
Northern Region 300 240 355 332 407
Western Region 312 355 415 441 383
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Figure 11.4.2  Trends in proceedings for possession of cannabis resin by region, excluding the DMR, 2003–
2007, reported by the CSO (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
Figure 11.4.3 shows trends in proceedings for possession of herbal cannabis in the 
Dublin Metropolitan Region and nationally from 2003 to 2007. There has been a steady 
upward trend in prosecutions for the DMR since 2004. As can be seen from Figure 
11.4.4, the steep upward trend in such proceedings in nationally since 2006 in 
particular, is due to the upward trend in all garda regions since 2004 and a sharp rise 
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in the South Eastern region during 2007 where proceedings in for the possession of 
herbal cannabis increased from 218 proceedings in 2006 to 472 the following year. 
 
2003 2004 2005 2006 2007
Ireland (total) 667 624 907 1618 3852
Dublin Metropolitan Region 190 151 316 424 963
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Figure 11.4.3  Trends in proceedings for possession of herbal cannabis nationally and in the Dublin 
Metropolitan Region (DMR), 2003–2007, reported by the CSO (Central Statistics Office 2008) (Central Statistics 
Office 2009) 
 
2003 2004 2005 2006 2007
Southern Region 221 187 200 417 1310
Eastern Region 84 108 173 275 527
South Eastern Region 69 67 82 218 472
Western Region 67 71 101 147 351
Northern Region 36 40 35 137 229
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Figure 11.4.4  Trends in proceedings for possession of herbal cannabis by region, excluding the DMR, 2003–
2007. Source: (Central Statistics Office 2008) (Central Statistics Office 2009) 
 
The number of proceedings for the possession of cannabis plants was too small to 
graph by garda region. To include such data may lead to the identification of individual 
suspects as the number of prosecutions is so low by garda region. 
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12. Treatment and care for older drug users 
12.1 Introduction 
Appropriate treatment has been shown to improve the survival of drug users.  
Additionally, the average age of drug users in Ireland is increasing so the proportion of 
those aged over 40 in the population is increasing.  It is likely that this trend will 
continue. This will present challenges for the health services, including the drug 
treatment service.  The issue of older drug users has not been examined previously in 
Ireland. 
 
National data collection tools 
 
This section presents information based on data on older drug users from the following 
information systems: 
 
The National Drug Treatment Reporting System (NDTRS) is a national epidemiological 
database which provides data on treated drug and alcohol misuse in Ireland. The 
NDTRS collects data from both public and private outpatient services, inpatient 
specialised residential centres and low-threshold services.  For the purposes of the 
NDTRS, treatment is broadly defined as ‘any activity which aims to ameliorate the 
psychological, medical or social state of individuals who seek help for their substance 
misuse problems’.  The NDTRS is a case-based, anonymised database. 
 
The Central Treatment List (CTL) was established under Statutory Instrument No 225 
following the Report of the Methadone Treatment Services Review Group 1998 
(Methadone Treatment Services Review Group 1998). This list is a register of all 
patients receiving methadone (for treatment of opiate misuse) in Ireland and provides 
all data on methadone treatment nationally. 
 
The National Psychiatric In-Patient Reporting System (NPIRS) is a national psychiatric 
database that provides detailed information on all admissions to and discharges from 
56 inpatient psychiatric services in Ireland, recording data on cases receiving inpatient 
treatment for problem drug and alcohol use. 
 
12.2 Trends of older drug users in treatment 
Numbers of older drug users in treatment 
 
In Ireland the proportion of clients aged 40 or over in treatment has risen steadily over 
the past decade, from 3.1% of the total in 1998  to 9.4% of the total in 2008 (Table 
12.2.1, also see Table 1 Selected issue Historical data).  Over the period, the biggest 
rise was observed in clients aged between 40 and 49, increasing from 2.7% in 1998 to 
8.0% in 2008.  The proportion of treated clients aged over 60 remained almost constant 
for all years between 1998 to 2008, not more than 0.2% of the total treated clients 
annually.   
 
Table 12.2.1 Numbers and percentages of clients in treatment in Ireland, by age group, 1998–2008 
 
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Total 5090 4394 4744 5135 5455 5560 4724 5039 5285 5775 6247 
            
< 40 4915  (96.6) 
4246  
(96.6) 
4561  
(96.1) 
4841  
(94.3) 
5105  
(93.6) 
5218  
(93.8) 
4445  
(94.1) 
4673  
(92.7) 
4883  
(92.4) 
5313 
(92.0) 
5647 
(90.4) 
40 - 49 135  (2.7) 
104  
(2.4) 
144  
(3.0) 
221  
(4.3) 
255  
(4.7) 
276  
(5.0) 
233 
(4.9) 
309 
(6.1) 
336 
(6.4) 
383 
(6.6) 
497 
(8.0) 
>= 50 23 (0.5) 
26 
(0.6) 
32 
(0.7) 
45 
(0.9) 
49 
(0.9) 
46 
(0.8) 
40 
(0.8) 
55 
(1.1) 
58 
(1.1) 
67 
(1.2) 
88 
(1.4) 
Unknown 17 (0.3) 
18 
(0.4) 
7 
(0.1) 
28 
(0.5) 
46 
(0.8) 
20 
(0.4) 
6 
(0.1) 
2 
(0.04) 
8 
(0.2) 
12 
(0.2) 
15 
(0.2) 
Source: NDTRS 
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Main problem drug of older drug users 
 
The main problem drug reported varied across different older age groups. Heroin was 
recorded as the main problem drug among the majority of treated clients aged 40 to 49, 
rising from 53% in 1998 to 70% in 2006, and dropping slightly to 66.% in 2008 (Table 
12.2.2).  Although small numbers, the proportion of drug users aged over 50 reporting 
heroin as their main problem drug also increased over the 10-year period under review, 
from 26.9% in 1999 to 55.2%% in 2007, again showing a decrease in 2008 to 46.6%.   
 
Only a small proportion of older drug users reported cocaine as their main problem 
drug.  The proportion fluctuated over the 10-year period but peaked in 2007dropping 
slightly in 2008.  Very few drug users aged over 50 years reported cocaine as their 
main problem drug and small numbers makes inferences difficult. 
 
Only very small proportions of any group of older drug users reported either cannabis 
or stimulants as a main problem drug.   
 
Other opiates and benzodiazepines were reported as the main problem drug for the 
majority of those drug users aged 60 years and over.   
 
Table 12.2.2 Percentage of treated older drug users by age group and main problem drug Ireland, 1998–2008 
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Total older drug users 
Heroin 48.1 59.2 49.4 54.5 51.6 58.4 63.4 64.8 65.2 65.3 63.5 
Other opiates 8.9 10.8 6.3 9.8 4.9 8.1 7.0 7.4 7.1 7.3 9.0 
Benzodiazepines 13.9 11.5 11.9 11.3 10.2 6.8 9.2 4.7 5.6 6.2 6.0 
Cocaine 3.2 0.8 1.1 1.1 4.3 3.1 4.0 6.0 6.1 7.3 6.5 
Methadone 12.0 3.8 8.0 2.6 3.9 2.2 3.7 4.1 3.8 3.6 2.8 
Cannabis 5.1 9.2 16.5 15.8 18.1 15.8 9.5 10.7 9.4 8.0 10.5 
            
40 to 49            
Heroin 53.3 67.3 54.9 61.5 57.3 63.4 66.1 66.7 70.2 67.1 66.0 
Other opiates 7.4 10.6 4.2 6.8 3.9 6.5 6.0 6.5 3.6 6.0 7.0 
Benzodiazepines 11.9 5.8 9.7 8.6 7.1 5.4 7.7 3.2 4.2 5.2 4.4 
Cocaine 3.7 ~ ~ ~ 4.7 3.3 4.3 6.5 6.8 8.6 7.0 
Methadone 11.9 3.8 9.0 3.2 3.9 1.4 3.0 4.2 4.2 4.2 3.0 
Cannabis 4.4 8.7 16.7 15.4 18.4 15.2 9.4 11.7 9.2 7.8 10.5 
            
50 to 59            
Heroin ~ 26.9 25.0 20.0 22.4 28.3 47.5 54.5 36.2 55.2 46.6 
Other opiates ~ ~ 12.8 15.1 5.3 12.1 10.9 12.3 24.2 12.7 18.4 
Benzodiazepines 15.0 20.5 17.9 15.1 13.7 10.6 15.2 12.3 12.1 10.1 11.7 
Cocaine ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 
Methadone 16.7 4.8 3.6 0.0 4.8 7.1 8.6 4.1 2.0 0.0 2.7 
Cannabis ~ ~ 15.6 17.8 16.3 19.6 ~ ~ 10.3 9.0 12.5 
Source: NDTRS 
~ Numbers less than five are not reported 
 
Initiation of drug use after the age of 40 
Another subgroup of older drug users is those who start their drug use after the age of 
40.  However in Ireland, of treated clients with a recorded age of first drug use, only a 
very small proportion (less than 0.5%) started their drug use after the age of 40.  The 
proportion did not change over the 10 years under review. 
 
Older drug users in methadone maintenance treatment (MMT) 
 
The number of individuals in MMT has increased in Ireland over the past 14 years and 
the proportion of drug users aged 40 and over in MMT has more than quadrupled in 
that time from 4.1% in 1994 to 19.2% in 2008 (Figure 12.2.1. and also see Selected 
Issue Table, historic data).   
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Figure 12.2.1 Proportion of drug users in MMT aged 40 and older, 1994–2008 (Source: CTL) 
 
Discussion 
The increase in problem drug users aged 40 to 49 indicates an aging drug user 
population, either owing to improved survival or longer drug careers.  Older problem 
drug users represent a small but increasing sub-population of users, which is likely to 
continue to increase over the coming years, but at a steady pace. 
 
The profile of the main problem drug used by the different older age groups did differ, 
with those aged 40 to 49 more closely resembling the trends among the younger age 
groups.  The profile among those aged 50 to 59 has changed to resemble more closely 
those aged 40 to 49, perhaps, again, indicating an aging heroin-using population; 
however, there were greater numbers using opiates other than heroin and 
benzodiazepines.  Although the figures are small, in general drug users aged 60 years 
and over used mainly other opiates and benzodiazepines. 
 
12.3 Trends in drug-related deaths in older drug users 
Of the total deaths owing to poisonings recorded in Ireland (as per Selection D) 
between 1998 and 2007, 290 (22.0%) were among individuals aged 40 and over (Table 
12.3.1). The number of deaths in the older age groups increased steadily from 18 
cases in 1998 to 28 cases in 2004, after which there was a jump in the number of 
deaths to 45 in 2005.  Since 2005, the number of deaths in this age group has fallen 
slightly, to 42 in 2006 and 38 in 2007.  Of the total deaths in the older age groups, the 
majority occurred among those aged 40 to 49 (66.6%).  The majority of older drug-
related deaths were male (184, 63.4%) see Standard Table 6.   
 
  
Table 12.3.1  Number of poisoning deaths by age group in Ireland (Selection D), 1998–2007 
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
Total 104 115 113 106 125 107 126 159 181 185 
           
<40 86 98 90 83 98 78 98 114 139 147 
40 to 49 12 12 15 16 22 18 19 27 27 25 
50+ 6 5 8 7 5 11 9 18 15 13 
Source: NDRDI 
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Types of drugs implicated in deaths among older drug users 
 
The majority of poisonings among older drug users were due to more than one 
substance (133, 63.3%).  Of these, almost all included an opiate-type drug. 
 
Although opiates were implicated in many of the deaths in older drug users, there were 
differences between the age groups (Table 12.3.2).  Heroin or methadone were rarely 
implicated in those aged 50 or older.  Cocaine was only very occasionally implicated in 
deaths in this older group. 
 
Table 12.3.2 Type of drug implicated in poisonings by age group (Selection D), by year 1998–2005 (n = 210) 
   1998 1999 2000 2001 2002 2003 2004 2005 Total 
40-49 Total 12 12 15 16 22 18 19 27 141 
 Heroin ~ ~ ~ 6 6 4 5 7 33 
  Methadone 5 5 5 ~ 6 ~ ~ 7 36 
  Other Opiates 6 ~ 12 8 13 11 16 12 82 
  Benzodiazepines 7 6 6 7 6 3 4 6 45 
  Cocaine ~ ~ ~ ~ ~ ~ ~ ~ 8 
  Alcohol ~ ~ ~ ~ 10 8 9 8 51 
 Other* 3 4 1 2 8 4 3 10 35 
           
50+ Total 6 5 8 7 5 11 9 18 69 
 Heroin ~ ~ ~ ~ ~ ~ ~ ~ 1 
 Methadone ~ ~ ~ ~ ~ ~ ~ ~ 3 
  Other Opiates 6 4 8 7 6 11 6 14 62 
  Cocaine ~ ~ ~ ~ ~ ~ ~ ~ 2 
 Other 6 3 8 8 4 11 8 11 59 
Multi-response table 
* Includes Amphetamines, MDMA, hallucinogens, volatile inhalants, non-opiate analgesics, anti-depressants and other prescription 
medication 
~ Numbers less than five are not reported 
 
Discussion 
 
Over the period under review, there was an increase in deaths owing to poisonings 
among individuals aged 40 and older.  The increase in users aged 40 to 49 points to an 
aging drug user population, as heroin was implicated in many of the deaths in this age 
group, but rarely in those aged 50 or older.  As drug users’ survival improves and drug 
using careers lengthen, it is likely that numbers of deaths in this age group will continue 
to increase but most likely at a steady pace. 
 
12.4 Characteristics of older Irish drug users in 2008 
There were 6,250 clients entering drug treatment in 2008 and recorded in the NDTRS, 
and of these, 585 (9%) were aged 40 or over (Table 12.2.1).  The majority of these 
older drug users were aged between 40 and 49. 
 
The majority of drug users aged less than 50 reported using heroin (Table 12.4.1).  
After the age of 40, the proportion reporting cocaine as a main problem drug 
decreased.  Similar proportions of users aged 40 to 49 and aged 50 years and older 
used cannabis.   
 
Small numbers of drug users aged 60 or over make inferences for this age group 
difficult, especially as the majority reported other drugs as their main problem.  
Analyses of this category of other drugs show that they are mainly benzodiazepines 
and other opiates. 
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Table 12.4.1  Main problem drug by age group, 2008  
 Total <40 40-49 50+ Not known 
Total 6247 5647 497 88 15 
Heroin 3753 (60.1) 3372 (59.7)  328 (66.0) 41 (46.6) 12 (80.0) 
Cocaine 733 (11.7) 694 (12.3) 35 (7.0) 3 (3.4) 1 (6.7) 
Cannabis 1153 (18.5) 1090 (19.3) 52 (10.5) 11 (12.5) 0 (0.0) 
Stimulants 140 (2.2) 137 (2.4) ~ ~ 0 (0.0) 
Other 468 (7.5) 354 (6.3) 79 (15.9) 33 (37.5) 2 (13.3) 
Source: NDTRS 
 
12.4.1 Older heroin users 
 
Analysis of 2008 data from the NDTRS shows that older heroin users experienced high 
levels of unemployment; the majority lived in stable accommodation, but unlike younger 
heroin users, a higher proportion lived alone.  While just as many injected heroin 
compared to younger users, a higher proportion of older drug users first started using 
drugs later in their life.  Only 3.1% of drug users aged under 40 reported starting their 
first drug use aged 30 years or older, while 40.7% of those heroin users aged over 40 
reported their first drug use occurring at 30 years or older. 
 
12.4.2 Older cocaine users 
The profile of older cocaine users from 2008 NDTRS data shows that they experienced 
higher levels of employment compared with younger cocaine users.  While similar 
proportions lived in stable accommodation, a much lower proportion of older cocaine 
users lived with parents/family (23.7%) compared to those aged less than 40 years 
(57.3%); they appeared to live either alone or with a partner and/or children.  Older 
cocaine users were more often referred by themselves or by a GP for treatment than 
younger users.   
 
A much higher proportion of older cocaine users reported that they started using drugs 
aged 30 years or older (68.4%) compared to only a very small proportion of those aged 
less than 40 years (3.5%). It should be noted that this variable does have a high 
proportion of unknown/missing values. 
 
12.4.3 Older cannabis users 
 
The profile of older cannabis users from 2008 NDTRS data shows that while they 
experienced higher levels of employment than younger users,  they had similar levels 
of unemployment  many younger users were still in school or college.  This is also 
reflected in their living status as two thirds of users under 40 (66.9%) reported living 
with parents or family compared to only one in ten of users aged over 40 (11.3%).  A 
higher proportion of older cannabis users appeared to live either alone or with a partner 
and/or children.   
 
A much higher proportion of older cannabis users appeared to have referred 
themselves compared to younger users. A higher proportion of younger users were 
referred by the courts for treatment compared to a higher proportion of older cannabis 
users, who were referred by their GPs and hospital/medical services for treatment. 
 
While the highest proportion of all age groups of drug users started using cannabis 
between the ages of 15 to 19, a higher proportion of older drug users reported first 
starting drug use aged 30 years or older (17.7%) compared to only a very small 
number of younger users (0.2%).  Again, it should be noted that this variable does have 
a high proportion of unknown/missing values. 
 
 
  172
12.4.4 Discussion 
Heroin continues to be the main problem drug for most users, regardless of their age.  
A much higher proportion of drug users aged 40 or over appear to have started their 
drug use later in life, often after 30 years of age. Drug users aged 60 or over  have a 
different drug use profile. Although the small numbers in this age group make 
inferences very difficult, it is possible that this age group may either not be accessing 
treatment services or indeed there may be a very small number of drug users in this 
age group. 
 
12.5 National policies, strategies and available research in Ireland 
All available national strategy documents and related policy documents covering 
developments at national, regional and local level were examined for any reference to 
over-40 drug users in treatment. There was no specific mention of this group in any 
policy document relating to drug treatment and rehabilitation services for drug users. 
 
While there were no documents that referred to the problem use of illicit drugs among 
older people, one document did refer to the issue of over-use and possible misuse of 
over-the-counter and prescription medication, especially benzodiazepines, among the 
Irish population, including older people (Flynn 2009). Excessive and imprudent 
prescribing practices were one of the factors implicated in this. Treatment data from the 
NDTRS  supports this finding, showing  that the highest proportion of clients aged over 
60 are treated for other opiates and benzodiazepines (see Table 12.2.2) although the 
small number of cases involved makes inferences difficult.  
 
In order to ensure that local initiatives for older drug users were not missed, a short 
one-page questionnaire was designed by the national focal point, asking about the 
provision or need for specific drug treatment and support services for over 40s.  The 
questionnaire was sent to ten services in August 2009, which were specifically chosen 
as they are well-established projects providing a range of services for drug users in 
local drug task forces. Based on their track record of evaluation and innovation it was 
decided that these projects would be the most likely to develop interventions for over 
40s if required.  A drug-users forum was included in the ten services selected, as it was 
felt that they would also know if interventions were either being planned or were 
operating. The questionnaire was sent by post and followed up a week later by a 
personal telephone call to the named contact.  
 
Five questionnaires were returned by post and showed that there were no specific 
interventions operating for drug users. This finding was substantiated by follow-up 
telephone calls with the remaining projects and these also showed no specific services 
for this age group. All projects contacted reported that they do not make any age 
discrimination when providing services and no one spoke of considering separate plans 
for this age cohort in the future. None of the projects who took part knew of any other 
project (not included) who offered services specifically to over 40s. 
 
Discussion 
 
To date, older drug users have not been identified as a vulnerable or high risk group in 
Ireland who need dedicated services at a policy level.  There appear to be no specific 
services offered specifically for users aged over 40 in the addiction services.  No 
specific research has been done on this group however as the cohort ages this may 
need to be re-evaluated in the near future.    
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13.2 List of relevant databases available on internet 
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For descriptions of relevant databases not currently available on-line, see introductions 
to chapters 5, 6, and 7. 
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14.5 List of abbreviations 
 
ADRU   Alcohol and Drug Research Unit 
AIDS   Acquired Immunodeficiency Syndrome 
ALDP   Ana Liffey Drug Project 
AUDIT   Alcohol Use Disorders Identification Test 
BBV   Blood Borne Viral 
BZP   Benzylpiperazine 
CAG   Comptroller and Auditor General 
CCTV   Closed Circuit Television 
CDLE   Customs Drug Law Enforcement 
CDVEC  City of Dublin Vocational Educational Committee 
CDYSB  City of Dublin Youth Services Board 
CE   Community Employment 
CES   Community Employment Schemes 
CLDTF  Clondalkin Local Drugs Task Force 
COFOG  Classification of the Functions of Government 
CSO   Central Statistics Office 
CTL   Central Treatment List 
CYPF   Children and Young Persons Forum 
DAIRU   Drugs and Alcohol Information and Research Unit (DHSSPS, NI) 
DAIS   Drugs/AIDS Information System 
DAP   Drug Awareness Programme 
DAST   Department of Arts, Sports and Tourism 
DES   Department of Education and Science 
DEHLG  Department of the Environment, Heritage and Local Government 
DEIS   Delivering Equality of opportunity in Schools 
DFA   Department of Foreign Affairs 
DMR   Dublin Metropolitan Region 
DSFA   Department of Social and Family Affairs 
DTC   Drug Treatment Court 
DTCB   Drug Treatment Centre Board 
DRCGA  Department of Rural, Community and Gaeltacht Affairs 
DUID   Driving Under the Influence of Drugs 
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EDDRA   Exchange on Drug Demand Reduction Activities 
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EU   European Union 
FESAT  European Foundation of Drug Helplines 
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HBSC   Health Behaviour in School-aged Children Survey 
HCV   Hepatitis C Virus 
HIV   Human Immunodeficiency Virus 
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SPHE   Social, Personal and Health Education 
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